,PMID,Other_terms
1469,32548696,compression symptoms
1470,32548696,fine needle aspiration cytology
1471,32548696,operative indications
1472,32548696,thyroid gland
1473,32548696,thyroid imaging reporting and data system
1474,32780357,goiter
1475,32780357,goiters
1476,32780357,intrathoracic goiter
1477,32780357,intrathoracic
1478,32780357,substernal
1479,31542786,*nodular goiter
1480,31542786,*thyroid cancer cois
1482,33445947,retrosternal goiter – sternotomy – thoracotomy − thyroid gland disease − vocal  cord paresis
1483,34941205,retrosternal goiter
1484,34941205,simultaneous surgery
1485,34941205,sternotomy
1486,32929476,*graves disease
1487,32929476,*tsh receptor antibodies
1488,32929476,*antithyroid drugs
1489,32929476,*diagnosis
1490,32929476,*management
1491,32929476,*radioactive iodine
1492,32929476,*thyroidectomy
1493,32929476,*treatment
1494,31583517,ectopic goiter
1495,31583517,ectopic thyroid
1496,31583517,intrapericardial goiter
1497,31583517,intrathoracic goiter
1499,34151940,american medicine
1500,34151940,benjamin smith barton
1501,34151940,goiter
1502,34151940,medical geography
1503,33069387,*enfermedad de graves-basedow
1504,33069387,*glucocorticoides
1505,33069387,*glucocorticoids
1506,33069387,*graves-basedow disease
1507,33069387,*graves’ ophthalmopathy
1508,33069387,*inflamación orbitaria
1509,33069387,*orbitopathy
1510,33069387,*orbitopatía
1511,33069387,*rituximab
1512,33069387,*teprotumumab
1513,33069387,*tocilizumab
1514,33835415,art and medicine
1515,33835415,epifania benintendi
1516,33835415,florence
1517,33835415,nodal goitre
1519,34288592,aspiration cytology
1520,34288592,dyshormonogenetic goiter
1521,34288592,thyroid
1522,33895978,dante alighieri
1523,33895978,goiter
1524,33895978,history
1525,33895978,middle ages
1533,32059832,*cxcl10
1534,32059832,*cxcr3
1535,32059832,*graves' disease
1536,32059832,*graves' ophthalmopathy
1537,32059832,*th1 immune response
1538,32059832,*teprotumumab cois
1540,33878810,*congenital hypothyroidism
1541,33878810,*literacy
1542,33878810,*cognitive dysfunction
1543,33878810,*indigenous population
1544,33878810,*prenatal care
1545,33878810,*chronic malnutrition
1546,33878810,*social vulnerability cois
1547,32472406,art
1548,32472406,drawing
1549,32472406,endemic
1550,32472406,endocrinology
1551,32472406,goiter
1552,33995810,goiter
1553,33995810,follicular carcinoma
1554,33995810,lymphoma
1555,33995810,malignancy
1556,33995810,papillary carcinoma cois
1558,32970371,rose
1559,32970371,us-fna
1560,32970371,amyloid
1561,32970371,amyloid goiter
1562,32970371,interventional pathologist
1563,34149612,*graves’ disease
1564,34149612,*autoimmune
1565,34149612,*goiter
1566,34149612,*growth factor
1567,34149612,*hormone
1568,34149612,*ophthalmopathy
1569,34149612,*thyroid cois autoimmune disease and consultancy for horizon therapeutics consultant immunovant.
1573,33507686,diet
1574,33507686,goiter
1575,33507686,helicobacter pylori
1576,33507686,gastric carcinoma
1577,33507686,stature
1578,33396042,endemic goiter
1579,33396042,hypo-and hyperthyroidism
1580,33396042,iodine nutrition
1581,33396042,thiocyanate
1582,33396042,thyroid echogenicity/cytomorphology
1585,33607721,cardiovascular diseases
1586,33607721,methylarginines
1587,33607721,multinodular goiter
1588,33607721,thyroid
1589,32500695,hypoparathyroidism
1590,32500695,laryngeal paresis
1591,32500695,polidocanol
1592,32500695,recurrent nodular goiter
1593,32500695,sclerotherapy
1596,32107168,*graves’ disease
1597,32107168,*th1 chemokines
1598,32107168,*epidemiology
1599,32107168,*hepatitis c virus
1600,32107168,*risk factors
1601,32107168,*viruses cois
1602,32893229,cardiopulmonary arrest
1603,32893229,intrathoracic goiter
1604,32893229,phrenic nerve paralysis cois
1605,33409915,multinodular goiter
1606,33409915,thyroid adenoma
1607,33409915,thyroid cancer
1608,33409915,trace elements
1609,34245984,goiter
1610,34245984,risk factors
1611,34245984,trace elements
1612,34707013,maximum density of ct
1613,34707013,nodular goiter
1614,34707013,parathyroid lesions
1615,34707013,single-photon emission computed tomography/computed tomography
1617,33574798,*graves’ hyperthyroidism
1618,33574798,*graves’ orbitopathy
1619,33574798,*oxidative stress
1620,33574798,*reactive oxygen species
1621,33574798,*selenium
1622,33574798,*selenocysteine
1623,33574798,*selenoproteins cois commercial or financial relationships that could be construed as a potential conflict of interest.
1624,32493403,antithyroid drug
1625,32493403,block-replace therapy
1626,32493403,case report
1627,32493403,fetal goiter
1628,32493403,perinatal management
1629,32493403,triiodothyronine-predominant graves’ disease cois
1630,34506000,compression syndrome
1631,34506000,goiter
1632,34506000,ischemic stroke
1633,34506000,thrombosis
1635,33804853,goiter
1636,33804853,sternotomy
1637,33804853,thyroidectomy cois
1639,33396135,association
1640,33396135,case-control study
1641,33396135,mineral elements
1642,33396135,thyroid function
1643,33396135,thyroid tumor and goiter
1644,31691192,iodine
1645,31691192,nodular goiter
1646,31691192,selenium
1647,31691192,thyroid gland
1648,31691192,thyroid hormones
1649,34628753,acupoint indications
1650,34628753,acupoints at the upper arms
1651,34628753,goiter
1652,34628753,scrofula
1653,34628753,specific effect
1656,32078117,*congenital hypothyroidism
1657,32078117,*gene mutation
1658,32078117,*tpo deficiency
1659,32078117,*thyroid dyshormonogenesis
1660,31907822,endemic
1661,31907822,goiter
1662,31907822,iconography
1663,31907822,surgery
1664,32474859,b-cell lymphoma
1665,32474859,hashimoto’s thyroiditis
1666,32474859,core needle biopsy
1667,32474859,fine needle aspiration cytology
1668,32474859,primary thyroid lymphoma
1670,32824922,*nf-e2-related factor 2
1671,32824922,*goiter
1672,32824922,*micrornas
1673,32824922,*thyroid neoplasms
1674,32824922,*vascular endothelial growth factor a cois commercial or financial relationships that could be construed as a potential conflict of interest.
1675,34244226,endocrine
1676,34244226,instrumentation
1677,34244226,radioactive iodine therapy
1678,34244226,radioactive iodine uptake
1679,34244226,radionuclide therapy
1680,34244226,substernal goiter
1683,33468112,*excessive iodine
1684,33468112,*goiter
1685,33468112,*iodization
1686,33468112,*school children
1687,33468112,*southern ethiopia cois
1689,31994506,aortic window
1690,31994506,ectopia
1691,31994506,hyperparathyroidism
1692,31994506,parathyroid adenoma
1693,31994506,thoracoscopy
1694,34167409,*intrathoracic goiter
1695,34167409,*ablation technique
1696,34167409,*ultrasound
1698,33579801,*diffuse and nodular goiter
1699,33579801,*lab tests for benign thyroid disorders
1700,33579801,*primary autoimmune hypothyroidism
1701,33579801,*radionuclide imaging
1702,33579801,"*subacute, destructive thyroiditis"
1703,33579801,*ultrasound imaging
1708,32341696,children
1709,32341696,dental pathology
1710,32341696,diffuse nontoxic goiter
1711,32341696,local protective mechanisms
1714,33837650,*anatomy
1715,33837650,*development
1716,33837650,*embryology
1717,33837650,*retrosternal goiter
1718,33837650,*thyroidectomy
1725,33310200,nodular goiter
1726,33310200,papillary thyroid carcinoma
1727,33310200,polycyclic aromatic hydrocarbon
1728,33310200,risk assessment cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
1729,32320467,*15 mci
1730,32320467,*fixed activity
1731,32320467,*hyperthyroidism
1732,32320467,*radioiodine
1733,32320467,*toxic multinodular goiter
1734,32320467,*volume reduction
1736,31376092,genetic interaction analysis
1737,31376092,goiter
1738,31376092,hif-1α
1739,31376092,multifactor dimensionality reduction methodology
1740,31376092,polymorphisms
1741,31376092,vegf
1742,31376092,vegfr-2
1743,33980774,graves disease
1744,33980774,hyperthyroidism
1745,33980774,large goiter
1746,33980774,radioiodine therapy
1749,34670889,hyperthyroidism
1750,34670889,multinodular goiter
1751,34670889,thyroglobulin
1752,34670889,tracheal compression
1753,34670889,tracheal deviation cois
1755,34220711,*congenital hypothyroidism
1756,34220711,*fetal goiter
1757,34220711,*growth
1758,34220711,*mutations
1759,34220711,*neuropsychological evaluation
1760,34220711,*thyroid peroxidase cois commercial or financial relationships that could be construed as a potential conflict of interest.
1761,33878943,retrosternal goiter
1762,33878943,acromegaly
1763,33878943,airway management
1764,33878943,anesthesia
1765,33878943,case report
1766,33878943,multidisciplinary strategy
1767,33878943,tracheal compression cois conflict of interest.
1769,33391188,*graves’ disease
1770,33391188,*asymmetry
1771,33391188,*exophthalmos
1772,33391188,*hyperthyroidism
1773,33391188,*unilateral cois commercial or financial relationships that could be construed as a potential conflict of interest.
1776,32812038,*15 mci
1777,32812038,*fixed activity
1778,32812038,*hyperthyroidism
1779,32812038,*radioiodine
1780,32812038,*toxic multinodular goiter
1781,32812038,*volume reduction
1782,33252592,*grave’s disease
1783,33252592,*trab
1784,33252592,*ft3:ft4 ratio
1786,31984866,*graves' disease
1787,31984866,*dementia
1788,31984866,*epidemiology
1789,31984866,*hyperthyroidism
1790,31984866,*toxic nodular goiter
1793,32633627,*anaplastic thyroid cancer
1794,32633627,*gene mutation
1795,32633627,*thyroglobulin
1796,32633627,*thyroid dyshormonogenesis
1798,31950881,*graves' disease
1799,31950881,*chronic lymphocytic thyroiditis
1800,31950881,*incidental thyroid microcarcinomas
1801,31950881,*multinodular goiter
1802,31950881,*papillary thyroid cancer
1803,31950881,*papillary thyroid microcarcinomas
1804,32495658,thyroid surgery
1805,32495658,anesthesia
1806,32495658,gastrointestinal intubation
1807,32495658,goiter
1808,32495658,intratracheal intubation
1809,32495658,nasogastric tube
1811,31811573,colloid goiter
1812,31811573,metals
1813,31811573,oxidative stress
1814,31811573,papillary thyroid carcinoma
1819,34272677,fine arts
1820,34272677,giovanni martino spanzotti
1821,34272677,goiter
1822,34272677,history
1823,34272677,renaissance
1827,33619720,graves’ disease
1828,33619720,coronary artery spasm
1829,33619720,myocardial infarction
1830,33619720,thyrotoxicosis
1831,33735381,*graves orbitopathy
1832,33735381,*cholesterol
1833,33735381,*statins
1834,32749654,graves’ orbitopathy
1835,32749654,pathogenesis
1836,32749654,thyrotropin receptor
1837,32749654,thyrotropin receptor antibodies cois
1838,33655885,graves' orbitopathy
1839,33655885,graves’ disease
1840,33655885,graves’ ophthalmopathy
1841,33655885,thyroid diseases
1842,32729049,compressive optic neuropathy
1843,32729049,dysthyroid optic neuropathy
1844,32729049,graves orbitopathy
1845,32729049,orbital decompression
1846,32729049,stretch optic neuropathy
1847,32729049,thyroid eye disease
1849,32826306,*oesophageal varices cois
1850,34112358,biomarkers
1851,34112358,dietary reference values
1852,34112358,estimated average requirement cut-point method
1853,34112358,goiter
1854,34112358,goitrogens
1855,34112358,iodine
1856,34112358,iodine deficiency disorders
1857,34112358,"thyroid hormones, salt iodization"
1858,34112358,urinary iodine concentration
1859,34476761,fermo stella
1860,34476761,fine arts
1861,34476761,goiter
1862,34476761,history
1863,34476761,renaissance
1865,34867996,*graves’ disease
1866,34867996,*hashimoto’s thyroiditis
1867,34867996,*autoimmune thyroid diseases (aitd)
1868,34867996,*exosomes
1869,34867996,*immune regulation cois commercial or financial relationships that could be construed as a potential conflict of interest.
1870,33484076,orbital disease
1871,33484076,thyroid eye disease
1872,33484076,thyroid ophthalmopathy
1873,32326785,chorioretinal folds
1874,32326785,grave’s ophthalmopathy
1875,32326785,choroidal folds
1876,32326785,thyroid eye disease
1877,32326785,thyroid orbitopathy
1879,32663624,autoimmunity
1880,32663624,hashimoto's thyroiditis
1881,32663624,helicobacter pylori
1882,32663624,hepatitis c
1883,32663624,mimicry
1884,32663624,thyroid cois declare. the authors did not recieve any funding from any institution for this article.
1885,33387353,art
1886,33387353,graves' disease
1887,33387353,thyroid swelling
1890,34680964,*pendred syndrome
1891,34680964,*whole-exome sequencing
1892,34680964,*genotype-phenotype correlation cois
1894,34362755,covid-19
1895,34362755,thyroid disease cois
1899,33011882,*chemiluminescence
1900,33011882,*cytochrome p450 reductase
1901,33011882,*cytochrome b5-reductase
1902,33011882,*nontoxic nodular goiter
1903,33011882,*papillary thyroid cancer
1904,33011882,*toxic goiter
1909,32880074,anterior
1910,32880074,computed tomography
1911,32880074,magnetic resonance imaging
1912,32880074,mediastinum
1918,34405392,autonomous multinodular goiter
1919,34405392,gene expression
1920,34405392,thyroid nodule cois
1922,34029917,cochlear implant
1923,34029917,deafness
1924,34029917,enlarged vestibular aqueduct
1925,34029917,hearing aid
1926,34029917,hearing loss
1927,34029917,incomplete partition
1928,34029917,pendred syndrome
1929,33619715,graves’ orbitopathy
1930,33619715,exophthalmos
1931,33619715,meningioma
1936,34410066,graves’ disease
1937,34410066,graves’ ophthalmopathy
1938,34410066,ted
1939,34410066,monoclonal antibodies
1940,34410066,thyroid eye disease
1942,32571507,benign
1943,32571507,goiter
1944,32571507,graves’ disease
1945,32571507,pediatric
1946,32571507,thyroid
1948,34033289,*implications
1949,34033289,*iodine deficiency
1950,34033289,*pregnancy
1952,35004341,*graves’ disease
1953,35004341,*graves’ orbitopathy (go)
1954,35004341,*lactobacillus
1955,35004341,*prevotella
1956,35004341,*tshr (thyroid-stimulating hormone receptor)
1957,35004341,*th17 and treg cells
1958,35004341,*veillonella
1959,35004341,*gut microbiota cois commercial or financial relationships that could be construed as a potential conflict of interest.
1960,33449383,*graves' disease
1961,33449383,*hashimoto's thyroiditis
1962,33449383,*interferon lambda 1
1963,33449383,*interleukin-29
1964,33449383,*subacute thyroiditis
1965,34026662,*16s rrna
1966,34026662,*graves’ disease
1967,34026662,*clinical parameters
1968,34026662,*gut microbiota
1969,34026662,*next-generation sequencing cois commercial or financial relationships that could be construed as a potential conflict of interest.
1970,34182968,dilated cardiomyopathy
1971,34182968,ethiopia
1972,34182968,methimazole
1973,34182968,propylthiouracil
1974,34182968,thyrotoxicosis
1975,34182968,β-blocker cois
1976,34855196,graves’ disease (gd)
1977,34855196,antithyroid drugs (atds)
1978,34855196,radioactive iodine (rai)
1979,34855196,total thyroidectomy (tt)
1980,30927742,*graves’ disease
1981,30927742,*factitious disorders
1982,30927742,*thyroxine
1983,33445994,graves’ disease
1984,33445994,intelligent diagnosis
1985,33445994,deep learning
1986,33445994,diagnostic performance
1987,33445994,nuclear medicine residents
1988,33445994,subacute thyroiditis
1989,33445994,thyroid disease
1990,33445994,thyroid scintigraphy cois conflict of interest.
1992,33515213,graves’ disease
1993,33515213,graves’ ophthalmopathy
1994,33515213,graves’ orbitopathy
1995,33515213,thyroglobulin cois as prejudicing the impartiality of the research reported.
1996,31919775,corticosteroids
1997,31919775,graves’ disease
1998,31919775,tshr
1999,31919775,thyroid eye disease
2000,32893226,cushing's syndrome
2001,32893226,graves' disease
2002,32893226,central hypothyroidism
2003,32893226,syndrome of inappropriate secretion of thyroid-stimulating hormone cois
2006,33487459,adipose tissue
2007,33487459,glande thyroïde
2008,33487459,thyroid gland
2009,33487459,thyrolipoma
2010,33487459,thyrolipomatose
2011,33487459,thyrolipomatosis
2012,33487459,thyrolipome
2013,33487459,tissu adipeux
2014,34965078,*graves’ disease
2015,34965078,*radioiodine therapy
2016,34965078,*thyroid eye disease
2017,34965078,*thyroidectomy
2022,34969797,ear
2023,34969797,nose and throat/otolaryngology
2024,34969797,vascular surgery cois
2025,34118212,cancer de la thyroïde
2026,34118212,goitre multinodulaire
2027,34118212,multinodular goiter
2028,34118212,mutation du gène pds
2029,34118212,pds gene mutation
2030,34118212,pendred syndrome
2031,34118212,syndrome de pendred
2032,34118212,thyroid cancer
2033,34195868,hypocalcemia
2034,34195868,hypoparathyroidism
2035,34195868,indocyanine green (icg)
2036,34195868,near-infrared autofluorescence (nir-af)
2037,34195868,near-infrared fluorescence imaging (nifi)
2038,34195868,parathyroid glands (pgs)
2039,34195868,thyroid surgery
2040,34195868,total thyroidectomy
2041,31512191,graves’ disease
2042,31512191,graves’s orbithopathy
2043,31512191,lenin
2044,31512191,theodor kocher
2045,33112798,*graves’ orbitopathy
2046,33112798,*binding immunoglobulin protein
2047,33112798,*endoplasmic reticulum stress
2048,33112798,*thyroid eye disease
2049,33112798,*unfolded protein response
2051,32638234,graves’ disease
2052,32638234,pancytopenia
2053,32638234,review
2056,33462034,calcium and bone
2057,33462034,hyperthyroidism cois
2058,33685911,pericardial disease
2059,33685911,thyroid disease cois
2068,32765422,*graves' disease
2069,32765422,*autoimmunity
2070,32765422,*hyperthyroidism
2071,32765422,*inflammation
2072,32765422,*natural killer cells
2073,33557156,*22q11.2 deletion syndrome
2074,33557156,*down syndrome
2075,33557156,*graves’ disease
2076,33557156,*hashimoto’s thyroiditis
2077,33557156,*klinefelter syndrome
2078,33557156,*prader–willi syndrome
2079,33557156,*rasopathies
2080,33557156,*turner syndrome
2081,33557156,*williams syndrome
2082,33557156,*genetic syndromes cois
2083,33661574,antithyroid drugs
2084,33661574,hepatitis
2085,33661574,hyperthyroidism
2086,33661574,plasma exchange
2087,33661574,plasmapheresis
2091,34303550,basedow
2092,34303550,dysthyroidism
2093,34303550,dysthyroïdie
2094,34303550,glaucoma
2095,34303550,glaucome
2096,34303550,graves’ disease
2097,34303550,hypertonie intra-oculaire
2098,34303550,ocular hypertension
2099,34753719,hepatitis other
2100,34753719,thyrotoxicosis cois
2102,34725062,cardiothoracic surgery
2103,34725062,otolaryngology / ent
2104,34725062,thyroid disease cois
2105,32441005,antithyroid drugs
2106,32441005,covid-19
2107,32441005,glucocorticoids
2108,32441005,graves’ disease
2109,32441005,graves’ orbitopathy cois
2111,33789121,alkaloid
2112,33789121,cyanogenic glucoside
2113,33789121,flavonoid
2114,33789121,phytochemical
2115,33789121,polyphenol
2116,33789121,thyroid
2117,32157663,art
2118,32157663,history
2119,32157663,thyroid swelling
2123,31948703,*epidemiology
2124,31948703,*goiter
2125,31948703,*national inpatient sample
2126,31948703,*predictive factors
2127,31948703,*thyroid disease
2128,31948703,*thyroidectomy cois conflicts of interest to disclose.
2129,33420947,*lingual thyroid
2130,33420947,*oropharynx
2131,33420947,*robotic thyroidectomy
2132,33420947,*thyroidectomy
2134,31127592,goiter
2135,31127592,medical diagnosis
2136,31127592,painting
2137,31127592,saints
2141,32910410,art
2142,32910410,graves’ disease
2143,32910410,history
2144,34874796,graves’ ophthalmopathy
2145,34874796,thyroid-associated orbitopathy
2146,34874796,thyroid eye disease
2147,34874796,thyroid ophthalmopathy
2149,33569041,*graves’ disease
2150,33569041,*hyperthyroidism
2151,33569041,*review
2152,33569041,*thyroxine
2153,33569041,*treatment cois commercial or financial relationships that could be construed as a potential conflict of interest.
2154,32173798,*benign thyroid disease
2155,32173798,*chris
2156,32173798,*radioiodine therapy
2157,32173798,*stunning
2158,32173798,*thyroid
2159,33367675,*graves’ disease
2160,33367675,*slit2
2161,33367675,*thyroid-associated ophthalmopathy
2163,34227705,*graves' disease
2164,34227705,*goiter
2165,34227705,*hyperthyroidism
2166,34227705,*pediatric
2167,34227705,*scintigraphy
2168,34969799,covid-19
2169,34969799,thyroid disease
2170,34969799,thyrotoxicosis
2171,34969799,unwanted effects/adverse reactions cois
2172,31757411,*graves disease
2173,31757411,*hyperthyroidism
2174,31757411,*nodular goiter
2175,31757411,*thyroid cancer
2179,32477269,*graves' disease
2180,32477269,*anti-thyroid drug
2181,32477269,*carbimazole
2182,32477269,*dose
2183,32477269,*hyperthyroidism
2184,32797478,amyloidosis
2185,32797478,goitre
2186,32797478,hypothyroidism
2187,33431523,neonatal and paediatric intensive care
2188,33431523,pregnancy
2189,33431523,thyroid disease
2190,33431523,thyrotoxicosis cois
2191,33988300,*lepr
2192,33988300,*graves' disease
2193,33988300,*immune-related genes
2194,33988300,*leptin receptor
2195,33988300,*thyroid-associated ophthalmopathy
2196,33988300,*weighted gene co-expression network analysis cois
2197,34787691,environment
2198,34787691,genetic codes
2199,34787691,graves’ ophthalmopathy
2200,34787691,human organism
2201,34787691,risk factor
2202,32199035,*hyperthyroidism
2203,32199035,*postoperative complications
2204,32199035,*surgery
2205,32199035,*thyroid diseases
2206,32199035,*thyroidectomy
2208,33832185,*congenital goiter
2209,33832185,*hypothyroidism
2210,33832185,*thyroglobulin
2211,33832185,*novel mutation
2212,33832185,*case report
2214,33597052,*goiter prevalence
2215,33597052,*iodine nutrition
2216,33597052,*thyroid cancer
2217,33597052,*urine iodine
2218,33934566,*graves’ disease
2219,33934566,*myh11
2220,33934566,*itraq technique
2221,33934566,*inflammatory response
2222,33934566,*proteomics
2223,33934566,*thyroid-associated obitopathy cois
2224,33367747,*graves’ disease
2225,33367747,*igf-1r
2226,33367747,*thsr
2227,33367747,*autoimmunity
2228,33367747,*exosomes
2229,33914707,*endocrinology
2230,33914707,*thyroid disease cois exists.
2232,34192497,complications
2233,34192497,goitre
2234,34192497,thyroidectomy
2235,34192497,tracheomalacia
2238,33509724,excisional biopsy
2239,33509724,foot
2240,33509724,radiation therapy
2241,33509724,thyroid dermopathy
2242,33579884,*dfnb4
2243,33579884,*menière
2244,33579884,*hydrops
2245,33579884,*mouse
2246,33579884,*pendred
2248,33283314,*graves' disease
2249,33283314,*rai
2250,33283314,*long-term atd
2251,33283314,*surgery
2252,33283314,*treatment
2253,31651072,*graves' disease
2254,31651072,*hashimoto's thyroiditis
2255,31651072,*difficulty
2256,31651072,*outcomes
2257,31651072,*thyroidectomy
2258,32847459,dry eye disease
2259,32847459,grave’s disease
2260,32847459,grave’s eye disease
2261,32847459,ocular inflammation
2262,32847459,ocular surface
2263,32847459,thyroid eye disease
2264,34560868,*amhara region
2265,34560868,*dessie
2266,34560868,*ethiopia
2267,34560868,*iodine deficiency
2268,34560868,*urinary iodine concentration cois
2270,33863564,acuité visuelle
2271,33863564,antioxidant therapy
2272,33863564,cas score
2273,33863564,exophthalmos
2274,33863564,légère orbitopathie thyroïdienne
2275,33863564,mild graves’ orbitopathy
2276,33863564,ouverture palpébrale
2277,33863564,oxidative stress
2278,33863564,palpebral fissure
2279,33863564,placebo
2280,33863564,proptose
2281,33863564,selenium
2282,33863564,stress oxydatif
2283,33863564,sélenium
2284,33863564,traitement anti-oxydatif
2285,33863564,visual acuity
2286,33994519,graves' disease
2287,33994519,antithyroid drug
2288,33994519,fetal goiter
2289,33994519,fetal hyperthyroidism
2290,33994519,tachycardia
2292,32553518,*graves’ disease
2293,32553518,*nsqip
2294,32553518,*racial disparities
2295,32553518,*thyroidectomy cois conflicts of interest to disclose.
2296,32968816,*graves disease
2297,32968816,*cytokine
2298,32968816,*fibroblasts
2299,32968816,*hyaluronan
2300,32968816,*ophthalmopathy
2301,32968816,*orbit
2302,33530368,*graves’ disease
2303,33530368,*autoimmunity
2304,33530368,*dendritic cells
2305,33530368,*methimazole cois
2306,33532627,*graves' disease
2307,33532627,*trab
2308,33532627,*multivariable analysis
2309,33532627,*thyroid surgery cois
2310,34806437,*iodine deficiency
2311,34806437,*iodine excess
2312,34806437,*iodized salt
2313,32709792,*dysthyroid optic neuropathy
2314,32709792,*indian
2315,32709792,*thyroid eye disease cois
2316,32130689,graves’ disease
2317,32130689,multiple sclerosis
2318,32130689,personalized medicine
2319,32130689,thyroidectomy
2320,32130689,thyroiditis
2321,33380646,immunohistochemistry
2322,33380646,molecular genetics
2323,33380646,thyroid paraganglioma
2324,33380646,thyroid tumor
2325,33380646,total thyroidectomy cois
2327,32691849,*graves’ disease
2328,32691849,*graves’ ophthalmopathy
2329,32691849,*eye diseases
2330,32691849,*geographical locations
2331,32691849,*meta-analysis
2332,32691849,*prevalence
2333,32691849,*thyroid diseases
2334,33226264,bactericide
2335,33226264,intestinal microbiota
2336,33226264,iodine
2337,33226264,nutrition
2338,33226264,thyroid diseases
2339,33226264,thyroid hormones
2340,33617351,dna methylation
2341,33617351,graves' disease
2342,33617351,bioinformatic analysis
2343,33617351,genome-wide
2344,33146848,application test
2345,33146848,artificial intelligence
2346,33146848,clinical trials
2347,33146848,thyroid-associated ophthalmopathy
2348,34774035,extraocular muscle
2349,34774035,magnetic resonance imaging
2350,34774035,short-tau inversion recovery
2351,34774035,thyroid-associated ophthalmopathy cois
2352,33658136,graves’ ophthalmopathy
2353,33658136,diffusion magnetic resonance imaging
2354,33658136,extraocular muscles
2355,33658136,magnetic resonance imaging
2356,33593429,*graves’ disease
2357,33593429,*graves’ orbitopathy
2358,33593429,*gut microbiota
2359,33593429,*human fecal microbiota transplant
2360,33593429,*microbiome modulation
2361,33593429,*murine model
2362,33593429,*probiotics
2363,33593429,*vancomycin cois other collaborative projects with cultech ltd. the other authors declare that they have no competing interests.
2364,33675208,graves’ disease
2365,33675208,antithyroid treatment
2366,33675208,pediatric thyroidology
2367,33675208,thyroidectomy
2368,33675208,thyrotoxicosis
2370,32034469,endocrine orbitopathy
2371,32034469,epidemiology
2372,32034469,graves’ disease
2373,32034469,healthcare research
2374,32034469,interdisciplinary orbit center
2375,34497059,endocrine system
2376,34497059,respiratory system
2377,34497059,thyroid disease cois
2378,32924380,graves’ disease
2379,32924380,graves’ orbitopathy
2380,32924380,children
2381,32924380,hepatic dysfunction
2382,32924380,lymphocyte subsets
2383,34647611,complications
2384,34647611,hypoparathyroidism
2385,34647611,nodular goitre
2386,34647611,surgical treatment
2387,34647611,thyroid cancer
2388,34518175,genetics
2389,34518175,hyperthyroidism
2390,34518175,thyroid disease cois
2391,34725068,general practice / family medicine
2392,34725068,otolaryngology / ent
2393,34725068,thyroid disease
2394,34725068,thyrotoxicosis cois
2397,34448404,airway obstruction
2398,34448404,asthma
2399,34448404,goitre
2400,34448404,pre-eclampsia
2401,34448404,pregnancy
2402,33779950,hypocalcemia
2403,33779950,intrathoracic goiter
2404,33779950,morbidity
2405,33779950,nerve paralysis
2406,33779950,sternotomy
2407,33779950,surgery
2408,33779950,thyroid cois
2409,32727336,graves’ disease
2410,32727336,thyrotoxicosis
2411,32727336,anti-thyroid therapy
2412,32727336,arrhythmia
2413,32727336,electrocardiogram
2414,32727336,hyperthyroidism
2415,32705333,alopecia areata
2416,32705333,cohort study
2417,32705333,epidemiology
2418,32705333,taiwan’s national health insurance research database
2419,32705333,thyroid disease
2421,33481211,graves’ disease
2422,33481211,gut microbiota
2423,33481211,lactobacillus
2424,33481211,ruminococcus
2425,33481211,trab
2427,33169897,goiter
2428,33169897,imaging mass spectrometry
2429,33169897,obesity
2430,33169897,thyroglobulin
2431,33169897,thyroid disease
2432,33169897,thyroid tissue
2433,33926416,baff
2434,33926416,br3
2435,33926416,graves’ disease
2436,33926416,hashimoto’s thyroiditis
2437,33926416,taci cois
2439,32203974,*antibodies
2440,32203974,*autoimmune diseases
2441,32203974,*drug therapy
2442,32203974,*hyperthyroidism
2443,32203974,*hypothyroidism
2444,32203974,*placenta
2445,32203974,*research laboratories
2446,32203974,*therapeutic drug monitoring
2447,32203974,*thyroid
2448,32203974,*thyroid-stimulating hormone
2450,33563685,anxiety disorders (including ocd and ptsd)
2451,33563685,endocrinology
2452,33563685,psychiatry
2453,33563685,psychotic disorders (incl schizophrenia)
2454,33563685,thyroid disease cois
2455,33966669,*endemic goitre
2456,33966669,*iodine deficiency disorders
2457,33966669,*salt iodine content
2458,33966669,*total goitre rate
2459,33966669,*ultrasonography
2460,33966669,*universal salt iodisation
2461,33966669,*urinary iodine concentration
2462,32875953,thyroid stimulating hormone
2463,32875953,hyperthyroidism
2464,32875953,thyroid uptake and scan
2467,32705522,glucocorticoids
2468,32705522,graves’ orbithopathy
2469,32705522,radiotherapy
2472,33106982,extracellular matrix
2473,33106982,fbln1 gene
2474,33106982,fibulin-1
2475,33106982,multinodular goiter
2476,33106982,papillary thyroid cancer
2478,34418335,graves’ disease
2479,34418335,hypothyroidism
2480,34418335,radioiodine therapy
2481,34418335,thyroid peroxidase antibody (tpoab)
2482,34418335,thyrotropin receptor antibody (trab)
2483,34194397,*graves’ disease
2484,34194397,*antithyroid drugs
2485,34194397,*children
2486,34194397,*hyperthyroidism
2487,34194397,*remission cois commercial or financial relationships that could be construed as a potential conflict of interest.
2488,34689799,fine-needle aspiration
2489,34689799,midkine
2490,34689799,multinodular goiter
2491,34689799,thyroid cancer
2492,34689799,thyroid nodule cois
2493,34521015,epid dosimetry
2494,34521015,machine learning
2495,34521015,multifactorial error sources
2496,34521015,positioning error detection
2497,34521015,radiomics analysis
2498,34448415,fine-needle cytology
2499,34448415,goitre
2500,34448415,thyroid cancer
2501,34448415,thyroid nodules
2502,34448415,thyroidectomy
2503,34893568,*endocrine
2504,34893568,*exophthalmos
2505,34893568,*goiter
2506,34893568,*selfie
2507,34893568,*thyroid
2508,34893568,*thyroidectomy cois
2509,33128357,*c cell hyperplasia
2510,33128357,*medullary thyroid cancer
2511,33128357,*calcitonin
2512,33128357,*pentagastrin
2513,33128357,*cut-off cois
2514,34019179,cd73
2515,34019179,immunohistochemistry
2516,34019179,papillary thyroid carcinoma
2517,34019179,thyroid adenoma
2518,34019179,thyroid carcinoma cois
2520,31562615,multinodular goiter
2521,31562615,nativity
2522,31562615,wooden little shepherds
2523,34782518,goitre
2524,34782518,intrathoracic
2525,34782518,retrosternal
2526,34782518,sternotomy cois
2528,33193994,grave’s disease
2529,33193994,hyperthyroidism
2530,33193994,radioactive iodine disease cois
2531,33619717,genetic
2532,33619717,mutation
2533,33619717,thyroid disease
2534,34560890,graves’ disease
2535,34560890,r282s
2536,34560890,resistance to thyroid hormone
2537,34560890,syndrome of inappropriate secretion of tsh
2538,34560890,thyroid hormone receptor β cois
2540,33474918,bony orbital decompression
2541,33474918,dysthyroid optic neuropathy
2542,33474918,endoscopic orbital decompression
2543,33474918,surgical treatment
2544,33474918,thyroid eye disease
2546,33345558,body composition
2547,33345558,hypocalcemia
2548,33345558,hypoparathyroidism
2549,33345558,thyroid
2550,33345558,total thyroidectomy
2552,34331946,diagnostic efficacy
2553,34331946,graves’ disease
2554,34331946,methimazole
2555,34331946,responsiveness
2556,34331946,thyroid-stimulating immunoglobulin
2557,32449092,16s rrna gene
2558,32449092,graves’ disease
2559,32449092,graves’ orbitopathy
2560,32449092,gut microbiota
2561,32449092,metabolic functions
2563,33349089,*elephantiasis
2564,33349089,*graves dermopathy
2565,33349089,*graves disease
2566,33349089,*thyroid eye disease
2567,32057544,goiter size
2568,32057544,graves' disease
2569,32057544,outcome
2570,32057544,radioiodine therapy cois declare.
2571,34552563,*dicer1 mutation
2572,34552563,*dicer1 syndrome
2573,34552563,*goiter
2574,34552563,*goitre
2575,34552563,*hereditary cancer
2576,34552563,*thyroidectomy cois commercial or financial relationships that could be construed as a potential conflict of interest. the reviewer kt declared a past collaboration with one of the authors kw to the handling editor.
2577,33528651,european group on graves’ orbitopathy
2578,33528651,graves’ orbitopathy
2579,33528651,quality of life
2580,33528651,thyroid eye disease
2583,32847889,ophthalmology
2584,32847889,pathology cois
2585,33346898,autoimmunity
2586,33346898,goiter
2587,33346898,graves’ disease
2588,33346898,graves’ orbitopathy
2589,33346898,hyperthyroidism cois
2590,31980413,*adolescents
2591,31980413,*antithyroid drugs
2592,31980413,*children
2593,31980413,*graves disease cois
2596,34630829,ectopic thyroid tissue
2597,34630829,case report
2598,34630829,submandibular mass
2599,34630829,thyroid goiter cois
2600,33026541,hyperthyroidism
2601,33026541,hypothyroidism
2602,33026541,iodine
2603,33026541,spa
2604,33026541,thyroid gland
2606,31982255,auto-immunité
2607,31982255,autoimmunity
2608,31982255,chest pain
2609,31982255,douleur thoracique
2610,31982255,graves’ disease
2611,31982255,maladie de basedow
2612,31982255,myocardite
2613,31982255,myocarditis
2616,34256242,graves' disease
2617,34256242,graves' orbitopathy
2618,34256242,interleukin 17
2619,34256242,interleukin 23
2620,34256242,thyrotropin receptor cois
2621,34823306,*aggression
2622,34823306,*graves disease
2623,34823306,*prevalence
2624,34823306,*prognosis
2625,34823306,*thyroid neoplasms cois was reported.
2626,34164724,deep lateral orbital wall decompression
2627,34164724,extraocular muscle expansion
2628,34164724,greater wing of sphenoid bone
2629,34164724,orbital fat removal
2630,33728674,graves' disease
2631,33728674,catalytic activity
2632,33728674,thyroid proteomics
2633,33728674,thyrotoxicosis
2634,33728674,toxic multinodular goitre
2635,34090378,non-specific orbital inflammation
2636,34090378,comorbidity
2637,34090378,orbital mass
2638,34090378,prednisolone
2639,34090378,thyroid eye disease cois
2640,32527309,case report
2641,32527309,lipoma
2642,32527309,minor salivary gland
2643,32527309,parotid gland
2644,32527309,sialolipoma cois
2645,33317492,case report
2646,33317492,graves’ disease
2647,33317492,orbitopathy
2648,33317492,pregnancy
2649,33317492,smoking
2650,33317492,tao cois
2651,34300095,*saudi arabia
2652,34300095,*iodine deficiency disorders
2653,34300095,*stunting cois
2654,31637658,*differentiated thyroid carcinoma
2655,31637658,*graves’ disease
2656,31637658,*mortality
2657,31637658,*recurrence
2658,34938274,*swedish endocrine society
2659,34938274,*desiccated thyroid extract (dte)
2660,34938274,*euthyroidism
2661,34938274,*hypothyroidism
2662,34938274,*levothyroxine
2663,34938274,*liothyronine
2664,34938274,"*survey cois authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. ibsa had no role in the design of the survey, data analysis, data presentation, data interpretation or writing the manuscript; the authors did not receive remuneration by ibsa."
2667,32279181,gender differences
2668,32279181,graves’ disease
2669,32279181,lymphocytic infiltration
2670,32279181,papillary thyroid cancer
2671,32279181,thyroidectomy
2672,32279181,thyroiditis and cancer
2673,34033290,*graves' disease
2674,34033290,*graves' orbitopathy
2675,34033290,*hyperthyroidism
2676,33544540,body surface area
2677,33544540,middle school students
2678,33544540,thyroid volume
2679,34252869,intravenous glucocorticoid
2680,34252869,t2 ideal
2681,34252869,t2 mapping
2682,34252869,therapeutic efficacy
2683,34252869,thyroid-associated ophthalmopathy
2684,32306294,*exophthalmos
2685,32306294,*graves’ disease
2686,32306294,*graves’ orbitopathy
2687,32306294,*igf-1 receptor
2688,32306294,*teprotumumab
2689,32306294,*thyroid eye disease
2691,32798996,*graves disease
2692,32798996,*outcomes
2693,32798996,*radioactive iodine ablation
2694,32798996,*thyroidectomy
2695,32166667,diabetes
2696,32166667,euthyroid hormones
2697,32166667,free thyroxine
2698,32166667,free triiodothyronine
2699,32166667,islet beta-cell function
2702,33860431,*antithyroid agents
2703,33860431,*grave’s disease
2704,33860431,*hyperthyroidism
2705,33860431,*recurrence
2706,33860431,*treatment outcome
2707,34381549,cameroon
2708,34381549,nodular goitre
2709,34381549,cancer
2710,34381549,thyroid cois
2711,32734611,*graves' disease
2712,32734611,*trabs
2713,32734611,*age
2714,32734611,*radioiodine
2715,32734611,*thyroid hormones cois
2716,34120661,complications
2717,34120661,recurrent laryngeal nerve
2718,34120661,surgery
2719,34120661,thyroid
2720,34120661,vagus nerve
2721,34120661,vocal fold palsy
2723,31713721,antithyroid drugs
2724,31713721,children
2725,31713721,graves’ disease
2726,31713721,hyperthyroidism
2727,31713721,“block-and-replace” method
2728,34334562,emo syndrome
2729,34334562,graves' disease
2730,34334562,musculoskeletal ultrasound
2731,34334562,osteoarthropathy cois
2732,33525898,teprotumumab
2733,33525898,compressive optic neuropathy
2734,33525898,dysthyroid optic neuropathy
2735,33525898,graves’ ophthalmopathy
2736,33525898,thyroid eye disease
2737,33993334,cerebrospinal fluid in the optic nerve sheath
2738,33993334,dysthyroid optic neuropathy
2739,33993334,magnetic resonance imaging
2740,33993334,optic nerve
2741,33993334,quantitative water-fat sequence
2742,32524368,antithyroid drugs
2743,32524368,graves’ disease treatment
2744,32524368,graves’ orbitopathy
2745,32524368,hyperthyroidism
2746,32461446,*diabetes mellitus
2747,32461446,*thyroid eye disease
2748,32461446,*thyroid-related orbitopathy
2749,32461446,*type-2 dm cois
2750,33439464,*effective half-life
2751,33439464,*graves’ disease
2752,33439464,*radioiodine therapy
2753,33439464,*radioiodine uptake test
2754,33439464,*thyroid cois
2755,31910731,graves’
2756,31910731,timp-1
2757,31910731,strain
2758,31910731,thyroid
2759,34659126,*n1b metastasis
2760,34659126,*nomogram
2761,34659126,*papillary thyroid cancer
2762,34659126,*predicting
2763,34659126,*skip metastasis cois commercial or financial relationships that could be construed as a potential conflict of interest.
2764,31927747,differentiated thyroid cancer
2765,31927747,pediatrics
2766,31927747,thyroid
2767,31927747,thyroid nodules
2768,32595602,*graves' hyperthyroidism
2769,32595602,*graves' ophthalmopathy
2770,32595602,*anti-thyroid drugs
2771,32595602,*corticosteroid pulse therapy
2772,32595602,*relapse of graves' hyperthyroidism
2773,34266819,head and neck surgery
2774,34266819,paediatric oncology
2775,34266819,radiotherapy
2776,34266819,thyroid disease cois
2779,32527127,prolonged endotracheal intubation
2780,32527127,retrosternal goitre (rsg)
2781,32527127,tracheomalacia
2782,32218623,point of care
2783,32218623,thyroid ultrasound cois
2784,33023116,endemic congenital hypothyroidism
2785,33023116,endemic goitre
2786,33023116,familial aggregation
2787,33023116,iodine deficiency
2788,33023116,thyroid metabolism cois
2789,32709788,*india
2790,32709788,*orbital decompression
2791,32709788,*survey
2792,32709788,*thyroid eye disease cois
2793,33908335,graves disease
2794,33908335,antithyroid agents
2795,33908335,hemodynamics
2796,33908335,hyperthyroidism
2797,33908335,thyroidectomy
2798,33908335,thyrotropin
2799,34954838,graves' disease
2800,34954838,head and neck
2801,34954838,hyperthyroidism
2802,34954838,surgery
2803,33947272,*graves'disease
2804,33947272,*radioactive iodine therapy
2805,33947272,*thyrotropin receptor antibody
2806,33947272,*thyrotropin-binding inhibitory immunoglobulins
2807,33947272,*total thyroidectomy cois
2808,31450040,*graves' disease
2809,31450040,*hyperthyroidism
2810,31450040,*toxic multinodular goiter
2811,31450040,*toxic solitary nodule
2812,32358735,choroidal thickness
2813,32358735,ganglion cell layer thickness
2814,32358735,graves’ disease
2815,32358735,graves’ orbitopathy
2816,32358735,optic nerve head
2817,32358735,optical coherence tomography
2818,32358735,retinal thickness
2819,32975031,*thypro
2820,32975031,*benign
2821,32975031,*quality of life
2822,32975031,*thyroid
2823,32975031,*thyroidectomy
2824,32173759,*graves disease
2825,32173759,*graves orbitopathy
2826,32173759,*th17.1 cell
2827,32173759,*effector t cell
2828,31869260,* tnfsf15
2829,31869260,*graves’ disease
2830,31869260,*graves’ ophthalmopathy
2831,31869260,*tl1a
2832,31869260,*single nucleotide polymorphism
2834,32602151,autofluorescence
2835,32602151,hypocalcemia
2836,32602151,parathyroid gland
2837,32602151,thyroidectomy
2838,34278816,*graves' disease
2839,34278816,*iodothyronine deiodinase
2840,34278816,*poorly differentiated thyroid carcinoma
2841,33080613,dicer1 syndrome
2842,33080613,multinodular goitre
2843,33080613,poorly differentiated thyroid cancer
2844,33080613,thyroid carcinoma
2845,33080613,thyroid nodule
2846,34291428,*art
2847,34291428,*exophthalmos
2848,34291428,*graves’ disease
2849,34291428,*history
2850,32944926,graves’ disease
2851,32944926,trab
2852,32944926,trab-negative
2853,32944926,hyperthyroidism
2854,32944926,smoking
2855,34028325,radioactive iodine
2856,34028325,graves’ disease
2857,34028325,hyperthyroidism
2858,34028325,lithium
2859,34028325,toxic nodule’ toxic multinodular goiter
2860,32037571,*dysthyroid optic neuropathy
2861,32037571,*optic nerve compression
2862,32037571,*thyroid eye disease
2864,32188795,graves’ disease
2865,32188795,graves’ hyperthyroidism
2866,32188795,potassium iodide
2867,32188795,wolff-chaikoff effect
2870,32451608,compressive optic neuropathy
2871,32451608,medial wall
2872,32451608,orbital floor
2873,32451608,spontaneous decompression
2874,32451608,thyroid eye disease
2875,32316214,goitre
2876,32316214,iodine pregnant women
2877,32316214,iodine schoolchildren
2878,32316214,iodised salt
2879,32316214,urine iodine
2880,32316214,water iodine cois the views of the institutions with which they are affiliated. the authors declare that there is no conflict of interest.
2885,32487052,131i−
2886,32487052,euthyreosis
2887,32487052,factors
2888,32487052,graves’ disease
2889,32487052,hyperthyroidism
2890,32487052,predictors
2891,32487052,radioiodine
2892,32487052,toxic multinodular goiter cois
2894,31762351,receptive language outcomes
2895,31762351,non-syndromic enlarged vestibular aqueduct
2896,31762351,peabody picture vocabulary test
2897,31762351,pediatric cohort
2898,31762351,pendred syndrome
2899,32532690,hepatitis
2900,32532690,methimazole
2901,32532690,plasmapheresis
2902,32532690,thyrotoxicosis
2904,32245343,*generalized additive model
2905,32245343,*salt iodine concentration
2906,32245343,*thyroid volume
2907,32245343,*urinary iodine concentration
2908,32504380,*magnetic resonance imaging
2909,32504380,*quantitative evaluation
2910,32504380,*thyroid-associated ophthalmopathy
2911,32504380,*treatment response
2912,32020533,iodine deficiency
2913,32020533,north macedonia
2914,32020533,schoolchildren
2915,32020533,thyroid gland ultrasonography
2916,32020533,thyroid volume
2917,31948188,*prevalence
2918,31948188,*school-age children
2919,31948188,*turkey
2920,31948188,*iodine deficiency
2922,32333320,energy vessel sealant device
2923,32333320,neck hematoma
2924,32333320,surgical complications
2925,32333320,thyroidectomy
2926,32139177,*graves' disease
2927,32139177,*antithyroid drugs
2928,32139177,*relapse
2929,32139177,*risk factors
2930,32253727,cognition
2931,32253727,diffusion tensor imaging
2932,32253727,thyroid-associated ophthalmopathy
2933,32253727,vision
2934,32253727,voxel-based morphometry
2935,31407208,autoimmune poliglandular syndromes
2936,31407208,graves’ disease
2937,31407208,hyperthyroidism
2938,31407208,thyroid
2939,30513035,dyshormonogenesis
2940,30513035,graves disease
2941,30513035,trab
2942,30513035,fetal goiter
2943,30513035,hyperthyroidism
2944,30513035,hypothyroidism
2945,31973681,*antithyroid medications
2946,31973681,*effectiveness of therapy
2947,31973681,*hyperthyroidism
2948,31973681,*radioactive iodine
2949,31973681,*thyroidectomy
2950,32758269,autoimmune antibody
2951,32758269,basedow’s disease
2952,32758269,hashimoto’s thyroiditis
2953,32758269,histopathological features cois
2954,32640447,*autoimmune diseases
2955,32640447,*costimulatory molecules
2956,32640447,*degranulation
2957,32640447,*mast cells
2958,32640447,*thyroid hormones
2961,30955162,*graves’ disease
2962,30955162,*hyperthyroidism
2963,30955162,*leg tremor
2964,30955162,*postural tremor
2965,32077044,anti-tsh receptor autoantibodies
2966,32077044,autoimmunity
2967,32077044,fine-needle aspiration biopsy
2968,32077044,graves’ disease
2969,32077044,graves’ orbitopathy
2970,32077044,hyperthyroidism
2971,32077044,thyroid
2972,32077044,thyroid nodules
2973,32474767,asymmetric
2974,32474767,graves’
2975,32474767,orbitopathy
2976,32474767,thyroid
2977,32474767,unilateral cois
2978,32658864,graves’ disease
2979,32658864,hashitoxicosis
2980,32658864,sudan
2981,32658864,adolescents
2982,32658864,childhood
2984,32174327,*generative adversarial network
2985,32174327,*orbital decompression
2986,32174327,*postoperative appearance
2987,32174327,*thyroid-associated ophthalmopathy cois declare.
2988,34642808,dysthyroid optic neuropathy
2989,34642808,graves orbitopathy
2990,34642808,magnetic resonance imaging
2991,34642808,muscle index
2992,34642808,optic neuropathy
2994,32593739,(131)i
2995,32593739,calculated dose
2996,32593739,dosimetry
2997,32593739,dosimetría
2998,32593739,dosis calculada
2999,32593739,dosis fija
3000,32593739,fixed dose
3001,32593739,hipertiroidismo
3002,32593739,hyperthyroidism
3003,32593739,radionuclide therapy
3004,32593739,radioterapia metabólica
3005,32847555,99mtc-pertechnetate scintigraphy
3006,32847555,graves’ disease
3007,32847555,immune checkpoint inhibitor
3008,32847555,nivolumab
3009,32847555,thyroid-stimulating hormone receptor antibody
3010,32847555,thyrotoxicosis cois
3011,32666542,pds
3012,32666542,slc26a4
3013,32666542,upd7
3014,32666542,growth retardation
3015,32709791,*graves orbitopathy
3016,32709791,*hindi
3017,32709791,*quality of life
3018,32709791,*questionnaire
3019,32709791,*validation cois
3020,31465286,131i
3021,31465286,goiter
3022,31465286,carbimazol
3023,31465286,chloride
3024,31465286,creatinine
3025,31465286,thyroid function tests
3026,31465286,thyrotoxicosis.
3027,33346473,21-oh-antibodies
3028,33346473,addison’s disease
3029,33346473,graves’ disease
3030,33346473,autoimmune polyglandular syndromes
3031,33346473,diabetes mellitus type 1
3032,33038927,autoimmune polyglandular syndrome
3033,33038927,chronic urticaria
3034,33038927,graves’ disease
3035,33038927,premature ovarian failure cois
3039,32154572,graves’ disease
3040,32154572,antithyroid drugs
3041,32154572,gender
3042,32154572,hyperthyroidism
3043,31646433,*exophthalmos
3044,31646433,*graves’ disease
3045,31646433,*orbital decompression
3046,31646433,*orbital radiotherapy
3047,31646433,*orbitopathy
3048,31586293,*endogenous thyrotropin
3049,31586293,*methimazole
3050,31586293,*multinodular goitre
3051,31586293,*radioiodine cois
3053,31727496,children
3054,31727496,iodized salt
3055,31727496,thyroid abnormalities
3056,31727496,urinary iodine
3057,31727496,water iodine
3058,31727496,water replacement
3059,33256801,autoimmune disease
3060,33256801,basedow-graves’s disease
3061,33256801,nutritional assessment
3062,33256801,pediatric disability
3063,33256801,stickler syndrome cois
3065,32499464,*clinical impression
3066,32499464,*euthyroid
3067,32499464,*goiter
3068,32499464,*thyroid disorder
3069,32499464,*thyroid function test cois
3071,34347269,*antiquity
3072,34347269,*endocrinology
3073,34347269,*etruscan
3074,34347269,*goitre
3075,34347269,*palaeopathology
3076,34347269,*thyroid
3077,33059514,epiblepharon
3078,33059514,singapore
3079,33059514,graves’ ophthalmopathy
3080,33059514,pediatric
3081,33059514,thyroid eye disease
3082,34970859,*graves' disease
3083,34970859,*metabolomics
3084,34970859,*myopathy
3085,34970859,*senescence
3086,34970859,*t cells cois
3087,32295532,*case report
3088,32295532,*congenital chloride diarrhea
3089,32295532,*deafness
3090,32295532,*neonatal diarrhea
3091,32295532,*pendred syndrome cois
3092,34782167,*nodular goiter
3093,34782167,*operated recurrent goiter
3094,34782167,*shear-wave velocity
3095,34782167,*thyroid sonoelastography cois
3096,34324163,autoimmune thyroid diseases
3097,34324163,bioassay
3098,34324163,disease
3099,34324163,functional thyrotropin receptor antibodies
3100,34324163,graves
3101,34324163,orbitopathy
3102,34324163,stimulatory antibodies
3103,34347224,blepharoptosis
3104,34347224,graves' disease
3105,34347224,myasthenic ptosis
3106,34347224,myogenic ptosis
3107,34347224,thyroid eye disease
3108,34613563,graves’ orbitopathy
3109,34613563,immunoassay
3110,34613563,thyroid stimulating immunoglobulin
3111,34613563,thyroid-associated orbitopathy
3112,34714163,*graves' disease
3113,34714163,*trab assay
3114,34714163,*thyroid autoimmunity-clinical
3115,34714163,*thyroid eye disease
3116,34714163,*thyroid stimulating immunoglobulins
3117,34544941,graves’ disease
3118,34544941,graves’ ophthalmopathy
3119,34544941,hyperthyroidism
3120,34544941,internal ophthalmoplegia
3121,34544941,tonic pupil
3122,34781042,graves ophthalmopathy
3123,34781042,diabetes
3124,34781042,extraocular muscles
3125,34781042,optic neuropathy
3126,34781042,severity
3127,34781042,thyroid eye disease
3128,35082799,*graves’ disease
3129,35082799,*berberine
3130,35082799,*methimazole
3131,35082799,*microbiome
3132,35082799,*prebiotics cois commercial or financial relationships that could be construed as a potential conflict of interest.
3133,34714162,*graves' disease
3134,34714162,*graves' orbitopathy
3135,34714162,*orbital cell stimulation
3136,34714162,*thyroid stimulation
3137,34714162,"*thyrotropin receptor stimulatory autoantibodies cois germany, has received research-associated funding from the jgu medical faculty, advancecor (germany), apitope (united kingdom), berlin-chemie (germany), byondis (the netherlands), horizon therapeutics (usa), immunovant (usa), isar (germany), mediomics (usa), merck (germany), novartis (usa), quidel (usa), river vision (usa), and roche (switzerland). g.j.k. consults for glycoera (switzerland), immunovant, mediomics, merck, novartis, roivant (usa), quidel, and vasaragen (usa)."
3138,34743487,*eyelids
3139,34743487,*inflammation
3140,34743487,*orbit
3141,34743487,*selenium cois was reported.
3142,34330200,dry eye
3143,34330200,graves’ ophthalmopathy
3144,34330200,meibography
3145,34330200,meibomian glands
3146,34330200,ocular surface
3147,34859391,anti-tg
3148,34859391,anti-tpo
3149,34859391,ctla-4
3150,34859391,graves´ disease
3151,34859391,radioiodine
3152,34859391,trab cois
3153,34851466,bell’s phenomenon
3154,34851466,graves
3155,34851466,ophthalmopathy
3156,34851466,orbital wall decompression
3157,34851466,thyroid-associated ophthalmopathy
3158,34468829,octa
3159,34468829,pulse therapy
3160,34468829,thyroid-associated orbitopathy cois
3163,35145480,*lymph node metastasis
3164,35145480,*papillary thyroid carcinoma
3165,35145480,*postoperative radioactive iodine
3166,35145480,*treatment strategy
3167,35145480,*tumor location cois commercial or financial relationships that could be construed as a potential conflict of interest.
3168,31813786,*antigen-specific immunotherapy
3169,31813786,*autoimmune thyroid disorders
3170,31813786,*corticosteroids
3171,31813786,*rituximab
3172,31813786,*teprotumumab
3173,31813786,*tocilizumab cois
3174,34916318,*clinical trials
3175,34916318,*ophthalmology
3176,34916318,*thyroid disease cois
3179,34726857,bony orbital decompression
3180,34726857,corneal ulcer
3181,34726857,exophthalmos
3182,34726857,keratopathy
3183,34726857,lagophthalmos
3184,34726857,neurotrophic keratitis
3185,34726857,tarsorrhaphy
3186,34726857,thyroid eye disease
3187,33860819,exophthalmos
3188,33860819,graves’ ophthalmopathy
3189,33860819,low dose radiation therapy
3190,33860819,radiotherapy
3191,33860819,"thyroid eye disease cois o. ott, m. hecht, r. fietkau, b. frey, and f. putz declare that they have no competing interests."
3192,33517799,*lid flare
3193,33517799,*beziér lines
3194,33517799,*graves orbitopathy
3195,33517799,*lid contour
3196,33517799,*lid retraction
3197,33109498,autoimmune thyroid disease
3198,33109498,chinese herbal medicine
3199,33109498,graves’ disease
3200,31721133,antithyroid drugs
3201,31721133,dietary supplements
3202,31721133,graves’ disease
3203,31721133,graves’ orbitopathy
3204,31721133,hyperthyroidism
3205,31721133,selenium cois assessment and supplementation.
3208,34895729,*graves hyperthyroidism
3209,34895729,*endocrine ophthalmopathy
3210,34895729,*orbital irradiation
3211,34895729,*radiotherapy
3212,34895729,*thyroid eye disease
3213,34895729,*thyroid-associated orbitopathy
3215,33797646,*131i
3216,33797646,*effective half-life
3217,33797646,*graves’ disease
3218,33797646,*mird
3219,33797646,*tld measurements
3220,33049131,dio2 gene
3221,33049131,graves’ disease
3222,33049131,polymorphisms
3223,32844239,epidemiology
3224,32844239,graves’ ophthalmopathy
3225,32844239,proptosis
3226,32844239,thyroid eye disease
3228,31237218,cd40
3229,31237218,cd40 ligand
3230,31237218,graves’ ophthalmopathy
3231,31237218,cytokine
3232,31237218,protein microarray
3233,31237218,tear.
3234,34545512,collagen1
3235,34545512,fibrocytes
3236,34545512,graves orbitopathy
3237,34545512,tshr
3238,34545512,peripheral blood mononuclear cells
3239,34531272,*graves’ disease
3240,34531272,*hyperthyroidism
3241,34531272,*thyrotoxic periodic paralysis
3242,34531272,*weakness
3245,31827052,aequorin
3246,31827052,graves’ ophthalmopathy
3247,31827052,thyroid-stimulating antibody
3248,31827052,thyrotropin receptor antibody
3251,33247453,*graves disease
3252,33247453,*edrophonium testing
3253,33247453,*myasthenia gravis
3254,33247453,*ocular myasthenia gravis
3255,33247453,*repetitive nerve stimulation
3256,33247453,*thyroid eye disease
3258,34681884,inflammation
3259,34681884,orbital fibroblasts
3260,34681884,proopiomelanocortin (pomc)
3261,34681884,thyroid eye disease
3262,34681884,α-melanocyte stimulating hormone (α-msh) cois
3263,32057773,*extraocular muscle
3264,32057773,*gene microarray
3265,32057773,*proteomic profiling
3266,32057773,*thyroid-associated ophthalmopathy cois
3267,34487995,diplopia
3268,34487995,endoscopic
3269,34487995,eye
3270,34487995,graves'
3271,34487995,oculoplastic
3272,34487995,orbital decompression
3273,34487995,proptosis
3274,34487995,revision
3275,34487995,rhinology
3276,34487995,sinus
3277,34487995,thyroid
3280,33676921,corticosteroid therapy
3281,33676921,corticothérapie
3282,33676921,graves’ orbitopathy
3283,33676921,mycophenolate mofetil
3284,33676921,mycophénolate mofetil
3285,33676921,orbitopathie basedowienne
3286,33676921,rituximab
3287,33676921,teprotumumab
3288,33676921,tocilizumab
3289,33367784,*graves disease
3290,33367784,*hla class i
3291,33367784,*stat1
3292,33367784,*autoimmune thyroid disease
3293,33367784,*enterovirus
3294,33367784,*viral infections
3295,32506060,*free triiodothyronine
3296,32506060,*free triiodothyronine to free thyroxine ratio
3297,32506060,*subcutaneous fat area
3298,32506060,*visceral fat area cois
3300,34185860,*basedow's disease
3301,34185860,*childhood onset
3302,34185860,*general anesthesia
3303,34185860,*graves' disease
3304,34185860,*hyperthyroidism
3305,34185860,*thyroid storm
3306,34185860,*thyrotoxicosis
3307,31749116,*antithyroid drug
3308,31749116,*graves’ disease
3309,31749116,*lymphocyte
3310,31749116,*neutrophil
3311,31749116,*relapse
3312,34033291,*graves' disease
3313,34033291,*il-27
3314,34033291,*il-35
3315,34033291,*anti-tpo
3316,34033291,*anti-tg
3317,35008579,graves’ disease
3318,35008579,graves’ orbitopathy
3319,35008579,vegf-a
3320,35008579,microrna-199a
3321,35008579,oxidative stress cois competing financial interests exist.
3325,32461007,evaluation of results of therapeutic interventions
3326,32461007,myxedema
3327,32461007,steroids
3328,32461007,therapeutics
3329,34484118,*graves’ disease (gd)
3330,34484118,*mendelian randomization
3331,34484118,*autoimmune disease (ad)
3332,34484118,*causal relationship
3333,34484118,*rheumatoid arthritis cois commercial or financial relationships that could be construed as a potential conflict of interest.
3334,34078122,*thyroid-associated ophthalmopathy
3335,34078122,*adipogenesis
3336,34078122,*adipose/connective tissue
3337,34078122,*alternative splicing
3338,34078122,"*rmats cois of interest with respect to the research, authorship, and/or publication of this article."
3339,32529279,intraocular pressure
3340,32529279,neuropathy
3341,32529279,orbitopathy
3342,32529279,thyroid
3343,32529279,visual field defect
3344,31496266,graves’ ophthalmopathy
3345,31496266,quantitative analysis
3346,31496266,radiation therapy
3347,31496266,thyroid eye disease
3348,31496266,volumetric analysis
3349,33845801,fat decompression
3350,33845801,radiological
3351,33845801,"thyroid-associated ophthalmopathy cois presentation, financial support and proprietary interest statement."
3353,32854466,*graves’ ophthalmopathy
3354,32854466,*choroidal thickness
3355,32854466,*optical coherence tomography
3356,32854466,*proptosis cois
3357,32709794,*activity
3358,32709794,*eugogo
3359,32709794,*thyroid eye disease
3360,32709794,*visa
3361,32709794,*hyperthyroidism
3362,32709794,*severity cois
3363,31804961,hyperthyroidism
3364,31804961,radioactive iodine therapy
3365,31804961,sinusitis
3366,34647609,cd4+ t cell
3367,34647609,th lymphocytes
3368,34647609,treg lymphocytes
3369,34647609,autoimmune thyroid disease
3370,33400175,*anti-thyroid drugs
3371,33400175,*hyperthyroidism
3372,33400175,*outcome
3373,33400175,*radioactive iodine therapy
3374,32737644,laryngopharyngeal reflux
3375,32737644,local neck symptoms
3376,32737644,nodular goiter
3377,32737644,thyroidectomy cois
3378,34144327,*cyclic peptide
3379,34144327,*graves' orbitopathy
3380,34144327,*long-term graves' disease mouse model
3381,34144327,*orbital collagen
3382,34144327,*thyroid dysfunction
3383,34144327,*thyrotropin receptor antibodies
3384,32088116,*autoimmune
3385,32088116,*biological agents
3386,32088116,*graves' disease
3387,32088116,*insulin-like growth factor-i receptor
3388,32088116,*monoclonal antibodies
3389,32088116,*teprotumumab
3390,33775197,entropion
3391,33775197,eyelid retraction
3392,33775197,orbital decompression
3393,33775197,thyroid eye disease
3394,33775197,ultrasound biomicroscopy
3395,33086191,*pdk2
3396,33086191,*glycolysis
3397,33086191,*orbital fibroblasts
3398,33086191,*proliferation
3399,33086191,*thyroid-associated ophthalmopathy
3400,31345156,graves’ ophthalmopathy
3401,31345156,angiotensinconverting enzyme inhibitors
3402,31345156,enalapril
3403,31345156,hyperthyroidism
3404,31345156,mild ophthalmopathy
3405,31345156,palpebral fissure.
3406,34855199,csvt
3407,34855199,graves’ disease
3408,34855199,cerebral sinus venous thrombosis
3409,34855199,child
3410,34855199,hyperthyroidism
3411,32474766,gene polymorphisms
3412,32474766,graves' disease
3413,32474766,interleukin-1 (il-1)
3414,32474766,interleukin-6 (il-6)
3415,32474766,tumor necrosis factor-α (tnf-α)
3416,34147078,graves’ orbitopathy
3417,34147078,in vivo confocal microscopy
3418,34147078,meibomian glands
3419,34147078,microstructure cois
3421,33268601,graves’ ophthalmopathy
3422,33268601,anti-thyroid-stimulating hormone receptor antibodies
3423,33268601,clinical activity score
3424,33268601,pregnancy
3425,33268601,thyroid stimulating antibody
3427,32588167,decompression
3428,32588167,diplopia
3429,32588167,exophthalmos
3430,32588167,graves’ ophthalmopathy
3431,32588167,orbit
3432,32588167,proptosis cois
3434,31953667,graves ophthalmopathy
3435,31953667,lacrimal apparatus
3436,31953667,magnetic resonance imaging
3437,31953667,orbital diseases
3440,34156783,bony regrowth
3441,34156783,deep lateral orbital decompression
3442,34156783,thyroid eye disease
3443,34156783,ultrasonic osteodestruction
3444,33431733,graves' disease
3445,33431733,painless thyroiditis
3446,33431733,potassium iodide cois
3447,32727578,circular rna
3448,32727578,exosomes
3449,32727578,graves’ disease
3450,32727578,immune activation
3451,32727578,hsa_circrna_000102 cois
3452,34273482,benign thyroid disorders
3453,34273482,biologically effective dose
3454,34273482,dose-rate effects
3455,34273482,outcome probability
3456,34273482,proportional odds model
3457,34273482,radioiodine therapy
3458,33943012,*t helper 17 cells
3459,33943012,*autoimmune thyroid disease
3460,33943012,*selenium cois
3461,32810095,"postpartum thyroiditis, graves' disease, colour doppler ultrasound."
3463,34867823,*graves’ disease (gd)
3464,34867823,*hashimoto thyroiditis (ht)
3465,34867823,*autoimmune thyroid disease
3466,34867823,*gut microbiota
3467,34867823,*meta-analysis cois commercial or financial relationships that could be construed as a potential conflict of interest.
3468,33329408,*graves’ disease
3469,33329408,*graves’ orbitopathy
3470,33329408,*tsh receptor antibodies
3471,33329408,*hyperthyroidism
3472,33329408,*hypothyroidism
3473,33329408,*radioiodine (131i) treatment
3474,33329408,*smoking cois commercial or financial relationships that could be construed as a potential conflict of interest.
3475,31849168,graves' disease
3476,31849168,antithyroid drug
3477,31849168,children
3478,31849168,remission
3479,31849168,thyroid-stimulating hormone receptor antibodies
3480,34628889,hyperthyroidism
3481,34628889,hypercalcemia
3482,34628889,morbidity
3483,34628889,thyroid related antibodies
3484,34628889,vitamin d3
3485,34536118,medial orbital wall decompression
3486,34536118,medial rectus muscle expansion
3487,34536118,medial rectus muscle misalignment
3488,34536118,periosteal flap
3489,34536118,thyroid eye disease
3490,32122631,computer-assisted surgery
3491,32122631,exophthalmos
3492,32122631,neuronavigation
3493,32122631,orbital decompression
3494,32122631,proptosis
3495,32122631,thyroid-associated ophthalmopathy
3497,34645767,autoimmune polyglandular syndrome
3498,34645767,superior mesenteric artery syndrome
3499,34645767,type 1 diabetes cois
3500,33941360,complications
3501,33941360,graves’ disease
3502,33941360,lugol
3503,33941360,potassium iodide
3504,33941360,thyroidectomy
3505,33832456,autoimmune disease
3506,33832456,biomarker
3507,33832456,graves’ disease
3508,33832456,thyroid eye disease cois manuscript.
3510,35285441,graves disease
3511,35285441,tsi
3512,35285441,cancer
3513,35285441,papillary
3514,35285441,thyroid
3515,34844465,*covid-19
3516,34844465,*graves’ disease
3517,34844465,*sars-cov-2
3518,34844465,*thyroid storm
3519,34844465,"*thyrotoxicosis cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
3520,31805011,*genetic diseases
3521,31805011,*genetics
3522,31805011,*oncology
3523,31805011,*rna processing
3524,31805011,*thyroid disease cois exists.
3528,32498091,*graves’ disease
3529,32498091,*hashimoto’s thyroiditis
3530,32498091,*irak1 polymorphism
3531,32498091,*x chromosome genetic analysis
3532,32498091,*autoimmune thyroid disease
3533,32498091,*thyroid-associated ophthalmopathy
3534,33568133,*graves’ disease
3535,33568133,*susceptibility genes
3536,33568133,*three generations
3537,33568133,*whole exome sequencing cois
3539,32845332,*graves’ disease
3540,32845332,*hyperthyroidism
3541,32845332,*immunomodulation
3542,32845332,*immunotherapy
3543,32845332,*thyroid hormone
3544,32845332,*thyroid-stimulating hormone receptor
3545,33858208,*graves'
3546,33858208,*sars-cov-2 vaccines
3547,33858208,*adverse vaccine reactions
3548,33858208,*autoimmune/inflammatory syndrome induced by adjuvants
3549,33858208,*disease
3550,33673340,*b cells
3551,33673340,*graves’ disease
3552,33673340,*igf-ir
3553,33673340,*igf-ir inhibitors
3554,33673340,*t cells
3555,33673340,*tshr
3556,33673340,*autoimmunity
3557,33673340,*proptosis
3558,33673340,*thyroid-associated ophthalmopathy cois inventions concerning the use of igf-ir inhibitors as therapy in graves’ disease. these patents are held by ucla school of medicine and los anglees biomedical research institute. he is a consultant for horizon therapeutics.
3559,32126013,graves
3560,32126013,hashimoto
3561,32126013,autoimmune thyroid
3564,32515628,corneal biomechanical properties
3565,32515628,corneal hysteresis
3566,32515628,ocular response analyzer
3567,32515628,thyroid associated ophthalmopathy
3571,34291345,diplopia
3572,34291345,exophthalmos
3573,34291345,graves’ orbitopathy
3574,34291345,orbital decompression
3575,34291345,surgical outcome cois paper and did not receive any financial support toward the completion of this work.
3576,33855963,thyroid eye disease
3577,33855963,tocilizumab
3578,33613458,*graves’ disease
3579,33613458,*hashimoto autoimmune thyroiditis
3580,33613458,*adolescents
3581,33613458,*autoimmune thyroid diseases
3582,33613458,*children cois commercial or financial relationships that could be construed as a potential conflict of interest.
3584,32930505,müllerectomy
3585,32930505,graves' orbitopathy
3586,32930505,levator disinsertion
3587,32930505,upper eyelid retraction
3588,32930505,upper eyelid surgery
3590,34020391,aitd
3591,34020391,il-10
3592,34020391,regulatory b cells
3594,34243868,graves disease
3595,34243868,hyperthyroidism
3596,34243868,thyroid
3597,34243868,thyroid cancer
3598,34243868,toxic nodule
3599,32785898,*cardiac output
3600,32785898,*echocardiography
3601,32785898,*n-terminal-pro-b-type natriuretic peptide
3602,32785898,*neonatal hyperthyroidism
3603,32785898,*thyroid-stimulating hormone receptor antibody
3604,34684053,creatine kinase
3605,34684053,graves’ disease
3606,34684053,methimazole
3607,34684053,myopathy cois
3609,32741892,graves' disease
3610,32741892,hyperthyroidism
3611,32741892,resting energy expenditure
3612,32741892,resting metabolic rate cois
3614,31424978,etiopathogenesis
3615,31424978,graves’ disease
3616,31424978,genetic factors
3617,31424978,thyroid-associated orbitopathy
3618,31424978,vitamin d receptor
3620,34742692,*eye proteins/*analysis
3621,34742692,*eye diseases/diagnosis/*metabolism
3622,34742692,*graves' ophthalmopathy
3623,34742692,*mesh
3624,34742692,*molecular diagnostic techniques/methods
3625,34742692,*orbital inflammatory diseases/diagnosis/*metabolism
3626,34742692,*proteome/*metabolism
3627,34742692,*proteomics/methods
3628,34742692,*tear biomarkers/*metabolism
3629,34742692,*tear proteomics
3630,34742692,"*tears/*metabolism cois eyevensys, santen, affibody, kyverna and covrus."
3631,33371640,cytochrome p450 system
3632,33371640,endocrine ophthalmopathy
3633,33371640,glucocorticoid receptor gene polymorphism
3634,33371640,glucocorticoid therapy
3635,33371640,resistance
3636,32507991,dynamic scheimpflug analyzer
3637,32507991,glucocorticoids
3638,32507991,graves’ orbitopathy
3639,32507991,ocular biomechanics
3640,32636230,drugs: endocrine system
3641,32636230,paediatrics (drugs and medicines)
3642,32636230,thyrotoxicosis cois
3645,32472423,*autoantibodies
3646,32472423,*graves’ disease
3647,32472423,*graves’ orbithopathy
3648,32472423,*tsh receptor
3649,32472423,*thyroid
3650,32472423,"*thyroid cancer cois a developer of medical diagnostics including kits for measuring tsh receptor antibodies. j.f., j.s. and b.r.s. are directors of av7 limited. av7 limited has no other competing interests to declare. k1-70 is currently in use as part of a phase i, single ascending intramuscular or single intravenous dose, safety, tolerability, pharmacokinetic and pharmacodynamic study in subjects with graves’ disease (iras id 199697, eudract number 2014-003815-12)."
3652,34130982,diabetes
3653,34130982,endocrinology
3654,34130982,thyroid disease
3655,34130982,thyrotoxicosis cois
3658,31079052,*cosmesis
3659,31079052,*eye lids
3660,31079052,*orbit cois
3661,34037961,*antiphospholipid antibodies
3662,34037961,*apolipoproteins
3663,34037961,*autoimmune thyroid diseases
3664,34037961,*graves’ orbitopathy
3665,34037961,*interleukine 6
3668,31132076,igf-1
3669,31132076,igf-1r
3670,31132076,thyroid cancer
3671,34202024,graves’ ophthalmopathy
3672,34202024,curcumin
3673,34202024,orbital fibrosis
3674,34202024,thyroid eye disease cois
3675,33844165,ablation
3676,33844165,autoimmunity
3677,33844165,graves’ disease
3678,33844165,graves’ orbitopathy
3679,33844165,radioiodine
3680,33844165,thyroid cois
3681,33484567,*graves’ orbitopathy
3682,33484567,*genetics
3683,33484567,*thyroid eye disease
3684,33246456,case report
3685,33246456,hashimoto’s disease
3686,33246456,hashimoto’s thyroiditis
3687,33246456,ophtalmopathy
3688,33246456,orbitopathy cois
3689,32112702,graves’ disease
3690,32112702,adrenal crisis
3691,32112702,autoimmune polyglandular syndrome type ii
3694,33514849,*cd4+ cytotoxic t lymphocytes
3695,33514849,*graves’ orbitopathy
3696,33514849,*single-cell rna sequencing cois
3697,32991886,*fibroblasts
3698,32991886,*orbit
3699,32991886,*polysaccharides
3700,32991886,*prunella vulgaris
3701,32991886,*thyroid-associated ophthalmopathy
3702,32340849,cas
3703,32340849,graves orbitopathy
3704,32340849,graves’ disease
3705,32340849,maladie de basedow
3706,32340849,orbitopathie basedowienne
3707,32340849,anticorps aux récepteurs d’hormone thyréostimulante
3708,32340849,hyperthyroidism
3709,32340849,hyperthyroïdie
3710,32340849,thyroid-stimulating hormone receptor antibodies
3711,32340849,tocilizumab
3712,32293702,graves’ disease
3713,32293702,graves’ orbitopathy
3714,32293702,tsh-receptor antibodies
3715,32293702,radioiodine
3716,32293702,thyroidectomy
3717,31144509,thyroid
3718,31144509,graves
3719,31144509,orbitopathy
3720,32564766,graves' disease
3721,32564766,yersinia enterocolitica
3722,32564766,autoimmune thyroid diseases
3723,32564766,hashimoto's thyroiditis
3724,32564766,meta-analysis
3725,32564766,thyroid dysfunction
3726,34248849,*graves’ disease
3727,34248849,*children
3728,34248849,*environmental substances
3729,34248849,*metabolomics
3730,34248849,*single-nucleotide polymorphisms cois commercial or financial relationships that could be construed as a potential conflict of interest.
3731,32405700,anti-cd20 antibody
3732,32405700,basedow’s disease
3733,32405700,clinical activity score (cas)
3734,32405700,graves’ orbitopathy
3735,32405700,rituximab
3738,34616359,*graves’ disease (gd)
3739,34616359,*rna methyltransferase
3740,34616359,*rna modification
3741,34616359,*methyltransferase like 3 (mettl3)
3742,34616359,*suppressor of cytokine signaling (socs) cois commercial or financial relationships that could be construed as a potential conflict of interest.
3744,34130234,graves’ ophthalmopathy
3745,34130234,lacrimal gland
3746,34130234,magnetic resonance imaging
3747,34130234,t1 mapping
3748,34130234,t2 mapping
3751,34328251,*graves disease
3752,34328251,*hiv
3753,34328251,*immune reconstitution inflammatory syndrome
3754,34328251,*radioactive iodine treatment
3755,33746907,*clinical activity score
3756,33746907,*disease severity
3757,33746907,*ethnically diverse
3758,33746907,*immunosuppression
3759,33746907,*polyautoimmunity
3760,33746907,*psoriasis
3761,33746907,*rheumatoid arthritis
3762,33746907,*thyroid eye disease cois commercial or financial relationships that could be construed as a potential conflict of interest.
3763,33658982,*dna methylation
3764,33658982,*epigenetics
3765,33658982,*graves’ ophthalmopathy
3766,33658982,*orbital fibroblast
3767,33658982,*proteomics cois commercial or financial relationships that could be construed as a potential conflict of interest.
3768,33560351,*3-hydroxy-3-methylglutaryl-coenzyme reductase inhibitors
3769,33560351,*graves disease
3770,33560351,*graves orbitopathy
3771,33560351,*statins
3772,31784912,embryopathy
3773,31784912,graves’ diseases
3774,31784912,methimazole
3775,31784912,pancreatitis
3776,31784912,pregnancy
3777,31784912,propylthiouracil
3778,31927748,cytokines
3779,31927748,ocular surface
3780,31927748,tear
3781,31927748,thyroid eye disease
3782,34358537,*drug intervention
3783,34358537,*graves’ disease
3784,34358537,*hashimoto’s thyroiditis
3785,34358537,*mathematical model
3786,34358537,*thyroid hormone regulation cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
3787,33786753,exophthalmos
3788,33786753,figuration and abstraction
3789,33786753,graves’orbitopathy
3790,33786753,natalie frank
3791,33786753,post-modern american art
3793,32767605,graves disease
3794,32767605,free region of interest
3795,32767605,shear wave elastography
3796,32767605,ultrasound
3797,32107993,*graves disease
3798,32107993,*technetium (99mtc) pertechnetate thyroid scintigraphy
3799,32107993,*autoimmune disorder
3800,32107993,*color doppler ultrasonography
3801,32107993,*thyroid hormones
3802,32107993,*thyrotropin
3804,34281356,*autoimmune
3805,34281356,*comorbidities
3806,34281356,*thyroid
3807,33663404,*amiodarone
3808,33663404,*dilated thyrotoxic cardiomyopathy
3809,33663404,*heart failure
3810,33663404,*multifocal atrial tachycardia
3811,33663404,*thyroid storm cois
3814,34773561,clinical features
3815,34773561,cytokines
3816,34773561,graves’ disease
3817,34773561,igg4-related diseases
3818,34773561,serum igg4
3820,34025584,*graves disease
3821,34025584,*graves ophthalmopathy
3822,34025584,*graves orbitopathy
3823,34025584,*optic neuropathy
3824,34025584,*thyroid eye disease
3825,34025584,*thyroid-associated ophthalmopathy cois thyroid eye disease amsterdam declaration implementation group). the remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
3826,32507887,*graves disease
3827,32507887,*epidemiology
3828,32507887,*hyperthyroidism
3829,32507887,*ulcerative colitis
3830,32315207,*graves’ disease
3831,32315207,*hyperthyroidism
3832,32315207,*antithyroid drugs
3833,32315207,*cardiovascular disease
3834,32315207,*mortality
3835,32315207,*pregnancy
3836,32315207,*radioactive iodine
3837,32315207,*thyroidectomy
3838,33941979,"carbimazole, graves's disease, hyperthyroidism, methimazole, prophylthiouracil,  thiomazole, thyrotoxicosis."
3841,33187482,child health
3842,33187482,iodine
3843,33187482,iodine deficiency
3844,33187482,iodine supplementation
3845,33187482,maternal health
3846,33187482,nutrition
3847,33187482,pregnancy
3848,33187482,psychomotor development
3849,33187482,public health intervention cois
3850,34549377,extra-cellular volume fraction
3851,34549377,extraocular muscle
3852,34549377,fibrosis
3853,34549377,t1 mapping
3854,34549377,thyroid-associated ophthalmopathy
3855,32949299,bovine pericardium
3856,32949299,strabismus surgery
3857,32949299,tendon elongation
3858,32949299,tutopatch® cois
3859,32771076,dexamethasone administration
3860,32771076,hypokalemia
3861,32771076,steroid-induced
3862,32771076,thyrotoxic periodic paralysis
3863,30457413,biotherapies
3864,30457413,eugogo
3865,30457413,graves’ ophthalmopathy
3866,30457413,proptosis
3867,30457413,tocilizumab
3869,33711978,ocular duction
3870,33711978,orbital decompression
3871,33711978,strabismus
3872,33711978,thyroid eye disease cois
3874,32060570,chronic sinusitis
3875,32060570,eosinophilic angiocentric fibrosis
3876,32060570,igg4-related disease
3877,32060570,immunoglobulin g
3878,32060570,orbit
3879,34465342,biomarker
3880,34465342,hashimoto’s thyroiditis
3881,34465342,lymph node metastasis
3882,34465342,nodular goiter
3883,34465342,pd-1
3884,34465342,papillary thyroid carcinoma cois manuscript is approved by all authors for publication.
3886,33716970,*t2 relaxation time
3887,33716970,*extraocular muscle
3888,33716970,*intravenous methylprednisolone pulse
3889,33716970,*thyroid associated ophthalmopathy
3890,33716970,*treatment response cois commercial or financial relationships that could be construed as a potential conflict of interest.
3892,34144042,autoimmunity
3893,34144042,graves’ disease
3894,34144042,trab
3895,34144042,tsi
3896,34144042,thyroid stimulating hormone receptor autoantibodies
3897,34144042,thyroid stimulating immunoglobulin
3899,32146747,blood flow velocity
3900,32146747,graves disease
3901,32146747,"thyroiditis, autoimmune"
3902,32146747,thyrotoxicosis
3904,34671950,b cells
3905,34671950,graves' ophthalmopathy
3906,34671950,graves' orbitopathy
3907,34671950,lymphocytes
3908,34671950,plasmacells
3909,34671950,t-cells
3910,34671950,thyroid eye disease
3911,34232313,*akt1
3912,34232313,*egfr/pi3k/akt signaling
3913,34232313,*lncrna lpal2
3914,34232313,*mir-1287-5p
3915,34232313,*orbital fibroblast activation
3916,34232313,*thyroid eye disease
3917,33511522,*full-field electroretinography
3918,33511522,*isolated-check visual evoked potential
3919,33511522,*pattern visual evoked potential
3920,33511522,*thyroid-associated ophthalmopathy
3924,33198476,"anaesthesia, thyroid eye disease, thyroid-associated orbitopathy, graves'  ophthalmopathy"
3925,32744317,*cluster of differentiation 74
3926,32744317,*graves disease
3927,32744317,*graves ophthalmopathy
3928,32744317,*immunology & inflammation
3929,32744317,*molecular bases of health & disease
3930,32744317,*subject areas: endocrinology
3931,32744317,*single nucleotide polymorphisms cois manuscript.
3933,33613444,*graves’ ophthalmopathy
3934,33613444,*hub gene
3935,33613444,*lacrimal gland
3936,33613444,*microarray data
3937,33613444,*protein processing in endoplasmic reticulum cois remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
3938,33576183,graves’ orbitopathy
3939,33576183,deviation correction
3940,33576183,dose-effect
3941,33576183,success rates
3942,33576183,superior rectus recession
3943,33343507,*hashimoto autoimmune thyroiditis
3944,33343507,*autoimmunity
3945,33343507,*cancer
3946,33343507,*gut microbiota
3947,33343507,*thyroid cois commercial or financial relationships that could be construed as a potential conflict of interest.
3948,33130479,down syndrome
3949,33130479,graves' disease
3950,33130479,moyamoya disease
3951,33130479,quasi-moyamoya
3952,33130479,thyrotoxicosis
3953,33130479,trisomy 21 cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
3954,33000387,block and replace treatment
3955,33000387,hyperthyroidism
3956,33000387,titration regimen
3957,34102155,*graves ophthalmopathy
3958,34102155,*coefficient variation of cell area
3959,34102155,*corneal endothelium
3960,34102155,*diagnostic capacity
3961,34102155,*disease activity
3963,32684074,go treatment
3964,32684074,graves ophthalmopathy treatment
3965,32684074,ted treatment
3966,32684074,thyroid eye disease treatment
3967,32684074,teprotumumab
3968,32133893,*antithyroid
3969,32133893,*graves’ disease
3970,32133893,*carbimazole
3971,32133893,*methimazole
3972,32133893,*pediatric
3973,32133893,*propylthiouracil
3974,31474503,graves’ orbitopathy
3975,31474503,endocrine ophthalmopathy
3976,31474503,fat removal
3977,31474503,orbital decompression
3978,34243871,extraocular muscles
3979,34243871,graves disease
3980,34243871,graves eye disease (ged)
3981,34243871,lacrimal gland
3984,34235979,*graves' ophthalmopathy
3985,34235979,*extracellular matrix
3986,34235979,*histone deacetylases
3987,34235979,*orbital fibroblasts
3988,34235979,*platelet-derived growth factor-bb
3989,32739299,*cardiac arrest
3990,32739299,*coronary artery spasm
3991,32739299,*iodine contrast
3992,32739299,*thyrotoxicosis
3993,33865565,graves’ disease
3994,33865565,iodine therapy
3995,33865565,meta-analysis
3996,33865565,radioactive iodine
3997,33865565,thyroid diseases
3999,33468490,*optic nerve
4000,33468490,*orbit cois
4001,32562184,*graves’ disease
4002,32562184,*thyroid-stimulating immunoglobulin
4003,32562184,*thyroid-stimulating hormone receptor autoantibody
4004,32300961,count ivan viii drašković
4005,32300961,graves’ disease
4006,32300961,iodine
4007,32300961,orbitopathy
4008,32300961,spontaneous remission
4009,32300961,tobacco
4011,32858059,autoimmunity
4012,32858059,brahms
4013,32858059,biotin
4014,32858059,graves’ disease
4015,32858059,roche cobas
4016,32858059,trace
4017,32858059,trab
4018,32858059,tsh-receptor antibody
4019,32858059,thermo scientific kryptor
4020,32858059,thyroid stimulating antibody
4021,32134013,*channelopathies
4022,32134013,*tpp
4023,32134013,*hypokalaemia
4024,32134013,*paralysis
4025,32134013,*periodic palsy
4026,32134013,*thyroid hormones
4027,32134013,*thyrotoxicosis cois
4028,34855075,mir-155
4029,34855075,microrna
4030,34855075,rennin—angiotensin—aldosterone system
4031,34855075,thyrotoxic heart disease
4032,34544076,16s ribosomal rna
4033,34544076,25(oh)d
4034,34544076,graves’ disease
4035,34544076,il-17
4036,34544076,intestinal flora
4038,32666762,thyroid autoimmunity
4039,32666762,vitamin d
4040,32666762,vitamin d supplementation
4041,31056988,extraocular muscle
4042,31056988,graves’ eye disease
4043,31056988,superior recuts
4044,31056988,thyroid eye disease
4045,33349844,*maternal thyroid function
4046,33349844,*pregnancy
4047,33349844,*thyroid in pregnancy
4048,32249902,*graves’ orbitopathy
4049,32249902,*adipogenesis
4050,32249902,*autophagy
4051,32249902,*chloroquine
4052,32249902,*hydroxychloroquine
4053,32249902,*orbital fibroblasts
4055,31865369,*graves hyperthyroidism
4056,31865369,*tsh-r blocking antibodies
4057,31865369,*tsh-r stimulating antibodies
4058,31865369,*dilution analysis
4059,31865369,*prospective trial
4060,32693696,thyroid-associated ophthalmopathy
4061,32693696,dose response
4062,32693696,strabismus surgery
4063,32693696,torsion
4064,31756165,graves’ disease (gd)
4065,31756165,autoimmune polyglandular syndrome type 3 variant (aps3v)
4066,31756165,autoimmune thyroid disease (aitd)
4067,31756165,rheumatoid arthritis (ra)
4068,31756165,type 1 diabetes mellitus (t1d)
4069,31756165,type 2 diabetes mellitus (t2d)
4070,32804020,chronic sinus
4071,32804020,neck abscess
4072,32804020,polyglactin 910
4073,32804020,post thyroidectomy
4074,32804020,retained suture
4075,33880967,*adpla
4076,33880967,*rna interference
4077,33880967,*tao
4078,33880967,*adipocytes
4079,33880967,"*microneedles cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
4080,33390059,exophthalmos
4081,33390059,eyelid retraction
4082,33390059,orbital decompression
4083,33390059,thyroid-associated orbitopathy
4084,33390059,vertical diplopia
4086,32176314,*cd34
4087,32176314,*cd68
4088,32176314,*fgf-b
4089,32176314,*foxp-3
4090,32176314,*graves’ orbitopathy
4091,32176314,*igf-1r
4092,32176314,*ihc
4093,32176314,*ppar-g
4094,32176314,*tgf-b
4095,32176314,*autoimmunity
4096,32176314,*tissue remodeling
4098,31952487,dysthyroid optic neuropathy
4099,31952487,graves’ orbitopathy
4100,31952487,japanese
4101,31952487,orbital decompression
4102,31952487,visual outcome cois
4103,33972303,endocrinology
4104,33972303,neurology (drugs and medicines)
4105,33972303,ophthalmology
4106,33972303,thyroid disease cois
4109,32638278,elastography
4110,32638278,graves
4111,32638278,medial rectus muscle
4112,32638278,optic nerve
4113,32638278,shear wave
4115,31997590,*blood vessels
4116,31997590,*children
4117,31997590,*microvascular imaging
4118,31997590,*ultrasonography
4119,31997590,"*ultrasonography, doppler, color cois"
4120,33050937,graves’ disease
4121,33050937,papillary thyroid carcinoma
4122,33050937,prognosis
4123,33050937,recurrence cois
4125,32874077,cascade testing
4126,32874077,thyroid dysfunction
4127,32874077,thyroid stimulating hormone
4128,32321476,extraocular muscles
4129,32321476,histopathology
4130,32321476,ocular myasthenia gravis
4131,32321476,thyroid-associated ophthalmopathy cois
4135,33381085,*enalapril
4136,33381085,*graves’ orbitopathy (go)
4137,33381085,*n-acetyl-l-cysteine
4138,33381085,*quercetin
4139,33381085,*vitamin c
4140,33381085,*melatonin
4141,33381085,*oxidative stress
4142,33381085,*β-carotene cois commercial or financial relationships that could be construed as a potential conflict of interest.
4145,34487739,*graves’ orbitopathy
4146,34487739,*thyroid eye disease
4147,34487739,*fibroblast
4148,34487739,*insulin-like growth factor 1 receptor
4149,34487739,*microrna
4150,34487739,*orbital fibroblast
4151,34487739,*teprotumumab
4152,34487739,"*therapeutics, targeted therapy cois"
4156,32447327,*drugs
4157,32447327,*orbit
4158,32447327,*treatment medical cois
4161,32297812,*graves’ disease (gd)
4162,32297812,*hyperlipidemia
4163,32297812,*polycystic ovary syndrome (pcos)
4164,32090526,*diffusion tensor imaging
4165,32090526,*extraocular muscle
4166,32090526,*optic nerve
4167,32090526,*readout-segmented echo-planar imaging
4168,32090526,*thyroid-associated orbitopathy cois
4169,34939881,*covid-19 vaccines
4170,34939881,*graves disease
4171,34939881,*sars-cov-2
4172,34939881,*case report
4173,34939881,*endocrinology
4174,34939881,*immunology
4175,34939881,"*pharmacovigilance cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
4176,33158379,thyroid eye disease
4177,33158379,eyelid disease: eyelid malpositions/trichiasis/ptosis
4178,33158379,neuro ophthalmology
4179,33158379,optic neuropathy
4180,33158379,orbital disease
4181,33158379,strabismus
4182,32969067,131i
4183,32969067,dosimetry
4184,32969067,hyperthyroidism
4190,31915884,chronic sinusitis
4191,31915884,eosinophilic angiocentric fibrosis
4192,31915884,igg4-related disease
4193,31915884,immunoglobulin g
4194,31915884,orbit
4195,31884304,autoantibodies
4196,31884304,graves' disease
4197,31884304,smoking
4198,31884304,vitamin 25(oh)d3 cois
4199,32712880,dicer1
4200,32712880,follicular thyroid carcinoma
4201,32712880,met
4202,32712880,macrofollicular variant
4203,32712880,mutation cois
4204,34704876,*graves’ ophthalmopathy
4205,34704876,*glucocorticoids
4206,34704876,*immunotherapy
4207,34704876,*therapy
4208,34704876,*tocilizumab
4209,34635084,bell’s phenomeon
4210,34635084,fibrosis
4211,34635084,inferior rectus muscle
4212,34635084,thryoid eye disease cois
4213,34250837,choroidal vascularity
4214,34250837,graves’ disease
4215,34250837,binarization
4216,34250837,choroidal thickness
4217,34250837,thyroid
4218,33543610,*tidm4 gene
4219,33543610,*functional mechanism
4220,33543610,*orbital adipose tissue
4221,33543610,*thyroid-associated ophthalmopathy
4224,34933777,b cell subsets
4225,34933777,cd32b
4226,34933777,graves’ disease
4227,34933777,inhibitory receptors cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
4229,34212219,histological confirmation
4230,34212219,idiopathic orbital inflammation
4231,34212219,lymphoid hyperplasia
4232,34212219,orbital lymphoma
4233,34212219,specific orbital inflammation
4234,33128233,*graves’ disease
4235,33128233,*hyperthyroidism
4236,33128233,*paediatric
4237,33128233,*quality of life
4238,33128233,*thyroid
4241,33121425,autoimmune hyperthyroidism
4242,33121425,gitelman syndrome
4243,33121425,endocrine
4244,33121425,gene mutation
4245,33121425,hypokalemia
4246,33121425,metabolic alkalosis.
4247,32643429,*b lymphocytes
4248,32643429,*cxcr5
4249,32643429,*cxcl13
4250,32643429,*graves’ orbitopathy
4251,32643429,*chemokine receptor
4252,32457697,*graves' disease
4253,32457697,*eosinophils
4254,32457697,*subacute thyroiditis
4255,32457697,*thyroxine
4256,32457697,*triiodothyronine
4257,33218789,extra-adrenal paraganglioma
4258,33218789,paraganglioma
4259,33218789,subclavian paraganglia
4260,33218789,superior mediastinum
4261,34473251,*atp production
4262,34473251,*graves orbitopathy
4263,34473251,*adipogenesis
4264,34473251,*fatty acid uptake
4265,34473251,*mitochondria oxphos
4266,34473251,*orbital adipose tissue
4267,34342859,covid
4268,34342859,graves’ disease
4269,34342859,sars-cov-2 rna vaccination
4270,34342859,thyroid cois employment by an organization that may gain or lose financially from publication of the article. there are also no other competing interests regarding the manuscript.
4273,31928169,*escape
4274,31928169,*methimazole
4275,31928169,*potassium iodide
4276,31928169,*pregnancy
4277,31928169,*thyrotoxicosis
4279,33930408,*graves' disease
4280,33930408,*graves' orbitopathy
4281,33930408,*teprotumumab
4282,33930408,*translational science
4283,33930408,*biologics
4284,33930408,*clinical activity score
4285,33930408,*randomized clinical trial
4286,33930408,*review
4287,33930408,*thyroid eye disease
4288,33783712,graves’ ophthalmopathy
4289,33783712,meta-analysis
4290,33783712,rituximab
4291,33783712,treatment
4292,32908802,*graves’ ophthalmopathy
4293,32908802,*lincs
4294,32908802,*adipogenesis
4295,32908802,*orbital adipose stem cells
4296,32908802,*thyroid eye disease
4297,32908802,"*thyroid-associated orbitopathy cois d.t. tse, none; d. pelaez, none; s.t. wester, horizon therapeutics (c)"
4298,32738825,*graves´ disease
4299,32738825,*hashimoto thyroiditis
4300,32738825,*autoimmune thyroid disease
4301,32738825,*cluster analysis
4302,32738825,*polyautoimmunity
4306,34867951,*graves’ disease
4307,34867951,*hashimoto’s thyroiditis (ht)
4308,34867951,*autoimmune thyroid diseases (aitds)
4309,34867951,*exosome
4310,34867951,*proteomics cois commercial or financial relationships that could be construed as a potential conflict of interest.
4311,34412613,graves’ disease
4312,34412613,growth hormone
4313,34412613,insulin-like growth factor-i
4314,34412613,thyroid-related ophthalmopathy cois
4316,32785703,* bacteroides fragilis
4317,32785703,*graves’ disease
4318,32785703,*treg/th17
4319,32785703,*intestinal flora
4320,32785703,*propionic acid
4322,34663089,*graves'
4323,34663089,*disease
4324,34663089,*patient-reported outcomes
4325,34663089,*quality of life
4326,34663089,*thyroidectomy cois
4327,33603715,*graves’ orbitopathy
4328,33603715,*biomarker
4329,33603715,*functional thyrotropin receptor antibodies
4330,33603715,*stimulatory tsh receptor antibodies
4331,33603715,"*thyroid eye disease cois authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. the jgu medical center has received research-associated funding unrelated to this study from the jgu medical faculty, advancecor, germany, apitope, united kingdom; immunovant, usa, isar, germany, horizon, usa, mediomics, usa, merck, germany, novartis, usa, quidel, usa, river vision, usa, and roche, switzerland. this article was not specifically funded by a company. the funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication."
4332,31057005,compressive optic neuropathy
4333,31057005,dysthyroid optic neuropathy
4334,31057005,extra-ocular muscles
4335,31057005,orbital computed tomography
4336,31057005,thyroid eye disease
4337,31057005,visual field
4338,34799942,c-reactive protein
4339,34799942,graves’ disease
4340,34799942,hashimoto's thyroiditis
4341,34799942,autoimmune thyroid disease
4342,34799942,interleukin-38 cois
4343,33964007,autoimmunity
4344,33964007,covid-19
4345,33964007,graves’ disease
4346,33964007,graves’ orbitopathy
4347,33964007,sars-cov-2
4348,33964007,thyroid cois
4349,33913798,graves’ disease
4350,33913798,medullary thyroid carcinoma
4351,33913798,carcinogenesis
4352,33913798,endothelin
4354,34602013,*graves’ orbitopathy
4355,34602013,*adipokines
4356,34602013,*methylprednisolone
4357,34051850,*go animal model
4358,34051850,*graves’ disease
4359,34051850,*graves’ ophthalmopathy
4360,34051850,*thyroid disease
4361,34051850,*adipogenesis
4362,34051850,*hpmscs cois paper.
4364,32567442,graves ophthalmopathy
4365,32567442,graves orbitopathy
4366,32567442,mri ted
4367,32567442,tendon sparing
4368,32567442,thyroid eye disease
4370,34117002,cardiovascular medicine
4371,34117002,emergency medicine
4372,34117002,endocrine system cois
4373,32968297,hyperthyroidism; pregnancy; pprom; thyrotoxicosis. cois
4374,34850456,autoimmune thyroid disease
4375,34850456,interference
4376,34850456,nonthyroid autoimmune diseases
4377,34850456,thyroid hormone autoantibody
4378,32648002,clinical activity score
4379,32648002,graves’ disease
4380,32648002,graves’ ophthalmopathy
4381,32648002,graves’ orbitopathy
4382,32648002,tsh receptor autoantibodies
4383,32648002,thyroid eye disease
4384,32583374,autoimmune thyroiditis
4385,32583374,graves’ disease
4386,32583374,graves’ ophthalmopathy
4387,32583374,graves’ orbitopathy
4388,32583374,insulin-like growth factor-1 receptor
4389,32583374,thyroid
4390,32583374,thyroid autoimmunity
4391,32583374,thyroid eye disease
4392,32567373,*thyroid-associated ophthalmopathy
4393,32567373,*decompression surgery & interventional medicine
4394,32567373,*gene network analysis
4395,32567373,*graves’ ophthalmopathy
4396,32567373,*therapeutics
4397,31595798,*graves’ ophthalmopathy
4398,31595798,*retina
4399,31595798,*density
4400,31595798,*microvasculature
4401,31595798,*optical coherence tomography angiography
4402,34116129,*adipogenesis
4403,34116129,*graves' orbitopathy
4404,34116129,*orbital fibroblasts
4405,34116129,*stat3
4406,34116129,*signal transducer and activator of transcription 3
4407,34116129,*thyroid eye disease
4409,31025590,b cells
4410,31025590,graves’ disease
4411,31025590,graves’ orbitopathy
4412,31025590,rituximab
4413,31025590,thyroid eye disease
4414,31025590,anti-cd20
4415,31025590,proptosis
4417,34688699,*long-term
4418,34688699,*proptosis
4419,34688699,*re-treatment
4420,34688699,*teprotumumab
4421,34688699,*thyroid eye disease
4422,34406498,go
4423,34406498,imaging
4424,34406498,mri
4425,34406498,pet
4426,34406498,ted
4427,34406498,thyroid eye disease cois
4428,34344134,graves ophthalmopathy
4429,34344134,retinal diseases
4430,34344134,smoking cois was reported.
4431,32842335,eye injections
4432,32842335,eyelid diseases
4433,32842335,graves ophthalmopathy
4434,32842335,triamcinolone acetonide
4437,34077777,graves’ disease
4438,34077777,graves’ ophthalmopathy
4439,34077777,single nucleotide polymorphism
4440,34077777,vitamin d receptor
4441,33261249,*hyperthyroidism
4442,33261249,*agranulocytosis
4443,33261249,*methimazole
4444,33261249,*neutropenia
4445,33261249,*thionamides
4446,34594339,*gnrh stimulation test
4447,34594339,*graves’ disease
4448,34594339,*autoimmune polyglandular syndrome type 3
4449,34594339,*isolated gonadotropin-releasing hormone deficiency
4450,34594339,*secondary amenorrhea
4451,34594339,*type 1 diabetes mellitus cois commercial or financial relationships that could be construed as a potential conflict of interest.
4452,33866536,foxp3
4453,33866536,glucocorticosteroids
4454,33866536,orbitopathy
4455,33866536,rorγt
4456,33866536,th17
4457,33866536,treg
4458,34114495,*graves' ophthalmopathy
4459,34114495,*tsh receptor
4460,34114495,*antibody drugs
4461,34114495,*autoantibodies
4462,34114495,*thyroid cancer
4463,34792795,autoimmune/inflammatory syndrome induced by adjuvants (asia)
4464,34792795,covid-19
4465,34792795,graves’ disease
4466,34792795,sars-cov2 vaccination
4467,34792795,thyroiditis cois
4468,33148577,endocrine system
4469,33148577,endocrinology
4470,33148577,thyroid disease
4471,33148577,thyroiditis
4472,33148577,thyrotoxicosis cois
4474,33844898,covid-19
4475,33844898,thyroid disorders
4476,33844898,hyperthyroidism
4477,33844898,hypothyroidism
4478,33844898,subacute thyroiditis
4480,32339726,*adult
4481,32339726,*case report
4482,32339726,*magnetic resonance imaging
4483,32339726,*pathology
4484,32339726,*pituitary blastoma
4486,31636036,ent surgery
4487,31636036,endocrine surgery
4488,31636036,gbi
4489,31636036,glasgow benefit inventory
4490,31636036,graves' disease
4491,31636036,patient recorded outcome measure
4492,31636036,patient satisfaction score
4493,31636036,thyroid
4494,31636036,total thyroidectomy cois
4495,33882721,*graves'
4496,33882721,*age
4497,33882721,*disease
4498,33882721,*disease prognosis
4499,33882721,*hyperthyroidism
4500,33882721,*sex
4501,33505575,africa
4502,33505575,paralysis
4503,33505575,hyperthyroidism
4504,33505575,hypokalemia cois
4505,32669187,graves disease
4506,32669187,"infant, newborn"
4507,32669187,mothers
4508,32669187,pregnancy complications
4509,32669187,prenatal exposure delayed effects
4515,33409786,artifacts
4516,33409786,eye diseases
4517,33409786,magnetic resonance imaging
4518,33409786,thyroid diseases
4519,33081749,choroidal thickness
4520,33081749,optical coherence tomography angiography
4521,33081749,retinal nerve fiber layer
4522,33081749,thyroid-associated ophthalmopathy cois publication of this paper.
4523,32855872,*graves' disease
4524,32855872,*murine model
4525,32855872,*orbital inflammation
4526,32855872,"*thyroid eye disease cois none; l. ramos, none; s.k. freitag, none; d.r. bielenberg, none; l.a. kim, none; n.g. lee, none"
4527,32779176,ct
4528,32779176,mri
4529,32779176,ultrasonography
4530,32779176,ectopic thyroid
4531,32779176,multimodality
4532,32779176,thyroid scintigraphy
4534,32546346,*bone mineral density
4535,32546346,*graves’ disease
4536,32546346,*dual energy x-ray absorptiometry
4537,34526052,3d photography
4538,34526052,blepharoplasty surgery
4539,34526052,digital facial-analysis tool
4540,34526052,endocrine orbitopathy
4541,34526052,lid refinement
4542,34526052,lid repositioning
4543,34526052,ocular surface area cois
4545,32799342,*graves’ disease
4546,32799342,*hyperthyroidism
4547,32799342,*neutropenia
4548,32799342,*white blood cells
4549,31021263,lower eyelid retraction
4550,31021263,orbital decompression
4551,31021263,proptosis
4552,31021263,surgical technique
4553,31021263,thyroid eye disease
4554,33391187,*graves’ disease
4555,33391187,*autoimmune
4556,33391187,*connective tissue
4557,33391187,*insulin-like growth factor i receptor
4558,33391187,*monoclonal antibody
4559,33391187,*thyroid-associated ophthalmopathy cois inhibitors as therapy in graves’ disease. these patents are held by ucla school of medicine and los angeles biomedical research institute.
4560,33311000,grave’s disease
4561,33311000,hashimoto’s thyroiditis
4562,33311000,igg4 thyroiditis
4563,33311000,igg4-related thyroid disease
4564,33311000,riedel’s thyroiditis
4566,32919017,*long non-coding rna
4567,32919017,*orbital adipose/connective tissue
4568,32919017,*rna sequencing
4569,32919017,*thyroid-associated ophthalmopathy
4572,34106438,*ace2
4573,34106438,*autoimmune
4574,34106438,*covid-19
4575,34106438,*graves’ disease
4576,34106438,*hyperthyroidism
4577,34106438,*raas
4578,34106438,*sars-cov-2
4579,34106438,*thyroid cois
4580,34060524,compressive optic neuropathy
4581,34060524,nasal endoscopy
4582,34060524,orbital decompression
4583,34060524,thyroid eye disease cois
4584,33817897,*fractional amplitude of low-frequency fluctuation
4585,33817897,"*regional homogeneity, degree centrality"
4586,33817897,*resting-state fmri
4587,33817897,*thyroid-associated ophthalmopathy
4588,33599843,diplopia
4589,33599843,exophthalmos
4590,33599843,graves’ orbitopathy
4591,33599843,orbital decompression
4592,33446163,machine learning
4593,33446163,magnetic resonance imaging
4594,33446163,thyroid-associated ophthalmopathy cois
4599,34417736,autoimmune
4600,34417736,fibrocyte
4601,34417736,graves’ ophthalmopathy
4602,34417736,insulin-like growth factor receptor
4603,34417736,orbit
4604,34180765,cystic teratoma
4605,34180765,graves’ disease
4606,34180765,primary papillary thyroid carcinoma
4607,33637620,experimental – laboratory
4608,33637620,inflammation
4609,33637620,"orbit cois coinvestigator on a study funded by genentech to evaluate the use of rituximab for orbital inflammatory diseases. jtr, rad, bsk, dok, and gjh are consultants to horizon pharmaceuticals which manufactures teprotumumab. jtr receives research support from horizon pharmaceuticals."
4610,32940167,*graves'
4611,32940167,*clinical trials
4612,32940167,*diplopia
4613,32940167,*ocular ductions
4614,32940167,*orbitopathy
4615,32940167,*rehabilitation
4616,32940167,*squint surgery
4617,33849364,*graves’ orbitopathy
4618,33849364,*clinical activity score
4619,33849364,*glucocorticoids
4620,33849364,*interleukin-6
4621,33849364,*interleukin-8
4622,33849364,*interleukin–10
4624,32849306,*graves' disease
4625,32849306,*tsh secreting pituitary adenoma
4626,32849306,*tshoma
4627,32849306,*concomitant
4628,32849306,*thyrotropin
4629,32238669,agranulocytosis
4630,32238669,antithyroid drug
4631,32238669,hyperthyroidism
4632,32238669,malignancy
4633,32238669,potassium iodide
4634,31603857,graves’ disease
4635,31603857,children
4636,31603857,hyperthyroidism
4637,31603857,radioiodine ablation
4638,34871593,*autoimmune thyroid disease
4639,34871593,*homogeneous camp biosensor
4640,34871593,*thyroid blocking immunoglobulins or antibodies
4641,34871593,*thyroid stimulating immunoglobulins or antibodies
4642,34871593,*thyroid-stimulating hormone receptor
4644,31742747,*hyperthyroidism
4645,31742747,*thyroid scintigraphy
4646,31742747,*thyroid ultrasonography
4647,31742747,*thyroid-stimulating immunoglobulins (tsi)
4648,31742747,*thyrotropin receptor antibodies (trab)
4649,34431214,*graves' disease (gd)
4650,34431214,*stat4
4651,34431214,*autoimmune disease
4652,34431214,*mir-363-5p
4653,34431214,*regulatory t cells (tregs) cois
4654,32429706,graves’ disease
4655,32429706,igf-ir
4656,32429706,r1507
4657,32429706,rv001
4658,32429706,tepezza
4659,32429706,teprotumumab
4660,32429706,thyroid eye disease
4661,32429706,thyroid-associated ophthalmopathy
4662,32192806,cancer héréditaire
4663,32192806,carcinome thyroïdien familial
4664,32192806,cowden syndrome
4665,32192806,dicer1 syndrome
4666,32192806,familial adenomatous polyposis
4667,32192806,familial thyroid carcinoma
4668,32192806,hereditary cancer
4669,32192806,polypose adénomateuse familial
4670,32192806,syndrome dicer1
4671,32192806,syndrome de cowden
4673,34867796,*graves’ disease
4674,34867796,*children
4675,34867796,*metabolic pathway
4676,34867796,*serum metabolomics
4677,34867796,*untargeted metabolomics cois commercial or financial relationships that could be construed as a potential conflict of interest.
4678,34532987,graves’ eye disease
4679,34532987,graves’ ophthalmopathy
4680,34532987,graves’ orbitopathy
4681,34532987,diplopia
4682,34532987,outcomes
4683,34532987,strabismus surgery
4684,34532987,thyroid eye disease
4685,34532987,topical anaesthesia
4686,33443817,*graves’ orbitopathy
4687,33443817,*neferine
4688,33443817,*adipocyte differentiation
4689,33443817,*autophagy
4690,33443817,*inflammation
4691,33443817,*oxidative stress cois topic of the manuscript.
4694,33481154,graves disease
4695,33481154,igf-1r
4696,33481154,r1507
4697,33481154,rv001
4698,33481154,tepezza
4699,33481154,teprotumumab
4700,33481154,thyroid eye disease
4701,33481154,thyroid-associated ophthalmopathy
4704,34889904,graves’ orbitopathy
4705,34889904,binding protein
4706,34889904,thyrostimulin
4707,34889904,thyrotropin receptor
4708,34889904,variant cois
4709,32823277,*nk cells
4710,32823277,*programmed cell death protein-1
4711,32823277,*autoimmune thyroid disease
4714,34122333,*graves’ disease
4715,34122333,*cross-sectional study
4716,34122333,*hyperthyroidism
4717,34122333,*iodine intake
4718,34122333,*thyroid autoimmune antibodies cois commercial or financial relationships that could be construed as a potential conflict of interest.
4719,32501499,*graves disease
4720,32501499,*autoimmune
4721,32501499,*genotyping
4722,32501499,*meta-analysis
4723,32501499,*polymorphism
4724,32501499,*thyroid
4725,31899052,*igf-1
4726,31899052,*orbital fibroblasts
4727,31899052,*thyroid-associated ophthalmopathy
4728,31899052,*thyroid-stimulating hormone receptor cois conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
4729,31827051,autoimmune thyroid diseases
4730,31827051,graves’ disease
4731,31827051,hashimoto’s thyroiditis
4732,31827051,meta-analysis
4733,31827051,regulatory t cells
4734,31617239,graves' disease
4735,31617239,autoantibody
4736,31617239,catalase
4737,31617239,hydrogen peroxide
4738,31617239,malondialdehyde
4739,31617239,oxidative stress
4740,34284740,diffusion tensor imaging
4741,34284740,lacrimal gland
4742,34284740,readout-segmented echo-planar imaging
4743,34284740,thyroid-associated ophthalmopathy cois
4744,33678636,graves’ disease
4745,33678636,graves’ disease associated cholestasis
4746,33678636,cholestasis
4747,33678636,clinical manifestation
4748,33678636,diagnosis
4749,33678636,treatment
4753,33906763,globe prominence
4754,33906763,proptosis
4755,33906763,thyroid eye disease cois therapeutics and osmotica pharmaceuticals.
4756,33858251,foxp3
4757,33858251,graves’ disease
4758,33858251,ethnicity
4759,33858251,meta-analysis
4760,33858251,polymorphism
4761,33858251,susceptibility cois conflict of interest.
4762,33172865,*anatomy
4763,33172865,*orbit
4764,33172865,"*treatment medical cois ak—employer, horizon therapeutics."
4765,32090348,*mri t1 mapping
4766,32090348,*diplopia
4767,32090348,*extraocular muscles
4768,32090348,*fibrosis
4769,32090348,*graves ophthalmopathy
4770,32090348,*intravenous glucocorticoids
4771,32090348,*magnetic resonance imaging
4774,33551434,active surveillance
4775,33551434,graves’ disease
4776,33551434,papillary thyroid microcarcinoma
4777,33551434,radioactive iodine therapy
4778,33551434,tumor volume-doubling rate
4779,33193097,*dysthyroid optic neuropathy
4780,33193097,*grave’s disease
4781,33193097,*grave’s ophthalmopathy
4782,33193097,*orbital decompression
4783,33193097,*rituximab
4784,32495527,*chemokine
4785,32495527,*cytokine
4786,32495527,*graves' orbitopathy
4787,32495527,*interleukin-1β
4788,32495527,*tumor necrosis factor-α cois
4789,34488259,decompression
4790,34488259,eyelids
4791,34488259,graves ophthalmopathy cois
4793,33938028,*graves’ disease
4794,33938028,*graves’ ophthalmopathy
4795,33938028,*igg4
4796,33938028,*glucocorticoid therapy
4797,33682498,dexamethasone
4798,33682498,graves’ disease
4799,33682498,drug resistance
4800,33682498,hyperthyroidism
4801,33682498,inorganic iodine
4802,33682498,lithium carbonate
4803,33682498,methimazole cois conflict of interest.
4804,33517506,deep lateral decompression
4805,33517506,graves disease
4806,33517506,graves orbitopathy
4807,33517506,orbital decompression
4808,33517506,orbital surgery
4810,32965148,graves’s orbitopathy
4811,32965148,tocilizumab
4812,32965148,outcome
4813,32965148,rituximab
4815,32814653,graves’ orbitopathy
4816,32814653,computed tomography
4817,32814653,computer-assisted image processing
4818,32814653,magnetic resonance imaging
4819,32814653,orbit
4821,33199029,dfnb4
4822,33199029,missense mutations
4823,33199029,next-generation sequencing
4824,33199029,pendred syndrome
4825,33199029,slc26a4 gene
4827,32074519,intractability
4828,32074519,polymorphism
4829,32074519,severity
4830,32074519,vegf receptor (vegfr)
4831,32074519,vascular endothelial growth factor (vegf)
4832,35069439,*graves’ disease
4833,35069439,*autoimmune thyroid disease
4834,35069439,*hyperthyroidism
4835,35069439,*pulmonary hypertension
4836,35069439,*thyroid hormone cois commercial or financial relationships that could be construed as a potential conflict of interest.
4837,32374820,*mendelian randomization
4838,32374820,*tsh
4839,32374820,*coronary artery disease
4840,32374820,*mediation
4841,32374820,*stroke
4842,32374820,*thyroid function
4843,32893239,basedow disease
4844,32893239,amyotrophic lateral sclerosis
4845,32893239,soluble il-2 receptor
4846,32893239,thyrotoxic myopathy
4847,32893239,tongue atrophy
4849,34479513,cholestatic liver injury
4850,34479513,graves' disease
4851,34479513,methimazole
4852,34479513,rash
4853,34479513,turner syndrome cois
4857,33132244,graves’ disease
4858,33132244,pd-1
4859,33132244,t lymphocytes
4860,33132244,thyroid follicular cells
4862,34238277,cd160
4863,34238277,graves’ disease
4864,34238277,hashimoto’s thyroiditis
4865,34238277,polymorphism cois
4866,33423386,graves’ orbitopathy
4867,33423386,glucocorticoids
4868,33423386,long-circulating pegylated liposomal prednisolone
4869,33423386,methylprednisolone
4870,33423386,orbit
4871,32651061,*graves' disease
4872,32651061,*breastfeeding
4873,32651061,*hypothyroidism
4874,32651061,*postpartum thyroid dysfunction
4875,32651061,*postpartum thyroiditis
4876,32651061,*thyrotoxicosis
4877,30452877,calprotectin
4878,30452877,graves’ orbitopathy
4879,30452877,inflammation
4880,30452877,orbital fibroblast
4881,30452877,thyroid eye disease
4883,33922887,antithyroid drug
4884,33922887,change
4885,33922887,ocular parameters cois
4888,34258936,dysthyroid optic neuropathy
4889,34258936,hospital anxiety and depression
4890,34258936,regional homogeneity
4891,34258936,resting-state fmri
4892,34258936,thyroid-associated ophthalmopathy cois
4893,33693700,*igf-1
4894,33693700,*il-38
4895,33693700,*m22
4896,33693700,*tgf-β1
4897,33693700,*orbital fibroblasts
4898,33693700,*thyroid-associated ophthalmopathy
4899,33386169,amino acid variants
4900,33386169,graves’ disease
4901,33386169,hla class ii
4902,33386169,hashimoto’s thyroiditis cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
4903,32825964,graves' disease
4904,32825964,hashimoto's thyroiditis
4905,32825964,prognosis
4906,32825964,thyroid cancer
4908,32025782,angio-oct
4909,32025782,choroid
4910,32025782,oct
4911,32025782,orbitopathy
4912,32025782,thyroid
4913,31900640,4-methylumbelliferone
4914,31900640,adipogenesis
4915,31900640,graves’ orbitopathy
4916,31900640,hyaluronic acid
4917,31792849,graves’ ophthalmopathy
4918,31792849,spect/ct
4919,31792849,triamcinolone
4920,33488527,*graves’ disease
4921,33488527,*autoimmune thyroiditis
4922,33488527,*differential diagnosis
4923,33488527,*thyroid function test
4924,33488527,*thyrotoxicosis cois commercial or financial relationships that could be construed as a potential conflict of interest.
4925,33380308,graves’ disease
4926,33380308,thyroid
4927,33380308,cancer
4928,33380308,nodules
4929,33380308,surgery
4930,33380308,thyroidectomy.
4931,34018373,clinical analysis
4932,34018373,extraocular muscles
4933,34018373,magnetic resonance imaging
4934,34018373,thyroid associated ophthalmoathy
4936,33658150,graves ophthalmopathy
4937,33658150,cosmetic reconstructive surgery
4938,33658150,exophthalmos
4939,33658150,ophthalmologic surgical procedure
4940,33658150,orbital decompression
4941,33658150,proptosis
4942,33658150,surgical decompression
4943,33658150,surgical technique
4944,33658150,thyroid eye disease
4945,33658150,thyroid-associated ophthalmopathies
4946,33658150,transantral
4947,34315743,endocrinology
4948,34315743,thyroid disease cois
4949,33630733,t2 mapping
4950,33630733,magnetic resonance imaging
4951,33630733,optic nerve
4952,33630733,thyroid-associated ophthalmopathy
4953,31887836,cytokines
4954,31887836,dihydrotestosterone
4955,31887836,graves disease
4956,31887836,mice
4958,33382429,*genetics
4959,33382429,*hyperthyroidism
4960,33382429,*hypothyroidism
4961,33382429,*twin studies
4962,33009740,graves’ disease
4963,33009740,exophthalmos
4964,33009740,neurosurgery
4965,33009740,ophthalmopathy
4966,33009740,thyroid diseases.
4967,32485674,*graves’ disease
4968,32485674,*nf-κb
4969,32485674,*sirt1
4970,32485674,*thyroid
4971,32545570,agranulocytosis
4972,32545570,hyperthyroidism
4973,32545570,plasmapheresis
4974,32545570,thyroidectomy
4975,32545570,thyrotoxicosis cois
4978,32324288,*graves
4979,32324288,*bone
4980,32324288,*disease
4981,32324288,*fractures
4982,32324288,*immunoglobulins
4983,32324288,*menopause
4984,32324288,*osteoporosis
4985,32324288,*thyroid-stimulating
4987,34334593,acromegaly
4988,34334593,adenomatous goiter
4989,34334593,neurofibromatosis type 1
4990,34334593,primary hyperparathyroidism cois
4993,32500462,alemtuzumab
4994,32500462,graves’ ophthalmopathy
4995,32500462,immune-reconstitution inflammatory syndrome
4996,32500462,marine-lenhart syndrome
4997,34598656,*graves'
4998,34598656,"*disease, meta-analysis, radiation absorbed dose, radioiodine, systematic review cois research and training program 2014–2018 and national institute for health research (nihr) and funding from national health service to the nihr biomedical research centre at the royal marsden and the institute of cancer research and nihr royal marsden clinical research facility outside the work of the study. j.i.g. reports personal fees and honoraria from the eanm outside the work of the study."
5000,32612577,*foxp3
5001,32612577,*graves' disease
5002,32612577,*autoimmune thyroid disease
5003,32612577,*meta-analysis
5004,32612577,*polymorphism
5005,32878536,ct imaging
5006,32878536,extraocular muscle
5007,32878536,fatty infiltration
5008,32878536,thyroid eye disease
5009,34637060,dysthyroid optic neuropathy
5010,34637060,octa
5011,34637060,peripapillary vessel density
5012,34637060,retinal nerve fiber layer thickness
5013,34637060,thyroid-associated ophthalmopathy cois
5014,33853289,autoimmune thyroid disease.
5015,33853289,children and adolescents
5016,33853289,type 1 diabetes
5017,33853289,metabolic disorders
5018,33579690,*eye (globe)
5019,33579690,*eye lids
5020,33579690,*immunology
5021,33579690,*orbit
5022,33579690,*pathology cois medical centre has received research-associated funding from horizon therapeutics.
5024,32689994,molecular docking
5025,32689994,network pharmacology
5026,32689994,spica prunellae
5027,32689994,tao
5028,32689994,thyroid-associated ophthalmopathy cois
5029,32363975,orbital decompression
5030,32363975,thyroid eye disease
5031,32363975,transantral orbital decompression
5033,32983115,*addison's disease
5034,32983115,*cdcp1
5035,32983115,*graves' disease
5036,32983115,*hashimoto's thyroiditis
5037,32983115,*slamf1
5038,32983115,*plasma
5039,32983115,*proximity extension assay
5040,32983115,*type 1 diabetes
5041,34915605,*antithyroid agents
5042,34915605,*diabetes mellitus
5043,34915605,*graves disease
5044,34915605,*hyperthyroidism
5045,34915605,*radioiodine ablation cois was reported.
5048,34101720,*actemra
5049,34101720,*cellcept
5050,34101720,*rituxan
5051,34101720,*tepezza
5052,34101720,*adverse effects
5053,34101720,*corticosteroids
5054,34101720,*dosage
5055,34101720,*efficacy
5056,34101720,*eye
5057,34101720,*lactation
5058,34101720,*methylprednisone
5059,34101720,*mycophenolate mofetil
5060,34101720,*prednisone
5061,34101720,*pregnancy
5062,34101720,*rituximab
5063,34101720,*safety
5064,34101720,*teprotumumab
5065,34101720,*tocilizumab
5067,31691261,graves’ disease
5068,31691261,graves’ orbitopathy
5069,31691261,idiopathic orbital inflammation
5070,31691261,orbital lymphoma
5071,31691261,pseudotumor
5072,34863412,cord blood
5073,34863412,embarazo
5074,34863412,enfermedad de graves
5075,34863412,graves’ disease
5076,34863412,hipertiroidismo
5077,34863412,hyperthyroidism
5078,34863412,newborn
5079,34863412,pregnancy
5080,34863412,recién nacido
5081,34863412,sangre del cordón umbilical
5082,34863412,trab
5084,32227795,*graves’
5085,32227795,*disease
5086,32227795,*radiation thyroiditis
5087,32227795,*radioactive iodine
5088,33383445,anti-inflammation
5089,33383445,il-23/il-17 axis
5090,33383445,il-23r
5091,33383445,il-38
5092,33383445,pge(2)
5093,33383445,thyroid-associated ophthalmopathy
5097,32933065,graves’ disease
5098,32933065,hashimoto thyroiditis
5099,32933065,autoimmune thyroid disease
5100,32933065,vitamin d
5101,32933065,vitamin d receptor cois
5102,32537950,clinical activity score
5103,32537950,glucocorticoids
5104,32537950,graves' ophthalmopathy
5105,32537950,response rate cois
5107,31834613,adverse events
5108,31834613,graves’ orbitopathy
5109,31834613,mycophenolate
5110,31834613,safety
5111,31782290,*thyroid hormone
5112,31782290,*thyroid volume
5113,31782290,*graves’ disease
5114,31782290,*soluble cd40 ligand (scd40l)
5115,31705858,graves' orbitopathy
5116,31705858,nrf2
5117,31705858,oxidative stress
5118,31705858,polydatin cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
5122,31296093,extraocular muscle
5123,31296093,graves’ ophthalmopathy
5124,31296093,real-time ultrasound elastography
5125,34987480,*graves’ disease
5126,34987480,*adhesion molecules
5127,34987480,*carotid intima media thickness
5128,34987480,*hyperthyroidism
5129,34987480,*methimazole
5130,34987480,*propylthiouracil
5131,34987480,*pulse wave velocity
5132,34987480,*vascular atherosclerosis cois commercial or financial relationships that could be construed as a potential conflict of interest.
5133,34287665,*foxo1
5134,34287665,*genetic susceptibility
5135,34287665,*graves’ disease
5136,34287665,*il2ra
5137,34287665,*mir182
5138,34287665,*mir27a
5140,33234032,*cas
5141,33234032,*cd20
5142,33234032,*graves' disease
5143,33234032,*graves' orbitopathy
5144,33234032,*cytokine release syndrome
5145,33234032,*dysthyroid optic neuropathy
5146,33234032,*rituximab
5147,33221730,*genetics
5148,33221730,*immunology
5149,33221730,*orbit cois
5151,31587179,adverse events
5152,31587179,graves’ disease
5153,31587179,graves’ orbitopathy
5154,31587179,oral prednisone
5155,31587179,radioiodine
5156,31587179,steroid prophylaxis
5158,33643223,*graves’ orbitopathy
5159,33643223,*t cells
5160,33643223,*immune
5161,33643223,*mucosa
5162,33643223,*paranasal sinus cois commercial or financial relationships that could be construed as a potential conflict of interest.
5163,33504525,clinical diagnostic tests
5164,33504525,hip prosthesis implantation
5165,33504525,neurology (drugs and medicines)
5166,33504525,psychiatry (drugs and medicines)
5167,33504525,rehabilitation medicine cois
5168,32893386,*graves' orbitopathy
5169,32893386,*extra-ocular muscles
5170,32893386,*eye diseases
5171,32893386,*eye muscles
5172,32893386,*muscle mri
5173,32893386,*myasthenia gravis
5174,32893386,*quantitative mri
5176,32522908,graves’ disease
5177,32522908,neonatal thyroid dysfunction
5178,32522908,tsh receptor antibody
5179,34963497,antineutrophil cytoplasmic antibody-associated vasculitis
5180,34963497,drug-induced anca-associated vasculitis
5181,34963497,graves’ disease
5182,34963497,hypertrophic pachymeningitis
5183,34963497,myeloperoxidase-antineutrophil cytoplasmic antibody cois
5185,34523298,graves´ disease
5186,34523298,immune reconstitution therapy
5187,34523298,multiple sclerosis
5188,34523298,ocrelizumab
5189,34477926,computed tomography
5190,34477926,extraocular muscles
5191,34477926,graves’ orbitopathy
5192,34477926,quantitative analysis
5193,34477926,thyroid eye disease
5194,33669123,fnah
5195,33669123,tshr
5196,33669123,central hypothyroidism
5197,33669123,familial non-autoimmune autosomal dominant hyperthyroidism
5198,33669123,radioiodine ablation therapy cois
5199,33443352,*activating variant of tshr gene
5200,33443352,*non-autoimmune hyperthyroidism
5201,33443352,*neonatal hyperthyroidism
5204,34124812,*graves' disease
5205,34124812,*hypercalcemia
5206,34124812,*hyperparathyroidism
5207,34124812,*parathyroid surgery
5208,34124812,*radioactive iodine
5209,33152840,graves ophthalmopathy
5210,33152840,macula lutea
5211,33152840,optic disk
5212,33152840,optic nerve diseases
5213,33152840,regional blood flow
5214,33152840,"tomography, optical coherence"
5216,31972501,*active graves’ orbitopathy
5217,31972501,*newly diagnosed graves’ disease
5218,31972501,*potential markers
5219,31972501,*pro-inflammatory cytokines
5220,31972501,*selenium cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
5221,31538314,cytokine
5222,31538314,graves’ orbitopathy
5223,31538314,human leukocyte antigen
5224,31538314,immunohistochemistry
5225,31538314,orbital tissue
5226,31538314,tsh receptor
5227,34218976,exophthalmos
5228,34218976,graves hyperthyroidism
5229,34218976,graves ophthalmopathy
5230,34218976,orbital decompression
5231,34218976,quality of life
5232,33910662,*copper deficiency
5233,33910662,*hematological disease
5234,33910662,*mri
5235,33910662,*myeloneuropathy
5237,33295879,*graves’ disease
5238,33295879,*autoimmune hyperthyroidism
5239,33295879,*autoimmune thyroid disease
5240,33295879,*genetic and epigenetic factors
5241,32729365,iodine
5242,32729365,endemic
5243,32729365,goiter
5244,32729365,nodule
5245,32729365,thyroid
5246,32729365,ultrasound
5247,34681587,aitd
5248,34681587,graves’ disease
5249,34681587,autoimmunity
5250,34681587,methimazole
5251,34681587,regulatory b cells
5252,34681587,thyroid cois
5254,33870911,*graves’ orbitopathy
5255,33870911,*perk
5256,33870911,*endoplasmic reticulum stress
5257,33870911,*protein kinase rna-like endoplasmic reticulum kinase
5258,33870911,*thyroid eye disease
5259,35069441,*dna methylation
5260,35069441,*graves’ ophthalmopathy
5261,35069441,*epigenetics
5262,35069441,*gut microbiome
5263,35069441,*histone modification
5264,35069441,*noncoding rnas cois commercial or financial relationships that could be construed as a potential conflict of interest.
5265,34888290,*covid-19
5266,34888290,*covid-19 vaccines
5267,34888290,*graves' disease
5268,34888290,*sars-cov-2
5269,34888290,*autoimmunity
5270,34888290,*thyroiditis cois commercial or financial relationships that could be construed as a potential conflict of interest.
5271,33451885,intraoperative neuromonitoring
5272,33451885,recurrent laryngeal nerve injury
5273,33451885,thyroid surgery
5274,31902232,2a típusú multiplex endokrin neoplasia szindróma
5275,31902232,genetic testing
5276,31902232,genetikai vizsgálat
5277,31902232,medullaris pajzsmirigydaganat
5278,31902232,medullary thyroid cancer
5279,31902232,multiple endocrine neoplasia type 2a
5280,31902232,phaeochromocytoma
5281,31902232,primary hyperparathyroidism
5282,31902232,primer hyperparathyreosis
5283,34047397,*trab
5284,34047397,*fibroblast
5285,34047397,*inducible skin-associated lymphoid tissue (isalt)
5286,34047397,*pretibial myxedema (ptm) cois
5287,32053002,t2 mapping
5288,32053002,thyroid-associated ophthalmopathy
5289,32053002,magnetic resonance imaging
5290,32053002,region of interest
5291,32053002,staging
5292,34690936,*graves’ disease
5293,34690936,*anti-thyroid drug
5294,34690936,*heart failure
5295,34690936,*hyperthyroidism
5296,34690936,*radioiodine ablation cois authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
5297,34647604,cas
5298,34647604,eugogo classification
5299,34647604,nospecs classification
5300,34647604,orbital decompression
5301,34647604,thyroid eye disease
5305,35184917,*decompression surgery
5306,35184917,*endocrine orbitopathy
5307,35184917,*fully digital analysis
5308,35184917,*navigated surgery
5309,34130446,*antithyroid agents
5310,34130446,*congenital abnormalities
5311,34130446,*graves disease
5312,34130446,*iodine
5313,34130446,*pregnancy
5314,34130446,*recurrence cois was reported.
5316,32880139,bony orbital decompression
5317,32880139,computerized perimetry
5318,32880139,dysthyroid optic neuropathy
5319,32880139,endonasal orbital decompression
5320,32880139,exophthalmos
5321,32880139,thyroid eye disease
5322,32681301,deep lateral wall resection
5323,32681301,exophthalmos
5324,32681301,graves’ disease
5325,32681301,orbit
5326,32681301,pterional decompression
5329,32096552,graves’ orbitopathy
5330,32096552,anti-thymocyte globulin
5331,32096552,dysthyroid optic neuropathy
5332,31162982,eyelid retraction
5333,31162982,hering’s phenomenon
5334,31162982,mueller’s muscle-conjunctiva resection
5335,31162982,marginal reflex distance
5336,31162982,phenylephrine test
5337,31162982,thyroid eye disease
5340,33980771,22q11.2 deletion syndrome
5341,33980771,graves’ disease
5342,33980771,hypocalcemia
5343,33980771,hypoparathyroidism
5345,31996918,*graves’ disease
5346,31996918,*hashimoto’s thyroiditis
5347,31996918,*igm
5348,31996918,*subacute thyroiditis
5349,31996918,*thyroglobulin
5350,31996918,*thyroglobulin autoantibodies
5354,32227311,addison’s disease
5355,32227311,autoimmune thyroid disease
5356,32227311,diabetes mellitus
5357,32227311,meta-analysis
5358,32227311,polyglandular autoimmune syndrome cois
5359,31740989,*grave’s disease
5360,31740989,*hepatotoxicity
5361,31740989,*mao-a
5362,31740989,*metabolomics
5363,31740989,*methimazole
5364,31740989,*ugt1a1*6
5365,32252386,*autoimmune thyroid disease (aitd)
5366,32252386,*grave disease (gd)
5367,32252386,*hashimoto thyroiditis (ht)
5368,32252386,*polycystic ovary syndrome (pcos) cois
5369,34149627,*cd40
5370,34149627,*graves’ disease
5371,34149627,*gene
5372,34149627,*precision medicine
5373,34149627,"*variant cois application no: 63/120,514) entitled: “method for predicting patient response to cd40-targeted therapies” which is related to the current manuscript. yt declares that he also submitted two additional patent disclosures that are not related to the content of this manuscript. yt was previously (january 2015 to june 2017) the pi on a basic research project jointly funded by the juvenile diabetes research foundation and pfizer. the current manuscript is not related to that research project. gk consults for immunovant, usa, mediomics, usa, merck, germany, novartis, switzerland, and quidel, usa. the remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
5374,33414766,*graves’ disease
5375,33414766,*graves’ ophthalmopathy
5376,33414766,*cholesterol
5377,33414766,*low-density lipoprotein cholesterol
5378,33414766,*parenteral corticosteroids cois commercial or financial relationships that could be construed as a potential conflict of interest.
5380,31842710,*graves disease
5381,31842710,*hashimoto's thyroiditis
5382,31842710,*active surveillance
5383,31842710,*cost-effectiveness
5384,31842710,*molecular markers
5385,31842710,*thyroid cancer
5386,31840740,*graves’ disease
5387,31840740,*radioactive iodine
5388,31840740,*radioiodine therapy
5389,31840740,"*thyroid radioactive iodine uptake cois association declaration of helsinki, and that all subjects provided written informed consent. the present study was approved by the irb of the second affiliated hospital, harbin medical university. the authors declare that there are no competing interests associated with the manuscript."
5390,32627588,deep lateral decompression
5391,32627588,lateral orbital wall distance
5392,32627588,removable surface area
5393,32627588,removable surface length
5394,32627588,sphenoid door jamb thickness
5395,32362875,*adolescents
5396,32362875,*autoimmune thyroid disease
5397,32362875,*children
5398,32362875,*gender difference
5399,32362875,*thyroiditis
5402,33297974,case report
5403,33297974,exophthalmos
5404,33297974,graves’ ophthalmopathy
5405,33297974,malformation
5406,33297974,ocular myasthenia gravis
5407,33297974,poland syndrome
5408,33297974,ptosis cois interest.
5409,33099562,*cystatin c
5410,33099562,*exophthalmos
5411,33099562,*serum
5412,33099562,*thyroxine
5413,33099562,*triiodothyronine cois
5414,33025559,*autoimmune thyroid disease (aitd)
5415,33025559,*graves’ disease (gd)
5416,33025559,*hashimoto’s thyroiditis (ht)
5417,33025559,*mettl3
5418,33025559,*polymorphism
5419,32592913,choroidal thickness
5420,32592913,inactive graves’ orbitopathy
5421,32592913,optical coherence tomography angiography
5422,32592913,retinal vessel density
5423,32592913,spectral domain-optical coherence tomography
5425,34142359,activating tshr pathogenic variant
5426,34142359,case report
5427,34142359,familial non-autoimmune hyperthyroidism
5428,34142359,functional study
5429,34142359,radioiodine ablative treatment
5430,34142359,repeated thyroid surgery
5432,33198545,octa
5433,33198545,ted
5434,33198545,thyroid eye disease
5435,33198545,optical coherence tomography angiography
5436,33198545,retinal vascularity
5438,32912014,myositis
5439,32912014,whipple’s disease
5440,32912014,orbitopathy
5441,32912014,tropheryma whipplei
5443,34277969,*graves’ disease
5444,34277969,*antithyroid drugs
5445,34277969,*hyperthyroidism
5446,34277969,*index patient
5447,34277969,*international surveys
5448,34277969,*long‐term follow‐up
5449,34277969,*radioactive iodine
5450,34277969,*thyroidectomy
5451,34277969,"*treatment options cois calissendorff, mikael lantz, bengt hallengren, helena filipsson nyström, tereza planck, göran wallin: none of the authors have competing financial interests."
5452,32999132,anti-neutrophil cytoplasmic antibody
5453,32999132,hearing loss
5454,32999132,otitis media
5455,32999132,propylthiouracil
5456,32999132,vasculitis
5457,32699051,*colour vision
5458,32699051,*field of vision
5459,32699051,*orbit cois
5460,34179589,carotid cavernous fistula
5461,34179589,graves-basedow disease
5462,34179589,graves’ ophthalmopathy
5463,34179589,orbit
5464,34179589,orbital inflammation
5465,34049504,"extraocular paralysis, case report"
5466,34049504,gq1b antibody
5467,34049504,graves’ disease
5468,34049504,limb weakness cois interest.
5470,32958019,graves’ orbitopathy
5471,32958019,predictive factors
5472,32958019,radiotherapy
5473,32958019,timing cois
5474,31705696,graves disease
5475,31705696,hashimoto thyroiditis
5476,31705696,superb microvascular imaging
5477,31705696,chronic autoimmune thyroiditis
5478,31705696,color doppler
5479,31705696,vascularity index
5481,33103521,graves’ disease
5482,33103521,hashimoto’s thyroiditis
5483,33103521,autoimmune thyroid diseases
5484,33103521,polymorphism
5485,33103521,protein tyrosine phosphatase nonreceptor 22
5486,31690110,graves’ orbitopathy
5487,31690110,endoscopic orbital decompression
5488,31690110,feasibility
5489,31690110,robotic endoscope guiding system
5490,31690110,robotic surgery
5491,31203506,cosmesis
5492,31203506,endoscopic surgery
5493,31203506,graves’ ophthalmopathy
5494,31203506,optic nerve
5495,31203506,orbital decompression
5496,32656666,bradycardia
5497,32656666,calcitonin
5498,32656666,calcium test
5499,32656666,cut-off
5500,32656666,medullary thyroid cancer cois perceived as prejudicing the impartiality of the research reported.
5501,33488522,*graves’ orbitopathy
5502,33488522,*pcsk9
5503,33488522,*adipogenesis
5504,33488522,*inflammation
5505,33488522,*oxidative stress
5506,33488522,*proprotein convertase subtilisin/kexin type 9
5507,33488522,*thyroid eye disease cois commercial or financial relationships that could be construed as a potential conflict of interest.
5508,32729394,*graves'
5509,32729394,*dietary iodine
5510,32729394,*disease
5511,32729394,*inorganic iodine
5512,32729394,*radioiodine
5513,32729394,*therapeutic effects
5514,31900992,il-13
5515,31900992,il-4
5516,31900992,il-5
5517,31900992,il-6
5518,31900992,autoimmune thyroid diseases
5519,31900992,polymorphism
5520,33327837,"*hyperthyroidism, graves' disease"
5521,33327837,*liver abnormalities
5522,33327837,*liver dysfunction
5524,32911689,graves’ orbital fibroblasts
5525,32911689,graves’ orbitopathy
5526,32911689,igf1r
5527,32911689,igf1r antibodies
5528,32911689,tshr
5529,32911689,tshr antibodies
5530,32911689,hyaluronan
5531,32911689,receptor crosstalk cois targeting tshr and igf-1r.
5532,32376473,*circular rna
5533,32376473,*rna sequencing
5534,32376473,*thyroid-associated ophthalmopathy cois
5535,32854689,coexistent primary and secondary hyperthyroidism
5536,32854689,graves’ disease
5537,32854689,tsh-secreting pituitary adenoma
5538,32854689,tshoma
5539,32854689,thyrotropinoma cois disorders editorial board.
5540,32573180,*graves’ disease
5541,32573180,*autoimmunity
5542,32573180,*peptides
5543,32573180,*thyroid
5545,32199749,*trab
5546,32199749,*antithyroid drugs
5547,32199749,*hyperthyroidism
5548,32199749,*methimazole
5549,32199749,*propylthiouracil cois of interests.
5551,32977740,*graves' orbitopathy
5552,32977740,*hif-1α
5553,32977740,*caveolin-1
5554,32977740,*deiodinase 3
5555,32977740,*enos
5556,32977740,*oxidative stress
5557,34494503,*pd-1
5558,34494503,*pd-l1
5559,34494503,*pd-l2
5560,34494503,*regulatory t cell
5561,34494503,*severity
5562,34494503,*single nucleotide polymorphism
5563,33541945,hyperthyroidism
5564,33541945,thyrotoxicosis
5565,33541945,valvar diseases cois
5566,33153489,*adipogenesis
5567,33153489,*gene modification
5568,33153489,*graves’ ophthalmopathy
5569,33153489,*phosphatase of regenerating liver-1
5570,33153489,*placenta-derived mesenchymal stem cells cois
5571,32605565,case report
5572,32605565,graves’ disease
5573,32605565,hypercalcemia
5574,32605565,osteoporosis
5575,32605565,thymic enlargement cois
5576,32342657,*graves’ disease
5577,32342657,*association analysis
5578,32342657,*sex-specific
5579,32342657,*single nucleotide polymorphism cois
5582,31910101,*graves' disease
5583,31910101,*muscle strength
5584,31910101,*quality of life
5585,31910101,*thyrotoxicosis
5586,31910101,*vitamin d
5588,34074094,*graves disease
5589,34074094,*hashimoto disease
5590,34074094,*immune checkpoint inhibitor
5591,34074094,"*polymorphism, single nucleotide"
5592,34074094,*programmed cell death 1 ligand cois was reported.
5595,34867801,*cd40
5596,34867801,*graves’ disease
5597,34867801,*association analysis
5598,34867801,*expression quantitative trait locus
5599,34867801,*single nucleotide polymorphisms cois commercial or financial relationships that could be construed as a potential conflict of interest.
5603,31505972,cd58
5604,31505972,autoimmune thyroid disease
5605,31505972,severity
5606,31505972,single nucleotide polymorphism
5607,34193409,experimental and laboratory
5608,34193409,orbit cois
5610,32088015,endoscopic modified lothrop procedure
5611,32088015,endoscopic sinus surgery
5612,32088015,frontal sinusitis
5613,32088015,graves’ orbitopathy
5614,32088015,orbital decompression cois related with this paper.
5616,31674156,cytology
5617,31674156,fine-needle aspiration biopsy
5618,31674156,histopathology
5619,31674156,hyperthyroidism
5620,31674156,radioactive iodine
5621,32483756,"thyroid stimulating hormone receptor, antagonist, thienopyrimidine, thyroid gland"
5622,31926048,anti-programmed death 1 therapy
5623,31926048,graves’ disease
5624,31926048,"type 1 diabetes cois k.k. and eli lilly japan k.k. hiroshi kagamu is a scientific advisor of immunit research inc; has received honoraria from astrazeneca k.k., bristol‐myers squibb co. and ono pharmaceutical co.; and research funding from boehringer ingelheim pharmaceuticals inc. the other authors declare no conflict of interest."
5625,33935970,*graves’ ophthalmopathy
5626,33935970,*corticosteroids
5627,33935970,*cytokines
5628,33935970,*rituximab
5629,33935970,*teprotumumab
5630,33935970,*tocilizumab cois commercial or financial relationships that could be construed as a potential conflict of interest.
5632,31755324,cd80
5633,31755324,cd86
5634,31755324,intractability
5635,31755324,polymorphism
5636,31755324,severity
5637,31657648,adipogenesis
5638,31657648,graves’ orbitopathy
5639,31657648,fibroblast growth factor receptors
5640,31657648,fibroblast growth factors
5641,31657648,myofibroblast
5643,31488432,*graves’ orbitopathy
5644,31488432,*orbital adipose tissue
5645,31488432,*orbital fibroblast cois
5646,33719776,*thyroid-associated ophthalmopathy
5647,33719776,*blood flow velocity
5648,33719776,*fractal analysis
5649,33719776,*functional slit-lamp biomicroscopy
5650,33675209,addison’s disease
5651,33675209,graves’ disease
5652,33675209,adrenal insufficiency
5653,33675209,autoimmune polyglandular syndrome type 2
5654,33675209,"thyrotoxicosis cois design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication."
5655,32820337,*case-control
5656,32820337,*grave's disease (gd)
5657,32820337,*hyperthyroidism
5658,32820337,*intestinal microbiota
5659,32820337,*prospective
5660,32820337,*thyroid-stimulating antibodies (tsab) cois manuscript.
5661,31707189,*3d anatomical modeling
5662,31707189,*biomechanical simulation
5663,31707189,*computer-assisted surgery planning
5664,31707189,*endocrine orbitopathy
5665,31707189,*fibrosis
5666,31707189,*retrospective cohort study
5667,35145479,*b lymphocytes
5668,35145479,*graves’ disease
5669,35145479,*graves’ orbitopathy
5670,35145479,*rituximab
5671,35145479,*tsh-receptor antibodies cois commercial or financial relationships that could be construed as a potential conflict of interest.
5672,34831419,*graves’ orbitopathy
5673,34831419,*igf-1
5674,34831419,*rock inhibitor
5675,34831419,*orbital fibroblast
5676,34831419,*prostanoid ep2 agonist
5677,34831419,*three-dimension (3d) cell culture cois
5678,33473054,acute respiratory distress syndrome (ards)
5679,33473054,coronavirus disease 2019 (covid-19)
5680,33473054,severe acute respiratory syndrome (sars)
5681,33473054,severe acute respiratory syndrome coronavirus-2 (sars-cov-2)
5682,33473054,thyroid
5684,31237221,graves’ ophthalmopathy
5685,31237221,thyroid disorders
5686,31237221,age-related macular degeneration
5687,31237221,amiodarone
5688,31237221,diabetic retinopathy
5689,31237221,ocular metastasis.
5690,34899596,*igf1r
5691,34899596,*tsab
5692,34899596,*tshr
5693,34899596,*adipogenesis
5694,34899596,*hyaluronan
5695,34899596,*thyroid eye disease cois commercial or financial relationships that could be construed as a potential conflict of interest.
5696,34778997,*hirata disease
5697,34778997,*human leukocyte antigen
5698,34778997,*hyperinsulinaemic hypoglycaemia
5699,34778997,*insulin autoantibody
5700,34778997,*insulin autoimmune syndrome
5701,34778997,*sulfhydryl group
5702,33776929,*dosimetry—radiation
5703,33776929,*hyperthyroidism (graves’ disease)
5704,33776929,*hyperthyroidism—diagnosis
5705,33776929,*hypothyroidism
5706,33776929,*radioiodine
5707,33776929,*radioiodine (131i) treatment cois distribute the software generated in this article. the remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
5709,32957802,graves’ orbitopathy
5710,32957802,ethmoid sinus volume
5711,32957802,proptosis reduction
5712,32957802,thyroid eye disease
5713,31739945,*arteriovenous malformations
5714,31739945,*benign disease
5715,31739945,*desmoid tumor
5716,31739945,*dupuytren contracture
5717,31739945,*graves ophthalmopathy
5718,31739945,*gynecomastia
5719,31739945,*heterotopic ossification
5720,31739945,*histiocytosis
5721,31739945,*radiation therapy
5722,31978406,anti-thyroid drugs
5723,31978406,graves’ disease
5724,31978406,hyperthyroidism
5725,31978406,lysophosphatidylserine
5726,31978406,phosphatidylserine-specific phospholipase a1
5727,31978406,thyroid hormones
5728,33583620,*endocrinology
5729,33583620,*h1n1 infection
5730,33583620,*influenza
5731,33583620,*thyroid storm cois
5732,32187946,"decompression, surgical"
5733,32187946,diplopia
5734,32187946,esotropia
5735,32187946,graves ophthalmopathy
5736,32187946,ophthalmologic surgical procedures
5737,32471411,early hypothyroidism
5738,32471411,graves’ disease
5739,32471411,radioactive iodine
5740,32471411,therapy cois publication of this paper.
5742,34061946,*addison’s disease
5743,34061946,*additional autoimmune disease
5744,34061946,*autoimmune polyglandular syndrome
5745,34061946,*autoimmune thyroid disease
5746,34061946,*type 1 diabetes mellitus
5747,33998766,case-control study
5748,33998766,dipeptidyl peptidase-4
5749,33998766,"graves' disease cois lectures and received research funding from some organizations as described below. there was no financial support for this study. akinobu nakamura received research funding from mitsubishi tanabe pharma co. and ono pharmaceutical co. ltd. hideaki miyoshi received honoraria for lectures from astellas pharma inc., dainippon pharma co., eli lilly, mitsubishi tanabe pharma co., msd, novartis pharma, novo nordisk pharma, kowa pharmaceutical co., ltd., nippon boehringer ingelheim co., ono pharmaceutical co. ltd. and sanofi, and received research funding from astellas pharma inc., daiichi sankyo, dainippon pharma co., eli lilly, mitsubishi tanabe pharma co., novo nordisk pharma, kowa pharmaceutical co., abbott japan co., nippon boehringer ingelheim co., ono pharmaceutical co. ltd. and taisho toyama pharmaceutical co., ltd. tatsuya atsumi received honoraria for lectures from mitsubishi tanabe pharma co., chugai pharmaceutical co. ltd., astellas pharma inc., takeda pharmaceutical co. ltd., pfizer inc., abbvie inc., eisai co. ltd., daiichi sankyo co. ltd., bristol‐myers squibb co., ucb japan co. ltd., eli lilly japan k.k., and received research funding from astellas pharma inc., takeda pharmaceutical co. ltd., mitsubishi tanabe pharma co., chugai pharmaceutical co. ltd., daiichi sankyo co. ltd., otsuka pharmaceutical co. ltd., pfizer inc. and alexion inc. the other authors declare no conflict of interest."
5751,33138008,*graves’ disease
5752,33138008,*human leukocyte antigen (hla)
5753,33138008,*recurrence
5754,33138008,*subacute thyroiditis cois
5755,34742035,*alemtuzumab
5756,34742035,*autoimmunity
5757,34742035,*crohn's disease
5758,34742035,*graves' disease
5759,34742035,*igg
5760,34742035,*igg4
5761,34742035,*multiple sclerosis
5762,31327128,graves’ disease
5763,31327128,graves’ orbitopathy
5764,31327128,outcome
5765,31327128,radioiodine
5766,31327128,tsh-receptor antibody
5767,31327128,thyroid carcinoma
5768,31327128,thyroidectomy
5769,32062033,autoimmunity
5770,32062033,graves' disease
5771,32062033,hashimoto's autoimmune thyroiditis
5772,32062033,single nucleotide polymorphism (snp)
5773,32062033,toll-like receptors (tlrs)
5774,32062033,type 1 diabetes mellitus (t1dm)
5775,33211376,graves' disease
5776,33211376,cohort
5777,33211376,systemic lupus erythematosus
5778,31669312,autoimmune hypothyroidism
5779,31669312,cribado neonatal tiroideo
5780,31669312,enfermedad de graves
5781,31669312,graves disease
5782,31669312,hipertirotropinemia
5783,31669312,hipotiroidismo autoinmune
5784,31669312,hyperthyrotropinemia
5785,31669312,neonatal thyroid screening
5786,31669312,thyroiditis
5787,31669312,tiroiditis
5789,32880061,bavans
5790,32880061,detachable steel wire-rimmed retractor
5791,32880061,kn retractor
5792,32880061,vans
5793,32880061,video-assisted neck surgery
5798,32359703,graves disease
5799,32359703,leukemia lymphocytic chronic b-cell
5800,32359703,neoplasms/secondary
5801,32359703,prostatic neoplasms
5802,32359703,pruritus
5803,32466854,*hypocalcemia
5804,32466854,*thyroidectomy
5805,32466854,*vitamin d deficiency
5807,31980336,*autoimmunity
5808,31980336,*graves' disease
5809,31980336,*t-cells
5810,31980336,*tsh receptor
5811,31980336,*thyroid cois patent application pct/us2016/067775 for using small molecules to block hla-dr3. dr. tomer also submitted 2 additional provisional patent disclosures that are not related to the content of this manuscript. dr. tomer was previously (1/2015–6/2017) the pi on a basic research project jointly funded by the juvenile diabetes research foundation and pfizer. the current manuscript is not related to that research project. the other authors have nothing to declare.
5812,33758937,*graves’ disease
5813,33758937,*programmed cell death 1
5814,33758937,*regulatory t cells
5815,33758937,*thyroid hormone
5816,34470463,*autoimmune thyroid disease
5817,34470463,*intractability
5818,34470463,*polymorphism
5819,34470463,*severity
5820,34470463,*vitamin a
5821,33234057,*16s rrna sequencing
5822,33234057,*graves' disease
5823,33234057,*alpha diversity
5824,33234057,*gut microbiota
5825,33234057,*metabolism cois
5826,31708111,*ctla4
5827,31708111,*graves’ disease
5828,31708111,*restriction fragment length polymorphism
5829,31708111,*single nucleotide polymorphism
5830,34975767,*graves’ disease
5831,34975767,*bacterial translocation
5832,34975767,*intestinal barrier
5833,34975767,*intestinal fatty acid-binding protein
5834,34975767,*leaky gut
5835,34975767,*lipopolysaccharide
5836,34975767,*quality of life cois commercial or financial relationships that could be construed as a potential conflict of interest.
5837,32666771,thyroid ophthalmopathy
5838,33587909,*3-dimension (3d) tissue culture
5839,33587909,*ep2 agonist
5840,33587909,*grave's disease
5841,33587909,*grave's orbitopathy
5842,33587909,*human orbital fibroblast
5843,33587909,*pgf2α agonist
5844,33587909,*rock inhibitor
5845,33587909,*rho-associated coiled-coil containing protein kinase (rock)
5846,33437990,*antinuclear antibodies
5847,33437990,*indirect immunofluorescence
5848,33437990,*systemic autoimmune disease
5849,32061922,*graves' ophthalmopathy fibroblasts
5850,32061922,*insulin-like growth factor 1 receptor
5851,32061922,*receptor crosstalk
5852,32061922,*tsh receptor stimulating antibodies
5853,32061922,*thyroid-stimulating hormone receptor cois of interest.
5854,31969085,*adipogenesis
5855,31969085,*chondrogenesis
5856,31969085,*muscle-derived stem cells
5857,31969085,*myogenesis
5858,31969085,*osteogenesis
5859,33476778,*dysthyroid optic neuropathy
5860,33476778,*grave disease
5861,33476778,*grave orbitopathy
5862,33476778,*orbit decompression
5864,32707005,*thyroid eye disease
5865,32707005,*insulin-like growth factor i receptor
5866,32707005,*monoclonal antibody
5867,32707005,*teprotumumab
5868,32707005,*thyrotropin receptor
5870,31733941,*graves’ disease
5871,31733941,*ifih1 gene
5872,31733941,*lada diabetes
5873,31733941,*multiple sclerosis
5874,31733941,*polymorphism cois
5875,31272958,*graves’ ophthalmopathy
5876,31272958,*glucocorticoid
5877,31272958,*network meta-analysis cois
5878,33645503,*covid-19
5879,33645503,*epidemics
5880,33645503,*influenza
5881,33645503,*predict
5882,33645503,*virus
5883,30111225,graves' disease
5884,30111225,acute kidney injury
5885,30111225,hyperthyroidism
5886,30111225,methimazole
5887,30111225,nephrotoxicity
5889,33298481,gynaecological cancer
5890,33298481,stroke
5891,33298481,thyrotoxicosis cois
5892,31833078,graves' disease
5893,31833078,hyperthyroidism
5894,31833078,tissue doppler imaging
5895,31833078,two-dimensional speckle tracking echocardiography
5896,33196862,antithyroid medication
5897,33196862,antithyroid-induced arthritis syndrome
5898,33196862,arthritis
5899,33196862,fever
5900,33196862,thiamazole
5901,33498689,graves’ ophthalmopathy
5902,33498689,eear fluids
5903,33498689,ehyroid-associated ophthalmopathy
5904,33498689,exosomes
5905,33498689,extracellular vesicle
5906,33498689,eytokines cois
5907,33877318,*akt1
5908,33877318,*egfr/pi3k/akt signaling
5909,33877318,*lncrna lpal2
5910,33877318,*mir-1287-5p
5911,33877318,*orbital fibroblast activation
5912,33877318,*thyroid eye disease
5914,32425952,*autoantibodies
5915,32425952,*autoimmune
5916,32425952,*nephropathy
5917,32425952,*phospholipase a2 receptor
5918,32425952,*thyroid disease
5923,34060342,graves’ disease
5924,34060342,hematoma
5925,34060342,hypocalcemia
5926,34060342,recurrent laryngeal nerve injury
5927,34060342,"thyroidectomy cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
5928,33745401,"*“thyroid eye disease, thermal imaging, ocular surface temperature, caruncular  temperature”"
5929,34752648,graves’ disease
5930,34752648,hyperthyroidism
5931,34752648,thyroid-stimulating hormone receptor antibody cois
5934,34680057,*graves’ ophthalmopathy
5935,34680057,*c-jun n-terminal kinase
5936,34680057,*orbital fibroblast
5937,34680057,*p38
5938,34680057,*pirfenidone
5939,34680057,*transforming growth factor-β1 cois
5940,33121876,*graves' disease
5941,33121876,*interferon
5942,33121876,*interleukin
5943,33121876,*thyroid-stimulating hormone receptor antibody
5944,33121876,*tumor necrosis factor
5945,33868176,*graves’ orbitopathy
5946,33868176,*t cell immunity
5947,33868176,*effector t cell
5948,33868176,*fibrocyte
5949,33868176,*orbital fibroblast
5950,33868176,"*thyroid-associated ophthalmology cois (81930024, 81761168037, 81770974, 81800695, 82071003, 82000879, 81570883, 81600766, 31701046, 31600971, and 31500714), the national key r&d program of china (2018yfc1106100, 2018yfc1106101), the shanghai sailing program (18yf1412300), the research grant of the shanghai science and technology committee (20dz2270800, 17dz2260100, 19410761100, and 19dz2331400), the clinical research plan of shdc (shdc2020cr3051b), the project of medical robots (imr-nph202002) from the clinical joint research center of the institute of medical robots, shanghai jiaotong university-shanghai ninth people’s hospital, the collaborative research project of translational medicine collaborative innovation center, shanghai jiaotong university school of medicine (tm201718), the shanghai municipal education commission—gaofeng clinical medicine grant support (20152228), the shanghai jiaotong university translational medicine crossed research grant (zh2018zda12, zh2018qna07), the sample database project of shanghai ninth people’s hospital (ybkb201901), and the joint innovation team for young physicians of shanghai ninth people’s hospital (qc202002).the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
5951,33419752,emergency medicine
5952,33419752,respiratory medicine cois
5953,34887833,*graves’ disease
5954,34887833,*hla variants
5955,34887833,*ptpn22 gene
5956,34887833,*genetic predictors
5957,34887833,*treatment cois commercial or financial relationships that could be construed as a potential conflict of interest.
5958,32519199,association
5959,32519199,graves’ disease
5960,32519199,mica
5961,32519199,thionamide-induced agranulocytosis
5962,32253999,*antithyroid drug
5963,32253999,*hyperthyroidism
5964,32253999,*long-term treatment
5966,34916298,*graves’ disease
5967,34916298,*organoids
5968,34916298,*thyroid
5970,34374618,graves’ hyperthyroidism
5971,34374618,anti-ttg
5972,34374618,celiac disease
5973,34374618,false-positivity
5974,33781112,*graves’ ophthalmopathy
5975,33781112,*tepezza
5976,33781112,*hearing loss
5977,33781112,*teprotumumab
5978,33781112,*thyroid eye disease
5979,34887857,*: autoimmune disease
5980,34887857,*autoimmunity
5981,34887857,*gastric cancer
5982,34887857,*risk
5983,34887857,*standardized incidence rate cois commercial or financial relationships that could be construed as a potential conflict of interest.
5984,34355625,trab
5985,34355625,thyroid function
5986,34355625,hysterosalpingography (hsg)
5987,34355625,infertility
5988,34355625,thyrotoxicosis
5989,31809586,*b10 cells
5990,31809586,*graves’ disease
5991,31809586,*ilc2s
5992,31809586,*autoantibodies
5993,34605662,*graves'
5994,34605662,*adipogenesis
5995,34605662,*antifibrotic
5996,34605662,*disulfiram
5997,34605662,*orbital fibroblast
5998,34605662,*orbitopathy
5999,34949642,*graves’ disease
6000,34949642,*autoimmune
6001,34949642,*fibrocyte
6002,34949642,"*thyroid cois therapeutic targeting of igf-i receptor in autoimmune diseases (to t.j.s. and held by the university of california, los angeles, and the lundquist institute). he is a consultant for horizon therapeutics."
6003,32419081,*cd40
6004,32419081,*ctla4
6005,32419081,*graves’ disease
6006,32419081,*pparg
6007,32419081,*ptpn22
6008,32419081,*polymorphism
6009,32372394,children and adolescents
6010,32372394,low-dose radioactive iodine (131i)
6011,32372394,outpatients treatment
6012,32372394,radiation exposure
6013,32874051,orbital decompression
6014,32874051,pneumocephalus
6015,32874051,thyroid eye disease cois
6016,32797475,graves’ disease
6017,32797475,antioxidant parameters
6018,32797475,hyperthyroidism
6019,32797475,lipid peroxidation
6020,32797475,thyroid orbitopathy
6022,33653401,children
6023,33653401,glucocorticoid pulse therapy
6024,33653401,graves’ disease
6025,33653401,thyroid antibodies
6026,33653401,thyroid function cois
6032,34381538,acromegaly
6033,34381538,case report
6034,34381538,empty sella
6035,34381538,grave´s disease
6036,34381538,hyperthyroidism cois
6038,31264142,anti-gastric parietal cell antibodies
6039,31264142,autoimmune gastritis
6040,31264142,autoimmune thyroid disease
6041,31264142,children
6042,31264142,screening
6043,32246145,*graves’ disease
6044,32246145,*hashimoto’s thyroiditis
6045,32246145,*genetic risk
6046,32246145,*heterogeneity
6047,32246145,*large chinese cohort
6048,33322192,*graves’ orbitopathy
6049,33322192,*exophthalmos
6050,33322192,*intraocular pressure
6051,33322192,*topical medications cois
6053,32328068,*graves' disease
6054,32328068,*hashimoto's thyroiditis
6055,32328068,*follicular helper t cells
6056,32328068,*lymphoid tissue–inducer-like cells
6057,32328068,*regulatory t cells
6058,32328068,*thyroid autoimmune disease
6059,33597925,*erk
6060,33597925,*graves’ ophthalmopathy
6061,33597925,*ras homolog family member a (rhoa)
6062,33597925,*rho‑associated protein kinase (rock)
6063,33597925,*y-27632
6064,33597925,*myofibroblast
6065,33597925,*p38
6066,33597925,*simvastatin cois commercial or financial relationships that could be construed as a potential conflict of interest.
6070,34271828,*ait
6071,34271828,*trab
6072,34271828,*amiodarone
6073,34271828,*autoimmunity
6074,34271828,*thyrotoxicosis
6075,32545596,grave´s disease
6076,32545596,hashimoto’s thyroiditis
6077,32545596,non-celiac wheat sensitivity
6078,32545596,celiac disease
6079,32545596,gut microbiota
6080,32545596,iodine
6081,32545596,iron
6082,32545596,probiotics
6083,32545596,thyroid
6084,32545596,thyroid cancer cois
6085,32338082,*b-cell activating factor
6086,32338082,*cytokines
6087,32338082,*graves’ disease
6088,32338082,*hashimoto’s thyroiditis
6089,32338082,*autoimmune thyroid disease
6090,31527321,denosumab
6091,31527321,fibroblast growth factor 23 (fgf-23)
6092,31527321,hypercalcemia
6093,31527321,hyperthyroidism
6094,31527321,zoledronic acid
6095,29235358,glioblastoma multiforme
6096,29235358,learning curve brain neoplasm
6097,29235358,multi-disciplinary team
6098,33912135,*graves’ disease
6099,33912135,*rna sequencing
6100,33912135,*t cell receptor sequencing
6101,33912135,*persistent graves’ disease
6102,33912135,*refractory graves’ disease
6103,33912135,*regulatory t cell cois commercial or financial relationships that could be construed as a potential conflict of interest.
6104,32116430,goiter
6105,32116430,thyroid
6106,32116430,thyroidectomy
6107,32121432,somatostatin analog
6108,32121432,cancer
6109,32121432,carcinoid
6110,32121432,lanreotide
6111,32121432,neuroendocrine tumor
6112,32121432,octreotide
6113,32121432,pasireotide
6114,32121432,"pituitary adenoma cois novartis, and pfizer as speaker fees, served on an advisory board, and received lecture fees and sponsorship for travel and accommodation in international scientific meetings from ipsen, novartis, and pfizer. none of them had role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."
6115,32572659,hypothyroidism
6116,32572659,goitre
6117,32572659,hyperthyroidism
6118,32572659,physiology
6119,32572659,thyroid carcinoma
6120,33040848,ct
6121,33040848,cancer
6122,33040848,goiter
6123,33040848,mr imaging
6124,33040848,surgical implications
6125,33040848,thyroid
6126,33040848,thyroid nodules cois
6127,31793246,highly differentiated follicular carcinoma of ovary
6128,31793246,imprint cytology
6129,31793246,monodermal teratoma
6130,31793246,struma ovarii
6131,32342248,hypoparathyroidism
6132,32342248,recurrent nerve injury
6133,32342248,thyroid carcinoma
6134,32342248,thyroid surgery
6135,32342248,thyroidectomy
6136,32234570,*central neck lymph node dissection
6137,32234570,*hypocalcemia
6138,32234570,*hypoparathyroidism
6139,32234570,*thyroidectomy
6140,31941844,adipogenesis
6141,31941844,caffeine
6142,31941844,graves’ orbitopathy
6143,31941844,oxidative stress
6144,31941844,thyroid eye disease
6145,33167878,bowel perforation
6146,33167878,gastrointestinal mucormycosis
6147,33167878,mucormycosis
6148,33167878,rhizopus microsporus
6149,33167878,streptococcus pyogenes
6150,33167878,toxic shock syndrome cois
6151,34653776,*graves' disease
6152,34653776,*sars-cov-2
6153,34653776,*type 1 diabetes mellitus
6154,34653776,*vaccine
6155,32896170,*graves’ disease
6156,32896170,*zinc transporter
6157,32896170,*children
6158,32896170,*non-toxic nodular goiter
6159,32896170,*thyroid tissue
6160,34241830,autoimmunity
6161,34241830,goiter
6162,34241830,lupus
6163,34241830,malar
6164,34241830,pregnancy
6165,34241830,rash
6166,34241830,sle
6167,34241830,thyroid cois
6168,34956094,*contrast-enhanced ultrasound (ceus)
6169,34956094,*partially cystic papillary thyroid carcinomas (pcptcs)
6170,34956094,*partially cystic thyroid nodules
6171,34956094,*thyroid carcinomas
6172,34956094,*thyroid ultrasonography cois commercial or financial relationships that could be construed as a potential conflict of interest.
6173,33208049,*graves' disease
6174,33208049,*hla-dr3 mice
6175,33208049,*t cells
6176,33208049,*tetramer assay
6177,32734637,*asian
6178,32734637,*cosmesis
6179,32734637,*minimally invasive video-assisted thyroidectomy
6180,32734637,*neck scar
6181,32734637,*thyroidectomy
6182,35130216,"thyroidectomy, harmonic scalpel, classical ligation, suture hemorrhage, recurrent  laryngeal nerve injury."
6185,32950466,covid-19
6186,32950466,free t3
6187,32950466,free t4
6188,32950466,hypothyroidism
6189,32950466,hypothyroïdie
6190,32950466,orbitopathie
6191,32950466,orbitopathy
6192,32950466,sars-cov-2
6193,32950466,t3l
6194,32950466,t4l
6195,32950466,tsh
6196,32950466,thyrotoxicose
6197,32950466,thyrotoxicosis
6198,33939906,thyroid nodule
6199,33939906,ablation techniques
6200,33939906,ethanol
6201,33939906,nodular goiter
6202,34920294,cyclind1
6203,34920294,d2–40
6204,34920294,follicular neoplasm
6205,34920294,multinodular goiter with dominant nodules
6206,34920294,oncocytic cell tumors
6207,34920294,poorly differentiated thyroid carcinoma
6208,33754530,anaplastic thyroid carcinoma
6209,33754530,leucocytosis; goitre
6211,33665799,turkey
6212,33665799,elderly people
6213,33665799,goitre
6214,33665799,hyperthyroidism
6215,33665799,hypothyroidism
6216,33665799,iodized salt
6217,34721289,*clnm
6218,34721289,*lasso
6219,34721289,*llnm
6220,34721289,*ptc
6221,34721289,*cn0 cois commercial or financial relationships that could be construed as a potential conflict of interest.
6222,32303903,*hereditary non-autoimmune hyperthyroidism
6223,32303903,*inverse agonist and antagonists
6224,32303903,*somatic and germline mutation
6225,32303903,*tsh receptor
6226,32303903,*toxic adenoma
6227,32303903,*toxic multinodular goitre cois
6229,33202999,*case-control studies
6230,33202999,*cohort studies
6231,33202999,*hearing loss
6232,33202999,*hyperthyroidism
6233,33202999,*sudden cois
6234,33339489,frank hartley
6235,33339489,clubfoot
6236,33339489,exstrophy of the bladder
6237,33339489,facial neuralgia
6238,33339489,goiter
6239,33964951,ck19
6240,33964951,follicular
6241,33964951,hbme1
6242,33964951,niftp
6243,33964951,papillary cois
6244,33402480,braf mutation
6245,33402480,microrna
6246,33402480,papillary thyroid cancer cois
6247,33466826,cohort
6248,33466826,diet
6249,33466826,iodine
6250,33466826,pregnancy
6251,33466826,"thyroid cois develop the myfood24 online dietary assessment system for use in research, teaching and for health. the remaining authors have nothing to declare. the funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript or in the decision to publish the results."
6252,33459001,*hashimoto disease
6253,33459001,*adolescent
6254,33459001,*child
6255,33459001,*goiter
6256,33459001,*hypothyroidism cois
6257,33213335,*hyperthyroidism
6258,33213335,*raiu test
6259,33213335,*graves' disease
6260,33213335,*multinodular
6261,33213335,*pathology
6262,33213335,*thyroid scan
6263,33213335,*toxic
6264,32518973,benign neoplasm
6265,32518973,goiter
6266,32518973,thyroid cancer
6267,32733376,*children
6268,32733376,*hypertrichosis
6269,32733376,*pituitary hypertrophy
6270,32733376,*severe autoimmune hypothyroidism
6271,32733376,*symptoms
6272,32267105,* metastasis
6273,32267105,* multinodular goiter
6274,32267105,*thyroid carcinoma
6275,31580203,neuromonitoring
6276,31580203,goiter
6277,31580203,recurrent laryngeal nerve palsy
6278,31580203,thyroid
6279,31580203,vocal cords
6280,33412925,*goiter
6281,33412925,*statins
6282,33412925,*thyroid cancer
6283,33412925,*thyroiditis
6284,33412925,*thyrotoxicosis
6285,34416585,france
6286,34416585,goiter cause
6287,34416585,hair analysis
6288,34416585,historical samples
6289,34416585,lead contamination
6290,34416585,savoy
6293,33812374,macroadenoma
6294,33812374,pituitary
6295,33812374,pregnancy
6296,33812374,thyrotoxicosis cois
6297,32697397,doppler ultrasound
6298,32697397,graves disease
6299,32697397,graves orbitopathy
6300,32697397,central retinal artery
6301,32697397,ophthalmic artery
6302,32697397,toxic goiter
6303,33980057,*decision aid tool
6304,33980057,*levothyroxine dosage
6305,33980057,*patient tailored
6306,33980057,*pharmacokinetic modeling
6307,33980057,*thyroidectomy cois
6308,32149464,* thyroid surgery
6309,32149464,*ent
6310,32149464,*hyperthyroidism
6311,32149464,*thyroid
6312,32149464,*thyroid cancer
6314,31868128,*alu element
6315,31868128,*tg
6316,31868128,*congenital hypothyroidism
6317,31868128,*goiter
6318,31868128,*novel mutation
6319,31868128,*thyroglobulin cois
6320,32939627,ectopic thyroid tissue
6321,32939627,follicular adenoma
6322,32939627,goiter
6323,32939627,lung
6324,32939627,thoracoscopic surgery
6326,34774300,*drinking water
6327,34774300,*goiter
6328,34774300,*nitrate
6329,34774300,*perchlorate
6330,34774300,*sodium iodide symporter
6331,34774300,*thiocyanate
6332,32909177,ancient rome
6333,32909177,fine arts
6334,32909177,goiter
6335,32909177,hans christian gram
6336,32909177,history
6337,32909177,hyperthyroidism
6339,32372240,egypt
6340,32372240,endemic goiter
6341,32372240,hashimoto’s thyroiditis
6342,32372240,papillary thyroid carcinoma
6343,32372240,thyroid cancer
6344,33619709,mri
6345,33619709,genetic diseases
6346,33619709,goitre
6347,33619709,haemochromatosis
6348,33619709,iron
6349,33619709,iron overload
6350,33619709,liver biopsy
6351,33619709,thyroid
6352,32377868,goiter
6353,32377868,graves’ disease
6354,32377868,hashimoto’s thyroiditis
6355,32377868,iodine-induced hyperthyroidism
6356,32377868,thyroid autonomy
6357,34378152,*congenital hypothyroidism
6358,34378152,*dyshormonogenesis
6359,34378152,*goiter
6360,34378152,*thyroid cancer
6361,33135832,*māori health
6362,33135832,*head and neck
6363,33135832,*thyroid surgery
6364,33319230,*hypothyroidism
6365,33319230,*chronic diseases
6366,33319230,*comorbidity
6367,33319230,*network analysis
6368,34637944,early diagnosis
6369,34637944,hamartoma syndrome
6370,34637944,hereditary
6371,34637944,multiple
6372,34637944,neoplastic syndromes
6373,34637944,pten phosphohydrolase
6374,34637944,phenotype
6376,33905626,thyroid cancer
6377,33905626,mrna expression
6378,33905626,polymorphism
6379,33905626,transforming growth factor-β
6380,33779362,thyroid
6381,33779362,hypocalcaemia
6382,33779362,meta-analysis
6383,33779362,prevalence
6384,33779362,risk factor cois conflicts of interest.
6386,33910357,complications − recurrent nerve
6387,33910357,hypoparathyroidism − lethality
6388,33910357,thyroid surgery
6389,34479126,diffuse thyroid diseases
6390,34479126,grave’s diseases
6391,34479126,hashimoto’s thyroiditis
6392,34479126,shear wave elastography
6393,34479126,ultrasonography
6394,33008929,*amiodarone-induced thyroid dysfunction
6395,33008929,*autoimmunity
6396,33008929,*destructive thyroiditis
6397,33008929,*hyperthyroidism
6398,33008929,*toxic multinodular goiter
6399,33008929,*toxic thyroid adenoma
6400,32458745,*goiter
6401,32458745,*iodine
6402,32458745,*iodine deficiency
6403,32458745,*salt
6404,32458745,*universal salt iodization cois
6405,34841823,*cohort studies
6406,34841823,*goiter
6407,34841823,*hyperthyroidism
6408,34841823,*hypothyroidism
6409,33072219,relapse risk
6410,33072219,benign focal pathology
6411,33072219,nodular goiter
6412,33072219,thyroid gland
6413,33028642,*ewing's sarcoma
6414,33028642,*multinodular goiter
6415,33028642,*neoplasm of the genitourinary tract
6416,34425332,gene expression
6417,34425332,klln
6418,34425332,multinodular goiter
6419,34425332,pten
6420,34425332,papillary thyroid carcinoma
6421,33914231,*goiter
6422,33914231,*iodine
6423,33914231,*iodized salt
6424,33914231,*thyroid
6425,33914231,*thyroid autoimmunity cois
6426,33749812,bethesda classification
6427,33749812,thyroid cancer
6428,33749812,thyroid nodule
6429,34780050,congenital hypothyroidism
6430,34780050,goiter
6431,34780050,next-generation sequencing
6432,34780050,tpo
6433,34780050,thyroid dyshormonogenesis
6434,34050454,dental fluorosis
6435,34050454,ptpn22
6436,34050454,polymorphisms
6437,34050454,tshr
6438,34050454,thyroid
6439,32838791,*breast cancer
6440,32838791,*genetic pleiotropy
6441,32838791,*hyperthyroidism
6442,32838791,*mammographic density cois
6443,32930933,congenital hypothyroidism
6444,32930933,duox2
6445,32930933,newborn screening
6446,32930933,tg
6447,32930933,tpo
6448,32930933,tshr
6449,32765423,*congenital hypothyroidism
6450,32765423,*dyshormonogenesis
6451,32765423,*genes
6452,32765423,*goiter
6453,32765423,*iodine
6454,32765423,*screening
6455,32765423,*thyroid hypoplasia
6456,34382851,cervical stitch sinus
6457,34382851,deep neck infection
6458,34382851,diabetes
6459,34382851,suture granuloma
6460,34382851,thyroidectomy
6461,34382851,wound
6462,34382851,wound healing
6464,31960358,mitochondria
6465,31960358,oxidative stress
6466,31960358,ros
6467,31960358,selenium
6468,31960358,thyroid
6470,34121740,autoimmune disease
6471,34121740,hashimoto's thyroiditis
6472,34121740,hypocalcemia
6473,34121740,thyroid peroxidase antibody
6474,34121740,thyroidectomy cois
6475,32505587,resistance to thyroid hormone
6476,32505587,thrb gene
6477,32505587,thyroid hormone receptor beta cois
6479,34426423,endoscopy
6480,34426423,surgery
6481,34426423,thyroid disease
6482,34426423,thyroiditis cois
6483,34051706,*goiter
6484,34051706,*nodule
6485,34051706,*thyroid
6486,32582023,*hashimoto's thyroiditis
6487,32582023,*hashitoxicosis
6488,32582023,*autoimmune thyroiditis (ait)
6489,32582023,*goiter
6490,32582023,*thyroid autoantibodies
6491,33901280,"*8-oxo-7,8-dihydro-2’-deoxyguanosine"
6492,33901280,"*8-oxo-7,8-dihydroguanosine"
6493,33901280,*graves disease
6494,33901280,*hyperthyroidism
6495,33901280,*oxidative stress
6496,33901280,*toxic nodular goiter
6497,34093427,*langerhans cell histiocytosis
6498,34093427,*chemotherapy
6499,34093427,*spontaneous thyroid hemorrhage
6500,34093427,*thyroid
6501,34093427,*thyroidectomy cois commercial or financial relationships that could be construed as a potential conflict of interest.
6504,33796075,*gh
6505,33796075,*igf-i
6506,33796075,*acromegaly
6507,33796075,*comorbidity
6508,33796075,*complication
6509,33796075,*pituitary adenoma cois commercial or financial relationships that could be construed as a potential conflict of interest.
6510,34219897,hyperthyroidsm
6511,34219897,thyroid neoplasms
6512,34219897,thyrostatic drugs cois interest. this article does not include any studies with human participants or animals performed by any of the authors.
6513,32792004,denosumab rebound
6514,32792004,fracture
6515,32792004,hypercalcemia
6516,32792004,hyperparathyroidism
6517,32792004,osteoporosis cois
6518,34937506,thyroid disorders
6519,34937506,male infertility factor
6520,34937506,pathospermia
6521,34248839,*congenital hypothyroidism
6522,34248839,*familial origin
6523,34248839,*high throughput molecular screening
6524,34248839,*oligogenicity
6525,34248839,*thyroid dyshormonogenesis cois commercial or financial relationships that could be construed as a potential conflict of interest.
6527,33052461,edge
6528,33052461,localization
6529,33052461,oxidative stress
6530,33052461,thyroid
6531,33052461,tumor
6532,34431326,covid-19
6533,34431326,sars-cov-2
6534,34431326,goiter
6535,34431326,surgery
6536,34431326,thyroid cancer
6537,34431326,thyroidectomy
6538,32178945,aberrant left subclavian artery
6539,32178945,non-recurrent inferior laryngeal nerve
6540,32178945,right-sided aortic arch
6541,32178945,thyroid surgery cois disclosed on this work.
6542,34196952,cost-effectiveness analysis
6543,34196952,intraoperative nerve monitoring
6544,34196952,recurrent laryngeal nerve palsy
6545,34196952,total thyroidectomy
6546,34196952,visual nerve identification
6547,32606189,thyroid
6548,32606189,malignancy
6549,32606189,microcalcifications
6550,32606189,nodule
6551,32606189,shape cois
6554,34889796,disfigurement
6555,34889796,horner syndrome
6556,34889796,steroids
6557,34889796,thyroidectomy cois
6560,33004747,follicular thyroid adenoma
6561,33004747,follicular thyroid carcinoma
6562,33004747,ultrasound signal cois
6563,32253953,*interventional ultrasonography
6564,32253953,*ablation techniques
6565,32253953,*high-intensity focused ultrasound ablation
6566,32253953,*nodular goiter
6567,32253953,*ultrasound imaging
6568,33459000,*graves disease
6569,33459000,*adolescent
6570,33459000,*antithyroid agents
6571,33459000,*child
6572,33459000,*hyperthyroidism cois
6573,33250466,alkaline phosphatase
6574,33250466,body pain
6575,33250466,muscle weakness
6576,33250466,normocalcemic hyperparathyroidism cois
6579,33194956,*kashmir
6580,33194956,*hypothyroidism
6581,33194956,*thyroid dysfunction
6582,33194956,*tribal population
6583,33194956,*urinary iodine
6584,32897650,*dicer1
6585,32897650,*cytology
6586,32897650,*fine-needle aspiration
6587,32897650,*follicular neoplasm
6588,32897650,*papillary thyroid carcinoma
6589,32897650,*poorly differentiated thyroid carcinoma
6590,32897650,*thyroid
6591,32430544,benign goiter
6592,32430544,case number threshold
6593,32430544,routine data
6594,32430544,vocal cord palsy
6595,32430544,volume outcome
6596,32458504,mitochondria
6597,32458504,mitochondria-eating protein
6598,32458504,mitophagy
6599,32458504,oncocytic cell tumor
6600,32458504,thyroid cois
6601,33541277,deficiency
6602,33541277,goiter
6603,33541277,magnitude
6604,33541277,micronutrient
6605,33541277,prevalence
6606,33541277,urine iodine cois
6608,32621001,*endocrine dysfunction
6609,32621001,*hemorrhagic stroke
6610,32621001,*ischemic stroke
6611,32621001,*pituitary
6612,31952842,*cervical embryonal rhabdomyosarcoma
6613,31952842,*dicer1-related multinodular goiter
6614,31952842,*ovarian sex-cord stromal tumors
6615,31952842,*pleuropulmonary blastoma
6616,31952842,"*sertoli-leydig cell tumors of the ovary cois private company with a mission to develop liquid biopsy diagnostics for rare cancers which includes dicer1-related cancers described in this work. none of the diagnostics under development are discussed in this work. dr. stewart provides contract telegenetics services to genome medical, inc."
6617,34670545,hyperthyroidism
6618,34670545,icm
6619,34670545,iodinated contrast media
6620,34670545,iodine-induced
6621,34670545,tachycardia cois
6622,32017356,*iodine deficiency
6623,32017356,*nepal
6624,32017356,*micronutrients
6625,32017356,"*salt iodization cois unicef, support the government of nepal's effort toward universal salt iodization but have no conflict of interest in developing this summary. the opinions and statements in this article are those of the authors and may not reflect official unicef policies. kedar parajuli, in his capacity working for government of nepal to prevent and control iodine deficiency in nepal, has no conflict of interest in developing this summary. robin houston, chandra pandav, macha raja maharjan, and jonathan gorstein have all both undertaken consultancies with various agencies working in nepal on nutrition issues, including in support of the usi program, but have no conflict of interest related to this paper."
6629,32189188,*distant metastases
6630,32189188,*ft-ump
6631,32189188,*mi-ftc
6632,32189188,*radioiodine therapy
6633,32189188,*wdt-ump
6634,32081771,*biomarker
6635,32081771,*follicular thyroid adenoma
6636,32081771,*follicular thyroid carcinoma
6637,32081771,*roc curve analysis
6638,32081771,*real-time pcr
6639,32081771,*microrna cois
6640,33119125,dielectric properties
6641,33119125,open-ended coaxial line
6642,33119125,thyroid nodules
6643,32974689,ablation techniques
6644,32974689,high-intensity focused ultrasound ablation
6645,32974689,interventional ultrasonography
6646,32974689,nodular goiter
6647,32974689,ultrasonic imaging
6651,33932399,*change
6652,33932399,*expression
6653,33932399,*s hla-g
6654,33932399,*thyroid cancer
6655,33932399,*mir-199b-5p
6656,32088313,*congenital hypothyroidism
6657,32088313,*genotype-phenotype analysis
6658,32088313,*next-generation sequencing
6659,32088313,*thyroid peroxidase cois
6660,31867598,*tg
6661,31867598,*tpo
6662,31867598,*congenital hypothyroidism
6663,31867598,*goiter
6664,34191415,thyroid cancer
6665,34191415,endoscopic
6666,34191415,goiter
6667,34191415,surgery
6668,34191415,thyroidectomy
6670,32757959,* dioscorea bulbifera l
6671,32757959,*8-epidiosbulbin e acetate
6672,32757959,*diosbulbin b
6673,32757959,*hepatotoxicity
6674,32757959,*metabolic activation
6675,31741093,adolescent
6676,31741093,child
6677,31741093,thyroid neoplasm
6678,31741093,thyroid nodule
6679,31741093,ultrasonography
6681,34706470,*anxiety
6682,34706470,*depression
6683,34706470,*obesity
6684,34706470,*personality
6685,34706470,*temperament
6686,34008223,dicer1
6687,34008223,follicular thyroid carcinoma
6688,34008223,histology
6689,34008223,macrofollicular variant
6690,34008223,mutation
6693,34050759,*adolescents
6694,34050759,*goiter
6695,34050759,*hyperthyroidism
6696,34050759,*hypothyroidism
6697,34050759,*thyroid
6698,34050759,*type 2 diabetes
6699,33210503,adenoma
6700,33210503,cyst
6701,33210503,follicular cancer
6702,33210503,thyroid gland
6703,33210503,ultrasound examination
6704,33329389,*diagnosis
6705,33329389,*hyperthyroidism
6706,33329389,*pathogenesis
6707,33329389,*pituitary adenoma
6708,33329389,*thyroid-stimulating hormone-secreting pituitary adenoma
6709,33329389,*treatment cois commercial or financial relationships that could be construed as a potential conflict of interest.
6710,33331320,adenoma
6711,33331320,diagnosis
6712,33331320,hürthle cell tumor
6713,33331320,thyroid gland
6715,34695620,pericardial effusion
6716,34695620,pleural effusion
6717,34695620,pleural hemangioma
6718,34695620,recurrent
6722,33180037,tshr mutation
6723,33180037,hyperthyroidism
6724,33180037,neonatal
6725,33180037,nonautoimmune
6726,32484412,diode
6727,32484412,laser
6728,32484412,metastatic
6729,32484412,thyroid
6730,32484412,trachea
6732,31502218,acromegaly
6733,31502218,complications
6734,31502218,doppler
6735,31502218,ultrasound
6736,31502218,visceromegaly
6738,31820353,iodine
6739,31820353,kombu
6740,31820353,risk assessment
6741,31820353,seaweeds
6742,31820353,toxic risk
6743,31820353,wakame
6744,33722923,18f-fdg
6745,33722923,pet/ct
6746,33722923,breast metastasis
6747,33722923,follicular thyroid carcinoma
6748,33722923,iodine scan
6749,33393527,follicular carcinoma
6750,33393527,malignant
6751,33393527,neoplasm
6752,33393527,ovary
6753,33393527,struma ovarii
6754,33393527,teratoma cois
6755,33405016,*dysphagia
6756,33405016,*dysphonia
6757,33405016,*reflux disease
6758,33405016,*swallowing
6759,33405016,*thyroid
6760,33405016,*thyroid weight
6761,33405016,*thyroidectomy
6762,33405016,*voice cois
6763,33690170,*braf
6764,33690170,*mmp2
6765,33690170,*cancer
6766,33690170,*invasion
6767,33690170,*mutation
6768,33690170,*oncogene
6769,33690170,*thyroid cancer
6770,33970434,global health
6771,33970434,goiter
6772,33970434,telemedicine
6773,33970434,thyroid cancer
6774,33970434,thyroid ultrasound
6775,33970434,"ultrasound cois technology have financial stake in medical innovation and technology which works on developing technology to bring medical imaging to rural areas. all other authors have no financial disclosures. the manuscript and its contents were produced by the university of rochester and medical imaging ministries of the americas authors without financial conflict. the medical innovation and technology authors previewed the document, and any changes were subject to approval from the university of rochester and medical imaging ministry of the americas authors."
6776,32228164,*dicer1
6777,32228164,*child
6778,32228164,*follicular thyroid carcinomas
6779,32228164,*multinodular goiter
6781,33557336,alternative diet
6782,33557336,diet
6783,33557336,iodine
6784,33557336,iodine deficiency
6785,33557336,vegetarian diet cois
6786,34069656,mediterranean diet
6787,34069656,sars-cov-2 infection
6788,34069656,dietary habits
6789,34069656,healthcare professionals cois
6790,32631402,graves’ disease
6791,32631402,hyperthyroidism
6792,32631402,scintigraphy
6793,32631402,thyroid uptake
6794,32631402,thyrotoxicosis cois
6796,34418036,"synchronous thyroid malignancies, papillary thyroid carcinoma, lymphoma"
6797,32166365,*child
6798,32166365,*congenital hypothyroidism
6799,32166365,*gland
6800,32166365,*intrathyroid thymus
6801,32166365,*nodules
6802,32166365,*thyroid
6803,32166365,*thyroiditis
6804,32166365,*ultrasonography
6805,33676861,*endoscopic surgery
6806,33676861,*minimally invasive surgery
6807,33676861,*toetva
6808,33676861,*thyroidectomy
6809,34219881,fine-needle biopsy
6810,34219881,galectin-3
6811,34219881,reverse transcriptase polymerase chain reaction
6812,34219881,thyroid neoplasms
6813,34219881,thyroid nodule
6814,33319473,*oligometastasis
6815,33319473,*small cell lung cancer
6816,33319473,*thyroid metastasis
6818,32731688,follicular thyroid adenoma
6819,32731688,follicular thyroid cancer
6820,32731688,recurrent laryngeal nerve palsy
6821,32731688,elective lymph node dissection
6822,32731688,follicular variant of papillary thyroid cancer
6823,32645970,covid-19 infection
6824,32645970,dietary habits
6825,32645970,lockdown
6826,32645970,obesity cois
6827,32703500,braf mutation
6828,32703500,fine-needle aspiration
6829,32703500,papillary thyroid carcinoma
6830,32703500,thyroid nodule
6835,34230069,hyperthyroidism
6836,34230069,molecular imaging
6837,34230069,thyroid functional autonomy
6838,34230069,thyroid nodules
6839,33507638,men 2
6840,33507638,thyroid gland surgery
6841,33507638,thyroid nodule
6842,33507638,thyroidectomy
6844,34822305,atf4
6845,34822305,pct
6846,34822305,ret mutation
6847,34822305,cancer médullaire de la thyroïde
6848,34822305,medullary thyroid carcinoma
6849,34822305,mutation de ret
6850,34822305,recurrence
6851,34822305,récidive
6852,34822305,survie
6853,34822305,survival
6855,31566142,intestinal microbiota
6856,31566142,autoimmune thyroid diseases
6857,31566142,gut dysbiosis
6858,31566142,hyperthyroidism
6859,31566142,hypothyroidism
6860,31566142,thyroid hormones.
6861,33077306,epithelial mesenchymal transition
6862,33077306,papillary thyroid carcinoma
6863,33077306,six1
6864,33077306,tgf-β/smad2/3 cois
6865,33028431,*iodine deficiency
6866,33028431,*iodine supplementation
6867,33028431,*lipiodol capsules
6868,33028431,*thyroid disease
6869,33028431,*women
6870,31770674,iodine
6871,31770674,adolescents
6872,31770674,children
6873,31770674,deficiency
6874,31770674,dietary intake
6875,31770674,pre-schoolers
6876,34855191,rathke
6877,34855191,cleft cysts
6878,34855191,headache
6879,34855191,hyperprolactinaemia
6880,34855191,hypopituitarism
6881,34855191,pituitary incidentaloma
6882,31835129,copper
6883,31835129,iodine
6884,31835129,selenium
6885,31835129,thyroiditis
6886,31835129,zinc
6887,32436480,*adults
6888,32436480,*iodine fortification
6889,32436480,*serum iodine
6890,32436480,*thyroid autoimmunity
6891,32436480,*urinary iodine
6893,34751793,laser therapy
6894,34751793,nodular goiter
6895,34751793,radiofrequency ablation
6896,34751793,thyroid nodule
6897,33007517,ccna1 gene
6898,33007517,cyclin a1
6899,33007517,diagnostic
6900,33007517,molecular marker
6901,33007517,papillary thyroid cancer
6902,33007517,protein expression
6903,33656790,afirma genomic sequencing classifier
6904,33656790,atypia of undetermined significance
6905,33656790,de quervain's thyroiditis
6906,33656790,molecular tests
6907,33176840,autosomal genetic disease
6908,33176840,gene mutation
6909,33176840,thyroid hormone
6910,33176840,thyroid hormone receptor β
6911,33176840,thyroid hormone resistance cois
6912,34803909,*biomarker
6913,34803909,*complement c4-a
6914,34803909,*papillary thyroid carcinoma
6915,34803909,*plasminogen
6916,34803909,*prediction cois commercial or financial relationships that could be construed as a potential conflict of interest.
6917,33750374,complication
6918,33750374,gasless trans-axillary endoscopic thyroidectomy
6919,33750374,hypoglossal nerve palsy cois
6920,33445950,thyroid surgery − transoral endoscopy – toetva − case report of the first toetva  patient at university hospital brno
6921,33213237,intratracheal ectopic thyroid
6922,33213237,adenomatous hyperplasia
6923,33213237,diagnosis
6924,33213237,ectopic
6925,33213237,thyroid
6926,33213237,treatment cois conflict of interest.
6928,33868182,*autoimmune thyroid disease
6929,33868182,*epigenetic effect
6930,33868182,*resistance to thyroid hormone
6931,33868182,*thyroid dysgenesis
6932,33868182,*thyroid hormone receptor
6933,33868182,*variant of unknown significance cois commercial or financial relationships that could be construed as a potential conflict of interest.
6935,32037778,*fine needle aspiration cytology
6936,32037778,*focus number
6937,32037778,*malignancy
6938,32037778,*predictivity
6939,32037778,*thyroid nodules
6940,30784009,acoustic respiratory rate monitoring
6941,30784009,airway obstruction
6942,30784009,postoperative hemorrhage
6943,30784009,tachypnea
6944,30784009,thyroidectomy
6946,32286703,*dapk
6947,32286703,*dna methylation
6948,32286703,*pten
6949,32286703,*diagnosis
6950,32286703,*thyroid nodules
6951,31808043,*fasting glucose
6952,31808043,*observational studies
6953,31808043,*randomized controlled trials
6954,31808043,*time restricted feeding
6955,31808043,*weight loss
6956,32816208,dropouts
6957,32816208,obesity
6958,32816208,treatment failure
6959,32816208,weight management cois
6960,34580763,dicer1
6961,34580763,papillary thyroid carcinoma
6962,34580763,poorly differentiated thyroid carcinoma
6963,34580763,thyroid carcinoma
6964,34365588,asthenia
6965,34365588,parathyroidectomy
6966,34365588,quality of life
6967,34365588,thyroidectomy
6968,34755283,autoimmune thyroiditis
6969,34755283,hypothyroidism
6970,34755283,survey
6971,34755283,thyroid
6972,34755283,thyroid hormones
6973,33346472,covid-19
6974,33346472,russia
6975,33346472,epidemic
6976,33346472,iodine deficiency
6977,33346472,iodized salt
6978,31751626,*congenital hypothyroidism
6979,31751626,*erad
6980,31751626,*protein folding
6981,31751626,*thyroid genes
6982,31821747,*braf mutation
6983,31821747,*fine-needle aspiration cytology
6984,31821747,*personalized medicine
6985,31821747,*programmed death-ligand 1 (pd-l1)
6986,31821747,*thyroid cancer
6988,33112496,dicer1
6989,33112496,autopsy
6990,33112496,prostate
6991,33112496,rhabdomyosarcoma
6992,32760349,*lymph node metastasis
6993,32760349,*papillary thyroid cancer
6994,32760349,*thyroglobulin antibodies
6995,32760349,*thyroid nodule
6996,32760349,*thyroidectomy
6999,33310924,*iodine supply
7000,33310924,*iodized salt
7001,33310924,*jódellátottság
7002,33310924,*jódozott só
7003,33310924,*pregnant women
7004,33310924,*várandós anyák
7005,33310924,*“silent” prophylaxis
7006,33310924,*„silent” profilaxis
7007,33773966,congenital hypothyroidism
7008,33773966,gland in situ
7009,33773966,monoallelic mutations
7010,33773966,thyroid dysgenesis
7011,33773966,thyroid transcription factors
7012,33740798,anxiety
7013,33740798,depression
7014,33740798,primary hyperparathyroidism
7015,33333891,rthβ
7016,33333891,thrb
7017,33333891,hypercholesterolemia
7018,33333891,hypothyroidism
7019,33333891,resistance to thyroid hormones
7020,33333891,thyroid
7021,33333891,thyroid hormone receptor cois
7022,32687189,* saliva iodine
7023,32687189,*iodine status
7024,32687189,*thyroid function
7025,32676935,covid-19; sars-cov-2
7026,32676935,subacute thyroiditis
7027,32676935,viral thyroiditis cois
7028,31703968,*contrast-enhanced ultrasonography
7029,31703968,*papillary thyroid microcarcinoma
7030,31703968,*tumor size stratification
7031,33921293,gluten sensitivity
7032,33921293,gut microbiota
7033,33921293,gut mycobiota
7034,33921293,mental status cois
7035,34803920,*cardiac arrhythmias
7036,34803920,*hypothyroidism
7037,34803920,*levothyroxine
7038,34803920,*osteoporosis
7039,34803920,*replacement therapy
7040,34803920,*thyroid cois commercial or financial relationships that could be construed as a potential conflict of interest.
7041,33631011,*duox system genes
7042,33631011,*clinical phenotype
7043,33631011,*congenital hypothyroidism
7044,33631011,*targeted region sequencing
7045,33631011,*thyroid gland
7046,32500518,*covid-19
7047,32500518,*endocrine emergencies
7048,32500518,*endocrine surgery
7049,32500518,*thyroid cancer cois
7050,31918249,braf(v600e)
7051,31918249,hbme-1
7052,31918249,lymph node metastasis
7053,31918249,papillary thyroid carcinoma
7054,31918249,ultrasound
7056,34400129,economic impact
7057,34400129,hypocalcemia
7058,34400129,hypocalcémie
7059,34400129,hypoparathyroidism
7060,34400129,hypoparathyroïdie
7061,34400129,impact économique
7062,34400129,quality of life
7063,34400129,qualité de vie
7064,34400129,thyroidectomy
7065,34400129,thyroïdectomie
7066,32811342,*elderly
7067,32811342,*hyperthyroidism
7068,32811342,*methimazole
7069,32811342,*radioiodine
7070,33582938,china
7071,33582938,morbidity
7072,33582938,thyroid nodules
7073,33582938,urinary iodine concentration cois
7075,33147928,dose effect
7076,33147928,iodine
7077,33147928,thyroid nodule
7078,33147928,u-shaped curve
7079,33147928,urine
7080,31983029,*lateral lymph node metastasis
7081,31983029,*papillary thyroid carcinoma
7082,31983029,*predictive model
7083,31983029,*risk stratification
7084,31983029,*treatment strategy
7085,31789139,ccl5
7086,31789139,cav-1
7087,31789139,chemokine
7088,31789139,hashimoto’s thyroiditis
7089,31789139,pparγ
7090,31789139,pioglitazone.
7092,34594299,*autoimmune thyroid antibodies
7093,34594299,*fine needle aspirate (fna)
7094,34594299,*microcalcification
7095,34594299,*thyroid cancer
7096,34594299,*tumor size cois commercial or financial relationships that could be construed as a potential conflict of interest.
7097,33460435,*dicer1 mutation
7098,33460435,*thyroid cancer genes
7099,33460435,*thyroid nodules
7100,33106852,*hypothyroidism
7101,33106852,*levothyroxine
7102,33106852,*meta-analysis
7103,33106852,*systematic review
7104,33106852,*thyroidectomy
7105,33106852,*weight gain
7106,32988358,thyroid carcinoma
7107,32988358,aggressive
7108,32988358,breast carcinoma
7109,32988358,diagnostic algorithm
7110,32988358,radiopharmaceuticals
7111,32988358,synchronous
7112,34376229,cardiac metastasis
7113,34376229,case report
7114,34376229,follicular thyroid carcinoma
7115,34376229,hurthle cell carcinoma
7116,34376229,multisite metastases
7117,34376229,pancreatic metastasis
7118,34376229,unusual metastases cois
7119,33111192,*toetva
7120,33111192,*tort
7121,33111192,*transoral endoscopic thyroidectomy
7122,33111192,*transoral robotic thyroidectomy
7124,31383578,hypocalcemia
7125,31383578,hypoparathyroidism
7126,31383578,pediatric population
7127,31383578,total thyroidectomy
7128,30953130,*brain tumor
7129,30953130,*cns sarcoma
7130,30953130,*ciliary body medulloepithelioma
7131,30953130,*dicer1
7132,30953130,*dicer1-associated cns sarcoma
7133,30953130,*etmr
7134,30953130,*pineoblastoma
7135,30953130,*pituitary blastoma
7136,34010443,desiccated thyroid extracts
7137,34010443,hypothyroidism
7138,34010443,iodine
7139,34010443,levothyroxine
7140,34010443,liothyronine
7141,34010443,selenium
7142,34010443,survey
7143,34010443,thyroid hormones
7144,33772338,thyroid
7145,33772338,malignancy
7146,33772338,nodule
7147,33772338,ultrasonography
7148,33406977,*salt iodization
7149,33406977,*thyroid autoantibodies
7150,33406977,*thyroid dysfunction
7151,31928176,*tibetan
7152,31928176,*iodine nutrition
7153,31928176,*oxygen-deficient plateau
7154,31928176,*thyroid disorders
7156,33645517,ptc
7157,33645517,tpoab
7158,33645517,tgab
7159,33645517,extrathyroidal extension
7160,33645517,lymph node metastasis
7161,32696176,*gli3 gene
7162,32696176,*glis3 gene
7163,32696176,*thyroid dysgenesis
7164,32696176,*thyroid hemiagenesis
7165,32696176,*whole-exome sequencing cois
7166,34861221,euthyroidism
7167,34861221,euthyroïdie
7168,34861221,french endocrine society
7169,34861221,hypothyroidism
7170,34861221,hypothyroïdie
7171,34861221,levothyroxine
7172,34861221,liothyronine
7173,34861221,lévothyroxine
7174,34861221,société française d’endocrinologie
7175,34861221,survey
7176,34861221,sondage
7177,34126658,autoantibody
7178,34126658,autoimmune thyroiditis
7179,34126658,pediatrics
7180,34126658,thyroid cancer
7181,34126658,thyroid nodule
7182,33643218,*radiofrequency ablation
7183,33643218,*technique
7184,33643218,*thermal ablation
7185,33643218,*thyroid nodules
7186,33643218,*ultrasound cois commercial or financial relationships that could be construed as a potential conflict of interest.
7188,32276716,*graves’ disease
7189,32276716,*outpatient surgery
7190,32276716,*pediatric surgery
7191,32276716,*thyroid cancer
7192,32276716,*thyroid nodule
7193,32276716,*thyroidectomy cois conflicts of interest to disclose.
7194,34539567,*biallelic variant
7195,34539567,*characteristic
7196,34539567,*hypothyroidism
7197,34539567,*oligogenic variant
7198,34539567,*whole-exome sequencing cois commercial or financial relationships that could be construed as a potential conflict of interest.
7199,34284528,cns tumor
7200,34284528,plurihormonal pituitary adenoma
7201,34284528,sella turcica
7202,33827539,hyperparathyroidism
7203,33827539,intrathyroidal parathyroid
7204,33827539,parathyroid cancer
7205,33827539,surgical approach
7206,33827539,thyroid cancer cois
7207,33683595,*chek2
7208,33683595,*dna repair
7209,33683595,*familial non-medullary thyroid carcinoma (fnmtc)
7210,33683595,*founder pathogenic variant
7211,33683595,*thyroid
7213,33104041,*hyperthyroidism
7214,33104041,*parkinson’s disease
7215,33104041,*hypothyroidism
7216,33104041,*neurodegenerative disorder
7217,33104041,*pathophysiology
7218,33104041,*thyroid disease
7219,33104041,*thyroid dysfunction
7222,33254347,"diagnosis, surgical procedures, operative"
7223,33254347,root of neck neoplasms cois relevant financial relationships with commercial interests to disclose.
7224,31621051,autoregulation
7225,31621051,cognition
7226,31621051,primary hyperparathyroidism
7227,31621051,vascular stiffness
7228,31621051,vasomotor reactivity cois
7229,34644122,*chloride channel
7230,34644122,*chloride exchanger
7231,34644122,*drug discovery
7232,34644122,*epithelium
7233,34644122,"*solute carrier proteins cois applications for chloride transport modulators, which are owned by their respective universities."
7234,33920190,*ages
7235,33920190,*mage
7236,33920190,*rage
7237,33920190,*glycation
7238,33920190,*oxidative stress
7239,33920190,*thyroid gland pathology cois
7241,33751486,autoimmune thyroid disease
7242,33751486,children and adolescents
7243,33751486,dna methylation
7244,33751486,hashimoto thyroiditis
7245,33751486,melting curve analysis
7246,33751486,ptpn22
7247,33035689,*cell free mtdna
7248,33035689,*nd4/nd1
7249,33035689,*thyroid cancer
7250,33035689,*mtdna copy number
7251,33035689,*mtdna integrity
7252,32430758,*ovarian sertoli-leydig cell tumors
7253,32430758,*slcts
7254,34171097,*cancer
7255,34171097,*carcinoma
7256,34171097,*follicular
7257,34171097,*mutation
7258,34171097,*thyroid
7259,34171097,*whole-genome
7260,32910988,*cysteine cathepsins
7261,32910988,*non-canonical trafficking
7262,32910988,*nuclear forms
7263,32910988,*proliferation-promoting
7264,32910988,*thyroid cancer cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
7266,33004735,ablation techniques
7267,33004735,consensus
7268,33004735,guideline
7269,33004735,nodular goiter
7270,33004735,thyroid neoplasms cois
7272,34080176,*hysterosalpingography
7273,34080176,*iodine excess
7274,34080176,*lactation
7275,34080176,*oil-soluble iodinated contrast
7276,34080176,*pregnancy
7277,33096991,*autoimmune thyroid disease
7278,33096991,*cardiac tamponade
7279,33096991,*hypothyroidism
7280,33096991,*pericardial effusion
7281,33096991,*turner syndrome cois
7282,32675393,papillary thyroid carcinoma
7283,32675393,genetic variation
7284,32675393,lncrna
7285,32675393,thyroid function
7286,32072403,fscn1
7287,32072403,immunohistochemistry
7288,32072403,methylation
7289,32072403,promoter
7290,32072403,thyroid cancer
7292,33124651,*tsh
7293,33124651,*congenital hypothyroidism
7294,33124651,*cutoff
7295,33124651,*newborn screening
7297,32188421,maternal and neonatal complications
7298,32188421,pregnancy
7299,32188421,urinary iodine concentration cois
7300,32851577,*cd71
7301,32851577,*primary immune deficiency
7302,32851577,*tfr1
7303,32851577,*a mutation in tfrc
7304,32851577,*combined immunodeficiency cois
7305,34854944,*fibrous dysplasia
7306,34854944,*gnas
7307,34854944,*intramuscular myxoma
7308,34854944,*mazabraud’s syndrome
7309,34854944,*mccune-albright syndrome
7310,32899424,mir-146b
7311,32899424,mir-181b
7312,32899424,mir-21
7313,32899424,mir-221
7314,32899424,mir-222
7315,32899424,papillary thyroid carcinoma
7316,32899424,plasma cois
7317,32842364,detection rate
7318,32842364,fluorescence intensity
7319,32842364,influencing factor
7320,32842364,parathyroid glands
7321,32714280,*cushing's disease
7322,32714280,*dicer1
7323,32714280,*corticotropinoma
7324,32714280,*disease-modifying gene
7325,32714280,*pituitary neuroendocrine tumor
7326,34740022,*acromegaly
7327,34740022,*igf-1
7328,34740022,*risk factors
7329,34740022,*thyroid nodules
7331,31964247,*cost-effectiveness
7332,31964247,*decision-analytic modeling
7333,31964247,*effectiveness
7334,31964247,*iodine deficiency-related diseases
7335,31964247,*systematic review
7336,31784815,comparison between germany and switzerland
7337,31784815,degs1
7338,31784815,iodine
7339,31784815,iodine-containing foods
7340,31784815,iodized salt
7341,31784815,salt
7342,33036505,axillary approach
7343,33036505,"surgical procedures, minimally invasive"
7344,33036505,thyroid neoplasms
7345,33036505,thyroidectomy
7347,32075540,*china
7348,32075540,*iodine
7349,32075540,*prevalence
7350,32075540,*thyroid disorders
7351,32075540,*universal salt iodization
7352,35288841,anaplastic thyroid carcinoma
7353,35288841,cribriform-morular thyroid carcinoma
7354,35288841,follicular nodular disease
7355,35288841,follicular thyroid carcinoma
7356,35288841,high-grade thyroid carcinoma
7357,35288841,hyalinizing trabecular tumor
7358,35288841,medullary thyroid carcinoma
7359,35288841,papillary thyroid carcinoma
7360,35288841,poorly differentiated thyroid carcinoma
7361,35288841,thyroblastoma
7362,35288841,who classification of thyroid tumors
7364,31447477,coronary artery
7365,31447477,ectopic goiter
7366,31447477,intrapericardial tumor
7367,31447477,thyroid tissue
7369,35657195,basedow
7370,35657195,hashimoto
7371,35657195,inflammation
7372,35657195,thyroiditis
7373,35657195,auto
7374,35657195,immunity
7375,35685217,*massive goiter
7376,35685217,*multinodular goiter
7377,35685217,*retrosternal extension
7378,35685217,*sternotomy
7379,35685217,*thyroidectomy cois commercial or financial relationships that could be construed as a potential conflict of interest.
7381,35538703,giant goiter
7382,35538703,hashimoto’s thyroiditis
7383,35538703,case report
7384,35538703,en bloc excision
7385,35538703,hyperthyroidism
7386,35538703,thyroid
7387,35567330,complication
7388,35567330,large intrathoracic goiter
7389,35567330,minimally invasive surgery
7390,35567330,robot-assisted thoracoscopic surgery
7391,35567330,tracheal stenosis cois
7393,34915750,*adaptor protein
7394,34915750,*aging
7395,34915750,*cytoskeleton
7396,34915750,*hypothyroidism
7397,34915750,*iodide organification cois
7398,35331216,micronodular goiter
7399,35331216,papillary thyroid microcarcinoma
7400,35331216,ultrasound grayscale ratio cois
7404,35221176,*airway stenosis
7405,35221176,*ecmo
7406,35221176,*nodular goiter cois authors were disclosed.
7409,35186140,alt – alanine aminotransferase
7410,35186140,ap – alkaline phosphatase
7411,35186140,ast – aspartate aminotransferase
7412,35186140,arttg – antibodies to thyroid-stimulating hormone receptors
7413,35186140,cdld – chronic diffuse liver diseases
7414,35186140,dtg – diffuse toxic goiter
7415,35186140,swv – shear wave velocity
7416,35186140,t3f – free triiodothyronine
7417,35186140,t4f – thyroxine free
7418,35186140,tg – thyroid gland
7419,35186140,tsh – thyroid-stimulating hormone
7420,35186140,diffuse toxic goiter
7421,35186140,shear wave elastography
7422,35186140,ultrasound examination
7423,34980104,*iodine
7424,34980104,*nodular goiter
7425,34980104,*perchlorate
7426,34980104,*thyroid cancer
7427,34980104,*thyroid function cois
7428,35469855,bkmr analysis
7429,35469855,ng
7430,35469855,pbdes
7431,35469855,risk factor
7432,35436270,diffuse non-toxic goiter
7433,35436270,mathematical model
7434,35436270,risk
7435,35436270,type 2 diabetes mellitus
7436,35390148,benign multinodular goiter
7437,35390148,postoperative morbidity
7438,35390148,total thyroidectomy
7439,35390148,vocal cord palsy
7440,35390148,weight of specimen
7448,34928376,*graves’ disease
7449,34928376,*adolescents
7450,34928376,*children
7451,34928376,*rituximab
7452,34928376,*thionamide
7453,34928376,*thyrotoxicosis
7455,35037871,hypercalcemia
7456,35037871,lithium
7457,35037871,nephrogenic diabetes insipidus
7458,35037871,thyroid disorders
7464,35264385,immunology
7465,35264385,materno-fetal medicine
7466,35264385,neonatal intensive care
7467,35264385,thyrotoxicosis cois
7468,35574000,epidemiology
7469,35574000,evaluation
7470,35574000,graves orbitopathy
7471,35574000,novel therapeutic approach
7472,35574000,pathogenesis cois commercial or financial relationships that could be construed as a potential conflict of interest.
7473,35307540,*covid-19
7474,35307540,*graves' disease
7475,35307540,*hashimoto's thyroiditis
7476,35307540,*thyroid cois
7477,35226548,coronavirus disease 2019
7478,35226548,hyperthyroidism
7479,35226548,hypothyroidism
7480,35226548,non-thyroidal illness
7481,35226548,thyroid
7482,35226548,thyroid cancer
7483,35226548,thyroiditis cois conflict of interest.
7484,35334525,cervicotomy
7485,35334525,intrathoracic goitre
7486,35334525,morbidity
7487,35334525,sternotomy
7488,35334525,thyroid surgery cois
7489,32975863,graves ophthalmopathy
7490,32975863,thyroid eye disease
7491,35167950,*dry eye
7492,35167950,*exposure keratopathy
7493,35167950,*ocular surface disease
7494,35167950,*thyroid eye disease
7495,35226748,*graves disease
7496,35226748,*autoimmune addison disease
7497,35226748,*autoimmune hypothyroidism
7498,35226748,*autoimmune polyendocrine syndromes
7499,35684009,cancer
7500,35684009,iodine
7501,35684009,iodine deficiency
7502,35684009,iodine supplementation
7503,35684009,prevalence
7504,35684009,thyroid dysfunction cois
7506,35614620,"graves, orbital fibroblasts, autoimmunity."
7507,35230257,graves‘ disease
7508,35230257,iceland
7509,35230257,pediatric
7510,35230257,treatment
7511,35422184,autoimmune eye diseases
7512,35422184,graves’ orbitopathy
7513,35422184,anti-il6-receptor antibodies
7514,35422184,neuromyelitis optica spectrum disorders
7515,35422184,noninfectious uveitis
7516,35422184,optic neuropathy
7517,35422184,peripheral ulcerative keratitis
7518,35422184,tocilizumab
7520,35287535,*graves’ disease
7521,35287535,*graves’ orbitopathy
7522,35287535,*k1-70
7523,35287535,*antithyroid drugs
7524,35287535,*hyperthyroidism
7525,35287535,*iscalimab
7526,35287535,*methimazole
7527,35287535,*propylthiouracil
7528,35287535,*radioactive iodine
7529,35287535,*rituximab
7530,35287535,*thyroidectomy
7531,35287535,*thyrotropin receptor
7533,35534869,*autoimmune thyroid disease
7534,35534869,*human leucocyte antigen
7535,35534869,*relapsing polychondritis cois
7536,35315985,graves' ophthalmopathy
7537,35315985,proptosis
7538,35315985,thiol-disulfide
7539,35658138,parathyroidectomy
7540,35658138,prevention of damage
7541,35658138,recurrent laryngeal nerve
7542,35658138,thyroidectomy
7543,34687316,*graves disease
7544,34687316,*adolescents
7545,34687316,*children
7546,34687316,*rituximab
7547,34687316,*thionamide
7548,34687316,*thyrotoxicosis
7549,35600602,graves’ disease
7550,35600602,central hypothyroidism
7551,35600602,maternal trab
7552,35600602,neonatal hyperthyroidism
7553,35600602,neonates cois commercial or financial relationships that could be construed as a potential conflict of interest.
7554,35379490,hypoparathyroidism
7555,35379490,paediatrics
7556,35379490,postoperative complications
7557,35379490,thyroidectomy
7558,35379490,"vocal cord palsy cois hy chung, and kenneth ky wong have no conflicts of interest or financial ties to disclose."
7561,35015288,adjuvants
7562,35015288,autoimmune syndrome
7563,35015288,graves’ disease
7564,35015288,sars-cov-2 vaccination
7565,35015288,subacute painful thyroiditis
7566,35015288,thyrotoxicosis cois
7567,35381100,graves’ disease
7568,35381100,antithyroid agents
7569,35381100,pericarditis
7570,35381100,pleurisy
7572,35504153,multinodular goiter
7573,35504153,neck hematoma
7574,35504153,recurrent laryngeal nerve injury
7575,35504153,substernal thyroid goiter
7576,35504153,thyroidectomy
7577,35303084,graves’ orbitopathy
7578,35303084,cystine deprivation
7579,35303084,ferroptosis
7580,35303084,glycolysis
7581,35303084,orbital fibroblast
7582,35100622,*covid-19
7583,35100622,*graves’ disease
7584,35100622,*sars-cov-2
7585,35100622,*revaccination
7586,35100622,*subacute thyroiditis
7587,35100622,*vaccine
7588,34996091,*addison disease
7589,34996091,*autoantibodies
7590,34996091,*graves
7591,34996091,*hashimoto thyroiditis
7592,34996091,*disease
7593,34996091,*insulin-dependent diabetes mellitus
7595,35580958,gynecological cancer
7596,35580958,obstetrics and gynaecology cois
7598,35662442,antithyroid drugs
7599,35662442,graves disease
7600,35662442,hyperthyroidism
7601,35662442,radioiodine therapy
7602,35662442,thyroid eye disease
7603,35662442,thyroidectomy cois
7604,35734334,compressive goitre
7605,35734334,case report
7606,35734334,dyspnea
7607,35734334,thyroidectomy cois
7608,35039921,central neck tumour
7609,35039921,hypercalcaemia
7610,35039921,hyperparathyroidism
7611,35039921,parathyroid adenoma
7612,35039921,parathyroid cancer
7613,35039921,parathyroid neoplasms
7614,34515780,graves’ disease
7615,34515780,juvenile dermatomyositis
7616,34515780,anti-melanoma differentiation antigen 5
7617,34515780,soluble interleukin-2 receptor
7618,33884704,graves' disease
7619,33884704,tsh receptor antibody
7620,33884704,antithyroid drug
7621,33884704,remission
7622,35418378,contraindications and precautions
7623,35418378,"ear, nose and throat/otolaryngology"
7624,35418378,eye
7625,35418378,ophthalmology
7626,35418378,thyroid disease cois
7627,35413468,covid-19
7628,35413468,graves' disease
7629,35413468,graves' ophthalmopathy
7630,35413468,sars-cov-2
7631,35413468,vaccine cois personal relationships that could have appeared to influence the work reported in this paper.
7632,35562686,multinodular goitre
7633,35562686,rln trifurcations
7634,35562686,recurrent laryngeal nerve variations
7635,35562686,thyroidectomy cois
7637,35504602,*graves disease
7638,35504602,*hashimoto disease
7639,35504602,*immunoglobulin g4
7640,35504602,*riedel thyroiditis
7641,35504602,*thyroid diseases cois was reported.
7643,35168232,benign intracranial hypertension
7644,35168232,child
7645,35168232,graves’ disease
7646,35168232,idiopathic intracranial hypertension
7647,35168232,pseudotumor cerebri
7650,35119087,18f-fch pet/ct
7651,35119087,fluorocholine
7652,35119087,hyperparathyroidism
7653,35119087,parathyroid imaging
7654,35651979,*graves’ disease (gd)
7655,35651979,*autoimmune disease (aid)
7656,35651979,*autoimmune thyroid disease (aitd)
7657,35651979,*inactivated sars-cov-2 vaccine
7658,35651979,*thyrotropin receptor antibody (trab) cois commercial or financial relationships that could be construed as a potential conflict of interest.
7659,35568525,*puberty
7660,35568525,*fetal programming
7661,35568525,*goiter
7662,35568525,*hyperthyroidism
7663,35568525,*hypothyroidism
7664,35627231,graves’ disease
7665,35627231,x chromosome
7666,35627231,covariates
7667,35627231,logistic regression
7668,35627231,robust cois
7669,35403994,*amyloid encephalopathy
7670,35403994,*graves’ orbitopathy
7671,35403994,*hearing loss
7672,35403994,*inflammatory bowel disease
7673,35403994,*teprotumumab
7674,35403994,*thyroid-eye disease
7676,35734176,*graves’ disease
7677,35734176,*auto-immune thyroiditis
7678,35734176,*kidney biopsy
7679,35734176,*membranous nephropathy
7680,35734176,*renal pathology cois commercial or financial relationships that could be construed as a potential conflict of interest.
7681,35320248,"graves, thyroid associated orbitopathy, immunomodulation"
7682,35112273,*atrial fibrillation
7683,35112273,*hypothyroidism
7684,35112273,*subclinical thyroid disease
7685,35112273,*thyroid disease
7686,35548945,graves disease
7687,35548945,hyperthyroidism
7688,35548945,newborn
7689,35548945,pregnancy
7690,35548945,thyroid-stimulating hormone receptor antibodies
7691,35615845,clinical activity score; intraocular pressure; orbitopathy; thyroid dysfunction.
7692,35707463,graves orbitopathy
7693,35707463,adipogenesis
7694,35707463,fibroblasts
7695,35707463,fibrosis
7696,35707463,inflammation
7697,35707463,periostin cois commercial or financial relationships that could be construed as a potential conflict of interest.
7698,35331947,decompression
7699,35331947,endonasal
7700,35331947,endoscopic
7701,35331947,nonthyroid
7702,35331947,orbital
7705,34752624,*graves disease
7706,34752624,*amygdala
7707,34752624,*cognition
7708,34752624,*depression
7709,34752624,*hippocampus
7710,34752624,*longitudinal
7712,35022743,*graves disease
7713,35022743,*pittsburgh sleep quality index
7714,35022743,*hyperthyroidism
7715,35022743,*subjective sleep disorders
7716,35022743,*sympathetic tone
7717,35606042,endocrine cancer
7718,35606042,hyperthyroidism
7719,35606042,thyroid disease
7720,35606042,thyrotoxicosis cois
7722,35614367,compressive optic neuropathy (con)
7723,35614367,diplopia
7724,35614367,dysthyroid optic neuropathy (don)
7725,35614367,graves ophthalmopathy (go)
7726,35614367,teprotumumab
7727,35614367,thyroid eye disease (ted)
7728,35182078,c-reactive protein
7729,35182078,graves' disease
7730,35182078,hashimoto's thyroiditis
7731,35182078,interleukin-39
7732,35182078,white blood cell cois
7733,35432203,*22q11.2 deletion syndrome
7734,35432203,*digeorge syndrome
7735,35432203,*growth disorders
7736,35432203,*hypoparathyroidism
7737,35432203,*thyroid disorders cois commercial or financial relationships that could be construed as a potential conflict of interest.
7739,35628410,smad
7740,35628410,tgfβ
7741,35628410,adipogenesis
7742,35628410,hpmscs
7743,35628410,thyroid disease
7744,35628410,thyroid-associated ophthalmopathy cois
7745,35528009,hashimoto thyroiditis
7746,35528009,anti-parietal cell antibodies
7747,35528009,gastric malignancies
7748,35528009,organ-specific autoimmunity
7749,35528009,systemic autoimmunity cois commercial or financial relationships that could be construed as a potential conflict of interest.
7752,35489725,gapdh
7753,35489725,papillary thyroid carcinoma
7754,35489725,cfdna integrity index
7755,35489725,circulating cell-free dna
7756,35489725,β-actin
7758,35675824,graves’ disease
7759,35675824,hashimoto’s thyroiditis
7760,35675824,autoimmune thyroid disease
7761,35675824,gut microbiota
7763,35429598,*autoimmune thyroid diseases
7764,35429598,*high-throughput sequencing
7765,35429598,*immune repertoires
7766,35429598,*t cells receptor
7768,35108585,"*botox-a (btx-a, botulinum toxin type a)"
7769,35108585,*orbital fibroblast
7770,35108585,*tgf-β/smad signaling
7771,35108585,*thyroid-associated ophthalmopathy (tao)
7772,35672057,"ear, nose and throat/otolaryngology"
7773,35672057,oncology
7774,35672057,thyroid disease cois
7775,35459655,cardiothoracic surgery
7776,35459655,surgical oncology
7777,35459655,thyroid disease cois
7778,35338690,*childhood cancer survivors
7779,35338690,*head and neck radiation
7780,35338690,*hypoparathyroidism
7781,35338690,*pediatric thyroidectomy
7782,35338690,*recurrent laryngeal nerve paralysis
7783,35018816,*italy
7784,35018816,*age-standardized rates
7785,35018816,*thyroid surgery
7786,35018816,*thyroidectomies
7787,35018816,*time trends
7788,35522861,autoimmune thyroiditis
7789,35522861,ctla
7790,35522861,graves’ disease
7791,35522861,hashimoto’s thyroiditis (ht)
7792,35522861,il-17
7793,35522861,il-23
7795,35235663,*graves’ disease
7796,35235663,*sars-cov-2 vaccine
7797,35235663,*hyperthyroidism
7798,35135806,general surgery
7799,35135806,head and neck surgery
7800,35135806,otolaryngology / ent
7801,35135806,thyroid disease
7802,35135806,thyrotoxicosis cois
7803,35024887,computed tomography
7804,35024887,correlations
7805,35024887,itmig classification
7806,35024887,lymphadenopathy
7807,35024887,thoracic radiography
7808,35381687,*antithyroid agents
7809,35381687,*epidemiology
7810,35381687,*graves disease
7811,35381687,"*kidney failure, chronic cois was reported."
7813,35624535,graves’ disease
7814,35624535,hyperthyroidism
7815,35624535,hypercalcemia
7816,35624535,liver damage
7817,35624535,palpitation
7818,35624535,vomiting cois non-financial interests to disclose.
7819,35273577,*il-11
7820,35273577,*clinical activity score
7821,35273577,*fibrosis
7822,35273577,*orbital fibroblast
7823,35273577,*thyroid-associated ophthalmopathy cois commercial or financial relationships that could be construed as a potential conflict of interest.
7824,34788857,*m22 (a monoclonal tsab)
7825,34788857,*tsh receptor (tshr)
7826,34788857,*tshr stimulating antibody (tsab)
7827,34788857,*crosstalk
7828,34788857,*insulin-like growth factor receptor 1 (igf1r)
7829,34788857,*teprotumumab
7830,34788857,*thyroid eye disease (ted)
7831,35728893,oculoplastics
7832,35728893,orbital and lacrimal disorders
7833,35728893,thyroid disease cois
7834,35018442,*individual participant data
7835,35018442,*meta-analysis
7836,35018442,*muscle strength
7837,35018442,*quality of life
7838,35018442,*vitamin d
7840,35663306,erk
7841,35663306,graves’ ophthalmopathy
7842,35663306,stat3
7843,35663306,dihydroartemisinin
7844,35663306,fibrosis
7845,35663306,inflammation
7846,35663306,orbital fibroblast cois commercial or financial relationships that could be construed as a potential conflict of interest.
7847,35119800,drug reaction with eosinophilia and systemic symptoms (dress)
7848,35119800,severe cutaneous adverse drug reactions (scars)
7849,35119800,thyroid dysfunction
7850,35119800,thyroiditis
7851,35244288,99mtechnetium uptake
7852,35244288,grave's disease
7853,35244288,trab
7854,35244288,nonuniform uptake
7855,35066781,*blood markers
7856,35066781,*clinical biomarkers
7857,35066781,*graves’ ophthalmopathy
7858,35066781,*orbital imaging
7859,35066781,*tear cytokines
7860,35610583,bayesian method
7861,35610583,graves’ disease data
7862,35610583,minnesota center for twin and family research data
7863,35610583,penalized fieller’s method
7864,35610583,skewed x chromosome inactivation cois
7865,35220164,*autoimmune thyroid diseases
7866,35220164,*graves' disease
7867,35220164,*hyperthyroidism
7868,35220164,*inactivated covid-19 vaccine
7869,35220164,*sars-cov-2
7870,35220164,*mrna vaccine cois
7871,35563653,graves’ orbitopathy
7872,35563653,disulfiram
7873,35563653,fibrosis
7874,35563653,myofibroblasts
7875,35563653,perimysial orbital fibroblasts cois
7876,35307774,dicer1
7877,35307774,multinodular goiter
7878,35307774,pediatric poorly differentiated thyroid carcinoma
7879,35307774,thyroblastoma cois
7880,35088381,antithyroid drug
7881,35088381,graves’ disease
7882,35088381,long-term
7883,35088381,methimazole
7884,35088381,remission
7885,35088381,thionamides
7886,35295987,*cancer diagnosis
7887,35295987,*cancer risk
7888,35295987,*familial non-medullary thyroid carcinoma
7889,35295987,*familial thyroid cancer
7890,35295987,*papillary thyroid carcinoma
7891,35295987,*susceptibility genes cois commercial or financial relationships that could be construed as a potential conflict of interest.
7892,35398834,dysthyroid optic neuropathy
7893,35398834,fat decompression
7894,35398834,grave’s disease
7895,35398834,orbital decompression
7896,35398834,thyroid eye disease
7897,35189399,*cd4(+) t cells
7898,35189399,*graves’ disease (gd)
7899,35189399,*immune
7900,35189399,*regulatory t cells
7901,35189399,*t helper cells 17
7902,34861792,*graves' disease
7903,34861792,*mica
7904,34861792,*mendelian randomization
7905,34861792,*nkg2d
7906,34861792,*community-based cohort
7907,34861792,*phenome-wide association
7908,35241008,*adpkd
7909,35241008,*polycystic kidney disease
7910,35241008,*thyroid nodules
7911,35241008,*ultrasonography cois commercial or financial relationships that could be construed as a potential conflict of interest.
7912,35615718,graves’ disease
7913,35615718,graves’ orbitopathy
7914,35615718,antithymocyte globulin
7915,35615718,proptosis
7916,35615718,thyroid eye disease cois commercial or financial relationships that could be construed as a potential conflict of interest.
7917,35565939,graves’ disease
7918,35565939,antithyroid drugs
7919,35565939,neonate
7920,35565939,thyroid volume
7921,35565939,ultrasound cois
7922,35300630,intraocular pressure
7923,35300630,strabismus
7924,35300630,surgery
7925,35300630,thyroid eye disease cois
7927,35508893,graves' disease
7928,35508893,dosimetry
7929,35508893,hyperthyroidism
7930,35508893,multinodular goitre
7931,35508893,radioiodine
7932,35508893,theranostics
7933,35508893,toxic adenoma
7934,34988642,benign goitre
7935,34988642,quality of life
7936,34988642,thypro 39 questionnaire
7937,34988642,thyroidectomy
7939,35386700,*cd11c+ b cells
7940,35386700,*cxcr3-cxcl10
7941,35386700,*graves’ disease
7942,35386700,*trab
7943,35386700,*cytokines cois commercial or financial relationships that could be construed as a potential conflict of interest.
7947,34928110,pediatric age.
7948,34928110,thyroid cancer
7949,34928110,grave's disease
7950,34877883,*go-qol
7951,34877883,*graves' orbitopathy
7952,34877883,*decompression
7953,34877883,*lid
7954,34877883,*quality of life
7955,34877883,*strabismus surgery
7956,34877883,*systematic review
7957,35458147,sarawak
7958,35458147,usi
7959,35458147,goitre
7960,35458147,school children
7961,35458147,urinary iodine concentration cois
7965,35405683,inflammatory myofibroblastic tumor
7966,35405683,surgery
7967,35405683,thyroid cancer
7968,35405683,ultrasonic examination
7969,35459658,endocrine system
7970,35459658,hyperthyroidism
7971,35459658,thyroid disease cois
7973,35402292,*16 rrna gene sequencing
7974,35402292,*graves’ disease
7975,35402292,*th17 & treg axis
7976,35402292,*intestinal flora
7977,35402292,*short chain fatty acids cois commercial or financial relationships that could be construed as a potential conflict of interest.
7979,35713042,"multinodular goitre, complications of total thyroidectomy, surgeons' experience  in thyroid surgery."
7981,35220890,graves’ disease
7982,35220890,nrcam
7983,35220890,th1 cells
7984,35220890,lncrna runx1-it1 cois
7985,35064543,bone mineral density
7986,35064543,graves’ disease
7987,35064543,muscle mass
7988,35064543,thyroid hormone
7989,35187713,elisa
7990,35187713,graves’ disease
7991,35187713,tsh-receptor antibody
7992,35187713,diagnostic performance
7993,35187713,dot blot assay cois
7994,34489313,*cardiomyopathies
7995,34489313,*diastolic
7996,34489313,*heart failure
7997,34489313,*systolic cois
7998,35569928,graves' disease
7999,35569928,coronavirus disease 2019
8000,35569928,type 1 diabetes
8001,35569928,vaccination cois
8005,35439657,dysthyroid optic neuropathy
8006,35439657,graves' disease
8007,35439657,orbital decompression surgery
8008,35439657,orbital surgery
8009,35439657,visual acuity
8012,34927457,*graves' orbitopathy
8013,34927457,*igf-1r
8014,34927457,*tshr antibody
8015,34927457,*teprotumumab cois
8016,35320246,"sub acute thyroiditis, nuclear scan, pyrexia of unknown origin, thyroid  antibodies."
8020,35555881,fat-suppression
8021,35555881,intravenous glucocorticoid therapy
8022,35555881,magnetic resonance imaging
8023,35555881,t2 mapping
8024,35555881,thyroid-associated ophthalmopathy
8025,35555881,treatment response cois
8026,35278055,abuja
8027,35278055,goitres
8028,35278055,management outcome
8029,35278055,pattern cois
8030,35734310,bahirdar
8031,35734310,ethiopia
8032,35734310,salt iodization
8033,35734310,households
8034,35734310,iodine deficiency cois
8036,35698219,case report
8037,35698219,graves' disease
8038,35698219,guillain-barré syndrome
8039,35698219,hashimoto's disease
8040,35698219,transition cois
8042,35396078,ethanol
8043,35396078,radiofrequency
8044,35396078,thermal ablation
8045,35396078,thyroid cancer
8046,35396078,thyroid nodule
8049,35592782,*diffusion tensor imaging
8050,35592782,*dysthyroid optic neuropathy
8051,35592782,*magnetic resonance imaging
8052,35592782,*optic nerve
8053,35592782,*thyroid-associated ophthalmopathy cois commercial or financial relationships that could be construed as a potential conflict of interest.
8054,35413779,*blood flow velocity
8055,35413779,*graves disease
8056,35413779,"*receptors, thyrotropin"
8057,35413779,*thyroiditis
8058,35413779,*thyrotoxicosis
8059,35413779,"*ultrasonography, doppler, color cois samsung medison co., ltd. (seoul, korea). the sponsor had no role in the writing of the manuscript or in the decision to submit the manuscript for publication."
8060,35144579,extraocular muscles
8061,35144579,graves’ disease
8062,35144579,lacrimal gland
8063,35144579,magnetic resonance imaging
8064,35144579,prolapse
8065,35144579,proptosis
8066,35144579,thyroid-associated ophthalmopathy cois
8067,35405579,clinical activity score prediction
8068,35405579,disease activity differentiation
8069,35405579,magnetic resonance imaging
8070,35405579,magnetization transfer
8071,35405579,thyroid-associated ophthalmopathy
8072,35235144,angptl3
8073,35235144,graves’ disease
8074,35235144,hdl subfractions
8075,35235144,hyperthyroidsim
8076,35235144,hypothyroidism
8077,35235144,pre-β1 hdl
8078,34979862,central choroidal thickness
8079,34979862,choroidal vascularity index
8080,34979862,clinical activity score
8081,34979862,non-inflammatory active ted
8082,34979862,thyroid eye disease
8083,35370997,*graves’ disease (gd)
8084,35370997,*hashimoto’s thyroiditis (ht)
8085,35370997,*n-glycosylation
8086,35370997,*immunoglobulin g (igg)
8087,35370997,*immunosuppressive therapy
8088,35370997,*ultraperformance liquid chromatography  cois commercial or financial relationships that could be construed as a potential conflict of interest.
8091,35094312,*antithyroid drugs
8092,35094312,*efficacy
8093,35094312,*graves
8094,35094312,*hyperthyroidism
8095,35094312,*therapeutic plasma exchange
8099,35061094,mibi
8100,35061094,parathyroidectomy
8101,35061094,primary hyperparathyroidism
8102,35061094,surgery
8103,35061094,thyroid nodule cois
8104,35429846,graves' disease
8105,35429846,incidentally discovered
8106,35429846,medullary thyroid carcinoma
8107,35429846,thyroid
8108,35619700,*cd40
8109,35619700,*pd-l1
8110,35619700,*t cell
8111,35619700,*orbital fibroblast
8112,35619700,*thyroid associated ophthalmopathy cois commercial or financial relationships that could be construed as a potential conflict of interest.
8113,34779257,*graves'
8114,34779257,*autoimmunity
8115,34779257,*disease
8116,34779257,*orbitopathy
8117,34779257,*preclinical mouse model
8118,35265076,*akt/nfκb signaling pathway
8119,35265076,*graves ophthalmopathy
8120,35265076,*glucocorticoid sensitivity
8121,35265076,*mir-885-3p
8122,35265076,*plasma exosomes cois commercial or financial relationships that could be construed as a potential conflict of interest.
8123,35321340,*graves’ disease (gd)
8124,35321340,*electronic medical record (emr)
8125,35321340,*genome-wide association study (gwas)
8126,35321340,*human leukocyte antigen (hla)
8127,35321340,*phenome-wide association studies (phewas) cois commercial or financial relationships that could be construed as a potential conflict of interest.
8129,35667695,"*ear, nose and throat"
8130,35667695,*genetics
8131,35667695,*thyroid disease cois
8133,35489145,biomedical informatics
8134,35489145,computer-aided diagnosis (cad)
8135,35489145,convolutional neural network (cnn)
8136,35489145,deep learning
8137,35489145,multi-class classification
8138,35489145,thyroid disease diagnosis
8143,35720300,graves’ disease
8144,35720300,hashimoto’s thyroiditis
8145,35720300,cell communication
8146,35720300,immune dysregulation
8147,35720300,thyroid tissue cois commercial or financial relationships that could be construed as a potential conflict of interest.
8149,35721705,*graves’ disease
8150,35721705,*biomedical modeling
8151,35721705,*computer-aided treatment
8152,35721705,*hyperthyroidism
8153,35721705,*mathematical thyroid model cois commercial or financial relationships that could be construed as a potential conflict of interest.
8154,35698208,biomechanical simulation
8155,35698208,computer tomography data
8156,35698208,decompression surgery
8157,35698208,endocrine orbitopathy cois
8158,35413827,antithyroid drug
8159,35413827,maternal subtotal thyroidectomy
8160,35413827,neonatal hyperthyroidism
8161,35413827,thyroid function
8162,35413827,thyroid-stimulating hormone receptor antibody cois
8163,35088429,graves' disease
8164,35088429,graves' ophthalmopathy
8165,35088429,autoimmune diseases
8166,35088429,hyperthyroidism
8167,35088429,thyroid diseases
8169,35229626,*graves' disease
8170,35229626,*autoimmune thyroid disease
8171,35229626,*primary thyroid lymphoma
8172,35566351,graves orbitopathy (go)
8173,35566351,alternative tobacco products
8174,35566351,cigarette smoke extract
8175,35566351,real time cell electronic sensing (rt ces)
8176,35566351,retrobulbar fibroblast cois
8178,35370990,*graves’ disease
8179,35370990,*iodine radioisotopes
8180,35370990,*radiopharmaceuticals
8181,35370990,*subclinical thyrotoxicosis
8182,35370990,*toxic multinodular goitre
8183,35370990,*toxic nodule
8184,35370990,*treatment outcome cois commercial or financial relationships that could be construed as a potential conflict of interest.
8186,35465762,*goiter
8187,35465762,*thyroid
8188,35465762,*thyroid nodule
8189,35465762,*thyroiditis
8190,35465762,"*ultrasound cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
8192,35538553,intraocular pressure
8193,35538553,lateral gaze
8194,35538553,primary gaze
8195,35538553,teprotumumab
8196,35538553,thyroid eye disease
8197,35538553,upgaze cois
8198,35144533,case report
8199,35144533,glucocorticoids
8200,35144533,graves’ disease
8201,35144533,hepatitis b virus
8202,35144533,methimazole cois
8203,35441746,benign thyroid nodule
8204,35441746,papillary thyroid carcinoma
8205,35441746,platelet count
8206,35441746,platelet distribution width
8207,35441746,thyroglobulin cois
8208,35579208,aneurysmal bone cyst
8209,35579208,graves’ disease
8210,35579208,moyamoya disease
8211,35579208,case report
8212,35579208,ischemic cerebral infarction
8213,35579208,proximal femur cois conflict of interest.
8214,35443720,case report
8215,35443720,germ cell tumor
8216,35443720,human chorionic gonadotropin
8217,35443720,hyperthyroidism
8218,35443720,paraneoplastic syndrome cois
8219,35091101,graves' disease
8220,35091101,trab
8221,35091101,bioassay
8222,35091101,diagnosis
8223,35091101,thyroid-stimulating immunoglobulin
8224,35091101,thyrotoxicosis
8225,35090420,acute transient thyroid swelling
8226,35090420,adenomatous goiter
8227,35090420,airway obstruction
8228,35090420,aortic regurgitation
8229,35090420,fine-needle aspiration
8230,35090420,nodular goiter
8231,35090420,thyroid gland
8232,35090420,tracheal intubation cois
8235,35562642,machine learning
8236,35562642,mass spectrometry imaging
8237,35562642,papillary thyroid carcinoma
8238,35562642,probe electrospray ionization mass
8239,35562642,rapid diagnosis
8240,35659565,acute inflammation
8241,35659565,fucoidan
8242,35659565,neutrophil adhesion
8243,35659565,p-selectin
8244,35659565,sargassum fusiforme
8245,35039349,immunological products and vaccines
8246,35039349,lung cancer (oncology)
8247,35039349,safety
8248,35039349,therapeutic indications
8249,35039349,thyroid disease cois
8251,35593680,l-thyroxine
8252,35593680,active follow-up
8253,35593680,active surveillance
8254,35593680,fine-needle aspiration biopsy
8255,35593680,indications for hemithyroidectomy
8256,35593680,nodular goiter
8257,35593680,papillary thyroid microcarcinoma
8258,35593680,radioiodine treatment
8259,35593680, thyroid cancer
8260,35382047,graves’ disease
8261,35382047,case report
8262,35382047,type 1 diabetes mellitus
11533,20463839,complications
11534,20463839,retrosternal goitre
11535,20463839,sternotomy
11536,20463839,surgical treatment
11537,20463839,thyroid
11649,19270831,graves' disease
11650,19270831,hantaan virus
11651,19270831,hemorrhagic fever with renal syndrome
11914,19759882,biometry
11915,19759882,eye abnormalities
11916,19759882,graves’
11917,19759882,graves’ disease
11918,19759882,ophthalmopathy
11919,19759882,photography
11996,19568361,drug-induced hypersensitivity
11997,19568361,graves' disease
11998,19568361,hyperthyroidism
11999,19568361,iodine therapy
12000,19568361,vogt-koyanagi-harada disease
12075,19547630,graves’ disease
12076,19547630,endocrine orbitopathy
12077,19547630,impaired earning capacity
12078,19547630,occupational disability
12079,19547630,quality of life
12523,20463832,stem cells
12524,20463832,thyroid
12525,20463832,thyroid cancer
12526,20463832,tissue repair
12715,19606248,calcitonin
12716,19606248,false-positive test
12717,19606248,ret mutation
12718,19606248,total thyroidectomy
13114,21274344,pendred syndrome
13115,21274344,congenital hypothyroidism
13116,21274344,pseudo−pendred syndrome
13117,21274344,thyroid peroxidase defect
13147,21274318,thyrotropin receptor
13148,21274318,germline mutation
13149,21274318,nonautoimmune hyperthyroidism
13383,21274321,congenital hypothyroidism
13384,21274321,thyroxine
13462,21052505,clinical course
13463,21052505,optic nerve diseases
13464,21052505,risk factors
13465,21052505,thyroid-associated orbitopathy cois
13580,21274336,hyperthyroidism
13581,21274336,isolated
13582,21274336,neonatal
13583,21274336,sialadenitis
13584,21274336,submandibular
13619,21716594,biological assay
13620,21716594,graves disease
13621,21716594,"immunoglobulins, thyroid-stimulating"
13622,21716594,"receptors, thyrotropin"
13623,21716594,thyrotropin-binding inhibitory immunoglobulin cois
13667,20379454,depression
13668,20379454,graves ophthalmopathy
13669,20379454,quality of life cois
13692,20195406,graves disease
13693,20195406,thyroid neoplasms
13694,20195406,ultrasonography cois
13830,20157407,congenital fibrosis syndrome of the extraocular muscles
13831,20157407,congenital retraction
13832,20157407,epiblepharon
13833,20157407,lower eyelid retraction
13834,20157407,thyroid-associated ophthalmopathy
13890,22148004,destructive thyroiditis
13891,22148004,graves disease
13892,22148004,interferons
13947,20835551,immunohistochemistry
13948,20835551,ndrg1
13949,20835551,thyroid carcinoma
13950,20835551,thyroid gland
13951,20835551,tissue microarray
14026,20808683,mutation
14027,20808683,thyroid hormone receptor
14028,20808683,thyroid hormone receptors beta
14029,20808683,thyroid hormone resistance syndrom
14030,20808683,thyroid neoplasms
14265,23646218,benign thyroid hypertrophy
14266,23646218,giant goiter
14267,23646218,goiter
14268,23646218,multinodular goiter
14269,23646218,thyroidectomy
14278,23136541,nodular goiter
14279,23136541,peri-operative treatment
14280,23136541,surgical intervention. cois
14281,23998691,hyperthyroidism
14282,23998691,hypothyroidism
14283,23998691,menopause
14284,23998691,nodular goiter
14285,23998691,thyroid hormone function
14298,22362641,congenital hypothyroidism
14299,22362641,dyshormonogenetic goiter
14300,22362641,euthyroid
14301,22362641,follicular lesion
14302,22362641,follicular neoplasm
14305,24847400,large goiter
14306,24847400,morbidity
14307,24847400,thyroidectomy
14317,23688788,complications
14318,23688788,goiter
14319,23688788,levothyroxine
14320,23688788,lobectomy
14321,23688788,mng
14322,23688788,multinodular
14323,23688788,recurrence
14324,23688788,resection
14325,23688788,thyroid
14326,23688788,thyroidectomy
14334,24117750,minimally invasive surgery
14335,24117750,retrosternal goiter
14336,24117750,robot-assisted surgery
14337,24227901,lingual thyroid goiter
14338,24227901,thyroid ectopias
14339,24227901,transoral robotic surgery
14360,24239133,bocio endotorácico
14361,24239133,esternotomía
14362,24239133,intrathoracic goiter
14363,24239133,mediastino posterior
14364,24239133,posterior mediastinum
14365,24239133,sternotomy
14366,24239133,thoracotomy
14367,24239133,thyroidectomy
14368,24239133,tiroidectomía
14369,24239133,toracotomía
14391,25047208,extracervical scarless neck thyroidectomy (esnt)
14392,25047208,minimal neck incision thyroidectomy (mnit)
14393,25047208,minimally invasive video-assisted thyroidectomy (mivat)
14394,25047208,nodular goitre
14395,25047208,thyroid cancer
14402,24239215,chirurgie oculo-motrice
14403,24239215,chirurgie palpébrale
14404,24239215,corticosteroids
14405,24239215,corticothérapie
14406,24239215,dysthyroid orbitopathy
14407,24239215,décompression orbitaire
14408,24239215,eyelid surgery
14409,24239215,graves’ disease
14410,24239215,graves’ orbitopathy
14411,24239215,maladie de basedow
14412,24239215,multidisciplinaire
14413,24239215,multidisciplinary
14414,24239215,oculomotor surgery
14415,24239215,orbital decompression surgery
14416,24239215,orbitopathie basedowienne
14417,24239215,orbitopathie dysthyroïdienne
14418,24239215,radiation therapy
14419,24239215,radiothérapie
14445,24043977,airway stenting
14446,24043977,radiofrequency ablation
14447,24043977,thyroid goiter
14502,23993801,airway obstruction
14503,23993801,caesarean section
14504,23993801,fibreoptic intubation
14505,23993801,thyroidectomy
14526,24211307,carcinome papillaire de la thyroïde
14527,24211307,goitre multi-nodulaire
14528,24211307,hyperthyroidie
14529,24211307,hyperthyroidism
14530,24211307,multinodular goiter
14531,24211307,panuveitis
14532,24211307,panuvéite
14533,24211307,papillary thyroid carcinoma
14534,24211307,vascularite veineuse
14535,24211307,venous vasculitis
14541,23337610,graves’ disease
14542,23337610,hyperthyroidism
14543,23337610,suicide
14551,23838540,deafness
14552,23838540,enlarged vestibular aqueduct
14553,23838540,pendred syndrome
14554,23838540,pendrin
14555,23838540,slc26a4
14561,24211158,anxiety disorders
14562,24211158,autoimmune thyroiditis
14563,24211158,depression
14564,24211158,goiter
14565,24211158,hashimoto's thyroiditis
14569,23685895,nob1
14570,23685895,papillary thyroid carcinoma
14571,23685895,clinical significance
14572,23685895,immunohistochemistry
14573,23685895,quantitative rt–pcr
14600,23650151,delhi
14601,23650151,iodine deficiency disorders
14602,23650151,iodized salt
14603,23650151,urinary iodine excretion
14607,24327568,fine-needle cytology
14608,24327568,mantel zone lymphoma
14609,24327568,micrornas
14610,24327568,primary thyroid lymphoma
14611,24327568,thyroid cancer
14614,24043280,goiter
14615,24043280,neonatal graves’ disease
14616,24043280,respiratory failure
14617,24043280,thyroid
14620,23690528,airway management
14621,23690528,anesthesia
14622,23690528,general
14623,23690528,thyroidectomy
14626,23428758,agreement
14627,23428758,bocio
14628,23428758,concordancia
14629,23428758,goitre
14630,23428758,interobservador
14631,23428758,interobserver
14634,23645248,oestrogen
14635,23645248,progenitor cells
14636,23645248,thyroid nodules
14637,23645248,thyroid stem cells
14639,24082285,radioiodine
14640,24082285,hyperthyroidism
14654,24144816,benign multinodular goiter
14655,24144816,complications
14656,24144816,incidental thyroid cancer
14657,24144816,jóindulatú multinodularis golyva
14658,24144816,szövődmények
14659,24144816,tapasztalatok
14660,24144816,total thyreoidectomia
14661,24144816,total thyroidectomy
14662,23303305,endocrinology
14663,23303305,intensive care
14664,23303305,neonatology
14690,24249820,laryngeal nerve palsy
14691,24249820,methimazole
14692,24249820,pediatric graves’ disease
14693,24249820,reversible
14694,24249820,vocal cord paralysis
14732,24222113,braf mutations
14733,24222113,"hras, kras and nras mutations"
14734,24222113,kras codon 59 deletion
14735,24222113,follicular-patterned thyroid lesions
14743,22987562,carotid sheath dissection
14744,22987562,intraoperative neuromonitoring
14745,22987562,recurrent laryngeal nerve
14746,22987562,thyroid surgery
14747,22987562,vagal nerve stimulation
14778,24376294,endemic goitre
14779,24376294,parathyroid surgery
14780,24376294,video-assisted parathyroidectomy
14781,24376294,video-assisted thyroidectomy
14796,23473435,bisturí armónico
14797,23473435,bocio multinodular
14798,23473435,budget impact
14799,23473435,harmonic scalpel
14800,23473435,impacto económico
14801,23473435,multinodular goitre
14802,23473435,thyroidectomy
14803,23473435,tiroidectomía
14838,22351646,fine-needle aspiration
14839,22351646,malignant melanoma
14840,22351646,thyroid cyst wall atypia
14859,25103076,graves disease
14860,25103076,thyroidectomy
14861,25103076,volume
14877,24629864,graves' disease
14878,24629864,childhood
14879,24629864,hyperthyroidism
14884,23918194,nerve monitoring
14885,23918194,parathyroid surgery
14886,23918194,recurrent laryngeal nerve
14887,23918194,thyroid surgery
14895,24411211,acute pericarditis
14896,24411211,graves' disease
14897,24411211,thyroid crisis
14898,24034725,adaptive thresholding
14899,24034725,contrast enhancement
14900,24034725,image segmentation
14901,24034725,morphology
14902,24034725,planar scintigraphy
14903,24034725,radioiodine therapy
14904,24034725,thyroid volume estimation
14905,24034725,ultrasonography
14942,22511831,decompression
14943,22511831,optic neuropathy
14944,22511831,radiation
14945,22511831,steroid
14946,22511831,thyroid eye diseases cois
14956,24070662,anti–thyroid peroxidase antibodies
14957,24070662,autoimmune thyroiditis
14958,24070662,hashimoto's thyroiditis
14959,24070662,quality of life
14960,24070662,thyroidectomy
14968,24199816,basedow graves’ disease
14969,24199816,cas
14970,24199816,proptosis
14971,24199816,thyroid
14978,24704350,graves ophthalmopathy
14979,24704350,diplopia
14980,24704350,exophthalmos
14981,24704350,keratitis
14982,24704350,natural orifice transluminal endoscopic surgery
14988,22991383,laser ablation
14989,22991383,multinodular goiter
14990,22991383,thyroid nodules
14992,24291390,at
14993,24291390,angiogenesis
14994,24291390,anti-tpo
14995,24291390,anti-tg
14996,24291390,autoantibody
14997,24291390,ci
14998,24291390,edn1
14999,24291390,ednra
15000,24291390,endothelin 1
15001,24291390,endothelin family
15002,24291390,endothelin receptor type a
15003,24291390,gd
15004,24291390,graves' disease
15005,24291390,hwe
15006,24291390,hardy–weinberg equilibrium
15007,24291390,icam1
15008,24291390,intercellular adhesion molecule 1
15009,24291390,mmi
15010,24291390,or
15011,24291390,odds ratio
15012,24291390,ophthalmopathy
15013,24291390,ptu
15014,24291390,polymorphism
15015,24291390,snps
15016,24291390,tnfα
15017,24291390,trab
15018,24291390,tsh
15019,24291390,tsh receptor antibody
15020,24291390,tumor necrosis factor α
15021,24291390,utr
15022,24291390,untranslated region
15023,24291390,vegf
15024,24291390,anti-thyroglobulin
15025,24291390,anti-thyroid
15026,24291390,anti-thyroid peroxidase
15027,24291390,confidence interval
15028,24291390,methimazole
15029,24291390,propylthiouracil
15030,24291390,single nucleotide polymorphisms
15031,24291390,thyroid-stimulating hormone
15032,24291390,vascular endothelial growth factor
15035,23518423,brain infarction
15036,23518423,encephaloduroarteriosynangiosis (edas)
15037,23518423,graves’ disease
15038,23518423,hyperthyroidism
15039,23518423,moyamoya disease
15072,23868574,goiter
15073,23868574,iodized salt
15074,23868574,thyroid
15075,23868574,urinary iodine excretion
15099,24311524,orbit
15105,23482353,medicare
15106,23482353,age-associated disease
15107,23482353,comorbidity
15108,23482353,disease onset
15109,23482353,older people
15110,23482353,time trends
15112,24154901,autoimmune thyroiditis
15113,24154901,inferior thyroid artery
15114,24154901,thyroid doppler sonography
15115,23329888,asian populations.
15116,23329888,graves' disease
15117,23329888,hla-b*46
15118,23329888,meta-analysis cois
15130,23477757,embarazo
15131,23477757,enfermedad de graves
15132,23477757,gestational transient thyrotoxicosis
15133,23477757,graves’ disease
15134,23477757,hiperemesis gravídica
15135,23477757,hipertiroidismo
15136,23477757,hyperemesis gravidarum
15137,23477757,hyperthyroidism
15138,23477757,pregnancy
15139,23477757,tirotoxicosis gestacional transitoria
15149,22952313,graves
15150,22952313,graves disease
15151,22952313,hyperthyroidism
15152,22952313,myasthenia gravis
15153,22952313,ophthalmoplegia
15154,22952313,ptosis
15155,22952313,thyroid
15195,23535627,asian continental ancestry group
15196,23535627,graves ophthalmopathy
15197,23535627,psychiatric status rating scales
15212,23709442,graves’ orbitopathy
15213,23709442,tsh-receptor autoantibody
15214,23709442,disease activity
15215,23709442,severity cois
15218,23835254,anestesia
15219,23835254,anesthesia
15220,23835254,cirugía de descompresión orbitaria
15221,23835254,embarazo
15222,23835254,graves-basedow
15223,23835254,oftalmopatía
15224,23835254,ophthalmopathy
15225,23835254,orbital decompression surgery
15226,23835254,orbitopathy
15227,23835254,orbitopatía
15228,23835254,pregnancy
15236,22416184,autoimmunity
15237,22416184,cag-a
15238,22416184,graves’ disease
15239,22416184,hashimoto’s thyroiditis
15240,22416184,helicobacter pylori
15241,22416184,hyperthyroidism
15242,22416184,hypothyroidism
15257,24119625,graves' disease
15258,24119625,moyamoya syndrome
15259,24119625,antithyroid therapy
15277,23796613,(131)i
15278,23796613,children
15279,23796613,edad pediátrica
15280,23796613,enfermedad de graves
15281,23796613,graves disease
15282,23796613,i(131)
15283,23796613,radioiodine therapy
15284,23796613,radioyodo
15285,23538281,cáncer de tiroides
15286,23538281,enfermedad de graves
15287,23538281,graves’ disease
15288,23538281,pequeñas-moléculas
15289,23538281,receptor de la tsh
15290,23538281,small molecules
15291,23538281,tsh-receptor
15292,23538281,thyroid
15293,23538281,thyroid cancer
15294,23538281,thyrotropin (tsh)
15295,23538281,tiroides
15296,23538281,tirotropina (tsh)
15304,24646903,enfermedad de la superficie ocular
15305,24646903,graves’ ophthalmopathy
15306,24646903,lentes de contacto mini esclerales
15307,24646903,mini-scleral contact lenses
15308,24646903,ocular surface disease
15309,24646903,oftalmopatía de graves
15320,23962080,autoimmune thyroid disease
15321,23962080,intractability
15322,23962080,polymorphism
15323,23962080,severity
15324,23962080,thyrotropin receptor
15364,24231095,graves' ophthalmopathy
15365,24231095,bulbar conjunctiva
15366,24231095,dry eye
15367,24231095,impression cytology
15368,24231095,in vivo confocal microscopy
15369,24135759,adipogenesis
15370,24135759,orbital fibroblasts
15371,24135759,proliferation
15372,24135759,thyroid eye disease
15374,22985335,graves’ disease
15375,22985335,hypoparathyroidism
15376,22985335,thyroid cancer
15377,22985335,thyroidectomy
15378,22985335,thyrotoxicosis
15385,23806737,ca-125
15386,23806737,ct
15387,23806737,hyperthyroidism
15388,23806737,meigs syndrome
15389,23806737,pleural effusion
15390,23806737,tfts
15391,23806737,tg-ab
15392,23806737,tpo-ab
15393,23806737,tsh
15394,23806737,tsh receptor
15395,23806737,tshr
15396,23806737,tshr-ab
15397,23806737,thyroid cancer
15398,23806737,us
15399,23806737,cancer antigen-125
15400,23806737,computed tomography
15401,23806737,thyroglobulin autoantibodies
15402,23806737,thyroid function tests
15403,23806737,thyroid peroxidase autoantibodies
15404,23806737,thyrotropin
15405,23806737,thyrotropin receptors
15406,23806737,thyrotropin receptors autoantibodies
15407,23806737,ultrasound
15434,23060717,acquired lower eyelid epiblepharon
15435,23060717,graves ophthalmopathy
15436,23060717,lower eyelid epiblepharon repair
15437,23060717,lower eyelid retraction cois
15441,23728841,dicer1
15442,23728841,family history
15443,23728841,multinodular goiter
15444,23728841,ovarian sertoli-leydig cell tumors
15445,23728841,tumor surveillance
15464,24029729,graves' disease
15465,24029729,rhesus monkeys
15466,24029729,thyrotropin receptor a-subunit
15472,24629859,fetal diseases
15473,24629859,goiter
15474,24629859,graves disease
15475,24629859,humans
15476,24629859,hyperthyroidism
15477,24629859,hypothyroidism
15478,24629859,maternal–fetal exchange
15479,24629859,pregnancy
15480,24629859,thyroid diseases: drug therapy
15481,24629859,thyroxine: administration and dosage
15491,24307850,agranulocytosis
15492,24307850,graves disease
15493,24307850,guillain-barre syndrome cois
15504,23757290,disease intractability
15505,23757290,disease severity
15506,23757290,hashimoto’s disease
15507,23757290,il-10
15508,23757290,single nucleotide polymorphism
15525,24177168,autoimmune thyroid diseases
15526,24177168,erythropoietin
15527,24177168,intractability
15528,24177168,severity
15529,24177168,single nucleotide polymorphism
15530,23954851,antioxidants
15531,23954851,biomarkers of oxidative stress
15532,23954851,chondroitin sulfate
15533,23954851,graves' disease
15551,23849367,asian patients
15552,23849367,hypokalemia
15553,23849367,paralysis
15554,23849367,thyrotoxicosis
15555,23849367,weakness
15574,24227294,gwas
15575,24227294,causal variants
15576,24227294,colocalisation
15577,24227294,genetic association
15579,22907781,graves' disease
15580,22907781,minimal-incision thyroidectomy
15581,22907781,minimally invasive surgery
15582,22907781,postoperative complications
15583,22907781,thyroid
15605,24289805,gpr174
15606,24289805,graves' disease
15607,24289805,poland
15608,24289805,x chromosome
15609,24289805,association
15610,24289805,autoimmune disease
15611,24289805,rs3827440
15612,24289805,single nucleotide polymorphism
15613,23756266,drug-induced cholestasis
15614,23756266,plasmapheresis
15615,23756266,thyrotoxicosis
15626,23954255,autoimmune thyroid disease
15627,23954255,ci
15628,23954255,caga
15629,23954255,edta
15630,23954255,ethylene diamine tetraacetic acid
15631,23954255,ft3
15632,23954255,ft4
15633,23954255,gd
15634,23954255,graves disease
15635,23954255,h. pylori
15636,23954255,hla
15637,23954255,helicobacter pylori
15638,23954255,human leukocyte antigen
15639,23954255,igg
15640,23954255,immunoglobulin g
15641,23954255,or
15642,23954255,pcr
15643,23954255,spss
15644,23954255,statistical product and service solutions
15645,23954255,tpoab
15646,23954255,trab
15647,23954255,tsh
15648,23954255,tgab
15649,23954255,confidence intervals
15650,23954255,cytotoxin-associated gene a
15651,23954255,dntp
15652,23954255,deoxy-ribonucleoside triphosphate
15653,23954255,free thyroxine
15654,23954255,free triiodothyronine
15656,23954255,odds ratio
15657,23954255,polymerase chain reaction
15658,23954255,thyroglobulin antibody
15659,23954255,thyroid peroxidase antibody
15660,23954255,thyroid stimulating hormone
15661,23954255,thyrotrophin receptor antibody
15667,24124099,diplopia
15668,24124099,endoscopic orbital floor decompression
15669,24124099,inferomedial orbital strut
15670,24124099,orbital decompression
15685,23839980,endoscopic orbital decompression
15686,23839980,graves' orbitopathy
15687,23839980,complications
15688,23839980,exophthalmos
15689,23839980,sinonasal
15697,22972028,*pingmu decoction
15698,22972028,*apoptosis
15699,22972028,*adipocytes
15700,22972028,*graves' ophthalmophathy
15720,24311923,epidemiology
15721,24311923,graves ophthalmopathy
15722,24311923,korea
15723,24311923,prevalence
15724,24311923,risk factors cois
15739,24411304,hashimoto's thyroiditis
15740,24411304,metastatic burden
15741,24411304,metastatic disease
15742,24411304,multi-nodular goiter
15743,24411304,thyroglobulin
15744,24411304,thyroid cancer
15745,24411304,thyroidectomy
15746,24411304,thyroiditis
15752,23827012,anticorps anti-cytoplasme des polynucléaires neutrophiles
15753,23827012,antineutrophil cytoplasmic antibodies
15754,23827012,benzylthio-uracile
15755,23827012,benzylthiouracil
15756,23827012,graves’ disease
15757,23827012,maladie de basedow
15758,23827012,vascularite
15759,23827012,vasculitis
15761,23667180,complex traits
15762,23667180,endocrinology
15763,23667180,genetics
15764,23667180,genome-wide
15765,23667180,thyroid disease
15768,25443353,hashimoto's thyroiditis
15769,25443353,autoimmune thyroiditis
15770,25443353,encephalopathy
15771,25443353,hallucinations
15772,25443353,steroids
15780,22787382,bullous systemic lupus erythematosus
15781,22787382,drug-induced lupus erythematosus
15782,22787382,graves disease
15783,22787382,methimazole
15796,23919315,graves' disease
15797,23919315,cardiomegaly
15798,23919315,forensic autopsy
15799,23919315,forensic science
15800,23919315,hyperthyroidism
15801,23919315,sudden unexpected death
15803,24456861,atrophic renal parenchyma-like tumor
15804,24456861,comparative genomic hybridization
15805,24456861,humara
15806,24456861,kidney
15807,24456861,thyroid-like renal tumor
15833,24011567,graves’ disease
15834,24011567,incidental malignancy
15835,24011567,surgical therapy
15856,23681867,endocrine diseases
15857,23681867,pharmacotherapy
15862,23901889,b lymphocytes
15863,23901889,graves' disease
15864,23901889,t lymphocytes
15876,23973401,cryptococcal meningitis
15877,23973401,lupus
15878,23973401,opportunist infection
15879,23578170,anti-gal
15880,23578170,increased immunogenicity
15881,23578170,tumour vaccine
15882,23578170,wound healing
15883,23578170,α-gal epitopes
15887,24095912,autoimmun thyreoiditis
15888,24095912,autoimmune thyroiditis
15889,24095912,diabetes mellitus
15890,24095912,fertility
15891,24095912,meddőség
15892,24095912,selenium
15893,24095912,szelén
15905,24334133,autoimmunity
15906,24334133,autoimmunitás
15907,24334133,infertility
15908,24334133,meddőség
15909,24334133,pajzsmirigy
15910,24334133,post partum periódus
15911,24334133,postpartum period
15912,24334133,pregnancy
15913,24334133,terhesség
15914,24334133,thyroid
15923,23845451,(131)i-iodide
15924,23845451,cáncer folicular de tiroides
15925,23845451,enfermedad metastásica
15926,23845451,follicular thyroid cancer
15927,23845451,metastatic disease
15928,23845451,radioiodine therapy
15929,23845451,spect
15930,23845451,terapia con yodo radioactivo
15931,23845451,yodo radioactivo (131)i cois this work there are no financial or ethical conflicts of interest.
15934,23664858,cox
15935,23664858,cox-2
15936,23664858,il
15937,23664858,il-1β
15938,23664858,nf
15939,23664858,nf-κb
15940,23664858,pg
15941,23664858,pge(2)
15942,23664858,tao
15943,23664858,cyclooxygenase
15944,23664858,interleukin
15945,23664858,nuclear factor
15946,23664858,orbital fibroblast
15947,23664858,pirfenidone
15948,23664858,prostaglandin
15949,23664858,thyroid-associated ophthalmopathy
15951,23958483,octreotide
15952,23958483,somatostatin analogs
15953,23958483,tsh-secreting pituitary tumor
15954,23958483,thyrotropinoma
15960,23958398,antibodies
15961,23958398,apoptosis
15962,23958398,proliferation
15963,23958398,ros-signaling
15964,23958398,tsh receptor
15965,23958398,thyrocyte
16006,24335091,thyroid carcinoma
16007,24335091,cancer
16008,24335091,endocrine surgery
16009,24335091,follicular carcinoma
16010,24335091,neoplastic thrombus
16021,24250332,jaundice
16022,24250332,thionamides
16023,24250332,thyrotoxicosis
16033,24291398,cox-2
16034,24291398,cellular antioxidant defense mechanisms
16035,24291398,cerebral cavernous malformations
16036,24291398,free radicals
16037,24291398,krit1
16038,24291398,reactive oxygen species
16039,24291398,c-jun
16043,22386642,ait
16044,22386642,amiodarone
16045,22386642,bmi
16046,22386642,body mass index
16047,22386642,chd
16048,22386642,congenital heart defects
16049,22386642,cyanosis
16050,22386642,drug toxicity
16051,22386642,hyperthyroidism
16052,22386642,lvef
16053,22386642,t3
16054,22386642,t4
16055,22386642,tsh
16056,22386642,amiodarone-induced thyrotoxicosis
16058,22386642,congenital heart disease
16059,22386642,left ventricular ejection fraction
16060,22386642,thyroid stimulating hormone
16061,22386642,thyroxine
16062,22386642,triiodothyronine
16066,23553532,thyroid disorders
16067,23553532,epidemiology
16068,23553532,otolaryngology
16069,23553532,specialty
16070,23553532,thyroid nodule
16071,23553532,thyroidectomy
16088,24273003,cd-44
16089,24273003,hbme-1
16090,24273003,fine needle aspiration cytology
16091,24273003,galectin-3
16092,24273003,papillary thyroid carcinoma
16102,23838336,angiosarcoma
16103,23838336,haematoma
16104,23838336,haemothorax
16105,23838336,pleural metastasis
16109,23569858,granuloma
16110,23569858,thyroid
16111,23569858,tuberculosis cois
16120,24189283,at
16121,24189283,autoimmune thyroiditis
16122,24189283,ccl
16123,24189283,cd
16124,24189283,cia
16125,24189283,cs
16126,24189283,csf
16127,24189283,cxcl
16128,24189283,cxcl10
16129,24189283,cxcr3
16130,24189283,circulating cxcl10 levels
16131,24189283,cryoglobulinemia
16132,24189283,gad
16133,24189283,gd
16134,24189283,go
16135,24189283,graves
16136,24189283,graves' disease
16137,24189283,graves' ophthalmopathy
16138,24189283,graves’ disease
16139,24189283,graves’ ophthalmopathy
16140,24189283,gtx
16141,24189283,hepatitis c virus infection associated mixed cryoglobulinemia
16142,24189283,ifn
16143,24189283,ifn-γ-induced protein 10
16144,24189283,il
16145,24189283,ip-10
16146,24189283,jia
16147,24189283,juvenile idiopathic arthritis
16148,24189283,mc
16149,24189283,mc+hcv
16150,24189283,mcp-1
16151,24189283,mdc/ccl22
16152,24189283,mig
16153,24189283,mmi
16154,24189283,mp
16155,24189283,nf-kb
16156,24189283,nk
16157,24189283,npsle
16158,24189283,ppar-γ
16159,24189283,ptc
16160,24189283,papillary thyroid cancer
16161,24189283,peroxisome proliferator-activated receptor-γ
16162,24189283,psa
16163,24189283,psoriatic arthritis
16164,24189283,ra
16165,24189283,rankl
16166,24189283,rantes
16167,24189283,ret/ptc
16168,24189283,rheumatoid arthritis
16169,24189283,sf
16170,24189283,sle
16171,24189283,ss
16172,24189283,ssc
16173,24189283,st
16174,24189283,sjögren syndrome
16175,24189283,systemic lupus erythematosus
16176,24189283,systemic sclerosis
16177,24189283,t helper
16178,24189283,t1d
16179,24189283,tarc/ccl17
16180,24189283,tfc
16181,24189283,tnf
16182,24189283,tng
16183,24189283,tr
16184,24189283,th
16185,24189283,thyroid follicular cells
16186,24189283,thyroiditis
16187,24189283,toxic nodular goiter
16188,24189283,type 1 diabetes
16190,24189283,cerebrospinal fluid
16191,24189283,chemokine (c–c motif) ligand
16192,24189283,chemokine (c–x–c motif) ligand
16193,24189283,chemokine (c–x–c motif) receptor 3
16195,24189283,cluster of differentiation
16196,24189283,collagen-induced arthritis
16197,24189283,corticosteroid
16198,24189283,glutamic acid decarboxylase
16200,24189283,hyperthyroid gd
16201,24189283,interferon
16202,24189283,interleukin
16204,24189283,macrophage-derived chemokine/ccl22
16205,24189283,methimazole
16206,24189283,methylprednisolone
16207,24189283,mixed cryoglobulinemia
16208,24189283,monocyte chemotactic protein-1
16209,24189283,monokine induced by ifn-γ
16210,24189283,natural killer
16211,24189283,neuropsychiatric sle
16212,24189283,normal t cell expressed and secreted
16213,24189283,nuclear factor-kappa b
16217,24189283,rearranged in transformation/ptc
16218,24189283,receptor activator of nuclear factor kappa-b ligand
16220,24189283,scxcl10
16221,24189283,synovial fluid
16222,24189283,synovial tissue
16225,24189283,teleradiotherapy
16226,24189283,thymus and activation regulated chemokine/ccl17
16229,24189283,tumor necrosis factor
16247,23808516,bronchoscopy
16248,23808516,cardiothoracic surgery
16249,23808516,critical care medicine
16250,23808516,intervention techniques
16251,23808516,ventilation
16256,24484950,ectopic thyroid
16257,24484950,laryngeal location
16258,24484950,surgical treatment
16259,24484950,leczenie chirurgiczne
16260,24484950,lokalizacja krtaniowa
16261,24484950,tarczyca ektopowa
16285,23572163,differentiated thyroid carcinoma
16286,23572163,follow-up
16287,23572163,neck ultrasound
16288,23572163,radioiodine remnant ablation
16289,23572163,recurrence
16290,23572163,thyroglobulin
16294,24292913,case-based learning
16295,24292913,self-directed learning
16296,24292913,soft skills
16308,23240978,cowden syndrome
16309,23240978,pten
16310,23240978,ganglioneuromas
16311,23240978,hamartomatous polyps
16312,23240978,mosaicism
16321,23780707,clinicopathological characteristics
16322,23780707,incidental
16323,23780707,nonincidental
16324,23780707,papillary thyroid microcarcinoma
16325,23780707,surgical treatment
16331,24077472,case-control studies
16332,24077472,congenital hypothyroidism
16333,24077472,iran
16334,24077472,logistic regression
16335,24077472,propensity score
16336,23881987,lymphoma
16337,23881987,primary thyroid lymphoma
16338,23881987,thyroid
16339,23881987,thyroid malignancy
16340,23881987,thyroid surgery cois article.
16350,22431287,cowden disease
16351,22431287,cowden syndrome
16352,22431287,pathology
16353,22431287,surgical management
16354,22431287,thyroid
16355,24629858,dehal1 gene
16356,24629858,iyd
16357,24629858,congenital hypothyroidism
16358,24629858,iodide recycling
16359,24629858,mass spectrometry
16360,24629858,mental retardation
16361,24629858,neonatal screening
16366,23693108,"carcinoma, papillary, follicular"
16367,23693108,thyroid neoplasms
16370,24067547,t3
16371,24067547,amiodarone-induced thyrotoxicosis
16372,24067547,heart
16373,24067547,hyperthyroidism
16374,24067547,hypothyroidism
16375,24067547,thyroid hormone
16376,24067547,thyrotoxicosis
16377,24067547,triiodothyronine
16385,23933148,congenital hypothyroidism
16386,23933148,deletion
16387,23933148,inversion
16388,23933148,mutation
16389,23933148,thyroglobulin gene
16419,24301304,circulating biomarkers
16420,24301304,microrna
16421,24301304,papillary thyroid cancer
16422,24301304,recurrence
16423,24301304,tissue biomarkers
16429,26392367,clinical evaluation
16430,26392367,multinodular goiter
16431,26392367,physiopathology
16432,26392367,treatment
16433,26708850,benign multinodular goiter
16434,26708850,dunhill procedure
16435,26708850,goiter recurrence
16436,26708850,post-operative complications
16437,26708850,subtotal thyroidectomy
16438,26708850,total thyroidectomy
16439,26433162,arrhythmias
16440,26433162,carlos chagas
16441,26433162,goiter
16442,26433162,history
16443,26433162,myxedema
16444,26433162,thyroid
16448,25058777,sternotomy
16449,25058777,substernal goiter
16450,25058777,surgery
16451,25058777,treatment
16452,26520480,ct
16453,26520480,fiberoptic endoscopy
16454,26520480,goiter
16455,26520480,substernal
16456,26520480,surgery
16457,25047203,us elastosonography
16458,25047203,indeterminate nodules
16459,25047203,thyroid
16460,25047203,thyroid nodules
16461,25047203,thyroid ultrasound
16464,24622964,adenomatous multinodular goiter
16465,24622964,airway obstruction
16466,24622964,mediastinum
16467,24622964,neck mass
16468,24622964,pediatric
16470,25297557,plummer's disease
16471,25297557,cat
16472,25297557,hyperthyroidism
16473,25297557,thyroid
16474,25297557,thyrotoxicosis
16476,25976851,sternotomy
16477,25976851,substernal goiter
16478,25976851,thyroidectomy
16479,25363013,amniocentesis
16480,25363013,intrauterine therapy
16481,25363013,l-thyroxine
16482,25363013,labor dystocia
16483,25363013,polyhydramnios
16484,26327954,histology
16485,26327954,pre-sternale
16486,26327954,surgery
16487,26327954,thyroid enlargement
16488,25555013,riedel thyroiditis
16489,25555013,amiodarone-induced thyroiditis
16490,25555013,subacute thyroiditis
16495,26472934,asthma
16496,26472934,goiter
16497,26472934,mediastinum
16498,26472934,sternotomy
16499,26472934,thyroidectomy
16500,26472934,substernal
16504,25752670,complications
16505,25752670,electrocautery
16506,25752670,substernal goiter
16507,25752670,thyroidectomy
16508,25752670,ultrasonic devise
16515,26955411,granuloma
16516,26955411,multinodular goiter
16517,26955411,tuberculosis
16520,25157987,cervical approach
16521,25157987,complications
16522,25157987,elderly
16523,25157987,mediastinal goiter
16524,25157987,thyroidectomy
16528,24931349,goiter
16529,24931349,recurrent laryngeal nerve
16530,24931349,thyroid
16531,24931349,thyroid hormone
16532,24931349,thyroidectomy
16539,26161201,immunohistochemical examination
16540,26161201,goiter
16541,26161201,systemic amyloidosis
16543,26403613,body surface area
16544,26403613,drinking water
16545,26403613,goiter
16546,26403613,iodized salt
16547,26403613,prevalence
16551,26708863,cervical approach
16552,26708863,mediastinal goiter
16553,26708863,sternotomy
16554,26708863,thoracotomy
16555,26708863,thyroidectomy
16556,26721191,cervico-mediastinal goiter
16557,26721191,cervicosternotomy
16558,26721191,cervicotomy
16559,26721191,goiter
16560,26721191,intrathoracic thyroid mass
16561,26721191,total thyroidectomy
16567,26443487,deafness
16568,26443487,genetics
16569,26443487,genome
16570,26443487,hearing loss
16571,26443487,sequencing
16581,25499094,developing countries
16582,25499094,endemic goiter
16583,25499094,iodine deficiency
16584,25499094,thyroidectomy
16586,25242682,anaplastic thyroid carcinoma
16587,25242682,goiter
16588,25242682,survival
16592,24880605,cervico-mediastinal goiter
16593,24880605,recurrent laryngeal nerve palsy
16594,24880605,substernal goiter
16595,24880605,thyroid surgery
16596,24880605,total thyroidectomy
16602,26389933,epidemiology
16603,26389933,metabolic syndrome
16604,26389933,prevalence
16605,26389933,risk factor
16610,24519672,iodine deficiency
16611,24519672,children
16612,24519672,goiter prevalence
16615,25594634,multinodular goiter
16616,25594634,recurrence classification description: endocrinology
16617,25594634,thyroidectomy
16620,25981745,multinodular goiter
16621,25981745,proliferation
16622,25981745,proteomics
16623,25981745,ttf1
16632,25614405,doppler sonography
16633,25614405,calcification
16634,25614405,diffuse large b-cell lymphoma
16635,25614405,head and neck ultrasound
16636,25614405,nodular goiter
16637,25614405,sonography
16638,25614405,thyroid lymphoma
16641,26293122,basedow
16642,26293122,graves
16643,26293122,autoimmunity
16644,26293122,chemokines
16645,26293122,thyroid
16647,25629792,endemic
16648,25629792,goiter
16649,25629792,iodine
16650,25629792,pregnancy
16651,25629792,thyroid
16652,25667715,atrioventricular
16653,25667715,hyperthyroidism
16654,25667715,multinodular goiter
16657,25047199,epidemiology
16658,25047199,goitre
16659,25047199,iodine deficiency
16660,25047199,nodular goitre
16661,25047199,nodules
16662,25047199,review
16664,25613936,endemic goiter
16665,25613936,enquête épidémiologique
16666,25613936,epidemiological survey
16667,25613936,goitre endémique
16668,25613936,hormones thyroïdiennes
16669,25613936,iode urinaire
16670,25613936,iodine deficiency disorders
16671,25613936,thyroid hormones
16672,25613936,troubles dus à la carence en iode
16673,25613936,urinary iodine
16679,25592327,graves’ disease
16680,25592327,hyperthyroidism
16681,25592327,hypocalcemia
16682,25592327,recurrent laryngeal nerve palsy
16683,25592327,thyroidectomy
16684,25592327,toxic multinodular goiter
16685,25047207,goitre
16686,25047207,iodine deficiency
16687,25047207,iodine prophylaxis
16690,24651704,graves' disease
16691,24651704,autoimmune
16692,24651704,inflammation
16696,25047210,nodular goitre
16697,25047210,radioiodine
16698,25047210,recombinant human thyrotropin
16699,25047210,thyroid diseases
16700,25047201,alcohol
16701,25047201,environmental risk factors
16702,25047201,goitre aetiology
16703,25047201,insulin resistance
16704,25047201,oral contraceptives
16705,25047201,parity
16706,25047201,smoking
16707,25047201,twins
16711,25047205,cytology
16712,25047205,fine needle aspiration
16713,25047205,molecular diagnostics
16714,25047205,thyroid cancer
16715,24595624,airway management
16716,24595624,airway obstruction
16717,24595624,endotracheal intubation
16718,24595624,goiter
16719,24595624,intubation
16720,24595624,nodular
16722,24462913,autoinmunidad tiroidea
16723,24462913,bipolar disorder
16724,24462913,bocio
16725,24462913,goitre
16726,24462913,hipertiroidismo
16727,24462913,hipotiroidismo
16728,24462913,hyperthyroidism
16729,24462913,hypothyroidism
16730,24462913,lithium
16731,24462913,litio
16732,24462913,thyroid
16733,24462913,thyroid autoimmunity
16734,24462913,tiroides
16735,24462913,trastorno bipolar
16738,26260217,antonello da messina
16739,26260217,goiter in holy images
16740,26260217,italian renaissance
16742,25047206,non-toxic goitre
16743,25047206,patient-reported outcome measure
16744,25047206,quality of life
16745,26337337,cardiac surgical procedures
16746,26337337,coronary artery bypass
16747,26337337,retrosternal goitre
16748,26337337,thyroidectomy
16750,25047202,nodular goitre
16751,25047202,nuclear medicine
16752,25047202,positron emission tomography
16753,25047202,scintigraphy
16754,25047204,fna
16755,25047204,cytology
16756,25047204,diagnostic pitfalls
16757,25047204,morphology
16758,25047204,nodular goitre
16763,25633667,compound heterozygous mutations
16764,25633667,congenital hypothyroidism
16765,25633667,cryptic splice site
16766,25633667,mutation
16767,25633667,thyroglobulin gene
16773,24628230,horner's syndrome
16774,24628230,carotid dissection
16775,24628230,multinodular goiter
16776,24628230,trigeminal autonomic cephalgia
16777,24589354,adenomatous goiter
16778,24589354,human thyroid
16779,24589354,leakiness
16780,24589354,nog mouse
16781,24589354,thymic lymphoma
16782,24589354,transplantation
16787,24706172,goitre
16788,24706172,risk factors
16789,24706172,sternotomy
16790,24706172,thyroid gland
16791,24706172,thyroidectomy
16792,24703798,graves' disease
16793,24703798,pericarditis
16794,24703798,thyrotoxicosis
16796,25896315,thyroid cancer
16797,25896315,thyroidectomy
16798,25896315,toxic nodular goiter
16802,26261619,intra-thyroid thyroglossal duct cyst (ittdc)
16803,26261619,nodule
16804,26261619,thyroid gland
16805,26261619,ultrasound (us)
16806,25047200,goitre
16807,25047200,oesophagus
16808,25047200,radioiodine
16809,25047200,swallowing
16810,25047200,thyroidectomy
16811,25047200,trachea
16812,25047200,upper airway obstruction
16813,27057257,inferior laryngeal nerve
16814,27057257,non-recurrent
16815,27057257,total thyroidectomy
16816,24759378,retrosternal goiter
16817,24759378,complications to surgery
16818,24759378,intrathoracic goiter
16819,24759378,nodular goiter
16820,24759378,recurrent laryngeal nerve injury
16821,24759378,substernal goiter
16822,24759378,surgical treatment
16836,26477042,goiter
16837,26477042,iodine deficiency disorders
16838,26477042,salt iodization
16839,26477042,urinary iodine concentration
16846,26466836,*graves’ disease
16847,26466836,*ophthalmopathy
16848,26466836,*radiotherapy
16849,26069028,allergy
16850,26069028,endocrinology
16851,26069028,nutrition
16857,26163018,acromegaly
16858,26163018,goiter
16859,26163018,thyroid autoimmunity
16860,26163018,thyroid nodules
16866,26039459,branchial cyst
16867,26039459,cervical sinus
16868,26039459,iodine deficiency
16869,26039459,thyroid goiter
16876,26826478,hypoparathyroidism
16877,26826478,outcome
16878,26826478,recurrent laryngeal nerve palsy
16879,26826478,surgery
16880,26826478,thyroid
16881,26826478,à venir
16885,24774362,acute pericarditis
16886,24774362,brown adipose tissue
16887,24774362,spodick's sign
16891,25167783,graves disease
16892,25167783,qol
16893,25167783,surgery
16894,25167783,thypro
16895,25167783,toxic goiter
16900,25667686,etiology
16901,25667686,ectopic intrathoracic goiter
16902,25667686,mediastinal cyst
16913,24530085,algorithmes
16914,24530085,algorithms
16915,24530085,anesthésie générale
16916,24530085,difficult intubation
16917,24530085,general anesthesia
16918,24530085,impossible mask ventilation
16919,24530085,intubation difficile
16920,24530085,thyroidectomy
16921,24530085,thyroïdectomie
16922,24530085,tracheostomy
16923,24530085,trachéotomie
16924,24530085,ventilation au masque impossible
16925,26504073,hashimoto's thyroiditis
16926,26504073,thyroid cancer
16927,26504073,intraglandular dissemination
16928,26504073,multinodular thyroid
16929,26504073,nodular goitre
16930,26504073,papillary carcinoma
16932,26315305,goitrous children
16933,26315305,iodine
16934,26315305,selenium
16935,26315305,trace elements
16936,26315305,zinc
16938,25261415,*life cycle
16939,25261415,*minerals/trace elements
16940,25261415,*nutrition
16941,25261415,*parenteral nutrition
16942,25261415,*pediatrics
16943,25113865,old people
16944,25113865,parathyroidectomy
16945,25113865,primary hyperparathyroidism
16946,25113865,thyroid nodules
16949,25389240,imp3
16950,25389240,immunohistochemistry
16951,25389240,nucleophosmin
16952,25389240,papillary carcinoma
16953,25389240,thyroid
16954,26669779,autoimmune thyroiditis
16955,26669779,fibrosing variant of hashimoto’s thyroiditis
16956,26669779,igg4-related disease
16957,26669779,riedel’s thyroiditis
16958,26824209,clinicopathologic characteristics
16959,26824209,familial
16960,26824209,papillary carcinoma
16961,26824209,thyroid carcinoma
16965,26194563,goiter
16966,26194563,medical diagnosis
16967,26194563,painting
16968,26194563,parmigianino
16974,25102228,adrenomedullin 2
16975,25102228,goiter
16976,25102228,immunohistochemistry
16977,25102228,intermedin
16978,25102228,iodine-deficiency
16982,26834286,cardiomyopathy
16983,26834286,extracorporeal membrane oxygenation
16984,26834286,heart failure
16985,26834286,hyperthyroidism
16986,26834286,"thyrotoxicosis cois financial, or other relationship with any healthcare-related business or other entity whose products or services are discussed in this paper."
16987,26438397,autophagy
16988,26438397,graves’ orbitopathy
16989,26438397,statins
16992,26405494,plunging goitre
16993,26405494,cervical region
16994,26405494,western algeria
16998,26514949,antithyroid drug
16999,26514949,graves’ disease
17000,26514949,maladie de basedow
17001,26514949,relapse
17002,26514949,récidive
17003,26514949,traitement médical antithyroïdien
17008,26337375,multinodular goiter
17009,26337375,thyroid autotransplantation
17010,26337375,thyroidectomy
17014,25661375,autophagy
17015,25661375,autophagy-related protein light chain 3 (lc3)-ii
17016,25661375,papillary thyroid cancer
17020,26270564,gpx
17021,26270564,gsh
17022,26270564,hashimoto’s thyroiditis
17023,26270564,lpo
17024,26270564,oxidative stress
17025,26270564,catalase
17026,26270564,thyroid cancer
17027,26270564,thyroid goitre
17028,25847147,goiter
17029,25847147,hypoparathyroidism
17030,25847147,parathyroid
17031,25847147,substernal
17032,25847147,thyroidectomy
17043,26322488,aggregate risk
17044,26322488,cumulative risk
17045,26322488,goitrogens
17046,26322488,perchlorate
17047,26322488,probabilistic risk assessment
17048,26322488,regulatory rationality
17055,25824071,graves’ orbitopathy
17056,25824071,guidance
17057,25824071,referral pathways
17058,25824071,thyroid eye disease
17065,24456910,benign tumor
17066,24456910,chirurgie cervicale
17067,24456910,glande submandibulaire
17068,24456910,neck surgery
17069,24456910,submandibular gland
17070,24456910,thyroid
17071,24456910,thyroïde
17072,24456910,tumeur bénigne
17074,24974154,central neck dissection
17075,24974154,lymph node metastasis
17076,24974154,papillary thyroid carcinoma
17077,24974154,thymosin beta 10
17082,26272351,taiwan
17083,26272351,iodine
17084,26272351,iodized salt
17085,26272351,nutrition survey
17086,26272351,thyroid gland
17088,26662651,myocardial scintigraphy
17089,26662651,sestamibi
17090,26662651,thyroid autoimmune disease
17091,26662651,thyroid cancer
17092,26662651,thyroid nodules
17097,26610563,khyber pakhtunkhwa
17098,26610563,pakistan
17099,26610563,community engagement
17100,26610563,goitre
17101,26610563,iodine deficiency
17102,26610563,iodised salt
17103,26610563,urinary iodine concentration
17108,26414819,drainage
17109,26414819,hemostasis
17110,26414819,thyroidectomy
17111,26414819,valsalva maneuver
17114,26074258,complications
17115,26074258,inferior
17116,26074258,intraoperative neurophysiological monitoring
17117,26074258,laryngeal nerve
17118,26074258,recurrent laryngeal nerve palsy
17119,26074258,thyroid gland
17122,26708845,fine needle cytology
17123,26708845,hurthle cells
17124,26708845,rapid on-site evaluation
17125,26708845,ultrasound
17126,26062519,graves’ orbitopathy
17127,26062519,hepatocyte growth factor
17128,26062519,interleukin-8
17129,26062519,methylprednisolone treatment
17130,24713328,dissociative amnesia
17131,24713328,dissociative disorder
17132,24713328,graves' disease
17133,24713328,hyperthyroidism
17139,25043767,airway
17140,25043767,goiter
17141,25043767,hemorrhage
17142,25043767,tpa
17143,25043767,thyroid
17144,26254997,benign goiter
17145,26254997,hashimoto thyroiditis
17146,26254997,quality of life
17147,26254997,thyroidectomy
17150,25722226,antithyroid drugs
17151,25722226,glucocorticoids
17152,25722226,graves’ disease
17153,25722226,graves’ orbitopathy
17154,25722226,radioiodine
17155,25722226,thionamides
17156,25722226,thyroidectomy
17157,26626435,coagulación
17158,26626435,coagulation
17159,26626435,thyroid
17160,26626435,tiroides
17162,25726089,graves’ disease
17163,25726089,postoperative complications
17164,25726089,total thyroidectomy
17166,25366513,drinking-water
17167,25366513,goitre
17168,25366513,iodine excess
17169,25366513,iodised salt
17170,25366513,prevalence
17172,25745526,thyroid
17173,25745526,papillary carcinoma
17174,25745526,tuberculosis
17175,24726024,bocio
17176,24726024,cervicotomy
17177,24726024,cervicotomía
17178,24726024,esternotomía
17179,24726024,goitre
17180,24726024,mediastinal
17181,24726024,mediastino
17182,24726024,sternotomy
17187,25342401,airway management
17188,25342401,endotracheal intubation
17189,25342401,goitre
17190,25342401,retrosternal
17191,25342401,thyroidectomy
17193,25194170,catatonia
17194,25194170,graves' disease
17195,25194170,hyperthyroidism
17196,25194170,postpartum psychosis
17197,25194170,psychosis
17200,26066526,children
17201,26066526,endemic goitre
17202,26066526,iodine-deficiency goitre
17203,26066526,salt iodine
17209,24795511,iodine deficiency disorder
17210,24795511,iodized salt
17211,24795511,thyroid functions
17212,24795511,urinary iodine concentration
17219,25914194,diagnostic accuracy
17220,25914194,fine-needle aspiration biopsy
17221,25914194,histopathology
17222,25914194,thyroid nodule
17223,25914194,ultrasonography
17226,26897110,iodine deficiency
17227,26897110,iodine prophylaxis
17228,26897110,iodized salt
17229,26897110,thyroid volume
17230,26897110,urinary iodine concentration
17233,25197416,ectopic thyroid tissue
17234,25197416,bilateral thyroid goiter
17235,25197416,the recurrent laryngeal nerve
17236,25197416,thyroiditis
17237,25197416,ultrasound
17247,25563504,drinking water
17248,25563504,iodine-deficiency disorders
17249,25563504,table salt
17250,25563504,urinary iodine content
17251,25066642,cáncer de tiroides
17252,25066642,enfermedad nodular tiroidea
17253,25066642,hormona paratiroidea
17254,25066642,nodular thyroid disease
17255,25066642,tsh
17256,25066642,thyroid cancer
17258,24670538,papillary thyroid carcinoma
17259,24670538,cyclo-oxygenase-2
17260,24670538,matrix metalloproteinase-9
17261,24670538,vascular endothelial growth factor
17274,26185318,adenolipoma
17275,26185318,cowden syndrome
17276,26185318,ganglioneuroma
17277,26185318,gastrointestinal polyps
17278,26185318,hamartoma
17279,26185318,pten
17280,26185318,pten-hamartoma tumor syndrome
17281,26185318,papillary carcinoma
17282,26185318,storiform collagenoma
17283,26185318,thyroid
17284,26457492,brafv600e mutation
17285,26457492,kras mutation
17286,26457492,rassf1a methylation
17287,26457492,fine-needle aspiration biopsy
17288,26457492,nodular goiter
17307,24525284,anesthésie péridurale cervicale
17308,24525284,cervical epidural anesthesia
17309,24525284,perioperative risk
17310,24525284,risque périopératoire
17311,24525284,thyroidectomy
17312,24525284,thyroïdectomie
17313,26117483,compression of tracheobronchial tree
17314,26117483,intrathoracic goitre
17315,26117483,pulmonary tuberculosis
17316,24962366,adenoid cystic pattern
17317,24962366,fine-needle aspiration
17318,24962366,hyaline globule
17319,24962366,spindle-cell thymoma
17320,24962366,type a thymoma
17326,25326671,intraoperative neuromonitoring
17327,25326671,palsied recurrent laryngeal nerve
17328,25326671,secondary thyroidectomy
17332,24876155,emergency department
17333,24876155,respiratory
17352,26834925,delayed diagnosis
17353,26834925,historical tumors
17354,26834925,socioeconomic level
17368,26321232,case-control study
17369,26321232,disease
17370,26321232,fcrl3
17371,26321232,graves’
17372,26321232,single nucleotide polymorphisms
17378,25421156,autoimmunity
17379,25421156,environment
17380,25421156,genetics
17381,25421156,graves’ disease
17382,25421156,hyperthyroidism
17388,26603660,graves' disease
17389,26603660,radioiodine therapy
17390,26603660,thyroid
17391,26603660,ultrasound
17393,25596664,age
17394,25596664,glucocorticoids
17395,25596664,graves’ disease
17396,25596664,graves’ orbitopathy
17397,25596664,natural history
17398,25596664,radiotherapy
17401,25637365,corticoides
17402,25637365,corticosteroids
17403,25637365,graves ophthalmopathy
17404,25637365,irradiación
17405,25637365,irradiation
17406,25637365,oftalmopatía de graves
17407,25637365,orbitopatía tiroidea
17408,25637365,radioterapia
17409,25637365,radiotherapy
17410,25637365,thyroid orbitopathy
17414,26742784,*creutzfeldt-jacob disease
17415,26742784,*heidenhain variant
17416,26742784,*compressive optic neuropathy
17417,26742784,*higher visual processing
17418,26742784,*proptosis
17419,26742784,*spongiform encephalopathy
17420,26742784,*thyroid eye disease
17421,26742784,*visual fields
17422,25313112,restrictive strabismus
17423,25313112,strabismus surgery
17430,24835350,corneal biomechanical properties
17431,24835350,corneal hysteresis
17432,24835350,thyroid eye disease
17433,24835350,visa classification
17435,26298554,autoimmune thyroiditis
17436,26298554,child
17437,26298554,doppler
17438,26298554,goiter
17439,26298554,thyroid gland
17440,26298554,ultrasound
17447,26567024,immunology
17448,26567024,inflammation
17449,26567024,orbit
17450,26567024,treatment medical
17454,26730171,dysfunction
17455,26730171,esophagopathy
17456,26730171,graves’ disease
17457,26730171,heartburn
17458,26730171,odynophagia
17460,25744236,calcification
17461,25744236,contrast-enhanced ultrasound
17462,25744236,roc curve
17463,25744236,thyroid nodules
17468,24661105,antibodies
17469,24661105,graves' disease
17470,24661105,hla drb1 haplotype
17471,24661105,phenotype
17472,24661105,severity
17478,26105719,antithyroid drugs
17479,26105719,basedow’s disease
17480,26105719,graves’ disease
17481,26105719,birth defects
17482,26105719,epidemiology
17483,26105719,incidence
17484,26105719,pregnancy
17485,26105719,spontaneous abortion
17486,26105719,stillbirth
17487,26105719,thy rotoxicosis
17488,26105719,thyroid disease
17495,24841498,dysthroid optic neuropathy
17496,24841498,orbital radiotherapy
17497,24841498,thyroid eye disease
17504,25953846,epidemiology
17505,25953846,orbit
17509,24510380,fish
17510,24510380,fna
17511,24510380,pax8/pparg
17512,24510380,ret/ptc
17513,24510380,thyroid cancer
17514,24891174,clinical practice guidelines
17515,24891174,clinical practice survey
17516,24891174,hyperthyroidism
17517,24891174,management
17520,25736544,25-hydroxyvitamin d
17521,25736544,graves’ disease
17522,25736544,hyperthyroidism
17523,25736544,prognosis
17524,25736544,radioiodine therapy
17525,25378983,graves disease
17526,25378983,renal infarction cois
17528,24830583,association
17529,24830583,graves’ disease
17530,24830583,polymorphisms
17531,24830583,toll like receptor
17538,25305147,estrogen
17539,25305147,fsh
17540,25305147,lh
17541,25305147,progesterone
17542,25305147,thyroid neoplasms
17549,24833206,euthyroidism
17550,24833206,graves disease
17551,24833206,methimazole
17552,24833206,remission
17556,25430040,graves' disease
17557,25430040,toll-like receptor
17558,25430040,association
17559,25430040,polymorphisms
17563,26100786,cd69
17564,26100786,graves’ disease
17565,26100786,hashimoto thyroiditis
17566,26100786,il-10
17567,26100786,nkg2d
17568,26100786,treg cells
17569,25746910,diabetes
17570,25746910,graves'
17571,25746910,ophthalmopath severity
17578,25239229,founder mutation
17579,25239229,haplotype analysis
17580,25239229,iran
17581,25239229,linkage analysis
17582,25239229,pendred syndrome
17583,25239229,slc26a4 gene
17589,26007334,graves’ disease
17590,26007334,vitamin d
17591,26007334,meta-analysis
17592,26007334,meta-regression
17593,26007334,sensitivity analysis
17610,25766333,graves’ disease
17611,25766333,magnetic resonance hydrography
17612,25766333,magnetic resonance imaging
17613,25766333,ureteral myxedema
17617,24409943,graves’ disease
17618,24409943,graves’ ophthalmopathy
17619,24409943,radioiodine
17620,24409943,thyroid eye disease
17622,25286078,graves' disease
17623,25286078,hashimoto's thyroiditis
17624,25286078,interleukin-4
17625,25286078,meta-analysis
17626,25286078,polymorphism
17630,24823620,brown adipose tissue (bat)
17631,24823620,glucose metabolism
17632,24823620,hyperthyroidism
17633,24823620,muscle
17634,24823620,positron-emission tomography and computed tomography (pet-ct)
17639,24505195,decompression
17640,24505195,exophthalmos
17641,24505195,graves ophthalmopathy
17642,24505195,orbit cois
17645,25253825,graves disease
17646,25253825,intrathyroid vascularity
17647,25253825,painless thyroiditis
17648,25253825,power doppler sonography
17649,25253825,superficial structures
17659,24994866,inflammatory cytokine
17660,24994866,lacrimal gland
17661,24994866,ocular surface
17662,24994866,tears
17663,24994866,thyroid-associated ophthalmopathy
17666,24970896,131i
17667,24970896,camera based uptake
17668,24970896,thyroid uptake probe
17672,25670394,autoimmune disease
17673,25670394,graves’ disease
17674,25670394,interleukin-23
17675,25670394,single nucleotide polymorphism
17684,25361748,orbit
17695,24502333,dysthyroid optic neuropathy
17696,24502333,graves orbitopathy
17697,24502333,intraocular pressure
17698,24502333,orbital decompression
17699,24502333,superior ophthalmic vein
17700,26686233,lateral rim repositioning
17701,26686233,orbital decompression
17702,26686233,proptosis
17703,26686233,thyroid eye disease
17704,26686233,thyroid related orbitopathy
17706,25244551,diplopia
17707,25244551,graves’ disease
17708,25244551,orbital decompression
17709,25244551,repeat
17710,25244551,thyroid ophthalmopathy
17711,25188661,hiv
17712,25188661,antiretroviral therapy
17713,25188661,hyperthyroidism
17714,25188661,hypothyroidism
17715,25188661,thyroid
17722,25444029,adolescent
17723,25444029,graves disease
17724,25444029,infarction
17725,25444029,magnetic resonance imaging
17726,25444029,middle cerebral artery
17727,25444029,muscular diseases
17730,25596774,basedow
17731,25596774,graves’ disease
17732,25596774,hashimoto
17733,25596774,ischémie sclérale
17734,25596774,ophtalmopathie
17735,25596774,ophthalmopathy
17736,25596774,plication
17737,25596774,plissement
17738,25596774,recession
17739,25596774,recul
17740,25596774,scleral ischemia
17741,25596774,surgical technique
17742,25596774,technique chirurgicale
17758,26505217,gaze-evoked amaurosis
17759,26505217,optic neuropathy
17760,26505217,thyroid eye disease
17769,26540014,intraoperative neuromonitoring (ionm)
17770,26540014,recurrent laryngeal nerve (rln)
17771,26540014,robotic thyroid surgery
17772,26540014,transaxillary robotic surgery
17773,26540014,vagal automatic periodic stimulation (aps)
17776,24697361,autoimmune thyroid diseases
17777,24697361,ctla-4
17778,24697361,meta-analysis
17779,24697361,single nucleoside polymorphisms
17780,24697361,susceptibility
17784,24646814,clec16a
17785,24646814,graves’ disease (gd)
17786,24646814,hashimoto’s thyroiditis (ht)
17787,24646814,autoimmune thyroid diseases (aitds)
17788,24646814,complex genetics
17789,24646814,complex immunity
17790,24646814,infection
17791,24646814,innate immunity
17792,24646814,resistance
17793,24646814,single-nucleotide polymorphisms (snps)
17794,24646814,tolerance
17799,25543543,autoimmunity
17800,25543543,graves’ disease
17801,25543543,polymorphisms
17802,25543543,thyroid-stimulating hormone receptor
17809,26499253,creatinine
17810,26499253,estimated glomerular filtration rate
17811,26499253,standardized cystatin c
17812,26499253,thyroid hormone
17814,25558015,cancer de la thyroïde
17815,25558015,graves’ disease
17816,25558015,maladie de basedow
17817,25558015,nodule non-palpable
17818,25558015,non-palpable nodule
17819,25558015,thyroid cancer
17820,25558015,ultrasonography
17821,25558015,échographie
17826,24560831,cellulitis
17827,24560831,ecthyma gangrenosum
17828,24560831,graves’ disease
17829,24560831,pseudomonas aeruginosa
17842,25835075,dythyroid optic neuropathy
17843,25835075,endoscopic transethomoid medial orbital wall decompression
17844,25835075,endoscopic transethomoid orbital fat decompression
17845,25835075,proptosis reduction
17846,25835051,dysthyroid optic neuropathy
17847,25835051,mean deviation
17848,25835051,pattern standard deviation
17849,25835051,three-wall orbital decompression
17850,25835051,two-wall orbital decompression
17854,25294349,"illness and disease, chronic"
17855,25294349,"illness and disease, experiences"
17856,25294349,interpretative phenomenological analysis (ipa)
17857,25294349,qualitative analysis
17858,25294349,quality of life
17859,25294349,rehabilitation
17860,25294349,"research, qualitative"
17861,26699948,brow fat hypertrophy
17862,26699948,premalar fat hypertrophy
17863,26699948,thyroid eye disease
17870,25775381,epo
17871,25775381,erythrocytosis
17872,25775381,hif-1α
17873,25775381,hyperthyroidism
17875,25058606,cytokines
17876,25058606,graves disease
17877,25058606,thyroid
17878,25692426,fine needle aspiration biopsy
17879,25692426,hashimoto's thyroiditis
17880,25692426,papillary thyroid carcinoma
17884,26240504,biological assay
17885,26240504,chronic inactive graves' orbitopathy
17886,26240504,mc4-tsi
17887,26240504,thyroid-stimulating immunoglobulin
17888,26240504,thyrotropin-binding inhibitory immunoglobulin cois was reported.
17892,25342622,cd44
17893,25342622,cox-2
17894,25342622,hyaluronic acid
17895,25342622,orbital fibroblast
17896,25342622,thyroid-associated ophthalmopathy
17897,25028161,association
17898,25028161,graves’ disease
17899,25028161,toll like receptor
17900,25028161,case-control study
17901,25028161,single nucleotide polymorphisms
17902,24627146,il-1β
17903,24627146,hyaluronic acid
17904,24627146,hyaluronic acid synthase
17905,24627146,mitogen-activated protein kinase
17906,24627146,orbital fibroblast
17907,24627146,pirfenidone
17908,24627146,thyroid-associated ophthalmopathy
17910,25567342,laryngopharyngeal reflux
17911,25567342,local neck symptoms
17912,25567342,nodular goiter
17913,25567342,thyroidectomy
17915,26567020,*cosmesis
17916,26567020,*orbit
17917,26567020,*treatment surgery
17919,25892161,thyroid eye disease
17920,25892161,decompression
17921,25892161,diplopia
17922,25892161,orbit
17923,25892161,proptosis
17932,25576458,graves’ orbitopathy
17933,25576458,ich guideline
17934,25576458,intravenous steroids
17935,25576458,medical dictionary for regulatory activities (meddra)
17936,25576458,safety
17937,24486115,autoinmunidad tiroidea materna
17938,24486115,children born from mothers with autoimmune thyroid disease
17939,24486115,enfermedad de graves en el embarazo
17940,24486115,hijo de mujer con enfermedad tiroidea autoinmunitaria
17941,24486115,hipotiroidismo
17942,24486115,hypothyroidism
17943,24486115,pregnancy in graves disease
17944,24486115,thyroid autoimmunity in pregnancy
17947,26321629,magnetic resonance imaging
17948,26321629,methylprednisolone pulse therapy
17949,26321629,proptosis
17950,26321629,thyroid-associated ophthalmopathy
17951,26321629,volume
17952,24742542,graves' disease
17953,24742542,polymorphism
17954,24742542,transforming growth factor β1
17959,25770161,epidemiology
17960,25770161,eye
17961,25770161,ophthalmology
17963,26666958,*cancer
17964,26666958,*coupling
17965,26666958,*metabolism
17966,26666958,*papillary
17967,26666958,*thyroid
17971,25223473,a1555g
17972,25223473,hearing loss
17973,25223473,heteroplasmy
17974,25223473,mt-rnr1
17975,25223473,pendred syndrome
17976,25223473,slc26a4
17978,25759125,autoantibody
17979,25759125,graves'
17980,25759125,disease
17981,25759125,latent virus
17982,25759125,pathogenesis
17983,25759125,plasma cell differentiation
17987,24714170,carcinoma
17988,24714170,goiter
17989,24714170,thyroidectomy
17992,25937486,"anti-neutrophil cytoplasmic antibodies,"
17993,25937486,"drug-induced,"
17994,25937486,"graves’ disease,"
17995,25937486,"propylthiouracil,"
17996,25937486,small vessel vasculitis
18000,24989709,diplopia
18001,24989709,image-guided surgery
18002,24989709,proptosis
18003,24989709,strabismus
18004,24989709,thyroid eye disease
18005,24989709,visual acuity
18006,24989709,visual field
18021,25768836,graves’ disease
18022,25768836,autoantibodies
18023,25768836,glycoprotein-hormone receptor
18024,25768836,small molecule ligands
18025,25768836,thyroid cancer
18026,25768836,thyroid-stimulating hormone receptor cois received no payment in preparation of this manuscript.
18032,25290043,deafness
18033,25290043,iran
18034,25290043,slc26a4
18035,25290043,enlarged vestibular aqueduct
18036,25290043,genetic linkage
18037,25290043,goiter
18038,25290043,mutation screening
18040,25257150,<sup>131</sup>i
18041,25257150,dose/response analysis
18042,25257150,graves’ disease
18043,25257150,hyperthyroidism
18044,25257150,radioiodine
18049,26028555,graves' disease
18050,26028555,hypothyroidism
18051,26028555,postpartum thyroid disease
18052,26028555,pregnancy
18053,26028555,thyrotoxicosis
18054,25836060,depression
18055,25836060,graves’ orbitopathy
18056,25836060,diplopia
18057,25836060,elevation
18058,25836060,vertical strabismus
18065,24938857,graves’ disease
18066,24938857,intraoperative blood loss
18067,24938857,thyroidectomy
18070,25207976,ipilimumab
18071,25207976,myositis
18072,25207976,thyroid eye disease
18073,25207976,thyroid orbitopathy
18074,25121573,asia-pacific
18075,25121573,graves’ orbitopathy
18076,25121573,survey
18080,26701678,antithyroid drugs
18081,26701678,graves’ disease
18082,26701678,natural killer t cells
18083,26701678,radioactive iodine
18084,26701678,regulatory t cells
18087,24697978,contour
18088,24697978,eyelid surgery
18089,24697978,keratopathy
18090,24697978,lagophthalmos
18091,24697978,symmetry
18095,25208306,reactivation
18096,25208306,thyroid-associated orbitopathy
18097,25208306,traum
18104,25134846,b-cell epitopes
18105,25134846,graves’ disease
18106,25134846,igg subclasses
18107,25134846,intramolecular epitope spreading
18108,25134846,thyroglobulin autoantibodies
18109,25120780,autoimmune thyroid diseases (aitds)
18110,25120780,graves’ disease (gd)
18111,25120780,hashimoto’s thyroiditis (ht)
18112,25120780,t helper 22 (th22) cell
18113,25120780,interleukin 22 (il-22)
18114,24903731,autoimmune co-morbidity
18115,24903731,autoimmune gastritis
18116,24903731,autoimmune thyroid diseases
18117,24903731,coeliac disease
18118,24903731,thyroid-associated orbitopathy
18125,25046415,autoimmune thyroid disease
18126,25046415,intractability
18127,25046415,polymorphism
18128,25046415,severity
18129,25046415,vitamin d
18136,25741204,children
18137,25741204,congenital hypothyroidism
18138,25741204,diffuse thyroid disease
18139,25741204,nodule
18140,25741204,thyroid disease
18141,25741204,ultrasonography
18142,25109914,graves-kór
18143,25109914,graves’ disease
18144,25109914,graves’ orbitopathy
18145,25109914,biological therapy
18146,25109914,biológiai terápia
18147,25109914,endokrin orbitopathia
18148,25109914,selenium
18149,25109914,szelén
18150,24938636,alemtuzumab
18151,24938636,autoimmunity
18152,24938636,sickle cell disease
18153,24938636,stem cell transplant
18154,24938636,thyroid dysfunction
18155,24838983,autoimmunity
18156,24838983,echocardiography
18157,24838983,hyperthyroidism
18158,24838983,pulmonary hypertension
18163,24674955,stroke
18164,24674955,cerebrovascular disease
18165,24674955,hematologic disease
18166,24674955,hyperthyroidism
18167,24674955,steroids
18168,24674955,thrombotic angiopathy
18172,25039242,biological treatment
18173,25039242,graves’disease
18174,25039242,endocrine orbitopathy
18175,25039242,hyperthyroidism
18176,25039242,thyroid
18180,24862674,focus
18181,24862674,harmonic
18182,24862674,knot tie technique
18183,24862674,sutureless
18184,24862674,thyroidectomy
18185,24862674,ultracision
18186,25839128,cd28
18187,25839128,cd4(+)cd28(−) t cells
18188,25839128,graves’ disease
18189,25839128,t-lymphocyte subsets
18192,25207388,electromagnetic image guidance
18193,25207388,graves’ ophthalmopathy
18194,25207388,orbital decompression
18199,25373929,graves’ disease
18200,25373929,hyperthyroidism
18201,25373929,laser doppler fluxmetry
18202,25373929,postocclusive reactive hyperaemia
18203,25373929,skin microcirculation
18206,24726178,antithyroid medication
18207,24726178,graves’ disease
18208,24726178,neonatal thyroid dysfunction
18209,24726178,outcome
18213,25122677,histone modifications
18214,25122677,interferon
18215,25122677,thyroiditis cois
18222,24784317,autoimmune thyroid diseases
18223,24784317,t regulatory cells
18224,24784317,forkhead box p3
18225,24784317,gene polymorphism
18226,25283079,midkine (mk)
18227,25283079,multi-nodular goiter (mng)
18228,25283079,nuclear factor-kappa b (nf-κb)
18229,25283079,papillary thyroid cancer (ptc)
18230,25283079,receiver operating characteristic (roc) curves
18231,25283079,synchronous metastasis
18235,26163757,gene expression profiling
18236,26163757,granulomatosis with polyangiitis
18237,26163757,microarray analysis
18238,26163757,molecular pathology
18239,26163757,orbit pathology
18240,26163757,orbital pseudotumor
18241,24793198,ct analysis
18242,24793198,deep lateral wall
18243,24793198,exophthalmos reduction
18244,24793198,orbital decompression
18245,24793198,orbital fat
18246,25615025,cytotoxic t-lymphocyte antigen-4
18247,25615025,polymorphism
18248,25615025,thyroid-associated ophthalmopathy
18249,24617953,graves' ophthalmopathy
18250,24617953,drug therapy
18251,24617953,glucocorticoid
18252,24617953,meta-analysis
18254,25648436,antibiotics
18255,25648436,mediastinitis
18256,25648436,negative pressure therapy
18257,25648436,streptococcus
18258,25648436,thyroidectomy
18262,24801540,autoimmunity
18263,24801540,children
18264,24801540,cytokines
18265,24801540,serum
18266,24801540,thyroid
18270,26626367,graves' disease
18271,26626367,hyperthyroidism
18272,26626367,surgery
18273,26626367,thyroid carcinoma
18274,26626367,thyroid nodules
18278,26523178,basedow disease
18279,26523178,papillary carcinoma
18280,26523178,thyroid
18281,25855160,autoimmune thyroid disease
18282,25855160,instrumentation
18283,25855160,thyroid
18284,25855160,tissue characterization
18285,25855160,ultrasound
18291,26593863,autoimmune thyroid disease (aitd)
18292,26593863,graves’ disease (gd)
18293,26593863,hashimoto's thyroiditis (ht)
18294,26593863,maladie de basedow (gd)
18295,26593863,maladies thyroïdiennes auto-immunes (mait)
18296,26593863,polymorphisme de nucléotide unique (snp)
18297,26593863,récepteur à la vitamine d (vdr)
18298,26593863,single nucleotide polymorphism (snp)
18299,26593863,thyroïdite de hashimoto (ht)
18300,26593863,vitamin d receptor (vdr)
18302,25876459,graves' orbitopathy
18303,25876459,quality of life
18304,25876459,strabismus surgery
18305,25876459,success criteria
18313,25455307,graves' disease
18314,25455307,sensory ataxia
18315,25455307,sensory evoked potentials
18316,25455307,thyrotoxicosis
18317,25132194,contact lens sensor
18318,25132194,glaucoma
18319,25132194,intraocular pressure
18320,25132194,thyroid eye disease
18332,26034078,immunology
18333,26034078,orbit
18334,25847746,anti tsh-receptor antibody
18335,25847746,immunoassay
18336,25847746,pre
18337,25550791,graves’ hyperthyroidism
18338,25550791,nuocytes
18339,25550791,cytokines
18340,25550791,transcription factors
18343,26373794,graves' disease (gd)
18344,26373794,hashimoto's thyroiditis (ht)
18345,26373794,il1f7
18346,26373794,il37
18347,26373794,autoimmune thyroid diseases (aitds)
18348,26373794,single nucleotide polymorphisms (snps)
18358,26180468,diplopia
18359,26180468,graves’ disease
18360,26180468,restrictive strabismus
18361,26180468,strabismus surgery
18362,26180468,thyroid orbitopathy cois
18364,25900177,graves’ disease
18365,25900177,hashimoto’s thyroiditis
18366,25900177,oxidative status
18367,25900177,prolidase
18372,26559967,strabismus
18373,26559967,surgical outcomes
18374,26559967,thyroid eye disease
18375,25859801,dsa = digital subtraction angiography
18376,25859801,gd = graves disease
18377,25859801,graves disease
18378,25859801,mmd = moyamoya disease
18379,25859801,mra = mr angiography
18380,25859801,t3 = triiodothyronine
18381,25859801,t4 = thyroxine
18382,25859801,tia = transient ischemic attack
18383,25859801,tsh = thyroid stimulating hormone
18384,25859801,disease progression
18385,25859801,ft3 = free triiodothyronine
18386,25859801,ft4 = free thyroxine
18387,25859801,moyamoya disease
18388,25859801,stroke
18389,25859801,vascular disorders
18391,25736545,dysthyroid optic neuropathy
18392,25736545,thyroid eye disease
18393,25736545,thyroid stimulating immunoglobulins
18399,25988433,exophthalmos
18400,25988433,graves’ orbitopathy
18401,25988433,globe luxation
18402,25988433,malar hypoplasia
18403,25988433,orbital decompression
18404,24434244,graves' ophthalmopathy
18405,24434244,quality of life
18406,24434244,questionnaire
18409,25176403,indirect calorimetry
18410,25176403,metabolic syndrome
18411,25176403,resting energy expenditure
18412,25176403,tetraiodothyronine
18413,25176403,thyroid stimulating hormone
18414,25176403,triiodothyronine
18415,26635355,slc26
18416,26635355,stas domain
18417,26635355,anion transporters
18418,26635355,inherited diseases
18419,26635355,membrane protein folding
18420,26256985,tsh receptor autoantibody
18421,26256985,total thyroidectomy
18422,26256985,thyroid benign mass
18423,26256985,thyroid cancer
18424,26256985,thyroid-associated orbitopathy cois
18426,25159204,graves' orbitopathy
18427,25159204,adipogenesis
18428,25159204,heme oxygenase-1
18429,25159204,inflammation
18430,25159204,orbital fibroblasts
18431,25159204,oxidative stress
18432,25159204,tanshinone iia
18436,24990808,autoimmune thyroid disease
18437,24990808,intractability
18438,24990808,mir-125a
18439,24990808,polymorphism
18440,24990808,severity
18444,26141364,endonasal approach
18445,26141364,endoscopic assisted
18446,26141364,optic nerve
18447,26141364,orbit
18448,26141364,paranasal sinuses
18449,26141364,skull base
18454,24798189,autoimmune thyroid disease
18455,24798189,graves'
18456,24798189,hashimoto's thyroiditis
18457,24798189,disease
18458,24798189,single nucleotide polymorphism
18459,24798189,tumor necrosis factor α-induced protein 3
18463,25708657,foxp3
18464,25708657,graves' disease
18465,25708657,regulatory t cell
18466,25708657,single nucleotide polymorphism
18472,24460515,dry eye syndrome
18473,24460515,graves’ disease
18474,24460515,graves’ orbitopathy
18476,27116895,igg4-related disease
18477,27116895,lymphocyte/plasma cell infiltrations
18478,27116895,malt lymphomas
18479,27116895,orbital pseudotumors
18483,26204988,berke incision approach
18484,26204988,chemosis
18485,26204988,deep lateral orbital wall decompression
18486,26204988,swinging eyelid approach
18487,26041458,graves’ disease
18488,26041458,tsh receptor antibody
18489,26041458,antithyroid drugs
18490,26041458,hyperthyroidism
18491,26041458,pregnancy
18493,25320726,drug induced liver injury (dili)
18494,25320726,endocrinology
18495,25320726,hepatotoxicity
18496,25320726,idiosyncratic hepatic injury
18497,25320726,risk factors cois
18501,26116233,graves' disease (gd)
18502,26116233,histone acetylation
18503,26116233,histone modifications
18504,26116233,peripheral blood mononuclear cells (pbmcs)
18516,25120331,drug-related side effects and adverse reactions
18517,25120331,graves disease
18518,25120331,methimazole
18519,25120331,pancreatitis cois
18522,26344731,eyelid retraction
18523,26344731,optic neuropathy
18524,26344731,orbit
18525,26344731,restrictive myopathy
18526,26344731,thyroid eye disease
18528,25310344,adult strabismus
18529,25310344,diplopia
18530,25310344,operation dosage
18531,25310344,orbit
18532,25310344,thyriod eye disease
18534,26564931,cyclotropia
18535,26564931,double maddox rod test
18536,26564931,strabismus surgery
18537,26564931,thyroid eye disease
18540,24510024,extraocular muscles
18541,24510024,magnetic resonance imaging
18542,24510024,orbit
18543,24510024,thyroid-associated orbitopathy
18544,24510024,ultrasound
18545,26113403,autoimmune disease
18546,26113403,graves’ disease
18547,26113403,interleukin 7
18548,26113403,soluble interleukin 7 receptor
18555,25936345,cd40
18556,25936345,ctla-4
18557,25936345,genetic polymorphism
18558,25936345,graves' disease
18559,24712973,linear morphoea
18560,24712973,localised scleroderma
18563,24777217,graves’ disease
18564,24777217,adverse drug reactions
18565,24777217,disease management
18566,24777217,methimazole
18567,24777217,pediatric
18569,25617714,dna methylation
18570,25617714,dnmts
18571,25617714,graves' disease
18572,25617714,icam1
18573,25617714,mbds
18574,25617714,medip-chip
18584,25256279,anca
18585,25256279,hyperthyroidism
18586,25256279,propylthiouracil
18587,25256279,vasculitis
18591,25172242,ccl2
18592,25172242,cxcl10
18593,25172242,chemokines
18594,25172242,extra-ocular muscles
18595,25172242,graves' ophthalmopathy
18598,25457466,compressive optic neuropathy
18599,25457466,graves' orbitopathy
18600,25457466,spontaneous decompression
18602,25444703,goitre ovarien
18603,25444703,meigs syndrome
18604,25444703,ovarian goiter
18605,25444703,ovarian tumor
18606,25444703,struma ovarii
18607,25444703,syndrome de meigs
18608,25444703,teratome
18609,25444703,thyroid
18610,25444703,thyroïde
18611,25444703,tumeur ovarienne
18612,25444703,tératome
18624,26415610,alkaline phosphatase
18625,26415610,graves disease
18626,26415610,hypocalcemia
18627,26415610,thyroidectomy
18631,25059686,decompression
18632,25059686,orbital surgery
18633,25059686,piezosurgery
18634,25059686,proptosis
18635,25059686,thyroid associated orbitopathy
18637,24576228,graves’ disease
18638,24576228,hyperthyroidism
18639,24576228,hypothyroidism
18640,24576228,prenatal care
18641,24576228,thyroidectomy
18642,25814196,aetiopathogenesis of warthin's tumour
18643,25814196,autoimmune diseases
18644,25814196,lymphatic-rich stroma
18645,25814196,warthin's tumour
18647,24478186,cd20
18648,24478186,cd4
18649,24478186,cd8
18650,24478186,foxp3
18651,24478186,graves’ disease
18652,24478186,hashimoto's thyroiditis
18653,24478186,regulatory t cells
18655,26459776,dna methylation
18656,26459776,epigenetics
18657,26459776,graves' disease
18658,26459776,t cell signaling
18659,26459776,tshr
18664,25455505,bone metastases
18665,25455505,cirugía
18666,25455505,dosimetry
18667,25455505,dosimetría
18668,25455505,metástasis ósea
18669,25455505,surgery
18670,25455505,thyroid
18671,25455505,tiroides
18672,25455505,rtsh
18676,26425054,graves disease
18677,26425054,plasmapheresis
18678,26425054,thyrotoxicosis cois
18687,25412700,graves' disease
18688,25412700,hashimoto's thyroiditis
18689,25412700,th17 cells
18690,25412700,interleukins
18691,25412700,regulatory t cells
18695,26600899,struma ovarii
18696,26600899,histopathology
18697,26600899,ovarian goiter
18698,26600899,ovarian teratoma
18699,26600899,thyroid
18700,25576242,adipokines
18701,25576242,graves׳ disease
18702,25576242,hashimoto׳s thyroiditis
18703,25576242,leptin
18704,25576242,pamp׳s
18706,24956560,cytokine
18707,24956560,graves disease
18708,24956560,graves ophthalmopathy
18709,24956560,parp-1
18710,24956560,polymorphism
18712,25989711,autoimmune thyroid disease
18713,25989711,graves' disease
18714,25989711,hashimoto's thyroiditis
18715,25989711,interferon regulatory factor 8
18718,25647271,autoimmune thyroid disease (aitd)
18719,25647271,graves’ disease (gd)
18720,25647271,hashimoto’s thyroiditis (ht)
18721,25647271,interleukin-21 (il-21)
18722,25647271,interleukin-21 receptor (il-21r)
18723,25281394,gd
18724,25281394,kir3dl1
18725,25281394,nk
18726,25281394,nkg2a
18727,25281394,nkg2d
18728,25281394,nkp30
18729,26791860,acute graft-versus-host disease
18730,26791860,dna typing
18731,26791860,epistatic interaction
18732,26791860,genome diversity
18733,26791860,graft-versus-leukemia effect
18734,26791860,graves’ disease
18735,26791860,hla allele
18736,26791860,hla class i and class ii gene and molecule
18737,26791860,hla haplotype
18738,26791860,hashimoto thyroiditis
18739,26791860,linkage disequilibrium
18740,26791860,next-generation sequencing
18741,26791860,polymorphism
18742,26791860,regulatory t cell
18743,26791860,thyroglobulin antibody and serum level
18744,26791860,thyroid peroxidase antibody and serum level
18745,26791860,thyroid stimulating hormone receptor antibody and serum level
18746,26791860,unrelated hematopoietic stem cell transplantation
18748,25434508,chester-erdheim disease
18749,25434508,diabetes insipidus
18750,25434508,diabetes insípida
18751,25434508,enfermedad de chester-erdheim
18752,25434508,hipopituitarismo
18753,25434508,histiocitosis de células de langerhans
18754,25434508,hypopituitarism
18755,25434508,langerhans cell histiocytosis
18763,25586901,marinelli
18764,25586901,thyroid nodules
18765,25586901,combined therapy
18766,25586901,dosimetry
18767,25586901,microwave ablation
18768,25586901,radioiodine therapy
18769,26518171,alopecia areata
18770,26518171,associations
18771,26518171,autoimmune disease
18772,26518171,comorbidities
18773,26518171,prevalence
18774,26518171,thyroid disease
18775,26518171,vitiligo
18777,24958412,benign and malignant thyroid nodules
18778,24958412,contrast-enhanced sonography
18779,24958412,maximum intensity
18780,24958412,microvessel density
18781,24958412,superficial structures
18787,25161183,cancer
18788,25161183,elastography
18789,25161183,thyroid nodules
18792,26406404,papillary thyroid carcinoma
18793,26406404,mutation
18794,26406404,thyroperoxidase
18796,25960045,follicular thyroid neoplasia
18797,25960045,differential diagnostics
18798,25960045,goitre
18799,25960045,immunohistochemistry
18800,25960045,stem cell marker
18811,26612322,advanced spectral imaging
18812,26612322,duel-energy computed tomography
18813,26612322,intranodular hemorrhage
18814,26612322,material decomposition
18815,26612322,thyroid nodule
18816,26048691,alström syndrome
18817,26048691,follicular variant of papillary thyroid carcinoma
18818,26048691,thyroid cancer
18819,26048691,thyroid goitre
18821,25994301,all-trans retinoic acid
18822,25994301,autoantibodies
18823,25994301,hashimoto’s thyroiditis
18824,25994301,γδ t cells
18825,25328134,cancer
18826,25328134,contrast agents
18827,25328134,follicular adenoma
18828,25328134,goiter
18829,25328134,quantitative parameter
18830,25328134,thyroid
18831,25328134,time-intensity curve
18832,25328134,ultrasonography
18833,26191283,cytokeratin 17
18834,26191283,immunohistochemistry
18835,26191283,lymph node metastasis
18836,26191283,papillary thyroid carcinoma
18839,26527084,fish bone
18840,26527084,foreign body
18841,26527084,neck radiograph
18842,26527084,retropharyngeal abscess
18843,26527084,retropharyngeal goiter
18844,26527084,tonsillitis
18845,25400776,papillary thyroid carcinoma (ptc)
18846,25400776,percentage of brafv600e alleles
18847,25400776,preoperative risk stratification
18848,25400776,pyrosequencing
18849,25940693,autonomously functioning thyroid nodule
18850,25940693,meta-analysis
18851,25940693,nodular goitre
18852,25940693,scintigraphy
18853,25940693,thyroid
18854,25940693,thyroid-stimulating hormone
18859,25707564,graves disease
18860,25707564,hypocalcemia
18861,25707564,multinodular goiter
18862,25707564,papillary carcinoma of thyroid
18863,25707564,parathyroid
18864,25707564,parathyroid adenoma
18865,25707564,recurrent laryngeal nerve
18866,25707564,thyroid
18867,25054230,aa amyloidosis
18868,25054230,chronic renal disease
18869,25054230,cystic fibrosis
18870,25054230,goiter
18871,25054230,intestinal disorders
18872,25054230,proteinuria
18876,25868389,ffpe
18877,25868389,nanostring analysis
18878,25868389,biomarkers
18879,25868389,circadian clock
18880,25868389,papillary thyroid carcinoma cois
18881,26578494,cribriform variant
18882,26578494,papillary carcinoma
18883,26578494,sonography
18884,26578494,thyroid
18885,26578494,ultrasound
18887,26437373,antiepileptic drugs
18888,26437373,goiter
18889,26437373,metabolic risk
18890,26437373,subclinical hypothyroidism
18891,26437373,thyroid hormones
18894,25120855,africa
18895,25120855,surgical camp
18896,25120855,uganda
18905,26526666,dicer1 syndrome
18906,26526666,hodgkin lymphoma
18907,26526666,t cell type
18915,27057249,harmonic focus curved shears
18916,27057249,hemostasis
18917,27057249,thyroid
18918,27057249,thyroidectomy
18921,26686396,*airflow
18922,26686396,*cfd
18923,26686396,*energy
18924,26686396,*power
18925,26686396,*trachea
18926,26686396,*work of breathing
18936,26511970,cyclooxygenase-2
18937,26511970,ep4 receptor
18938,26511970,microsomal prostaglandin e synthase-1
18939,26511970,papillary thyroid carcinoma
18940,26511970,prostaglandin e2
18942,24993783,child
18943,24993783,differentiated thyroid cancer
18944,24993783,goitre
18945,24993783,hypoparathyroidism
18946,24993783,lobectomy with isthmusectomy
18947,24993783,medullary thyroid cancer
18948,24993783,recurrent laryngeal nerve paralysis
18949,24993783,thyroidectomy
18950,24434360,autoimmunity
18951,24434360,hashimoto
18952,24434360,thyroiditis
18957,25524940,papillary thyroid carcinoma
18958,25524940,rt-pcr
18959,25524940,mir-146a
18960,25524940,mir-146b
18962,25017947,cost-benefit
18963,25017947,goiter
18964,25017947,thyroid cancer
18965,25017947,thyroidectomy
18969,24866072,incidental carcinoma
18970,24866072,microcarcinoma
18971,24866072,thyroid
18972,24862663,hypocalcemia
18973,24862663,parathyroid hormone
18974,24862663,thyroidectomy
18978,25601586,thyroid cancer
18979,25601586,complications of thyroid surgery
18980,25601586,intraoperative neuromonitoring
18981,25601586,patient outcomes
18982,25601586,recurrent laryngeal nerve injury
18986,26537235,atrial fibrillation
18987,26537235,elderly
18988,26537235,hyperthyroidism
18989,26537235,iodine
18990,26537235,thyreostatic therapy
19002,25217004,percutaneous tracheostomy
19003,25217004,tracheostomy
19006,26708844,chylous fistula
19007,26708844,thoracic duct
19008,26708844,thyroid-surgery
19009,25889269,goiter
19010,25889269,nitrate
19011,25889269,nitrite
19012,25889269,thyroid cancer
19013,25889269,thyroid function
19017,26327979,hashimoto′s thyroitidis
19018,26327979,acute
19019,26327979,sickle cell anemia
19021,26905714,association
19022,26905714,hashimoto's thyroiditis
19023,26905714,histopathology
19024,26905714,medullary carcinoma of thyroid.
19028,26708858,inferior thyroid artery
19029,26708858,multinodular goiter
19030,26708858,thyroidectomy
19032,25946974,nicotinamide phosphoribosyltransferase
19033,25946974,nodular goiter
19034,25946974,reverse transcriptase polymerase chain reaction
19035,25946974,thyroid cancer
19036,25946974,thyroid gland
19037,25946974,visfatin
19040,24550235,calcitonin
19041,24550235,fine-needle aspiration cytology
19042,24550235,medullary thyroid carcinoma
19046,24388198,cadmium toxicity
19047,24388198,preneoplastic lesions
19048,24388198,thyroid gland
19049,26443708,general surgery
19050,26443708,minimally invasive surgery
19051,26443708,robotics
19053,25556330,hyperthyroidism
19054,25556330,potassium chloride repletion
19055,25556330,thyrotoxic hypokalemic periodic paralysis
19056,25556330,ventricular arrhythmia
19057,25934417,hypoparathyroidism
19058,25934417,intra-operative parathyroid hormone
19059,25934417,parathyroid hormone decline
19060,25934417,total thyroidectomy
19062,25156133,graves’ disease
19063,25156133,hyperthyroidism
19064,25156133,hyperthyroïdie
19065,25156133,iode 131
19066,25156133,maladie de basedow
19067,25156133,radioiodine dose
19068,25156133,thyroid
19069,25156133,thyroïde
19070,26886166,dicer1
19071,26886166,laser capture microdissection
19072,26886166,mutation
19073,26886166,well-differentiated fetal adenocarcinoma
19074,26886166,β-catenin
19084,25824846,drug overdose
19085,25824846,hyperthyroxinemia
19086,25824846,levothyroxine overdose
19087,25824846,thyroid crisis
19088,25824846,thyrotoxicosis
19089,25598424,differential diagnosis
19090,25598424,hydatid cyst
19091,25598424,thyroid
19092,25598424,unusual location
19093,25476178,ct
19094,25476178,hyperthyroidism
19095,25476178,incidental thyroid nodule
19096,25476178,mr imaging
19097,25476178,radioactive iodine scan
19098,25476178,thyroid cancer
19099,25476178,ultrasonography
19104,26577641,basal cell carcinoma
19105,26577641,basal cell nevus syndrome
19106,26577641,dicer1 syndrome
19107,26577641,familial adenomatous polyposis
19108,26577641,pilomatrixoma
19109,26577641,pleuropulmonary blastoma
19111,26210625,children
19112,26210625,hyperthyroidism
19113,26210625,hypothyroidism
19114,26210625,incidental
19115,26210625,nodule
19116,26210625,overt
19117,26210625,thyroid
19118,26210625,ultrasonography
19124,25873114,antiandrogens  prolactin
19143,24760746,graves' disease
19144,24760746,hashimoto's thyroiditis
19145,24760746,autoimmune thyroiditis
19146,24760746,erythrovirus b19
19147,24760746,parvovirus b19
19152,26347012,angiogenesis
19153,26347012,atherosclerosis
19154,26347012,cholesterol
19155,26347012,pleiotropic effect
19156,26347012,statins
19159,25480825,cancer
19160,25480825,nodules
19161,25480825,oncology
19162,25480825,pediatrics
19163,25480825,therapeutics
19164,25480825,thyroid cois article.
19168,24578322,double salt fortification
19169,24578322,human health
19170,24578322,micronutrient assessment
19171,24578322,mineral deficiency
19178,26193980,fnab
19179,26193980,nodule depth
19180,26193980,pain
19181,26193980,thyroid nodule
19182,26193980,vas score
19185,24768495,fine needle aspiration
19186,24768495,thyroid
19187,24768495,thyroid bed
19188,26374222,adenomatous hyperplasia
19189,26374222,brenner tumor
19190,26374222,mucinous cystadenoma
19191,26374222,papillary thyroid carcinoma
19192,26374222,serous cystadenoma
19193,26374222,struma ovarii
19194,26374222,strumal carcinoid
19195,25755717,cd147
19196,25755717,rna interference
19197,25755717,thyroid cancer-experimental
19198,25755717,genetics
19199,25755717,glycolysis
19200,25755717,pathology-thyroid
19201,24493789,barriers
19202,24493789,discharge
19203,24493789,outpatient
19204,24493789,thyroidectomy
19205,26823860,braf
19206,26823860,papillary thyroid cancer
19207,26823860,ras
19208,26823860,ret
19209,26744989,drinking water
19210,26744989,ion chromatography
19211,26744989,method development
19212,26744989,nis inhibitors
19217,26406959,thyroid cancer
19218,26406959,diagnosis
19219,26406959,fine needle aspiration biopsy (fnab)
19220,26406959,transforming growth factor-β 1
19223,26475096,ectopic lymphoid tissue
19224,26475096,hashimoto's thyroiditis
19225,26475096,human parvovirus b19
19226,26475096,pathogenesis
19227,26475096,positive regulatory domain zinc finger protein 1
19228,26246426,hypothyroidism
19229,26246426,end-stage renal disease
19230,26246426,hemodialysis
19231,26246426,thyroid nodule
19233,24750986,difficult thyroidectomy
19234,24750986,difficulty scale
19235,24750986,graves disease
19236,24750986,hashimotos thyroiditis
19237,24750986,risk adjustment
19238,24750986,thyroid
19245,26408676,thyroid sarcoma
19246,26408676,clinical sign
19247,26408676,review
19248,26408676,thyroid imaging
19250,25487217,131i therapy
19251,25487217,benign thyroid disease
19252,25487217,dosimetry
19258,26417067,ccm
19259,26417067,ros
19260,26417067,autophagy
19261,26417067,endothelial‐to‐mesenchymal transition (endmt)
19262,26417067,mtor
19266,25639351,saccharomyces cerevisiae
19267,25639351,antioxidants
19268,25639351,avenanthramides
19269,25639351,biofactors
19270,25639351,cerebral cavernous malformation
19271,25639351,metabolic engineering
19272,25639351,phenolic compounds
19273,25639351,plant secondary metabolites
19274,26302664,*iodine intake
19275,26302664,*iodized salt
19276,26302664,*nutrición yódica
19277,26302664,*sal yodada
19278,26302664,*urinary iodine concentrations
19279,26302664,*yoduria
19282,25829390,ambulatory surgical procedures
19283,25829390,outpatient
19284,25829390,perioperative complications
19285,25829390,revisits
19286,25829390,surgery
19287,25829390,thyroid surgery
19288,25829390,thyroidectomy
19289,25041837,galectin-3
19290,25041837,hbme-1
19291,25041837,immunohistochemistry
19292,25041837,thyroid nodules
19296,25593151,dietary intake
19297,25593151,dietary supplements
19298,25593151,folate
19299,25593151,folic acid
19300,25593151,"vitamin b-9 cois the scientific advisory boards of conagra, inc., mccormick spice, the mushroom council, the california walnut commission, and bay state milling; and is a consultant to nestle, inc. kl wiemer and kb miller are employees of general mills, inc. o dary, ma philbert, v tarasuk, and cl taylor, no conflicts of interest. cl keen serves on advisory boards of advocare, herbalife, mars, inc., mccormick spice, and theralogix. jc king serves on the scientific advisory board for conagra; has received research funding from the almond board of california, the california walnut commission, thrasher foundation, harvest plus, the nestle foundation, usda, and nih; and has provided consultation to the alliance for potato research and education and ilsi north america. pc gaine and ab jarvis were employees of ilsi north america when the manuscript was prepared. rl bailey is a government liaison to the ilsi north america committee on fortification."
19302,25968604,founder effect
19303,25968604,mutation
19304,25968604,structural modeling
19305,25968604,tpo
19306,25968604,thyroid dyshormonogenesis
19308,25193578,adjuvant therapy
19309,25193578,differentiated thyroid carcinoma
19310,25193578,radioiodine ablation
19311,25193578,total thyroidectomy
19312,25193578,urinary iodine
19313,25175810,new sporadic neoplastic syndrome
19314,25175810,papillary and medullary carcinomas
19315,25175810,urothelial
19316,25917998,levothyroxine
19317,25917998,preoperative localization
19318,25917998,primary hyperparathyroidism
19319,25917998,sestamibi scintigraphy
19320,25917998,ultrasound
19326,25837167,braf
19327,25837167,dna
19328,25837167,biomarker
19329,25837167,papillary thyroid carcinoma
19330,25837167,plasma cois
19331,24582076,cleft lip and palate
19332,24582076,ex utero intrapartum treatment (exit)
19333,24582076,fetal diagnosis
19334,24582076,micrognathia
19335,24582076,prenatal consultation
19338,26119458,acoustic radiation force impulse
19339,26119458,elastography
19340,26119458,thyroid nodule
19341,26119458,ultrasound
19344,25111330,chinese population
19345,25111330,fine-needle aspiration biopsy
19346,25111330,genetic alterations
19347,25111330,thyroid nodules
19352,25836323,dicer1
19353,25836323,embryonal rhabdomyosarcoma
19354,25836323,ovary
19355,25836323,pediatric tumors
19356,25836323,mirna
19358,26342107,papillary thyroid carcinoma
19359,26342107,undifferentiated thyroid carcinoma
19360,26342107,vegf
19361,26342107,mir-205
19362,26342107,microrna
19364,26370671,diagnostic
19365,26370671,foxe1
19366,26370671,follicular thyroid lesion
19367,26370671,pax8
19368,26370671,ttf-1
19369,26370671,thyroid nodules
19370,26796150,24-h urine
19371,26796150,adults
19372,26796150,benin
19373,26796150,icp-ms
19374,26796150,iodine
19377,26041374,h271d
19378,26041374,resistance to thyroid hormones
19379,26041374,thyroid hormone receptor beta gene (thrβ)
19382,25155806,dairy product
19383,25155806,iodized salt
19384,25155806,urinary iodine
19385,25486933,cerebrovascular disorders
19386,25486933,endothelium
19387,25486933,genetics
19388,25486933,hemorrhage
19389,25486933,stroke
19392,28668317,goiter
19393,28668317,retrograde dissection of the inferior laryngeal nerve
19394,28668317,sternotomy
19395,27701774,graves’ ophthalmopathy
19396,27701774,graves’ orbitopathy
19397,27701774,thyroid eye disease
19399,28648509,*pendred syndrome
19400,28648509,*congenital hypothyroidism
19401,28648509,*goiter
19402,28648509,*iodide
19403,28648509,*sensorineural deafness
19404,28648509,*thyroid hormone
19405,27221572,*substernal goiter
19406,27221572,*thyroid disease
19407,27221572,*thyroid neoplasm
19408,27221572,*thyroid nodule
19409,27221572,*thyroidectomy
19410,28572231,grave’s disease
19411,28572231,radioiodine
19412,28572231,thionamides
19413,28572231,thyroidectomy
19414,28572231,thyrotoxicosis
19419,27480576,*goiter
19420,27480576,*rhtsh
19421,28516755,dietary iodine intake
19422,28516755,goiter
19423,28516755,iodine
19424,28516755,japanese
19425,28516755,kombu
19426,28516755,seaweed
19427,28516755,thyroid function
19431,27687679,anatomy
19432,27687679,intrathoracic goiter
19433,27687679,multinodular goiter
19434,27687679,thoracic inlet
19435,27687679,thyroid gland
19436,27687679,thyroidectomy
19437,28749783,children
19438,28749783,goiter
19439,28749783,l thyroxine
19440,28749783,nodular
19441,28749783,recurrence
19442,28749783,thyroidectomy
19445,29172409,ethiopia
19446,29172409,goiter
19447,29172409,prevalence
19448,29172409,risk factors cois
19449,27173499,*clinical images
19450,27173499,*endocrinology
19451,27173499,*surgery cois
19456,28271464,goiter
19457,28271464,medical diagnosis
19458,28271464,painting
19459,28271464,rubens
19461,28840845,*sternotomy
19462,28840845,*computerized tomography
19463,28840845,*retrosternal goiter substernal.
19464,28840845,*surgery
19465,28840845,*thyroid
19466,28840845,*thyroidectomy
19467,27059986,graves’ disease
19468,27059986,graves’ orbitopathy
19469,27059986,immunmodulatory therapy
19470,27059986,reconstructive surgical procedures
19471,27059986,thyroid-stimulating hormone receptor
19472,28551882,acid sulfate soils
19473,28551882,iodide
19474,28551882,laterite
19475,28551882,salt iodization
19476,28551882,selenium
19477,28551882,soil organic matter
19479,28395497,"goiter, substernal"
19480,28395497,harmonic scalpel
19481,28395497,"surgical procedures, operative"
19482,26995097,cervical approach
19483,26995097,ectopic goiter
19484,26995097,ectopic thyroid
19485,26995097,intrathoracic goiter
19486,26995097,substernal goiter
19487,26995097,thyroidectomy
19490,28331628,*china
19491,28331628,*iodine deficiency disorders (idd)
19492,28331628,*iodized salt
19493,28258641,amyloid goiter
19494,28258641,familial mediterranean fever
19495,28258641,head and neck ultrasound
19496,28258641,thyroid
19497,29275168,*goiter
19498,29275168,*hypothyroidism
19499,29275168,*mutation
19500,29275168,*thyroglobulin gene
19501,29275168,*truncated thyroglobulin protein
19504,28602544,*sternotomy
19505,28602544,*substernal goiter
19506,28602544,*thyroidectomy
19512,29242007,*ecmo
19513,29242007,*extracorporeal membrane oxygenation
19514,29242007,*airway management
19515,29242007,*airway obstruction
19516,29242007,*mediastinal goiter
19517,29242007,*thyroid surgery
19521,29215302,traditional chinese medicine
19522,29215302,goiter
19523,29215302,herbal regimen
19524,28612896,*complications
19525,28612896,*recurrent goiter
19526,28612896,*surgery
19527,28612896,*thyroidectomy
19533,28648505,*digeorge syndrome
19534,28648505,*hypoparathyroidism
19535,28648505,*parathyroid
19536,28648505,*pseudohypoparathyroidism
19537,28648505,*thyroid
19540,27005286,*areola approach
19541,27005286,*laparoscope
19542,27005286,*silk thread
19543,27005286,*strategies
19544,27005286,*substernal goiter
19545,27005286,*thyroidectomy
19546,28606271,"antigens, cd40"
19547,28606271,bone marrow cells
19548,28606271,fibroblasts
19549,28606271,graves ophthalmopathy
19550,28606271,insulin-like growth factor ⅰ
19551,28606271,"receptors, thyrotropin"
19553,28535654,clinicopathological characteristics
19554,28535654,nuclear factor erythroid 2-related factor 2
19555,28535654,thyroid neoplasms
19558,28471268,*graves' disease
19559,28471268,*cardiovascular risk
19560,28471268,*hyperthyroidism
19561,28471268,*morbidity
19562,28471268,*mortality
19563,28471268,*toxic nodular goiter
19564,28190186,iodine
19565,28190186,nis
19566,28190186,nodular goiter
19567,28190186,tshr
19569,28292346,*endemic goiter
19570,28292346,*high iodine
19571,28292346,*iodine deficiency
19574,27779276,adolescents
19575,27779276,children
19576,27779276,overt hypothyroidism
19577,27779276,pregnancy
19578,27779276,subclinical hypothyroidism
19581,28805773,diffuse toxic goiter
19582,28805773,long-term results
19583,28805773,subtotal resection of the thyroid gland
19584,28805773,surgical treatment
19585,28805773,thyroidectomy
19586,29265071,angiogenesis
19587,29265071,apoptosis
19588,29265071,diffuse toxic goiter
19589,29265071,thyroid cell proliferation
19591,28835334,fine needle aspiration and biopsy
19592,28835334,nodules
19593,28835334,thyroid
19594,28835334,ultrasound
19595,26900630,*autoimmune thyroiditis
19596,26900630,*cxcl10
19597,26900630,*cxcr3
19598,26900630,*graves ophthalmopathy
19599,26900630,*graves disease
19600,26900630,*chemokines
19601,26900630,*corticosteroids
19602,26900630,*rituximab
19603,26900630,*teprotumumab
19604,26900630,*tocilizumab
19605,28215480,goiter prevalence
19606,28215480,iodine deficiency disorder
19607,28215480,iodine nutritional status
19608,28215480,pakistan
19609,28215480,salt iodization
19612,27106540,boron
19613,27106540,goiter
19614,27106540,iodine
19615,27106540,schoolchildren
19616,27106540,silicon
19617,27106540,thyroid
19618,28841887,intravascular lymphoma
19619,28841887,large b-cell
19620,28841887,nodular goiter
19621,28841887,"thyroid cois waived by the institutional ethics committee of the central hospital of wuhan, china. consent for publication: written informed consent for the publication of clinical details and clinical images of the patient was obtained from a relative of the patient. a copy of the consent form is available for review by the editor of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
19625,28061776,*ethiopia
19626,28061776,*goiter
19627,28061776,*salt iodine content
19628,28061776,*school children
19630,28011236,dicer
19631,28011236,iodine metabolism-related genes
19632,28011236,microrna
19633,28011236,thyroid
19634,28011236,thyroid cell differentiation
19635,28011236,thyroid tumor
19637,28127991,*autoimmunity
19638,28127991,*graves’ disease
19639,28127991,*ophthalmopathy
19640,28127991,*tyrosine kinase
19641,26966785,*graves’ disease
19642,26966785,*graves’ ophthalmopathy
19643,26966785,*graves’ orbitopathy
19644,26966785,*antithyroid drugs
19645,26966785,*glucocorticoids
19646,26966785,*hyperthyroidism
19647,26966785,*radiotherapy
19648,26966785,*rituximab
19649,26966785,*selenium
19650,28872214,*thyroid-related quality-of-life patient-reported outcome (thypro)
19651,28872214,*goiter
19652,28872214,*quality of life
19653,28872214,*surgery
19654,28872214,*thyroid
19655,28580573,*ex-utero intrapartum treatment
19656,28580573,*airways obstruction
19657,28580573,*fetus
19658,28580573,*neck tumors
19659,28580573,*ultrasound
19662,27460951,congenital goiter
19663,27460951,endemic goiter
19664,27460951,fifteenth century
19665,27460951,fine arts
19666,27460951,hyperthyroidism
19667,28703113,intraoperative neuromonitoring
19668,28703113,recurrent goiter
19669,28703113,recurrent laryngeal nerve
19671,26750728,benign thyroid diseases
19672,26750728,changes of radioiodine therapy
19673,26750728,jóindulatú pajzsmirigybetegségek
19674,26750728,pajzsmirigyrák
19675,26750728,radiojódterápia változásai
19676,26750728,thyroid cancer
19679,27927635,*children
19680,27927635,*thyroid volume
19681,27927635,*total goiter rate
19682,27927635,*urine iodine concentration
19683,27927635,*urine iodine excretion
19684,26884295,doppler
19685,26884295,elasticity imaging techniques
19686,26884295,goiter
19687,26884295,nodular
19688,26884295,thyroid
19689,26884295,ultrasonography
19690,27153850,*hepatotoxicity
19691,27153850,*hyperthyroidism
19692,27153850,*methimazole
19693,27153850,*propylthiouracil
19694,27153850,*radioactive iodine
19695,27153850,*thyroid
19696,27153850,*thyroidectomy
19699,28891673,lead
19700,28891673,nodular goiter
19701,28891673,papillary thyroid carcinoma
19702,28891673,thyroid adenoma
19703,28891673,thyroid hormones
19707,27673426,*goiter
19708,27673426,*hypothyroidism
19709,27673426,*respiratory function
19710,27673426,*sleep apnea syndrome
19711,27673426,*thyroid disease
19712,27673426,*upper airway obstruction
19717,27552913,bmn
19718,27552913,egipcios
19719,27552913,egyptian
19720,27552913,mng
19721,27552913,tsh
19722,27552913,vitamin d
19723,27552913,vitamina d
19725,28025831,*goiter
19726,28025831,*headache attributed to hypothyroidism
19727,28025831,*hyperthyroidism
19728,28025831,*migraine
19729,28025831,*new daily persistent headache
19730,28178662,han chinese
19731,28178662,snps
19732,28178662,vegfa
19733,28178662,nodular goiter
19734,28178662,papillary thyroid carcinoma cois
19737,27862717,*congenital hypothyroidism
19738,27862717,*fetal therapy
19739,27862717,*goiter
19740,28506088,leukocytes
19741,28506088,papillary thyroid carcinoma
19742,28506088,platelets
19743,28506088,thyroid cancer
19744,28506088,white blood cells
19745,28728986,benign multi-nodular goitre
19746,28728986,thyroidectomy
19748,26841373,i-131
19749,26841373,large goiter
19750,26841373,multinodular goiter
19751,26841373,radioiodine therapy
19752,26841373,radioiodine uptake
19753,26841373,rhtsh
19754,27931874,follicular thyroid cancer
19755,27931874,goiter
19756,27931874,papillary thyroid cancer
19757,27931874,raman spectroscopy
19758,27931874,thyroid
19759,28879586,amyloid
19760,28879586,amyloid goiter
19761,28879586,frozen section
19762,28879586,medullary thyroid carcinoma
19763,28879586,parathyroid cois interest to disclose. ethical approval: this article does not contain any studies with human participants or animals performed by any of the authors.
19765,29374396,adenolipoma
19766,29374396,thyroid
19767,29374396,ultrasound cois informed consent: written informed consent was obtained from the patient for the publication of this case report and accompanying images. ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards.
19770,29183897,paediatrics
19771,29183897,thyroid disease cois
19774,27828690,*graves disease
19775,27828690,*hashimoto’s thyroiditis
19776,27828690,*igg4 related disease
19777,27828690,*riedel’s thyroiditis
19778,27828690,*immunoglobulin
19783,28887209,*biomarkers
19784,28887209,*gas-phase fractionation (gpf)
19785,28887209,*proteomics
19786,28887209,*tandem mass tag™ (tmt)
19787,28887209,*tears
19788,28887209,*thyroid-associated orbitopathy
19789,27029843,graves’ disease
19790,27029843,hyperthyroidism
19791,27029843,mediastinal mass
19792,27029843,thyroid remnant
19793,27029843,total thyroidectomy
19794,29395824,*airway obstruction
19795,29395824,*cardiopulmonary bypass
19796,29395824,*morbid
19797,29395824,*obese
19798,29395824,*retrosternal goiter
19799,29395824,*thyroid disease
19800,29395824,*tracheal compression
19801,28578595,*graves’ disease
19802,28578595,*autoimmune
19803,28578595,*hyperplasia
19804,28578595,*thymic
19805,28578595,*thymic lymphoid hyperplasia
19806,28578595,*true thymic hyperplasia
19807,26850414,*goiter
19808,26850414,*medical diagnosis
19809,26850414,*painting
19810,26850414,*titian
19811,27385363,disparity
19812,27385363,graves’ ophthalmopathy
19813,27385363,orbitopathy
19814,27385363,socioeconomic status
19817,28533884,graves’ disease
19818,28533884,thyroid gland
19819,28533884,tuberculosis
19821,28606272,autoimmunity
19822,28606272,genetic predisposition to disease
19823,28606272,graves ophthalmopathy
19824,28606272,oxidative stress
19825,28606272,smoking
19833,27565137,*cretinism
19834,27565137,*goiter
19835,27565137,*iodine
19836,27565137,*thyroid
19838,28899873,endocrine system
19839,28899873,paediatrics (drugs and medicines)
19840,28899873,thyroid disease cois
19844,29075974,adjuvant treatment
19845,29075974,escape
19846,29075974,hyperthyroidism
19847,29075974,iodide
19848,29075974,thyroidectomy cois ethical approval: this article does not contain any studies with human participants or animals performed by any of the authors.
19849,28942732,*etiology
19850,28942732,*graves’ disease
19851,28942732,*pathophysiology
19852,28942732,*primary immunodeficiency
19853,28942732,*review cois publication: not applicable competing interests: all authors declare they have no competing interest.
19854,28770897,"thyroid associated orbitopathy, graves ophthalmopathy, hypothyroidism."
19871,27169853,dietary
19872,27169853,goitrogens
19873,27169853,nitrate
19874,27169853,perchlorate
19875,27169853,risk assessment
19876,27169853,thiocyanate
19879,27795799,*toxic goiter
19880,27795799,*thyroid abscess
19881,27795799,*thyroiditis cois
19883,27819113,ata
19884,27819113,graves’ disease
19885,27819113,igg4
19886,27819113,ophthalmopathy
19887,27819113,tpoab
19889,28493593,*recurrent laryngeal nerve
19890,28493593,*superior parathyroid
19891,28493593,*thyroid
19892,28493593,*thyroidectomy
19894,29027675,airway management
19895,29027675,anesthesia
19896,29027675,head and neck
19897,29027675,neck neoplasm
19898,29027675,tracheostomy
19899,29027675,ultrasound
19902,29108474,*oncogene testing
19903,29108474,*pediatric thyroid cancer cois of the other authors have any conflicts of interest to declare.
19904,27481173,*thyroidectomy
19905,27481173,*graves
19906,27481173,*hematoma
19907,27481173,*malignancy
19908,27481173,*toxic nodular goitre
19910,27470116,drainage
19911,27470116,hematoma
19912,27470116,surgical outcomes
19913,27470116,thyroid surgery
19916,29138656,hyperthyroidism
19917,29138656,senegal
19918,29138656,child
19919,29138656,profile
19921,26994869,*graves' ophthalmopathy
19922,26994869,*chronic lymphocytic leukemia (cll)
19923,26994869,*lymphoproliferative disorder
19924,26994869,*orbital inflammation
19925,26994869,*orbital lymphoma
19926,26994869,*proptosis
19927,26994869,*small lymphocytic lymphoma (sll)
19928,26994869,*thyroid eye disease
19930,28450994,graves-basedow's disease
19931,28450994,child
19932,28450994,student abuse cois
19934,27933384,autoimmune thyroid disease
19935,27933384,papillary thyroid cancer
19936,27933384,thyroglobulin antibodies
19937,27933384,thyroid peroxidase antibodies
19939,29422752,goiter
19940,29422752,graves' disease
19941,29422752,ophthalmopathy
19942,29422752,thyroid
19943,29422752,thyroid-associated orbitopathy cois
19946,28533836,thyroid
19947,28533836,pathology
19948,28533836,sarcoma
19949,28533836,treatment cois
19951,28363119,ct
19952,28363119,grave's disease
19953,28363119,pulmonary hypertension
19954,28755510,graves' disease
19955,28755510,graves' hyperthyroidism
19956,28755510,graves' orbitopathy
19957,28755510,thyroid eye disease
19958,28606263,"decompression, surgical"
19959,28606263,graves ophthalmopathy
19960,28606263,"imaging, three-dimensional"
19961,28606263,orbit
19962,28278511,graves ophthalmopathy
19963,28278511,il-6
19964,28278511,microrna-146a
19965,28278511,notch2
19966,28278511,orbital fibroblast reporter gene
19967,28278511,qrt-pcr
19968,27609530,diplopia
19969,27609530,intraocular pressure
19970,27609530,orbital decompression
19971,27609530,proptosis
19972,27609530,visual acuity
19973,27609530,visual field
19974,29890100,*thyroidectomy
19975,29890100,*thyroid nodule
19976,29890100,*recurrent laryngeal nerve palsy
19977,29890100,*hypoparathyroidism
19978,29890100,*postoperative pain
19983,28635216,"carcinoma, papillary"
19984,28635216,multifocal tumor
19985,28635216,ret/ ptcrearrangement
19986,28635216,thyroid neoplasms
19987,26927707,*graves' disease
19988,26927707,*thyroid surgery
19989,26927707,*hyperthyroidism
19990,26927707,*thyroid storm
19991,26927707,*thyroidectomy
19992,26927707,*thyrotoxicosis
19993,27375108,antithyroïdien de synthèse
19994,27375108,graves’ disease
19995,27375108,grossesse
19996,27375108,hyperthyroidism
19997,27375108,hyperthyroïdie
19998,27375108,maladie de basedow
19999,27375108,pregnancy
20000,27375108,synthetic antithyroid drug
20004,27494076,*biomarkers
20005,27494076,*graves’ disease
20006,27494076,*hashimoto thyroiditis
20007,27494076,*vegf
20008,27494076,*splicing isoforms
20011,27555041,calcium oxalate
20012,27555041,colloid
20013,27555041,crystals
20014,27555041,cytology
20015,27555041,thyroid
20016,27402179,bocio endémico
20017,27402179,cirugía general
20018,27402179,cooperación sanitaria
20019,27402179,endemic goiter
20020,27402179,equipamiento quirúrgico
20021,27402179,general surgery
20022,27402179,nódulo tiroideo
20023,27402179,surgical aid program
20024,27402179,surgical equipment
20025,27402179,thyroid gland
20026,27402179,thyroid nodule
20027,27402179,thyroidectomy
20028,27402179,tiroidectomía
20029,27402179,tiroides
20030,28456099,goiter
20031,28456099,hashimoto thyroiditis
20032,28456099,hyperthyroidism
20033,28456099,hypothyroidisms
20034,28456099,mammographic density
20035,28456099,thyroid
20038,29871201,e-cadherin
20039,29871201,papillary thyroid carcinoma
20040,29871201,serum cois relevant financial relationships with commercial interests to disclose.
20043,27773627,bocio multinodular
20044,27773627,horner
20045,27773627,multinodular goiter
20046,27773627,oculosympathetic pathway
20047,27773627,thyroid
20048,27773627,tiroides
20049,27773627,vía oculosimpática
20052,29043478,goiter
20053,29043478,growth
20054,29043478,mri
20055,29043478,observer agreement
20056,29043478,quality of life
20057,29043478,thyroid function
20058,29043478,thyroidectomy
20062,26932403,hashimoto thyroiditis
20063,26932403,igg4-related disease
20064,26932403,immunoglobulin g cois
20068,26813846,disparity
20069,26813846,substernal goiter
20070,26813846,thyroidectomy
20071,28569050,graves’ disease
20072,28569050,mir-146a
20073,28569050,mir-155
20074,28569050,mir-210
20075,28569050,regulatory t cells
20076,27083552,art
20077,27083552,goitre
20078,27083552,renaissance
20081,28329777,graves’ disease
20082,28329777,children
20083,28329777,thyreostatics
20084,28606260,clinical protocols
20085,28606260,graves ophthalmopathy
20086,28606260,practice guidelines as topic
20087,27619197,*airflow
20088,27619197,*cfd
20089,27619197,*energy loss
20090,27619197,*goiters
20091,27619197,*trachea
20094,28420409,adolescent students
20095,28420409,ethiopia
20096,28420409,iodine deficiency
20097,28420409,wolaita and dawuro zone
20105,28766837,dicer1
20106,28766837,cystic nephroma
20107,28766837,multinodular goiter
20108,28766837,mutation
20109,28766837,neuroblastoma
20110,28766837,syndrome
20112,27222685,nodular goiter
20113,27222685,malignancy
20114,27222685,ultrasound
20117,29798067,hornor's symptoms
20118,29798067,lymph node dissection
20119,29798067,thyroid gland operation cois relevant financial relationships with commercial interests to disclose.
20124,28606261,clinical protocols
20125,28606261,glucocorticoids
20126,28606261,graves ophthalmopathy
20127,28606261,radiotherapy
20130,27383156,e-cadherin
20131,27383156,thyroid cancer
20132,27383156,β-catenin
20133,29541314,intubation
20134,29541314,cervical spine surgery
20135,29541314,thyroidectomy
20141,27809623,*hyperthyroidism
20142,27809623,*hypothyroidism
20143,27809623,*pregnancy
20145,28537560,tsh
20146,28537560,calcium
20147,28537560,hypocalcemia
20148,28537560,multinodular goiter
20149,28537560,thyroidectomy
20150,27687458,difficult airway
20151,27687458,difficult ventilation
20152,27687458,fiberoptic intubation
20153,27687458,general anesthesia
20156,28457178,*complications
20157,28457178,*hematoma
20158,28457178,*hypocalcemia
20159,28457178,*outcomes
20160,28457178,*safety
20161,28457178,*thyroidectomy
20162,28389359,aitd
20163,28389359,ps
20164,28389359,slc26a4
20165,28389359,splicing minigene assay
20166,28389809,computer-assisted
20167,28389809,diagnosis
20168,28389809,thyroid neoplasms
20169,28389809,ultrasonography
20171,27426718,cáncer de tiroides
20172,27426718,cáncer tiroideo incidental
20173,27426718,incidental thyroid cancer
20174,27426718,prognosis
20175,27426718,pronóstico
20176,27426718,thyroid cancer
20181,28699427,*t3
20182,28699427,*t4
20183,28699427,*hyperthyroidism
20184,28699427,*metabolomics
20186,27659020,goiter
20187,27659020,subtotal resection
20188,27659020,thyroidectomy
20189,27601286,methimazole
20190,27601286,mild graves' disease
20191,27601286,thyroid function
20192,27601286,thyroid volume
20193,29084476,*graves' disease
20194,29084476,*graves' orbitopathy
20195,29084476,*mortality
20196,29084476,*suicide
20197,29084476,*unnatural death
20198,29032778,*iodine-deficiency disorders
20199,29032778,*iodized salt
20200,29032778,*iran
20201,29032778,*school-aged children
20209,28806880,*goiter
20210,28806880,*neck ultrasound
20211,28806880,*nodular goiter
20212,28806880,*thyroid gland
20213,28806880,*volume
20218,27882431,cervico-mediastinal goiters
20219,27882431,chest x-rays
20220,27882431,intrathoracic goiters
20221,27882431,mediastinal nodules
20222,27882431,thyroid surgery
20223,28255974,*acromegaly
20224,28255974,*meta-analysis
20225,28255974,*pituitary
20226,28255974,*thyroid
20227,28255974,*thyroid cancer
20229,26925783,*are
20230,26925783,*auf1
20231,26925783,*ftc.
20232,26925783,*hur
20233,26925783,*follicular adenoma
20234,26925783,*thyroid carcinoma
20236,28974848,i131 therapy
20237,28974848,hyperthyreoidism treatment
20238,28974848,"incidence of hypotihyeoidism cois sabrina licina participate in study design and acquisition, analysis and interpretation of data. authors equally participate in drafting the article and give final approval for the version which is submitted."
20239,27716078,*asystole
20240,27716078,*hyperextension
20241,27716078,*position
20242,27716078,*thyroidectomy
20244,29120123,*graves ophthalmopathy – diagnostic imaging
20245,29120123,*orbit – diagnostic imaging
20246,29120123,*multidetector computed tomography
20247,29120123,*exophthalmos – diagnosis
20248,29120123,*cross-sectional studies
20249,29198022,*glaucoma
20250,29198022,*graves' disease
20251,29198022,*register study
20252,29198022,*toxic nodular goiter
20257,27438852,slovenia
20258,27438852,food supply
20259,27438852,iodine
20260,27438852,sales
20261,27438852,salt
20262,27438852,sodium
20265,28619420,(131)i treatment
20266,28619420,bocio nodular
20267,28619420,fracaso de tratamiento
20268,28619420,hipertiroidismo
20269,28619420,hipotiroidismo
20270,28619420,hyperthyroidism
20271,28619420,hypothyroidism
20272,28619420,nodular goitre
20273,28619420,tratamiento (131)i
20274,28619420,treatment failure
20275,26969710,*imaging
20276,26969710,*muscles
20277,26969710,*orbit
20278,26969710,*treatment surgery
20279,29197845,materno-fetal medicine
20280,29197845,neonatal and paediatric intensive care
20281,29197845,neonatal health cois
20285,27693824,harmonic scalpel
20286,27693824,ligasure vessel sealing system
20287,27693824,substernal goitre
20288,27693824,thyroid surgery
20289,27693824,total thyroidectomy
20293,28025026,graves
20294,28025026,pulmonary hypertension
20295,28025026,right heart function
20296,28025026,strain
20297,28025026,tapse
20298,28025026,thyroid
20299,26936928,*dyshormonogenesis
20300,26936928,*goiter
20301,26936928,*hypothyroidism
20302,26936928,*pendred syndrome
20307,28771438,fetal goiter
20308,28771438,intra-amniotic levothyroxine administration
20309,28771438,maternal graves’ disease
20321,28737965,m22
20322,28737965,trab
20323,28737965,diagnosis
20324,28737965,hyperthyroidism
20326,29026936,*eyelid retraction
20327,29026936,*graves’ orbitopathy
20328,29026936,*lid surgery
20329,29026936,*upper eyelid retraction
20332,26886211,autoimmune thyroid disease
20333,26886211,breast neoplasms
20334,26886211,trastuzumab cois
20335,28832090,*aortic grafting
20336,28832090,*goitre
20337,28832090,*retrotracheal
20338,28832090,*thoracotomy
20339,28832090,*thyroidectomy
20340,28576912,endocrine cancer
20341,28576912,head and neck cancer
20342,28576912,head and neck surgery
20343,28576912,pathology
20344,28576912,thyroid disease cois
20346,28781316,graves' disease
20347,28781316,autoimmune hepatitis
20348,28781316,interface hepatitis
20349,28781316,liver histology
20350,28781316,pediatric case
20352,27586672,robotics
20353,27586672,thymectomy
20354,27586672,thymus
20355,27586672,thyroid
20356,27586672,transaxillary thyroidectomy
20362,26796368,recurrent laryngeal nerve injury
20363,26796368,substernal goitres
20364,26796368,surgical management
20365,28444621,criminal offense
20366,28444621,goiter
20367,28444621,major part
20368,28444621,metabolic disease
20369,28444621,public health
20370,28427469,*eugogo
20371,28427469,*epidemiology
20372,28427469,*graves’ orbitopathy
20373,28427469,*incidence
20374,28427469,*ophthalmopathy
20375,28427469,*prevalence
20376,28427469,*rare disease
20378,27206523,antiviral
20379,27206523,extrahepatic manifestation
20380,27206523,graves’ hyperthyroidism
20381,27206523,hbv infection
20383,27465670,*antithyroid drugs
20384,27465670,*goiter
20385,27465670,*graves’ disease
20386,27465670,*graves’ orbitopathy
20387,27465670,*hyperthyroidism
20388,27465670,*thyrotropin receptor antibody
20390,27422154,bocio multinodular
20391,27422154,bocio multinodular tóxico
20392,27422154,hipertiroidismo
20393,27422154,hyperthyroidism
20394,27422154,multinodular goitre
20395,27422154,radioiodine
20396,27422154,radioyodo
20397,27422154,toxic multinodular goitre
20398,27422154,rhtsh
20399,28215490,ectopic goitre
20400,28215490,horner's syndrome
20401,28215490,parapharyngeal space
20405,28389487,*surgery
20406,28389487,*cancer
20407,28389487,*overdiagnosis cois
20408,27531964,surgery
20409,28124062,papillon initiative
20410,28124062,diffuse goitre
20411,28124062,geriatric medicine
20412,28124062,nodular goitre
20413,28124062,thyroid dysfunction
20414,28992728,intrapartum treatment
20415,28992728,cesarean section
20416,28992728,congenital high airway obstruction
20417,28992728,fetal neck tumors
20418,28992728,trachea
20419,27358549,*coronary artery bypass grafting
20420,27358549,*subtotal thyroidectomy
20421,27358549,*surgery
20424,27241825,cochlear implantation
20425,27241825,pendred syndrome
20426,27241825,enlarged vestibular aqueduct
20427,27241825,gusher
20428,27241825,malformations
20429,27241825,surgical complications
20435,28458607,*computed tomography
20436,28458607,*euthyroidism
20437,28458607,*graves' disease
20438,28458607,*methimazole
20439,28458607,*single-photon emission computed tomography
20443,28812921,dacryoadenitis
20444,28812921,idiopathic orbital inflammatory syndrome
20445,28812921,silent sinus syndrome
20446,28812921,thyroid eye disease
20447,26975391,autoimmunity
20448,26975391,hormone secretion
20449,26975391,nodular goiter
20450,26975391,thyroid
20451,27553050,graves’ disease
20452,27553050,marinelli’s formula
20453,27553050,thyroid iodine uptake
20454,27553050,thyroid technetium uptake cois
20455,28874217,hypocalcemia
20456,28874217,hypoparathyroidism
20457,28874217,parathyroid hormone
20458,28874217,thyroidectomy
20459,28874217,vitamin d
20462,27927064,*graves’ disease
20463,27927064,*cytokines
20464,27927064,*traditional chinese medicine
20465,27051255,computed tomography
20466,27051255,exophthalmos reduction
20467,27051255,graves ophthalmopathy
20468,27051255,orbital decompression cois was reported.
20472,28540810,*thyroid nodules
20473,28540810,*combined therapy
20474,28540810,*radiofrequency ablation (rfa)
20475,28540810,*radioiodine therapy (rit)
20478,26726836,hashimoto’s thyroiditis
20479,26726836,nodular goiter
20480,26726836,hepatocyte growth factor
20481,26726836,hypothyroidism
20483,28154699,*autoimmunity
20484,28154699,*dakar
20485,28154699,*hyperthyroidism cois
20486,27214836,berkeley drosophila genome project (bdgp)
20487,27214836,computerised tomography (ct)
20488,27214836,enlarged vestibular aqueduct (eva)
20489,27214836,hearing loss (hl)
20490,27214836,magnetic resonance imaging (mri)
20491,27214836,pendred syndrome (ps)
20492,27214836,videonystagmography (vng)
20493,27465319,*graves’ disease
20494,27465319,*graves’ ophthalmopathy
20495,27465319,*genetic polymorphism
20496,27465319,*meta-analysis
20498,28052261,*pendred syndrome
20499,28052261,*disease-specific ips cells
20500,28052261,*inner ear
20501,28052261,*outer sulcus cells
20506,27510038,*developmental delay
20507,27510038,*failure to thrive
20508,27510038,*spontaneous transient graves’ thyrotoxicosis
20518,28458304,basedow's disease
20519,28458304,igg4
20520,28458304,igg4 thyroiditis
20521,28458304,igg4-related disease
20522,27941044,*diagnostic tests/investigation
20523,27941044,*eye (globe)
20524,27941044,*imaging
20525,27941044,*orbit cois
20529,27906671,bethesda category iii
20530,27906671,acoustic radiation force impulse elastography
20531,27906671,fine-needle aspiration cytology
20532,27906671,thyroid nodules
20533,27906671,ultrasound cois
20539,27157450,*hashimoto thyroiditis
20540,27157450,*autoimmune disease
20541,27157450,*autoimmune thyroid disease
20542,27157450,*hyperthyroidism
20543,27157450,*hypothyroidism
20544,27157450,*type 1 diabetes
20547,28688760,hypothyroidism
20548,28688760,hypothyroïdie
20549,28688760,l-thyroxine
20550,28688760,non adherence
20551,28688760,non-observance
20554,26801325,depression
20555,26801325,exophthalmos
20556,26801325,graves’ disease
20557,26801325,psychotherapy
20558,26801325,stress
20559,28074218,graves disease
20560,28074218,hashimoto disease
20561,28074218,hyperthyroidism
20562,28074218,hypothyroidism
20563,28074218,levothyroxine
20564,28050807,alternative first-line therapy
20565,28050807,graves ophthalmopathy
20566,28050807,orbital radiotherapy
20567,28050807,thyroid eye disease
20568,28001456,*graves’ ophthalmopathy
20569,28001456,*rasch analysis
20570,28001456,*quality of life
20571,28001456,*questionnaires
20572,28001456,*reliability
20573,28001456,*validation study
20574,28001456,*validity
20576,27106887,down's syndrome
20577,27106887,graves’ disease
20578,27106887,adolescent
20579,27106887,hemodialysis
20580,27106887,renal transplantation
20583,27350133,carcinoma
20584,27350133,diagnostic discrepancies
20585,27350133,histology
20586,27350133,sources of error
20587,27350133,thyroid cytology
20591,28861686,bell’s phenomenon
20592,28861686,inferior rectus muscle recession
20593,28861686,nasal transposition of the inferior rectus muscle
20594,28861686,thyroid-associated inferior rectus myopathy
20595,28656526,antioxidant
20596,28656526,fibroblast
20597,28656526,graves’
20598,28656526,melatonin
20599,28656526,n-acetyl-l-cysteine
20600,28656526,ophthalmopathy
20601,28656526,orbitopathy
20602,28656526,vitamin c
20603,28450378,*decompression
20604,28450378,*diplopia
20605,28450378,*graves ophthalmopathy
20606,28450378,*orbital fat
20607,28450378,*proptosis cois
20609,28296512,amsterdam declaration
20610,28296512,thyroid eye disease
20611,28296512,radioiodine
20612,28296512,smoking
20613,28296512,thyroid function
20614,26996584,thymus hyperplasia
20615,26996584,graves disease
20616,26996584,"immunoglobulins, thyroid-stimulating"
20617,26996584,receptors thyrotropin cois
20620,27651496,graves
20621,27651496,hyperthyroidism
20622,27651496,radioiodine
20623,27651496,thyroidectomy
20625,28755140,biomarker
20626,28755140,enzyme-linked immunosorbent assay
20627,28755140,klln protein
20628,28755140,pten protein
20629,28755140,papillary thyroid carcinoma
20634,28870952,*metallothioneins
20635,28870952,*papillary thyroid carcinoma
20636,28870952,*thyroid gland
20638,28882932,muscle disease
20639,28882932,thyroid disease cois
20640,28805160,*graves' disease
20641,28805160,*graves' ophthalmopathy
20642,28805160,*clinical activity score
20643,28805160,*immunoglobulin g4
20644,28805160,*thyroid autoantibody
20645,28675712,graves’ disease
20646,28675712,hashimoto’s disease
20647,28675712,thyroglobulin
20648,28675712,polymorphism
20649,28675712,severity
20650,28162094,graves’ disease
20651,28162094,human leukocyte antigen
20652,28162094,hyperthyroidism
20653,28162094,thiamazole
20654,28162094,thyroid scintigraphy
20655,28162094,thyroid-stimulating hormone-binding inhibitory immunoglobulin
20656,27664101,graves’ disease
20657,27664101,graves’ orbitopathy
20658,27664101,natural course
20660,29096966,*calcificaciones
20661,29096966,*calcifications
20662,29096966,*carcinoma tiroideo
20663,29096966,*doppler
20664,29096966,*ecografía
20665,29096966,*elastografía
20666,29096966,*elastography
20667,29096966,*malignancy
20668,29096966,*malignidad
20669,29096966,*nódulo tiroideo
20670,29096966,*thyroid carcinoma
20671,29096966,*thyroid nodule
20672,29096966,*ultrasound
20674,29023978,body mass index
20675,29023978,levothyroxine
20676,29023978,radioactive iodine ablation
20678,28319410,*mean platelet volume
20679,28319410,*papillary thyroid cancer
20680,28319410,*platelet distribution width plateletcrit.
20682,28478488,anti-thyroid drugs
20683,28478488,graves’ disease
20684,28478488,hyperthyroidism
20685,28478488,radio-iodine
20686,28478488,surgery
20687,28478488,"thyroid cois currently in uk for observational studies. conflict of interest: the authors declare that they have no competing interests. ethical approval: no specific approval was obtained from an ethics committee. as this is an observational study of a current clinical pathway and no intervention was involved, permission was only obtained from the audit and service evaluation office of the sheffield teaching hospitals nhs foundation trust. as the data was anonymised and individual patients cannot be identified from the report, individual patient consent was not deemed to be necessary and was not obtained."
20691,28379055,diffusion
20692,28379055,graves
20693,28379055,magnetic resonance imaging
20694,28379055,orbit
20696,27804243,*graves’ disease
20697,27804243,*hyperthyroidism
20698,27804243,*pulmonary hypertension
20699,27804243,*pulmonary hypertensive crisis
20700,27804243,*thyroid storm
20701,27486810,dysthyroid optic neuropathy
20702,27486810,graves’ orbitopathy
20703,27486810,thyroid eye disease
20707,28738723,*thyroid eye disease
20708,28738723,*patient expectations
20709,28738723,*psychosocial adjustment
20710,28738723,*reconstructive surgery
20711,28738723,*treatment satisfaction
20712,28500433,dysthyroid optic neuropathy
20713,28500433,orbital radiation therapy
20714,28500433,thyroid-associated orbitopathy
20715,28130596,angle kappa
20716,28130596,interpupillary distance
20717,28130596,orbital decompression
20718,28130596,thyroid-associated orbitopathy
20722,27638651,*graves’ disease
20723,27638651,*hyperthyroidism
20724,27638651,*mathematical modeling
20725,27638651,*relapse
20731,29053044,graves’ ophthalmopathy
20732,29053044,graves’ orbitopathy
20733,29053044,thyroid eye disease
20734,29053044,superior ophthalmic vein thrombosis
20736,27319009,agranulocytosis
20737,27319009,alemtuzumab
20738,27319009,childhood
20739,27319009,graves’ disease
20740,27319009,graves’ orbitopathy
20741,27319009,hyperthyroidism
20742,27319009,methimazole
20743,27319009,pregnancy
20744,27319009,propylthiouracil
20745,27319009,radioiodine
20746,27319009,thionamides
20747,27319009,thyroidectomy
20748,28568286,gpr174
20749,28568286,ptpn22
20750,28568286,rnaset2
20751,28568286,gene polymorphism
20752,28568286,liver damage
20755,26951052,autoimmunity
20756,26951052,graves’ disease
20757,26951052,hla
20758,26951052,stress
20759,27838267,*graves’ disease
20760,27838267,*coronary vasospasm
20761,27838267,*hyperthyroidism
20762,27838267,*methimazole
20763,27838267,*nitroglycerin
20764,27838267,*thyroid peroxidase antibody
20765,27838267,*thyroid-stimulating immunoglobulin
20766,28835054,graves′ disease
20767,28835054,hashimoto disease
20768,28835054,thyroid neoplasms
20769,28811719,cirrhosis
20770,28811719,cognitive impairment
20771,28811719,hepatic encephalopathy
20772,28811719,hypothyroidism
20773,28811719,magnetic resonance spectroscopy
20774,28811719,portosystemic shunt cois regarding funding or conflict of interest with respect to this manuscript.
20777,27560939,thyroid eye disease
20778,27560939,ptosis
20779,27560939,upper eyelid retraction
20782,26787873,cell engineering
20783,26787873,designer cells
20784,26787873,gene switch
20785,26787873,prosthetic networks
20786,26787873,synthetic biology cois
20787,29096933,graves’ orbitopathy
20788,29096933,balanced decompression
20789,29096933,deep lateral decompression
20790,29096933,intact rim
20791,29096933,proptosis
20792,29096933,rim removal
20793,28070771,*graves disease
20794,28070771,*clinical reasoning
20795,28070771,*dual process theory
20796,28070771,*framing cois interest. funding: none.
20797,27169807,compressive optic neuropathy
20798,27169807,dysthyroid optic neuropathy
20799,27169807,dysthyroid orbitopathy
20800,27169807,graves’ orbitopathy
20801,27169807,optical coherence tomography
20802,27169807,peripapillary retinal nerve fiber layer thickness
20805,27599688,graves ophthalmopathy
20806,27599688,quality of life
20807,27599688,thyroid eye disease
20808,27159575,graves’ ophthalmopathy
20809,27159575,long-term follow-up
20810,27159575,orbital decompression
20811,27159575,quality of life
20812,27159575,thyroid associated ophthalmopathy
20816,28222800,*autosomal recessive inheritance
20817,28222800,*childhood deafness
20818,28222800,*exome sequencing
20819,28222800,*pendred syndrome
20820,28222800,*syndromic hearing loss
20821,28347567,*art
20822,28347567,*exophthalmos
20823,28347567,*graves disease
20824,27086918,benign nodule
20825,27086918,programmed death-ligand 1
20826,27086918,protein biomarkers
20827,27086918,subcellular localization
20828,27086918,"thyroid cancer cois (sc, jv, fj, op, aa and cm) have nothing to disclose."
20829,27914141,children
20830,27914141,hashimoto disease
20831,27914141,hypothyroidism
20832,27914141,thyroid disease cois
20835,27220843,*antithyroid drugs
20836,27220843,*graves’ disease
20837,27220843,*graves’ ophthalmopathy
20838,27220843,*radioactive iodine
20839,27220843,*thyroidectomy
20843,28273705,congenital hypothyroidism
20844,28273705,gene
20845,28273705,mutation
20846,29270757,graves’ ophthalmopathy
20847,29270757,magnetic resonance
20848,29270757,methylprednisolone
20852,28715111,* hla-b*40:238
20853,28715111,*new allele
20854,28715111,*sequencing-based typing
20855,27715404,african descent
20856,27715404,graves orbitopathy
20857,27715404,pediatric
20858,27715404,optic neuropathy
20859,27709471,age
20860,27709471,glucocorticoids
20861,27709471,graves’ disease
20862,27709471,graves’ orbitopathy
20863,27709471,natural history
20864,27709471,radiotherapy
20865,27680576,echocardiography
20866,27680576,graves’ disease
20867,27680576,tissue doppler
20868,27170049,*graves’ ophthalmopathy
20869,27170049,*histamine
20870,27170049,*histamine receptor type-1
20871,27170049,*loratadine
20872,27170049,*mast cell
20873,27170049,*nf-κb controlled cytokine
20874,27170049,*nf-κb inhibitor
20875,27170049,*orbital fibroblast
20881,28941661,*anion transporters
20882,28941661,*homology modeling
20883,28941661,*membrane proteins
20884,28941661,*pathogenic mutations
20885,28941661,*slc26
20886,28941661,*solute carriers
20887,28941661,*trafficking
20888,28941661,*transport
20890,28063079,autoimmunity
20891,28063079,graves’ disease
20892,28063079,graves’ orbitopathy
20893,28063079,microbiota and dysbiosis
20894,26864507,*graves disease
20895,26864507,*hypothyroidism
20896,26864507,*radioiodine therapy
20897,26864507,*thyroid hormones
20898,26864507,*treatment outcome
20902,29166180,*corvis-st
20903,29166180,*dynamic scheimpflug analyzer
20904,29166180,*biomechanics
20905,29166180,*thyroid orbitopathy
20906,29166180,*whole eye movement
20907,28177666,graves’ disease
20908,28177666,graves’ ophthalmopathy
20909,28177666,cytokine
20910,28177666,gene
20911,28177666,genetic polymorphism
20912,28177666,maladie de graves
20913,28177666,ophtalmopathie de graves
20914,28177666,poly (adp-ribose) polymerase-1
20915,28177666,poly (adp-ribose) polymérase-1
20916,28177666,polymorphism
20917,28177666,polymorphisme
20918,28177666,polymorphisme génétique
20920,29190000,autoimmune
20921,29190000,dna methylation
20922,29190000,genome-wide
20923,29190000,graves’ orbitopathy
20925,27762730,*tshr
20926,27762730,*autoimmune thyroid disease
20927,27762730,*intractability
20928,27762730,*polymorphism
20929,27762730,*severity
20930,27245701,col13a1
20931,27245701,thyroid-associated ophthalmopathy
20932,27245701,collagen xiii
20933,27245701,extraocular fat
20934,27245701,thyroid eye disease
20939,29273685,*igf receptor
20940,29273685,*immune system
20941,29273685,*signal transduction
20942,29273685,"*thyroid cois member at the ucla school of medicine covering the diagnostic methods for monitoring anti-igf-ir antibodies and the therapeutic targeting of igf-ir in graves’ disease and other autoimmune diseases. i have requested that my current employer, the university of michigan medical school, adjudicate any conflicts of interest."
20943,26799350,breastfeeding
20944,26799350,endocrinology
20945,26799350,pharmacology
20946,26799350,pregnancy
20947,26799350,thyroid
20948,26799350,women's health
20949,28463526,*overcorrection
20950,28463526,*strabismus surgery
20951,28463526,*thyroid eye disease
20952,28463526,*vertical strabismus
20954,27376649,ectopic (parasitic) goiter
20955,27376649,hashimoto’s autoimmune thyroiditis
20956,27376649,high plasma cell content
20957,27376649,hürthle cell
20958,27376649,lymph node metastasis
20959,29262478,genetic testing
20960,29262478,"receptors, thyroid hormone"
20961,29262478,thyroid hormone resistance syndrome
20962,28684549,*bisphenol a
20963,28684549,*endocrine disrupting chemical
20964,28684549,*iodine excess intake
20965,28684549,*nodular goiter
20966,28684549,*papillary thyroid carcinoma cois manuscript.
20974,27371612,histopathology
20975,27371612,molecular pathology
20976,27371612,thyroid cancer
20977,26876240,*graves’ orbitopathy
20978,26876240,*orbital radiation
20979,26876240,*systemic steroids
20980,26876240,*thyroid-associated orbitopathy
20983,29085976,grave’s orbitopathy
20984,29085976,increase of intraorbital pressure
20985,29085976,orbital diseases
20986,29085976,postoperative complications
20987,29085976,postoperative intraorbital hemorrhage
20988,28822031,thyroid eye disease
20989,28822031,thyroid ophthalmopathy
20990,28822031,visa
20994,28392335,(131)i
20995,28392335,agranulocitosis
20996,28392335,agranulocytosis
20997,28392335,anti-thyroid drugs
20998,28392335,enfermedad de graves
20999,28392335,fármacos antitiroideos
21000,28392335,graves’ disease
21004,27848228,dna polymerase
21005,27848228,graves’ disease
21006,27848228,iodide peroxidase and mrnas
21007,29047240,exophthalmos
21008,29047240,korea
21009,29047240,sialyltransferases
21010,29047240,single nucleotide polymorphism
21011,29047240,thyroid-associated ophthalmopathy cois
21012,27792295,*graves' disease
21013,27792295,*hashimoto's thyroiditis
21014,27792295,*lymphocytic thyroiditis
21015,27792295,*papillary carcinoma
21016,27792295,*thyroid cancer
21018,28944477,*endoscopy
21019,28944477,*graves disease
21020,28944477,*orbit
21021,28944477,*paranasal sinus
21022,28944477,*quality of life
21023,28944477,*surgical decompression
21025,27729751,*age group
21026,27729751,*computed tomography
21027,27729751,*computer communication network
21028,27729751,*lacrimal gland
21029,27729751,*thyroid-associated ophthalmopathy cois
21031,28195542,autoimmune thyroid diseases
21032,28195542,intractability
21033,28195542,intraindividual variation
21034,28195542,microrna
21035,28195542,severity
21037,27844093,diffusion tensor imaging
21038,27844093,extraocular muscle
21039,27844093,mri
21040,27844093,thyroid associated orbitopathy
21043,26860528,botulinum toxin
21044,26860528,restrictive strabismus
21045,26860528,strabismus surgery
21046,26860528,thyroid eye disease
21047,27449491,alternating diplopia
21048,27449491,alternating orthotropia
21049,27449491,cyclic vertical deviation
21050,27449491,dysthyroid ophthalmopathy
21052,27272160,*graves’ disease
21053,27272160,*adverse drug reactions
21054,27272160,*cutaneous figurate erythema
21055,27272160,"*methimazole cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
21056,29030215,cost-effectiveness
21057,29030215,ionm
21058,29030215,nerve injury
21059,29030215,neural monitoring
21060,29030215,thyroid surgery
21063,28388869,graves’ disease
21064,28388869,s-trabs
21065,28388869,hyperthyroidism
21066,27919794,*graves disease
21067,27919794,*ischemic stroke
21068,27919794,*magnetic resonance imaging
21069,27919794,*vasculitis
21070,27919794,*vessel wall imaging
21072,28845025,anti-thyroid peroxidase antibody
21073,28845025,graves’ disease
21074,28845025,hashimoto’s disease
21075,28845025,polymorphism
21076,28845025,severity
21083,27734978,complications
21084,27734978,different approaches
21085,27734978,graves’ orbitopathy
21086,27734978,orbital decompression
21088,29152991,esophageal carcinoma
21089,29152991,gastrointestinal stromal tumors
21090,29152991,non-small cell lung cancer
21091,29152991,thyroid papillary carcinoma
21092,29152991,multi-organ primary carcinoma
21093,28284988,*cd279
21094,28284988,*graves' disease
21095,28284988,*hyperthyroidism
21096,28284988,*lymphocytes
21097,28284988,*pd-1
21102,28606259,"decompression, surgical"
21103,28606259,graves ophthalmopathy
21104,28606259,orbit
21107,29027055,deficiency disorder
21108,29027055,iodine in soil and plants
21109,29027055,people’s perception
21110,29027055,socio-economic determinants
21111,29027055,wheat crop
21112,29406005,*fetal
21113,29406005,*graves disease
21114,29406005,*hyperthyroidism
21115,29406005,*neonatal
21116,29406005,*thyrotoxicosis
21117,28547036,atrial fibrillation
21118,28547036,graves’ disease
21119,28547036,microrna
21120,28547036,thyroid hormone
21121,28768936,hashimoto’s thyroiditis
21122,28768936,thyroglobulin antibodies
21123,28768936,thyroid peroxidase antibodies
21125,27245255,*graves’ disease
21126,27245255,*hashimoto’s disease
21127,27245255,*sirt1
21128,27245255,*snp
21129,27245255,*intractability
21130,27245255,*severity
21131,27808570,*dicer
21132,27808570,*drosha
21133,27808570,*autoimmune thyroid disease
21134,27808570,*severity
21135,27808570,*single nucleotide polymorphism
21136,27387241,graves’ orbitiopathy
21137,27387241,anti-cel
21138,27387241,anti-cml
21139,27387241,methylprednisolone treatment
21140,28669056,autoimmune thyroiditis
21141,28669056,graves’ disease
21142,28669056,hashimoto’s thyroiditis
21143,28669056,th17 cells
21144,28669056,th22 cells
21148,28598035,graves’ disease
21149,28598035,association analysis
21150,28598035,early-onset
21151,28598035,heterogeneity analysis
21152,28598035,single nucleotide polymorphisms
21155,27422248,*gas inflation
21156,27422248,*single-incision endoscopic thyroidectomy
21157,27422248,*trans-axillary endoscopic thyroidectomy
21161,28343872,*balanced decompression
21162,28343872,*dysthyroid optic neuropathy
21163,28343872,*fat decompression
21164,28343872,*lateral decompression
21165,28343872,*medial decompression
21166,28343872,*orbital decompression
21167,28343872,*surgical technique
21168,28343872,*thyroid eye disease
21171,28742402,graves’ disease
21172,28742402,hashimoto’s disease
21173,28742402,il-10
21174,28742402,mirna
21175,28742402,polymorphism
21177,28243072,graves ophthalmopathy
21178,28243072,age-related
21179,28243072,autoimmune thyroidopathy
21180,28243072,elderly
21181,28243072,subconjunctival orbital fat prolapse
21182,28243072,thyroid associated orbitopathy cois
21184,26744121,pendred syndrome
21185,26744121,tp53
21186,26744121,thyroid carcinoma
21187,26683653,capsular dissection
21188,26683653,guidelines
21189,26683653,intraoperative
21190,26683653,neurophysiological monitoring
21191,26683653,nodular goiter
21192,27877085,*autophagy
21193,27877085,*age-related macular degeneration
21194,27877085,*cataracts
21195,27877085,*diabetic retinopathy
21196,27877085,*ocular tumours.
21197,27877085,*thyroid-associated ophthalmopathy cois
21199,28413173,autoimmune thyroid diseases
21200,28413173,graves’ disease
21201,28413173,hashimoto’s thyroiditis
21202,28413173,serum 25-hydroxyvitamin d
21203,28413173,vitamin d deficiency
21206,29266775,*bmpr2
21207,29266775,*epstein-barr virus
21208,29266775,*graves’ disease
21209,29266775,*tgf-β/bmp
21210,29266775,*expression assay
21211,29266775,*functional analysis
21212,29266775,*lymphoblastoid cell lines
21213,29266775,*pulmonary arterial hypertension
21215,28219358,*graves’ disease
21216,28219358,*innate immunity
21217,28219358,*tlrs
21218,28883260,graves’ disease
21219,28883260,metastasis
21220,28883260,thyroid carcinoma
21221,28473357,arrhythmias
21222,28473357,paediatrics (drugs and medicines)
21223,28473357,thyroid disease cois
21226,28078992,*tobacco smoking
21227,28078992,*adults
21228,28078992,*children
21229,28078992,*ocular inflammation
21230,28078992,*optic neuropathy
21231,28078992,*orbitopathy
21232,28078992,*retinopathy
21235,29174550,decompression
21236,29174550,endocrine orbitopathy
21237,29174550,scleral show
21240,27769543,*grave's disease
21241,27769543,*potassium iodide
21242,27769543,*thyroidectomy
21246,26884288,graves’ disease
21247,26884288,graves’ orbitopathy
21248,26884288,dysthyroid optic neuropathy
21249,26884288,endoscopic intranasal orbital decompression
21250,26884288,methylprednisolone
21251,26884288,orbital decompression
21259,28851197,graves ophthalmopathy
21260,28851197,psychometrics
21261,28851197,quality of life
21262,28851197,root cause analysis
21263,28741406,thyroid eye disease
21264,28741406,compressive optic neuropathy
21265,28741406,decompression
21266,28741406,diplopia
21267,28741406,orbit
21268,28741406,proptosis
21269,28699478,*graves' disease
21270,28699478,*antithyroid drugs
21271,28699478,*continuous therapy
21272,28699478,*long-term therapy
21273,28699478,*meta-analysis
21274,28699478,*methimazole
21275,28699478,*propylthiouracil
21277,27692684,*endocrine orbitopathy
21278,27692684,*navigated surgery
21279,27692684,*piezosurgery
21285,28341401,*hearing loss
21286,28341401,*localization
21287,28341401,*misfolding
21288,28341401,*molecular chaperone
21289,28341401,*morphological analysis
21290,28341401,*p123s mutant
21291,28341401,*pendrin
21293,26979769,*graves’ orbitopathy
21294,26979769,*pai-1
21295,26979769,*tgf-β
21296,26979769,*cell density
21297,26979769,*hyaluronan
21298,26979769,*orbital fibroblasts
21303,28859864,decision making
21304,28859864,game of dice task
21305,28859864,graves’ disease
21306,28859864,hyperthyroidism
21307,28859864,thyroid hormones
21308,28856610,ablation
21309,28856610,autoimmunity
21310,28856610,graves’ disease
21311,28856610,graves’ orbitopathy
21312,28856610,radioiodine
21313,28856610,thyroid
21314,28235670,*comparative study
21315,28235670,*conventional open
21316,28235670,*endoscopy
21317,28235670,*graves' disease
21318,28235670,*meta-analysis
21319,28235670,*thyroidectomy
21320,27615550,*graves’ disease
21321,27615550,*hyperthyroidism
21322,27615550,*antithyroid drugs
21323,27615550,*carbimazole
21324,27615550,*methimazole
21325,27615550,*propylthiouracil
21326,28259878,cytopathology
21327,28259878,fine needle aspiration
21328,28259878,graves disease
21329,28259878,thyroid
21330,29147850,*active
21331,29147850,*cytokines
21332,29147850,*eye
21333,29147850,*graves’
21334,29147850,*specificity
21335,29147850,*tears
21338,27771369,homology modeling
21339,27771369,mutation mapping
21340,27771369,non-syndromic hearing loss with enlarged vestibular aqueduct (ns-eva)
21341,27771369,pendred syndrome
21342,27771369,pendrin
21343,27771369,slc26a4
21344,27771369,transmembrane protein
21347,28515387,aitd
21348,28515387,il-12
21349,28515387,il-18
21350,28515387,polymorphism
21351,28515387,socs1
21359,27160433,*diabetes mellitus
21360,27160433,*endocrine tumor
21361,27160433,*granulomatous insulitis
21362,27160433,*pancreas
21366,27612658,*graves' disease
21367,27612658,*autoimmunity
21368,27612658,*fibrocyte
21369,27612658,*interleukin-12
21370,27612658,*thyroid-associated ophthalmopathy cois interest in any material discussed in this article.
21372,27543288,*biochemistry
21373,27543288,*experimental &#8211 laboratory
21374,27543288,*inflammation
21375,27543288,*orbit
21377,27580012,col13a1
21378,27580012,collagen xiii
21379,27580012,thyroid eye disease
21380,27580012,thyroid-associated ophthalmopathy
21382,28500376,graves’ disease
21383,28500376,ptpn22
21384,28500376,rheumatoid arthritis
21385,28500376,systemic lupus erythematosus
21386,27369733,convergence spasm
21387,27369733,cranial nerve palsy
21388,27369733,double vision
21389,27369733,graves’ disease
21390,27369733,strabismus
21394,26675405,adipocyte
21395,26675405,cytokine
21396,26675405,fibrocyte
21397,26675405,fibrosis
21398,26675405,graves' ophthalmopathy
21399,26675405,growth factor
21400,26675405,hyaluronan
21401,26675405,inflammation
21402,26675405,orbital fibroblast
21404,29256262,*ago
21405,29256262,*autoimmune thyroid disease
21406,29256262,*intractability
21407,29256262,*polymorphism
21408,29256262,*severity
21409,29093229,ctla-4 gene exon 1
21410,29093229,ctla-4 gene with promotor-318
21411,29093229,regulatory t cells
21412,29093229,tshr gene rs2268458 intron 1
21413,29093229,thyroid receptor antibody (trab)
21414,29093229,graves’ disease
21415,29093229,relapse
21418,29101123,*experimental laboratory cois
21419,27987077,epstein–barr virus
21420,27987077,graves’ disease
21421,27987077,graves’ orbitopathy
21422,27987077,idiopathic inflammatory pseudotumor
21423,27987077,thyroid
21424,27637079,graves’ disease
21425,27637079,t3
21426,27637079,neutrophils
21427,27637079,resistin
21429,27113266,pediatric graves' disease
21430,27113266,pediatric hyperthyroidism
21431,27113266,shared decision making
21432,27113266,thyroidectomy
21433,27793633,(177)lu-dotatate
21434,27793633,cáncer de tiroides
21435,27793633,peptide receptor radionuclide therapy
21436,27793633,radioactive iodine refractory
21437,27793633,refractario al yodo radiactivo
21438,27793633,thyroid neoplasms
21439,27793633,tratamiento con análogos de la somatostatina radiomarcados
21443,27130144,ck5/6
21444,27130144,cytokeratin
21445,27130144,lymphoepithelial complex
21446,27130144,p63
21447,27130144,squamous cell metaplasia
21448,27130144,thyroid
21449,27130144,thyroiditis
21452,28201927,graves’ disease
21453,28201927,cytological alteration
21454,28201927,histologic changes
21455,28201927,radioactive iodine treatment
21456,28201927,thyroid
21459,27700191,parathyroid autotransplantation
21460,27700191,hypocalcemia
21461,27700191,inadvertent parathyroidectomy
21462,27700191,parathormone
21463,27700191,thyroidectomy
21467,29037117,*graves'
21468,29037117,"*disease, relapse, predictive biomarker, siglec1, ifn signature"
21469,28336282,botulinum toxin type a
21470,28336282,dysthyroid orbitopathy
21471,28336282,grave's disease
21472,28336282,maladie de basedow
21473,28336282,ophtalmopathie dysthyroïdienne
21474,28336282,orbital inflammatory disease
21475,28336282,orbitopathie inflammatoire
21476,28336282,rétraction palpébrale supérieure
21477,28336282,toxine botulique a
21478,28336282,upper eyelid retraction
21479,27638540,cd28/ctla-4/icos
21480,27638540,gene polymorphism
21481,27638540,graves’ disease
21482,27638540,graves’ orbitopathy
21483,27638540,haplotype cois
21484,28825582,*immunosuppressive agents
21485,28825582,*multiple organ failure
21486,28825582,*plasmapheresis
21487,28825582,*thyroid crisis
21488,28825582,*thyroidectomy
21491,28895066,131i therapy
21492,28895066,graves’ hyperthyroidism
21493,28895066,lithium carbonate
21494,28895066,thyroid
21496,28185649,*anti-cd20
21497,28185649,*graves ophthalmopathy
21498,28185649,*neuropathie optique
21499,28185649,*optic neuropathy
21500,28185649,*orbitopathie basedowienne
21501,28185649,*rituximab
21504,28001121,*graves' disease
21505,28001121,*antithyroid agents
21506,28001121,*long-term prognosis
21507,27734319,autoimmunity
21508,27734319,graves’ disease
21509,27734319,hyperthyroidism
21510,27734319,selenium
21511,27734319,thyroid
21514,28705701,graves disease
21515,28705701,orbital decompression surgery
21516,28705701,piezosurgery
21517,28705701,thyroid-associated orbitopathy
21519,28176220,clinical activity score
21520,28176220,cyclosporine
21521,28176220,graves’ orbitopathy or ophthalmopathy
21522,28176220,intravenous glucocorticoids
21523,28176220,orbital radiotherapy
21524,28176220,shared decision-making
21526,29058517,thyroid eye disease
21527,29058517,abducens nerve
21528,29058517,orbital decompression
21531,27266815,aire
21532,27266815,apeced
21533,27266815,autoimmunity
21534,27266815,graves’ disease
21535,27266815,mutation
21536,27266815,polymorphism
21539,29307154,graves
21540,29307154,interleukin-6
21541,29307154,meta-analysis
21542,29307154,polymorphism
21543,28223014,decompression
21544,28223014,endocrine orbitopathy
21545,28223014,navigated surgery
21548,27863461,*genome-wide association study
21549,27863461,*graves’ disease
21550,27863461,*pooled blood
21552,27618833,graves’ disease
21553,27618833,iodine radioisotopes
21554,27618833,pregnancy outcome
21555,27566407,calreticulin(calr)
21556,27566407,endoplasmic reticulum (er) stress
21557,27566407,graves' disease(gd)
21558,27566407,heat shock 70kda protein 5(hspa5)
21559,27566407,proteomics
21560,27419847,*choroidal thickness
21561,27419847,*graves’ disease
21562,27419847,*graves’ ophthalmopathy
21563,27419847,*clinical activity score
21564,27419847,*optical coherence tomography
21565,27163552,graves disease
21566,27163552,moyamoya
21567,27163552,stroke
21568,27163552,vasculopathy
21569,26932949,*graves’ disease
21570,26932949,*balanced decompression
21571,26932949,*endoscopic orbital decompression
21572,26932949,*orbital decompression
21573,26932949,*orbital sling
21574,26932949,*orbital strut
21577,28181061,amsterdam declaration
21578,28181061,graves’ disease
21579,28181061,joint thyroid eye clinic
21580,28181061,ophthalmopathy
21581,28181061,thyroid
21582,28042648,*graves’ orbitopathy
21583,28042648,*intravenous steroids
21584,28042648,*orbital irradiation
21585,28042648,*radioiodine therapy
21587,26886940,graves’ orbitopathy
21588,26886940,ich guideline
21589,26886940,medical dictionary for regulatory activities (meddra)
21590,26886940,mycophenolate
21591,26886940,safety
21592,27206624,*graves’ disease
21593,27206624,*hashimoto’s thyroiditis
21594,27206624,*th17
21595,27206624,*tregs
21596,27206624,*anti-thyroid antibodies
21598,28506419,99m tc-mibi scintigraphy
21599,28506419,mibi uptake
21600,28506419,radioguided surgery
21601,28506419,thyroid cancer
21602,28506419,thyroid follicular neoplasm
21603,28506419,thyroidectomy
21608,27107937,*coexpression
21609,27107937,*graves' disease
21610,27107937,*ox40/ox40l
21611,27107937,*t cell activation
21613,27762178,endoscopic surgical procedure
21614,27762178,mri
21615,27762178,skull base
21616,28548552,biomarker
21617,28548552,ccn1
21618,28548552,cyr61
21619,28548552,inflammation
21620,28548552,thyroid ophthalmopathy
21621,29246597,*autoantibody
21622,29246597,*encephalitis
21623,29246597,*hashimoto's encephalopathy
21624,29246597,*intravenous immunoglobulin
21630,27143020,intraoperative neuromonitoring
21631,27143020,prognostic value
21632,27143020,recurrent laryngeal nerve
21633,27143020,staged thyroidectomy
21634,27143020,thyroid surgery cois interest: author małgorzata stopa declares that she has no conflict of interest. author marcin barczyński declares that he has no conflict of interest. ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. informed consent: informed consent was obtained from all individual participants included in the study.
21639,29199443,inferior laryngeal nerve
21640,29199443,nonrecurrent laryngeal nerve
21641,29199443,thyroid surgery
21643,28119492,*antibody
21644,28119492,*gene polymorphism
21645,28119492,*hla-dq
21646,28119492,*ocular myasthenia gravis
21647,28119492,*tnf-α
21648,28119492,*thyroid associated ophthalmopathy cois manuscript.
21651,29098964,biotin
21652,29098964,graves’ hyperthyroidism
21653,29098964,tsh receptor antibodies
21654,29098964,false laboratory results
21655,29098964,immunoassay
21657,28236218,agranulocytosis
21658,28236218,antithyroid drug
21659,28236218,graves’ disease
21660,28236218,hyperthyroidism
21661,26850223,autoimmune thyroid diseases
21662,26850223,cytokines
21663,26850223,graves' disease
21664,26850223,hashimoto's disease
21665,26850223,single nucleotide polymorphisms
21666,26850223,thyroid-associated ophthalmopathy
21668,28606262,"decompression, surgical"
21669,28606262,graves ophthalmopathy
21670,28606262,optic nerve diseases
21671,28606262,orbit
21672,28606262,treatment outcome
21676,26735162,*in vivo confocal microscopy
21677,26735162,*langerhans cells
21678,26735162,*inflammation
21679,26735162,*ocular surface
21680,26735162,*thyroid-associated ophthalmopathy
21681,28453366,thyroid eye disease
21682,28453366,compressive optic neuropathy
21683,28453366,visual field
21686,26775634,adjustable sutures
21687,26775634,endocrine orbitopathy
21688,26775634,orbital decompression
21689,26775634,restrictive strabismus
21690,26775634,strabismus surgery
21691,26775634,thyroid associated ophthalmopathy
21692,28061802,endoscopy
21693,28061802,graves’ disease
21694,28061802,neurosurgery
21695,28061802,pituitary neoplasms
21696,28061802,tsh-producing tumor
21697,28061802,tshoma
21698,28061802,thyrotropin
21699,28502931,22q11.2 deletion syndrome
21700,28502931,graves' disease
21701,28502931,hla
21702,28502931,regulatory t-cell
21706,27824294,*graves'
21707,27824294,*fibroblast
21708,27824294,*ophthalmopathy
21709,27824294,*orbitopathy
21710,27824294,*selenium
21712,26795296,arylesterase
21713,26795296,autoimmune thyroid disease
21714,26795296,oxidative status
21715,26795296,paraoxonase cois that could be perceived as prejudicing the impartiality of the research reported.
21718,29053038,igg4-related orbital disease
21719,29053038,thyroid eye disease
21720,29053038,rituximab
21721,29023175,orbital
21722,29023175,autologous
21723,29023175,cosmetic
21724,29023175,decompression
21725,29023175,fat
21726,29023175,graft
21727,27838736,activity
21728,27838736,computed tomography
21729,27838736,hounsfield unit
21730,27838736,orbital volume
21731,27838736,thyroid-associated orbitopathy
21733,28070798,*addison’s disease
21734,28070798,*autoimmune polyendocrine syndromes
21735,28070798,*autoimmunity
21736,28070798,*environment
21737,28070798,*graves’ disease
21738,28070798,*hashimoto’s thyroiditis
21739,28070798,*lifestyle
21740,28070798,*type 1 diabetes mellitus
21741,28070798,*vitamin d
21744,27465669,*glucocorticoid
21745,27465669,*graves’ ophthalmopathy
21746,27465669,*hepatitis
21747,27465669,*statins
21748,29187926,basedow-graves ophthalmopathy
21749,29187926,corticosteroids
21750,29187926,exophthalmos decompression
21751,29187926,neuropathy
21753,29103088,diastolic function
21754,29103088,echocardiography
21755,29103088,graves’ disease
21756,29103088,left ventricular function
21757,29103088,left ventricular mass index
21758,29103088,myocardial performance index
21759,29103088,tissue doppler imaging
21760,28742400,autoimmune thyroid diseases
21761,28742400,cd40
21762,28742400,single nucleotide polymorphism
21767,26935935,autoimmunity
21768,26935935,graves’ disease
21769,26935935,primary biliary cirrhosis
21770,26864865,autoimmune thyroid diseases
21771,26864865,graves’ disease
21772,26864865,hashimoto thyroiditis
21773,26864865,cytokine
21774,26864865,interleukin-1β
21775,29058307,*graves' disease
21776,29058307,*graves' orbitopathy
21777,29058307,*autoimmunity
21778,29058307,*self-antigen mouse model
21779,29058307,*thyroid disease
21780,28209438,graves’ disease
21781,28209438,hypocretin
21782,28209438,myasthenia gravis
21783,28209438,myotonic dystrophy
21784,28081504,hashimoto's thyroiditis
21785,28081504,igg
21786,28081504,neonatal fc receptor
21787,28081504,tgab
21788,28081504,th1/th2 cytokines
21789,28630226,disturbances
21790,28630226,endocrinology
21791,28630226,fluid electrolyte and acid-base
21792,28630226,muscle
21793,28630226,thyroid disease cois
21794,27810496,alopecia areata
21795,27810496,graves’ disease
21796,27810496,non-hla genes
21797,27810496,trab
21798,27810496,type 1 diabetes
21799,26876268,graves’ orbitopathy
21800,26876268,igg4-asszociált betegség
21801,26876268,igg4-related disease
21802,26876268,endokrin orbitopathia
21803,26876268,idiopathic inflammatory orbitopathy
21804,26876268,idiopathiás inflammatorikus orbitopathia
21805,26876268,myasthenia gravis
21806,26876268,occularis lymphoma
21807,26876268,ocular lymphoma
21808,29196352,deaf awareness
21809,29196352,hearing impaired
21810,29196352,young people
21811,28238453,graves disease
21812,28238453,hashimoto thyroiditis
21813,28238453,autoimmune thyroiditis
21814,28238453,hyperthyroidism
21815,28238453,hypothyroidism
21816,28238453,thyroid cancer
21817,28238453,vitiligo
21822,26965896,endoscopic thyroidectomy
21823,26965896,graves’ disease
21824,26965896,hypocalcemia
21825,26965896,parathyroid preservation
21826,27273008,oscillopsia
21827,27273008,proptosis
21828,27273008,temporal hollowing
21829,27273008,thyroid eye disease
21830,27273008,visual acuity
21831,27259978,clpp
21832,27259978,slc26a4
21833,27259978,tbc1d24
21834,27259978,pendred syndrome
21835,27259978,perrault syndrome
21836,27259978,enlarged vestibular aqueduct
21837,27259978,hereditary deafness cois
21838,28665696,14q32.2
21839,28665696,ciqtnf6
21840,28665696,graves' disease
21841,28665696,rac2
21842,28665696,snp
21843,28665696,association
21844,28660988,graves' orbitopathy
21845,28660988,clinical activity score
21846,28660988,dysthyroid optic neuropathy
21847,28660988,rituximab
21848,28660988,thyroid gland
21850,28364200,graves’ orbitopathy
21851,28364200,inflammation
21852,28364200,orbital fibroblasts
21853,28364200,s1p receptor antagonist
21854,28364200,sphingosine-1-phosphate
21855,26955881,*genetics
21856,26955881,*graves’ disease
21857,26955881,*hashimoto thyroiditis
21858,26955881,*vegf
21859,26955881,*polymorphisms
21860,28689782,*bacteria
21861,28689782,*graves' disease
21862,28689782,*hashimotos's thyroiditis
21863,29180171,*graves' disease
21864,29180171,*hyperthyroidism
21865,29180171,*recurrence
21866,29180171,*subtotal thyroidectomy
21867,29088997,*graves' disease
21868,29088997,*antineutrophil cytoplasmic antibody
21869,29088997,*propylthiouracil
21870,29088997,*vasculitis
21871,29050489,*graves' ophthalmopathy
21872,29050489,*inflammation biomarker.
21873,29050489,*neutrophil-to-lymphocyte ratio
21874,29050489,*thyroid ophthalmopathy
21876,27247969,*grave’s disease
21877,27247969,*ted
21878,27247969,*ted treatment options
21879,27247969,*thyroid eye disease
21881,28260364,"decompression, surgical"
21882,28260364,graves ophthalmopathy
21883,28260364,orbit
21884,28260364,"surgical procedures, minimally invasive"
21885,28260364,treatment outcome
21886,26865797,diplopia
21887,26865797,exophthalmos
21888,26865797,eyelid retraction
21889,26865797,graves ophthalmopathy
21890,26865797,orbital decompression cois was reported.
21892,28606264,graves ophthalmopathy
21893,28606264,magnetic resonance imaging
21894,28606264,oculomotor muscles
21895,28388348,decompression
21896,28388348,graves’ disease
21897,28388348,geriatric
21898,28388348,strabismus
21899,28388348,thyroid eye disease cois alone are responsible for the content and writing of the paper.
21901,28439882,*graves' disease
21902,28439882,*hashimoto's thyroiditis
21903,28439882,*tsh-receptor blocking antibodies
21904,28439882,*tsh-receptor stimulating antibodies
21905,28439882,*bioassay
21907,28743746,*graves' disease
21908,28743746,*iodination
21909,28743746,*post-translational modification (ptm)
21910,28743746,*protein processing
21911,28743746,*protein secretion
21912,28743746,*thyroglobulin
21913,28743746,*thyroid
21914,28743746,*thyroid hormone cois this article
21916,27888002,*autoimmune thyroid diseases (aitd)
21917,27888002,*graves' disease (gd)
21918,27888002,*hashimoto's thyroiditis (ht)
21919,27888002,*micrornas
21920,27888002,*single nucleotide polymorphism (snp)
21923,26767650,graves’ disease
21924,26767650,graves’ ophthalmopathy
21925,26767650,graves’ orbitopathy
21926,26767650,nicotinamide phosphoribosyltransferase
21927,26767650,pre-b cell colony-enhancing factor
21928,26767650,visfatin
21930,29174716,autoimmune thyroid disease
21931,29174716,ctla4
21932,29174716,drb1*
21933,29174716,graves' disease
21934,29174716,hashimoto's thyroiditis
21935,29174716,human leukocyte antigen
21936,29110673,clinical outcomes
21937,29110673,graves’ ophthalmopathy
21938,29110673,"imrt cois ethics committee of west china hospital, sichuan university. informed consent was obtained from all individual participants included in the study. consent for publication: the consent to publish the study and accompanying images was obtained. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
21939,29021480,continuous glucose monitoring
21940,29021480,methylprednisolone pulse therapy
21941,29021480,mitiglinide
21942,29021480,rapid-acting insulin secretagogue
21943,29021480,repaglinide
21944,29021480,steroid-induced diabetes
21948,29256181,antioxidant
21949,29256181,fibroblast
21950,29256181,graves’
21951,29256181,ophthalmopathy
21952,29256181,orbitopathy
21953,29256181,retinol
21954,29256181,vitamin e
21955,29256181,β-carotene
21956,28895880,graves’ disease
21957,28895880,hashimoto’s thyroiditis
21958,28895880,autoimmune thyroid disease
21959,28895880,thyroid cancer
21960,28895880,vitamin d cois
21961,28833367,graves’ hyperthyroidism
21962,28833367,ferritin
21963,28833367,hepcidin
21964,28833367,iron metabolism
21966,28133945,graves' orbitopathy
21967,28133945,field of binocular single vision
21968,28133945,quality of life
21969,28133945,strabismus surgery
21971,28521825,"*graves’ disease, susceptibility, single nucleotide polymorphisms, 4p14, 6q27"
21973,29549956,*graves' disease
21974,29549956,*autoantibodies
21975,29549956,*breast milk
21976,29549956,*methimazole
21977,29549956,*propylthiouracil
21978,29549956,*thyroid hormones
21979,27003434,acute liver damage
21980,27003434,graves’ ophthalmopathy
21981,27003434,hepatotoxicity
21982,27003434,intravenous glucocorticoid therapy
21983,27003434,methylprednisolone
21984,29130665,hyaluronic acid
21985,29130665,insulin-like growth factor-1 receptor
21986,29130665,signal pathway
21987,29130665,thyroid associated ophthalmopathy
21988,28781323,sitsh
21989,28781323,familial dysalbuminemic hyperthyroxinemia (fdh)
21990,28781323,thiamazole
21992,27160786,enlarged
21993,27160786,fluctuation
21994,27160786,hearing loss
21995,27160786,large
21996,27160786,risk factor
21997,27160786,vertigo
21998,27160786,vestibular aqueduct
21999,29141453,*nodular thyroid diseases
22000,29141453,*goitre
22001,29141453,*insulin resistance
22002,29141453,*metabolic syndrome
22003,29141453,*thyroid volume
22004,28756232,*akt/nf-κb
22005,28756232,*galectin-9
22006,28756232,*inflammation
22007,28756232,*thyroid-associated ophthalmopathy
22008,28756232,*tim3
22009,29233566,*anergy
22010,29233566,*autoimmune thyroid disease
22011,29233566,*b lymphocytes
22012,29233566,*flow cytometry
22014,27558389,*auto-immune thyroid dysfunction
22015,27558389,*chordoma
22016,27558389,*tyrosine kinase inhibitors
22017,27718482,graves’ disease
22018,27718482,analytical interference
22019,27718482,biotin
22020,27718482,hyperestrogenism
22021,27718482,immunoassay
22024,27234136,células t reguladoras (tregs)
22025,27234136,enfermedad de graves
22026,27234136,graves’ disease
22027,27234136,hashimoto's thyroiditis
22028,27234136,t helper
22029,27234136,t regulatory cells (treg)
22030,27234136,th17
22031,27234136,thyroid autoimmunity
22032,27234136,tiroideas autoinmunitarias
22033,27234136,tiroiditis de hashimoto
22036,27267669,*fibroblast growth factor
22037,27267669,*graves’ ophthalmopathy
22038,27267669,*hyaluronan
22039,27267669,*orbital fibroblast
22040,27267669,*platelet-derived growth factor-bb
22041,27267669,*vascular endothelial growth factor
22042,29269558,*endocrinology
22043,29269558,*pharmacology cois
22044,28450690,*basedow’s disease
22045,28450690,*sjogren’s syndrome
22046,28450690,*autoimmune diseases
22047,28450690,*chronic myopathic type
22048,28450690,*sarcoid myopathy
22049,28333576,*epstein–barr virus
22050,28333576,*graves' disease
22051,28333576,*activation-induced cytidine deaminase
22052,28333576,*autoreactive b cells
22053,28333576,*polyclonal b cell activation
22054,28333576,*reactivation cois
22057,26854256,autoimmune diseases
22058,26854256,coeliac disease
22059,26854256,comorbidity
22060,28960748,hashimoto's
22061,28960748,autoimmune
22062,28960748,goiter
22063,28960748,hypothyroidism
22064,28960748,iodine
22065,28960748,vitiligo
22067,28636775,autoimmune thyroid disease
22068,28636775,cd163
22069,28636775,fn14
22070,28636775,tweak
22071,27986127,*graves' disease
22072,27986127,*hyperthyroidism
22073,27986127,*irisin
22074,27986127,*myostatin
22077,27458112,apoptosis
22078,27458112,autoimmune thyroid disease
22079,27458112,intractability
22080,27458112,polymorphism
22081,27458112,severity
22082,28049375,*graves' disease
22083,28049375,*antithyroid drugs (atds)
22084,28049375,*comparative effectiveness
22085,28049375,*hyperthyroidism
22086,28049375,*radioactive iodine (rai)
22087,28049375,*thyroidectomy cois
22090,28725932,alzheimer’s disease
22091,28725932,chronological age
22092,28725932,dna methylation
22093,28725932,graves’ disease
22094,28725932,neural networks
22095,28725932,prediction accuracy
22096,29102101,graves disease
22097,29102101,cardiogenic shock
22098,29102101,iodinated contrast
22099,29102101,thyroid storm
22100,28187375,8-ohdg
22101,28187375,graves's disease
22102,28187375,hashimoto thyroiditis
22103,28187375,papillary thyroid carcinoma
22105,26997461,goitre ovarien
22106,26997461,kyste ovaire
22107,26997461,ovarian cyst
22108,26997461,struma ovarii
22109,26997461,thyroid
22110,26997461,thyroïde
22111,28087387,*a proliferation-inducing ligand (april)
22112,28087387,*b-cell activating factor (baff)
22113,28087387,*graves' orbitopathy
22114,28087387,*orbital fibroblasts
22116,27729026,*goitre in pregnancy
22117,27729026,*iodine status in pregnancy
22118,27729026,*thyroid stimulating hormone
22119,27729026,*thyroid volume
22120,27729026,*urinary iodine
22122,28099999,*graves' disease
22123,28099999,*tshr autoantibodies
22124,28099999,*autoimmunity
22125,28099999,*intrathymic transcription
22126,28099999,*thyroid autoantigens
22127,28099999,*tolerance
22129,27345036,graves’ disease
22130,27345036,tgfbeta1
22131,27345036,nodular goiter
22132,27345036,papillary cancer
22133,27345036,thyroid
22134,27345036,transforming growth factor beta 1
22135,28604944,graves’ orbitopathy
22136,28604944,adrenal insufficiency
22137,28604944,cortisol
22138,28604944,glucocorticoids
22139,28604944,methylprednisolone
22141,27245471,*autoimmune thyroid disease
22142,27245471,*chemokine
22143,27245471,*intractability
22144,27245471,*severity
22145,27245471,*single nucleotide polymorphism
22146,28595789,goitre prevalence
22147,28595789,iodine intake
22148,28595789,saharawi refugee camps
22149,28595789,urinary iodine concentration
22150,28595789,water iodine concentration
22151,29398296,*goitre
22152,29398296,*myasthenia gravis
22153,29398296,*ophthalmoplgia
22154,29398296,*thyrotoxicosis
22155,28693960,backdoor
22156,28693960,lateral approach
22157,28693960,open throidectomy
22158,28693960,sternomastoid
22159,27888493,goitre
22160,27888493,medical diagnosis
22161,27888493,painting
22162,27888493,de ribera
22165,28420934,"goitre, hyperthyroidism, hypothyroidism, thyroid nodules."
22166,29169383,multinodular goitre
22167,29169383,saudi arabia
22168,29169383,solitary nodule
22169,29169383,thyroid fine needle aspiration cytology
22170,26996162,airway obstruction
22171,26996162,goitre
22172,26996162,intratracheal
22173,26996162,intubation
22174,28521312,children
22175,28521312,goitre
22176,28521312,iodine prophylaxis
22177,28521312,thyroid volume
22178,28521312,ultrasound examination
22179,25880137,*iodine
22180,25880137,*cognition
22181,25880137,*development
22182,25880137,*goitre
22183,25880137,*thyroid hormones
22185,27364542,*esrd
22186,27364542,*tsh
22187,27364542,*nodular goiter
22188,27364542,*thyroid gland
22189,27364542,*urinary iodine excretion
22190,28474274,*endoscopic thyroidectomy
22191,28474274,*goiter
22192,28474274,*mediastinal emphysema
22193,28474274,*robotic thyroidectomy
22194,28474274,*subcutaneous emphysema
22195,28098046,* ht-us hypoechoic pattern at thyroid ultrasound
22196,28098046,* iqr interquartile range
22197,28098046,* tpoab thyroperoxidase antibodies
22198,28098046,* tsh thyroid-stimulating hormone
22199,28098046,* tgab thyroglobulin
22200,28098046,* uie urinary i excretion
22201,28098046,*goitre
22202,28098046,*iodine intake
22203,28098046,*thyroid antibodies
22204,28098046,*thyroid diseases
22205,29197093,*fndc5 gene
22206,29197093,*hyperthyroidism
22207,29197093,*hypothyroidism
22208,29197093,*irisin
22209,28858843,methimazole
22210,28858843,plasma exchange
22211,28858843,thrombotic thrombocytopenic purpura
22212,28858843,thyrotoxicosis
22213,28858843,toxic multinodular goiter
22214,28627279,graves’ disease
22215,28627279,maternal autoantibodies
22216,28627279,anti-ro and anti-la antibodies
22217,28627279,athrogryposis multiplex congenital
22218,28627279,autoimmune thrombocytopenia
22219,28627279,fetal brain hemorrhage
22220,28627279,fetal heart block
22221,28627279,fetal thyroid goiter
22222,28627279,myasthenia gravis
22226,27421794,epidemiology
22227,27421794,iodine
22228,27421794,iodine deficiency disorders
22229,27421794,iodine fortification
22230,27421794,prophylaxis
22231,27421794,risk of iodine fortification
22235,27852654,*cardiomyopathies
22236,27852654,*cobalt
22237,27852654,*heart failure
22238,27852654,*hip prosthesis
22239,27852654,*polycythemia
22241,28613043,congenital hypothyroidism with defective dehalogenation of iodotyrosines
22242,28613043,cretinism
22243,28613043,endemic goiter
22244,28613043,iodine deficiency
22245,28613043,thyroid hormones and mental development
22246,27119700,thyroid nodule
22247,27119700,benign adenoma
22248,27119700,multinodular goiter
22249,27119700,thyroid cancer
22250,28585680,radioactive iodine
22251,28585680,thyroid cancer
22252,28585680,toxic multinodular goitre
22253,29589552,antithyroid medication
22254,29589552,graves' disease
22255,29589552,hashitoxicosis
22256,29589552,hyperthyroidism
22257,29589552,radioactive iodine
22258,29589552,subacute granulomatous thyroiditis
22259,29589552,thyroidectomy
22260,29589552,toxic adenoma
22261,29589552,toxic multinodular goiter.
22262,29871272,langerhans cell histiocytosis
22263,29871272,thyroid cois relevant financial relationships with commercial interests to disclose.
22265,28297755,interleukin-17
22266,28297755,micrornas
22267,28297755,thyroid neoplasms
22268,28690737,struma ovarii
22269,28690737,malignant ovarian goiter
22270,28690737,thyroid cois
22271,28262255,cowden syndrome
22272,28262255,hamartomatous tumour
22273,28262255,multinodular goiter
22274,28262255,pten
22275,28262255,pten hamartoma tumour syndrome
22276,28712235,total thyroidectomy
22277,28712235,recurrent laryngeal nerve injury
22278,28712235,subtotal thyroidectomy
22279,29503241,atrial fibrillation
22280,29503241,congestive heart failure
22281,29503241,graves’ disease
22282,29503241,hyperthyroidism
22283,29503241,toxic multinodular goitre
22286,29415534,*pegylated interferon alpha
22287,29415534,*chronic hepatitis c
22288,29415534,*thyroid dysfunction
22291,29798345,cn0
22292,29798345,lymph node metastasis
22293,29798345,papillary thyroid carcinoma
22294,29798345,risk factors cois relevant financial relationships with commercial interests to disclose.
22295,27263038,calcifications
22296,27263038,doppler
22297,27263038,malignancy
22298,27263038,thyroid carcinoma
22299,27263038,thyroid nodule
22300,27263038,ultrasound
22301,28569114,children
22302,28569114,goiter
22303,28569114,iodine deficiency disorders
22304,28569114,thyroid volume
22305,28569114,urinary iodine
22307,28476227,*congenital hypothyroidism
22308,28476227,*deiodinase
22309,28476227,*dysgenesis
22310,28476227,*dyshormonogenesis
22311,28476227,*goiter
22312,28476227,*resistance to thyroid hormone
22313,28476227,*thyroid hormone receptors
22316,27922153,*graves’ disease
22317,27922153,*guideline
22318,27922153,*hyperthyroidism
22319,27922153,*radioiodine therapy
22320,27922153,*thyrotoxicosis
22321,27922153,*toxic goiter
22329,27913858,fnac
22330,27913858,frozen section
22331,27913858,multinodular goiter
22332,27913858,papillary carcinoma
22333,27913858,thyroid cancer
22334,27913858,thyroid nodule
22337,28952819,ebsln
22338,28952819,ionm
22339,28952819,rln
22340,28952819,goiter
22341,28952819,surgery
22342,28952819,thyroid
22343,26876062,*goiter
22344,26876062,*medullary
22345,26876062,*multiple endocrine neoplasia (men)
22346,26876062,*parathyroid
22347,26876062,*thyroidectomy
22350,28940588,ectopic thyroid
22351,28940588,endobronchial ultrasonography
22352,28940588,transbrochial needle aspiration
22355,28042647,*core-needle aspiration biopsy
22356,28042647,*cytokeratin 17
22357,28042647,*fine-needle aspiration biopsy
22358,28042647,*nodular goiter
22359,28042647,*thyroid
22361,28224254,eastern mediterranean region (emr)
22362,28224254,goiter
22363,28224254,iodine
22364,28224254,iodine deficiency disorders (idds)
22365,28224254,who
22366,28103777,iodine
22367,28103777,iodine deficiency.
22368,28103777,iodine prophylaxis
22369,28103777,metabolic pathway
22370,28103777,synthesis
22371,28103777,thyroid hormones
22372,28085013,il-23
22373,28085013,papillary thyroid carcinoma
22374,28085013,mir-15a
22375,28085013,mir-16
22376,28085013,mir-940
22379,28756521,anticholinesterase pesticide
22380,28756521,hypothyroidism
22381,28756521,poisoning
22382,28954336,"goiter, nodular"
22383,28954336,thyroid neoplasms
22384,28954336,"tomography, x-ray computed"
22386,27259353,diffuse goiter
22387,27259353,iodine intake
22388,27259353,subclinical hypothyroidism
22389,27259353,thyroid nodule
22390,27259353,universal salt iodization (usi)
22391,27259353,urinary iodine concentration (uic)
22393,28405949,endoscopic thyroidectomy
22394,28405949,minimally invasive thyroidectomy
22395,28405949,thyroid surgery
22402,27152602,thyroid diseases
22403,27152602,autoimmunity
22404,27152602,iodization
22405,27152602,study
22413,28867693,congenital hypothyroidism
22414,28867693,genetics
22415,28867693,mutation
22416,28867693,newborn screening
22417,28867693,thyroid peroxidase (tpo)
22418,27510155,benign goiter
22419,27510155,complications
22420,27510155,routine data
22421,27510155,thyroid surgery
22422,27510155,volume outcome
22429,27405595,*thyroid
22430,27405595,*laser
22431,27405595,*nodule
22432,27405595,*thermal ablation
22433,27405595,*ultrasound
22435,27344303,classification
22436,27344303,juan rosai
22437,27344303,poorly differentiated carcinoma
22438,27344303,thyroid
22440,29039144,*endoscopic thyroidectomy
22441,29039144,*natural orifice transluminal endoscopic surgery
22442,29039144,*robotic thyroidectomy
22443,29039144,*transoral thyroidectomy
22447,28845837,*mazabraud syndrome
22448,28845837,*mccune-albright syndrome
22449,28845837,"*fibrous dysplasia, malignant transformation."
22450,28845837,*myxoma
22453,28276222,*ataxia telengiectasia
22454,28276222,*papillary thyroid carcinoma
22456,26884118,*68ga
22457,26884118,*cck2 receptor
22458,26884118,*pet/ct
22459,26884118,*medullary thyroid carcinoma
22460,26884118,*somatostatin receptor
22461,27094775,hashimotos
22462,27094775,hypothyroidism
22463,27094775,thyroiditis
22465,29529424,*goiter
22466,29529424,*iodine deficiency disorders
22467,29529424,*iodine supplementation
22468,29529424,*pregnancy
22469,29529424,*thyroid hormones
22470,29050166,lymphoma
22471,29050166,pathology
22472,29050166,thyroid
22473,29050166,ultrasonography
22475,27784321,*case report
22476,27784321,*cervical sympathetic chain damage
22477,27784321,*horner’s syndrome
22478,27784321,*thyroidectomy
22480,27025990,*children
22481,27025990,*congenital hypothyroidism
22482,27025990,*cáncer de tiroides
22483,27025990,*hipotiroidismo congénito
22484,27025990,*ionising radiation
22485,27025990,*niños
22486,27025990,*radiación ionizante
22487,27025990,*thyroid cancer
22488,29038858,parathyroidectomy
22489,29038858,radiology
22490,29038858,synchronous thyroid pathology
22491,28771678,sjögren syndrome
22492,28771678,annular erythema
22493,28771678,eccrine gland
22494,28771678,hidradenitis
22495,28771678,lymphocyte
22496,27530498,intra-operative
22497,27530498,pth
22498,27530498,post operative hypocalcemia
22499,27530498,thyroidectomy
22500,27121690,hyperthyroidism
22501,27121690,lithium
22502,27121690,radioactive iodine ablation
22503,27121690,thyroxine
22504,26884115,biopsy
22505,26884115,fine-needle biopsy
22506,26884115,thyroid cancer
22507,26884115,thyroid nodule
22508,26884115,thyroiditis
22515,28694722,acute illness
22516,28694722,guidelines
22517,28694722,thyroid tests cois
22518,28387096,diagnosis
22519,28387096,fnmtc
22520,28387096,genetic
22521,28387096,hereditary
22522,28387096,familial thyroid cancer
22525,28648507,*pax8
22526,28648507,*tshr
22527,28648507,*congenital hypothyroidism
22528,28648507,*hormone resistance
22529,28648507,*mutations
22530,28648507,*subclinical hypothyroidism
22531,28490006,adenoid cystic carcinoma
22532,28490006,cytopathology
22533,28490006,fine needle aspiration
22534,28490006,larynx
22535,28490006,thyroid
22536,27756965,*chlorpheniramine
22537,27756965,*drug-induced torsades de pointes
22538,27756965,*propranolol
22540,28276223,*kocher-debre-semelaigne syndrome
22541,28276223,*atrophic autoimmune thyroiditis
22542,28276223,*pituitary expansion
22543,28276223,*rickets
22544,27387245,*hypocalcemia
22545,27387245,*postoperative hypoparathyroidism
22546,27387245,*teriparatide
22548,29275552,hyperthyroidism
22549,29275552,blood chemical analysis
22550,29275552,case analysis
22551,29275552,"death, sudden, cardiac"
22552,29275552,forensic pathology cois relevant financial relationships with commercial interests to disclose.
22554,28479907,diagnostic accuracy
22555,28479907,cytology
22556,28479907,fine needle aspiration
22557,28479907,tertiary hospital
22558,28479907,thyroidectomy
22559,27162199,fnab
22560,27162199,immunohistochemistry
22561,27162199,neuroendocrine tumors
22562,27162199,thyroid paraganglioma
22565,27041628,fluorescence
22566,27041628,fluorescence-guided surgery
22567,27041628,indocyanine green
22568,27041628,near-infrared imaging
22569,27041628,parathyroid
22570,27041628,thyroidectomy
22572,28291538,anca anti-protéinase 3 (pr3-anca)
22573,28291538,anti-neutrophil cytoplasmic antibody (anca)
22574,28291538,anticorps anti-cytoplasme des neutrophiles (anca)
22575,28291538,propylthiouracil
22576,28291538,propylthiouracile
22577,28291538,proteinase3-anca (pr3-anca)
22578,28291538,pyoderma gangrenosum
22579,27520400,*c-reactive protein
22580,27520400,*resveratrol
22581,27520400,*resveratrol (pubchem cid: 445154)
22582,27520400,*type 2 diabetes mellitus
22583,27091372,laryngeal nerves
22584,27091372,prospective study
22585,27091372,recurrent laryngeal nerve
22586,27091372,recurrent laryngeal nerve injuries
22587,27091372,thyroidectomy
22590,28952196,c-cell
22591,28952196,ret mutation
22592,28952196,minute medullary thyroid carcinoma
22593,28952196,solid cell nests
22594,28025468,t1-weighted imaging
22595,28025468,fetus
22596,28025468,magnetic resonance imaging
22597,28025468,thyroid cois interest.
22598,27233786,diabetes mellitus
22599,27233786,hormone replacement therapy
22600,27233786,hypercalcemia
22601,27233786,hypertension
22602,27233786,osteoporosis
22603,29798949,carcinoma
22604,29798949,papillary
22605,29798949,thyroid cois
22606,28389458,drug interaction
22607,28389458,levothyroxine
22608,28389458,ritonavir
22610,28756810,high iodine
22611,28756810,iodine deficiency
22612,28756810,thyroglobulin
22613,28294052,cognition
22614,28294052,iodine deficiency
22615,28294052,iodine excess
22616,28294052,neurodevelopment
22617,28294052,pregnancy
22618,28294052,prophylaxis.
22620,29871097,"carcinoma, papillary"
22621,29871097,lymph node metastasis
22622,29871097,thyroid neoplasms cois relevant financial relationships with commercial interests to disclose.
22624,28717869,endoscopic thyroidectomy
22625,28717869,toetva
22626,28717869,thyroidectomy
22627,28717869,transoral
22628,28717869,transoral endoscopic thyroidectomy
22629,28717869,transoral neck surgery
22633,28688118,dicer1
22634,28688118,acute transient hepatitis
22635,28688118,monozygotic twins
22636,28688118,pleuropulmonary blastoma
22637,27105534,gene expression profile
22638,27105534,hypoxia
22639,27105534,microenvironment
22640,27105534,oncogenes
22641,27105534,thyroid cancer cois
22642,29079441,graves’ disease
22643,29079441,ompf porin
22644,29079441,serological cross-reactivity
22645,29079441,thyroid-stimulating hormone receptor
22646,29079441,yersinia pseudotuberculosis
22647,28196954,*metformin
22648,28196954,*thyroid cancer
22649,28196954,*thyroid disease
22650,28196954,*thyroid nodule
22651,28196954,*thyrotropin
22652,28188700,afirma
22653,28188700,fna
22654,28188700,cytology
22655,28188700,thyroid nodules
22657,28317625,*autoimmunity
22658,28317625,*hyperthyroidism
22659,28317625,*hypothyroidism
22660,28317625,*pulmonary hypertension
22661,28317625,*trab
22662,28229359,calcitonin
22663,28229359,pregnancy
22664,28229359,thyroid volume
22666,27461263,hyperthyroidism
22667,27461263,papillary thyroid cancer
22668,27461263,thyroid cancer
22669,27245300,*biokinetics
22670,27245300,*hyperthyroidism
22671,27245300,*internal dosimetry
22672,27245300,*radioiodine therapy
22673,27013327,ablation
22674,27013327,nodule
22675,27013327,radiofrequency
22676,27013327,thyroid
22677,26931517,patient safety
22678,26931517,resident involvement
22679,26931517,resident participation
22680,26931517,surgical education
22681,26931517,thyroid
22682,29102947,*cancer
22683,29102947,*cardiovascular disease
22684,29102947,*end-stage renal disease
22685,29102947,*hypothyroidism
22686,29102947,*thyroid abnormalities
22687,29102947,*thyroid nodules
22688,29102947,*waiting list for renal transplant
22689,28432675,mini-invasive thyroidectomy
22690,28432675,thyroid
22691,28432675,thyroidectomy
22692,28432675,transoral thyroidectomy
22695,28684081,adherence to diet
22696,28684081,attitude towards diet
22697,28684081,body mass index
22698,28684081,meal plan
22699,28684081,type 2 diabetes mellitus
22700,28034775,*intra-operative neuro-monitoring
22701,28034775,*re-operation
22702,28034775,*recurrent laryngeal nerve palsy
22703,28034775,*thyroid cancer
22704,28034775,*thyroidectomy
22705,28238190,*pentraxin 3
22706,28238190,*resveratrol
22707,28238190,*total antioxidant status
22708,28238190,*type 2 diabetes mellitus
22709,27071746,all-cause mortality
22710,27071746,cardiovascular mortality
22711,27071746,cardiovascular risk
22712,27071746,mediterranean diet
22713,28982849,*thyroid
22714,28982849,*immunohistochemistry
22715,28982849,*lymph node metastasis
22716,28982849,*papillary thyroid carcinoma
22717,28982849,*sphingosine kinase 1
22718,28791817,binder syndrome
22719,28791817,bone graft
22720,28791817,cartilage graft
22721,28791817,maxillary underdevelopment
22722,28791817,resorption
22723,26932954,*4d ct
22724,26932954,*parathyroid adenoma
22725,26932954,*parathyroid hyperplasia
22726,26932954,*sestamibi scintigraphy
22727,28626131,congenital hypothyroidism
22728,28626131,duoxa2
22729,28626131,genetics
22730,28626131,mutation
22731,28626131,newborn screening
22732,28387647,thyroid nodule
22733,28387647,frozen section fine-needle aspiration biopsy.
22734,28387647,papillary carcinoma
22735,28387647,thyroidectomy
22736,28250870,*congenital hypothyroidism
22737,28250870,*growth retardation
22738,28250870,*mental retardation cois
22739,27488391,breast and endometrial cancer
22740,27488391,cowden syndrome
22741,27488391,multiple meningiomas
22742,27488391,pten hamartoma
22743,27488391,radiology
22744,26786663,tc99m sestamibi scintigraphy
22745,26786663,primary hyperparathyroidism
22746,26786663,thyroid disorder
22747,26786663,thyroid pathology
22748,26786663,ultrasonography
22749,28703115,completion lymphadenectomy
22750,28703115,tall-cell variant
22751,28703115,thyroid carcinoma
22752,26780986,hypocalcemia
22753,26780986,hypoparathyroidism
22754,26780986,parathyroid hormone
22755,26780986,thyroidectomy
22756,26780986,vitamin d
22757,26711165,assays
22758,26711165,biomarker
22759,26711165,differentiated thyroid cancers
22760,26711165,thyroglobulin
22762,29022276,central hyperthyroidism
22763,29022276,hyperthyroidism
22764,29022276,pituitary tumors
22765,29022276,tsh-secreting pituitary adenoma
22766,29022276,thyrotropinoma
22769,29059259,*bone metabolism markers
22770,29059259,*hyperthyroidism
22771,29059259,*sclerostin
22773,28109483,global health
22774,28109483,haiti
22775,28109483,head and neck surgery
22776,28109483,otolaryngology
22777,27744598,99mtc-mibi
22778,27744598,autonomously functioning thyroid nodules
22779,27744598,parathyroid carcinoma
22780,27744598,parathyroid scintigraphy
22782,29164514,iodine
22783,29164514,microcarcinoma
22784,29164514,papillary thyroid cancer
22785,29164514,risk factors
22786,29164514,thyroid thyroglobulin antibody
22787,29164514,thyroid-stimulating hormone
22789,28604619,cancer
22790,28604619,flavonoid
22791,28604619,invasiveness
22792,28604619,iodide uptake
22793,28604619,phytochemical
22794,28604619,proliferation
22795,28604619,radioiodine therapy
22796,28604619,sodium iodide symporter (nis)
22797,28604619,thyroid cois
22798,26983701,dicer-1
22799,26983701,pleuropulmonary blastoma
22800,26983701,sertoli-leydig cell tumor
22801,26983701,thyroid carcinoma
22802,26983701,familial neoplasia
22804,28506409,bethesda classification
22805,28506409,guidelines
22806,28506409,lobectomy
22807,28506409,thyroid
22808,28506409,thyroid carcinoma
22809,28506409,thyroidectomy
22810,27639841,abtpo
22811,27639841,autoimmune thyroid diseases
22812,27639841,autoimmune thyroiditis
22813,27639841,hypothyroidism
22814,27639841,organ specific autoimmune diseases
22815,27639841,systemic rheumatological disorders
22816,29273943,children
22817,29273943,pten hamartoma tumor syndrome (phts)
22818,29273943,screening
22819,29273943,thyroid cancer
22820,29273943,thyroid disease
22822,28189449,hyperthyroidism
22823,28189449,lymphadenectomy
22824,28189449,pediatric thyroidectomy
22825,28189449,total thyroidectomy
22826,28189449,transient hypocalcemia
22827,27208531,computer-aided diagnosis
22828,27208531,medical imaging
22829,27208531,morphometry
22833,27809694,*us elastography
22834,27809694,*fibronectin-1
22835,27809694,*fibrosis
22836,27809694,*galectin-3
22837,27809694,*indeterminate cytology
22838,27809694,*thyroid nodules
22839,27833458,*epidemiology
22840,27833458,*monitoring
22841,27833458,*prevalence trend
22842,27833458,*thyroid disorders
22843,27288566,elderly
22844,27288566,harmonic
22845,27288566,ligasure
22846,27288566,thyroidectomy
22847,27288566,vessel sealing
22850,26838584,growth hormone deficiency
22851,26838584,hypothyroidism
22852,26838584,pituitary hyperplasia
22854,28025932,*global health
22855,28025932,*humanitarian
22856,28025932,*quality of life
22857,28025932,*resource limited
22858,28025932,*thyroid
22859,28025932,*thyroidectomy
22861,28039060,*calcium prophylaxis
22862,28039060,*hypocalcemia
22863,28039060,*oral calcium
22864,28039060,*parathyroid hormone
22865,28039060,*thyroidectomy
22869,29030129,acoustic analysis
22870,29030129,análise acústica
22871,29030129,disfonia
22872,29030129,dysphonia
22873,29030129,hoarseness
22874,29030129,laryngeal paralysis
22875,29030129,paralisia laríngea
22876,29030129,rouquidão
22877,29030129,thyroidectomy
22878,29030129,tireoidectomia
22880,28875268,hashimoto’s thyroiditis
22881,28875268,papillary thyroid carcinoma
22882,28875268,tsh
22883,28875268,thyroid cytology
22884,28875268,thyroid nodules
22885,28870235,barley young leaf
22886,28870235,chronic lymphocytic thyroiditis
22887,28870235,hypothyroidism
22888,28870235,isoflavones
22889,28870235,soybean
22890,28870235,thin-layer chromatography
22891,28870235,kale cois from the patient for publication of this case report and any accompanying images. a copy of the written consent is available for review by the editor-in-chief of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
22892,28222777,*dicer1 mutations
22893,28222777,*dicer1 syndrome
22894,29170092,*adaptive redox homeostasis
22895,29170092,*antioxidant defense
22896,29170092,*argpyrimidine-modified heat-shock proteins
22897,29170092,*ccm1/krit1
22898,29170092,*cerebral cavernous malformations
22899,29170092,*cerebrovascular disease
22900,29170092,*glyoxalase 1 (glo1)
22901,29170092,*heme oxygenase-1 (ho-1)
22902,29170092,*nuclear factor erythroid 2-related factor 2 (nrf2)
22903,29170092,*oxidative dna damage and apoptosis
22904,29170092,*oxidative stress
22905,29170092,*redox signaling
22906,29170092,*c-jun
22907,26970173,*27 kd heat-shock protein
22908,26970173,*antioxidants
22909,26970173,*oxidants
22910,26970173,*thyroid tumors
22911,29043574,autoimmunity
22912,29043574,ctla4
22913,29043574,immune checkpoint inhibitors
22914,29043574,melanoma
22915,29043574,pd1
22916,29043574,thyroid diseases
22918,26289771,dicer1
22919,26289771,mirna
22920,26289771,ovarian cancer
22921,26289771,sarcoma
22922,26289771,sertoli-leydig cell tumor cois interest to disclose.
22924,28964290,hearing loss
22925,28964290,slc26a4
22926,28964290,whole exome sequencing cois to report.
22930,26795600,cerebral cavernous malformation (ccm)
22931,26795600,cerebrovascular disease
22932,26795600,cytochrome p450 (cyp)
22933,26795600,disease severity
22934,26795600,familial cerebral cavernous malformation type 1
22935,26795600,free radicals
22936,26795600,genetic markers set association study
22937,26795600,inter-individual variability in disease susceptibility and outcome
22938,26795600,intracerebral hemorrhage
22939,26795600,krit1/ccm1
22940,26795600,matrix metalloproteinase (mmp)
22941,26795600,oxidative stress
22942,26795600,reactive oxygen species (ros)
22943,26795600,vascular brain lesions
22945,31427038,goitre multinodulaire
22946,31427038,hyperthyroïdie infra-clinique
22947,31427038,multinodular goiter
22948,31427038,subclinical hyperthyroidism
22949,31427038,tsh
22950,31427038,thyroid
22951,31427038,thyroïde
22952,31477522,*substernal goiter
22953,31477522,*thyroid
22954,31477522,*thyroidectomy cois disclose.
22955,29950539,american thyroid association (ata)
22956,29950539,european thyroid association (eta)
22957,29950539,grave's disease
22958,29950539,japan thyroid association/ japan endocrine society
22959,29950539,thyroid
22960,31129908,*art
22961,31129908,*history
22962,31129908,*thyroid swelling
22965,32233333,nodules
22966,32233333,thyroid
22967,30788771,art
22968,30788771,endemic goiter
22969,30788771,history
22970,30788771,thyroid swelling
22971,30105567,goiter
22972,30105567,iodine deficiency
22973,30105567,prevalence
22974,30105567,school children
22975,30105567,urinary iodine
22976,30224035,fetal ultrasound
22977,30224035,graves’ disease
22978,30224035,maladie de basedow
22979,30224035,multidisciplinarity
22980,30224035,multidisciplinarité
22981,30224035,neonatal monitoring
22982,30224035,surveillance néonatale
22983,30224035,trab
22984,30224035,teratogenicity
22985,30224035,tératogénicité
22986,30224035,échographie fœtale
22988,30193753,antithyroid drugs
22989,30193753,antithyroïdien
22990,30193753,chirurgie
22991,30193753,graves’ disease
22992,30193753,grossesse
22993,30193753,maladie de basedow
22994,30193753,myxœdeme prétibial
22995,30193753,orbitopathie
22996,30193753,orbitopathy
22997,30193753,pregnancy
22998,30193753,radioiode
22999,30193753,radioiodine
23000,30193753,surgery
23001,30193753,thyroid dermopathy
23004,32041923,graves’ ophthalmopathy
23005,32041923,diagnosis
23006,32041923,management
23007,30342794,epidemiology
23008,30342794,graves’ disease
23009,30342794,pathophysiology
23010,31464605,children
23011,31464605,ethiopia
23012,31464605,goiter
23013,31464605,meta-analysis cois
23016,31221571,*continuous neuromonitoring
23017,31221571,*intraoperative neuromonitoring
23018,31221571,*recurrent laryngeal nerve
23019,31221571,*staged thyroidectomy
23020,31221571,*thyroidectomy
23021,31221571,*vagus nerve stimulation
23023,30177259,chirurgie ophtalmologique
23024,30177259,corticotherapy
23025,30177259,corticothérapie
23026,30177259,eugogo
23027,30177259,graves’ orbitopathy
23028,30177259,immunosuppression treatment
23029,30177259,orbitopathie basedowienne
23030,30177259,smoking
23031,30177259,tabac
23032,30177259,traitement immunosuppresseur
23033,30880038,deep vein thrombosis
23034,30880038,goiter
23035,30880038,upper-extremity
23037,30180972,adolescent
23038,30180972,carbimazole
23039,30180972,child
23040,30180972,chirurgie
23041,30180972,enfant
23042,30180972,graves’ disease
23043,30180972,hyperthyroidism
23044,30180972,hyperthyroïdie
23045,30180972,iode radioactif
23046,30180972,long term
23047,30180972,long terme
23048,30180972,maladie de basedow
23049,30180972,prognosis
23050,30180972,pronostic
23051,30180972,radioactive iodine treatment
23052,30180972,surgery
23053,30180972,thiamazole
23054,30017236,computed tomography
23055,30017236,retrosternal goiter
23056,30017236,sternotomy
23057,30017236,thyroidectomy
23058,30778906,fine arts
23059,30778906,goiter
23060,30778906,history
23061,30778906,moretto da brescia
23062,30778906,renaissance
23064,31614658,goiter
23065,31614658,iodine deficiency
23066,31614658,iodine prophylaxis
23067,31614658,urinary iodine concentration cois
23069,30055961,neck approach
23070,30055961,sternotomy
23071,30055961,substernal goiter
23072,30055961,tertiary center
23073,30055961,thyroidectomy
23075,31552848,goiter
23076,31552848,iodine
23077,31552848,reproductive age
23078,31552848,salt iodine
23079,31552848,urinary iodine
23080,31552848,women cois
23083,30803411,*longterm
23084,30803411,*methimazole
23085,30803411,*radioiodine
23086,30803411,*toxic multinodular goiter
23087,31074402,cervico-mediastinal goiter
23088,31074402,sternotomy
23089,31074402,thyroidectomy
23090,31074402,thyroiditis cois
23091,30900322,microwave
23092,30900322,substernal goiter
23093,30900322,thermal ablation
23094,30900322,thyroid
23095,30900322,ultrasound
23096,30694184,*endocrine disruptor
23097,30694184,*goiter
23098,30694184,*groundwater
23099,30694184,*subclinical hypothyroidism
23101,31270773,*art
23102,31270773,*goiter
23103,31270773,*history of medicine
23104,31270773,*thyroid
23106,31668873,*adipocyte complement factors
23107,31668873,*adipokines
23108,31668873,*brown fat commitment
23109,31668873,*brown fat differentiation
23110,31668873,*extracellular matrix proteins
23111,31668873,*human batokines
23112,31668873,*human brown adipocytes
23113,31668873,*human brown fat
23114,31668873,*mitochondria
23115,31668873,*secretomics
23120,29897006,*copy-number variation
23121,29897006,*genome-wide linkage analysis
23122,29897006,*multinodular goiter
23123,29897006,*next-generation sequencing
23124,29315620,amyloid goiter
23125,29315620,subacute thyroiditis
23126,29315620,thyroid
23127,29315620,ultrasonography
23128,30146569,*fdg-pet
23129,30146569,*hashimoto's thyroiditis
23130,30146569,*malignant lymphoma cois
23132,30306416,advances
23133,30306416,decade
23134,30306416,thyroid cois
23139,30141079,artificial pneumothorax
23140,30141079,carina
23141,30141079,mediastinal goiter
23142,30141079,prone position
23143,30141079,two-lung ventilation
23145,29310524,*art
23146,29310524,*goiter
23147,29310524,*sculptures
23148,31030636,*french-canadian
23149,31030636,*airway compromise
23150,31030636,*congenital hypothyroidism
23151,31030636,*dyshormonogenesis
23152,31285663,*dicer1
23153,31285663,*sertoli–leydig
23154,31285663,*genetic mutation
23155,31285663,*microrna
23156,31285663,*multinodular goiter
23157,31285663,"*sex cord–stromal tumour cois policy on disclosing conflicts of interest, and we declare that we have none."
23158,29548512,developed world
23159,29548512,developing world
23160,29548512,iodine deficiency
23161,29548512,low-resource setting
23162,29548512,thyroid cancer
23163,29548512,thyroid disease
23164,29548512,thyroid surgery
23165,30989520,*thyroid nodule
23166,30989520,*benign adenoma
23167,30989520,*multinodular goiter
23168,30989520,*thyroid cancer
23169,30037617,goiter
23170,30037617,hypothyroidism
23171,30037617,iodine deficiency
23172,30037617,native americans
23173,30037617,paleopathology
23176,31740871,thyroid papillary cancer haemogram
23177,29406821,graves' disease
23178,29406821,traditional chinese medicine
23179,29406821,goiter dispersion formula
23180,29406821,hyperthyroidism
23181,29406821,neurologic manifestations
23183,30055100,children
23184,30055100,iodine supply
23185,30055100,thyroid diseases
23186,30055100,thyromegaly
23187,29452573,metformin
23188,29452573,diffuse/nodular goiter
23189,29452573,insulin resistance
23190,29452573,obesity
23191,29452573,thyroid
23192,30820869,acute external compression of the trachea
23193,30820869,basedow’s goiter
23194,30820869,death
23195,30820869,intra-thyroid hemorrhage
23197,30084100,*euthyroid nodular goiter
23198,30084100,*insulin resistance
23199,30084100,*pulse wave velocity
23200,30084100,*strain index
23204,30506185,intrathoracic goitres
23205,30506185,retrosternal goitres
23206,30506185,substernal goitres
23207,30506185,thyroidectomy
23212,30220410,diagnosis
23213,30220410,diagnostic
23214,30220410,graves’ disease
23215,30220410,hyperthyroidism
23216,30220410,hyperthyroïdie
23217,30220410,maladie de basedow
23218,30843179,graves’ disease
23219,30843179,n-glycosylation
23220,30843179,tshr
23221,30843179,sialylation
23222,30843179,thyroid
23224,29360235,*avoiding sternotomy
23225,29360235,*intracapsular thyroidectomy
23226,29360235,*microdebrider
23227,29360235,*retrosternal goiter
23228,29360235,*thyroidectomy
23230,29348117,*graves' disease
23231,29348117,*carbimazole
23232,29348117,*radioiodine
23233,29348117,*thyroid
23234,29348117,*thyrotoxicosis cois
23238,30583800,completion thyroidectomy
23239,30583800,complications
23240,30583800,hemithyroidectomy
23241,30583800,hormone replacement
23242,30583800,isthmolobectomie
23243,30583800,supplémentation hormonale
23244,30583800,thyroïdectomie totale
23245,30583800,total thyroidectomy
23246,30583800,totalisation
23250,31281088,*asymmetrical nodular goitre
23251,31281088,*benign thyroid disease
23252,31281088,*hemithyroidectomy
23253,31281088,*thyroid surgery
23255,30634005,fetal therapy
23256,30634005,fetal thyroid
23257,30634005,thyroid disorders
23258,30158361,bone mineral density
23259,30158361,multinodular goiter
23260,30158361,thyroxine
23264,30044192,goitre
23265,30044192,theodor kocher
23266,30044192,thyroidectomy
23272,30701789,graves’ disease
23273,30701789,hyperthyroidism
23274,30701789,thyroid
23275,30701789,thyrotoxicosis
23276,30701789,toxic multinodular goiter
23277,30417713,autoimmune thyroid disease
23278,30417713,graves’ disease
23279,30417713,hashitoxicosis
23280,30417713,fetal and neonatal hyperthyroidism
23281,30417713,methimazole treatment
23282,30417713,pediatric age
23283,30417713,radioiodine therapy
23284,30417713,thyroidectomy
23286,30456548,goiter
23287,30456548,graves’ disease
23288,30456548,iodine
23289,30456548,thyroid function tests
23290,30456548,thyroid gland
23291,31250924,*endocrinology
23292,31250924,*head and neck surgery
23293,31250924,*thyroid diseases
23294,31250924,*thyroid hormones
23299,31533103,acne
23300,31533103,minocycline
23301,31533103,tetracycline
23302,31533103,thyroiditis
23303,31235068,acfa
23304,31235068,atrial fibrillation
23305,31235068,complication
23306,31235068,complications
23307,31235068,heart failure
23308,31235068,hyperthyroidism
23309,31235068,hyperthyroïdie
23310,31235068,insuffisance cardiaque
23312,30637676,*goiter
23313,30637676,*hypothyroidism
23314,30637676,*iodine deficiency disorders
23318,30835061,euthyroid
23319,30835061,medical diagnosis
23320,30835061,portrait
23324,30196262,emergency medicine
23325,30196262,haematology (incl blood transfusion)
23326,30196262,radiology (diagnostics)
23327,30196262,thyroid disease cois
23328,30989613,endocrinology
23329,30989613,frederic bazille
23330,30989613,painting cois conflict of interest.
23336,31182347,hipocalcemia
23337,31182347,hipoparatiroidismo
23338,31182347,hormona paratiroidea
23339,31182347,hypocalcemia
23340,31182347,hypoparathyroidism
23341,31182347,parathyroid hormone
23342,31182347,thyroidectomy
23343,31182347,tiroidectomía
23344,29911397,hyperthyroidism
23345,29911397,thyroiditis
23346,29911397,thyrotoxicosis
23347,29911397,ultrasonography
23348,29911397,ultrasonography/adverse effects
23351,31007819,hyperthyroidism
23352,31007819,senegal
23353,31007819,jaundice cois
23355,29319139,99mtc-dtpa
23356,29319139,go
23357,29319139,hyperthyroidism
23358,31691668,balanced orbital decompression
23359,31691668,bony orbital decompression
23360,31691668,lateral orbital wall
23361,31691668,medial orbital wall
23362,31691668,optic neuropathy
23363,31691668,strabismus
23365,30918569,hyperthyroidism
23366,30918569,surgery
23367,30918569,thyroidectomy cois
23369,30333321,*endocrinology
23370,30333321,*genetics
23371,30333321,*molecular genetics
23372,30333321,*monogenic diseases
23373,30333321,*thyroid disease cois exists
23374,30375286,* gene
23375,30375286,*congenital hypothyroidism
23376,30375286,*oligogenic mutations cois
23377,29461666,*ligament of berry
23378,29461666,*laryngeal
23379,29461666,*nerve
23380,29461666,*recurrent
23381,29461666,*thyroidectomy
23383,29729448,graves' disease
23384,29729448,graves' orbitopathy
23385,29729448,neuropsychiatric disorders
23386,29729448,quality of life
23391,31400860,ambulatoire
23392,31400860,chirurgie
23393,31400860,facteurs de risque
23394,31400860,outpatient
23395,31400860,risk factors
23396,31400860,surgery
23397,31400860,thyroid
23398,31400860,thyroïde
23399,30843109,*children
23400,30843109,*graves’ disease
23401,30843109,*proteinuria
23402,30213303,epigenetics
23403,30213303,genetics
23404,30213303,graves’disease
23405,30213303,génétique
23406,30213303,maladie de basedow
23407,30213303,prediction score
23408,30213303,score de prédiction
23409,30213303,épigénétique
23412,31143336,graves´ disease
23413,31143336,onycholysis
23414,31143336,hyperthyroidism
23415,31143336,hypothyroidism
23416,31143336,plummer´s nails
23417,31143336,thyroid disease cois
23419,29452583,drugs
23420,29452583,eye lids
23421,29452583,inflammation
23422,29452583,orbit
23423,29452583,vision cois publication: not applicable. competing interests: the authors state that there is no competing interests regarding the publication of this paper. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
23424,29325833,antithyroid drugs
23425,29325833,encuesta
23426,29325833,enfermedad de graves
23427,29325833,fármaco antitiroideo
23428,29325833,graves’ disease
23429,29325833,hipertiroidismo
23430,29325833,hyperthyroidism
23431,29325833,pediatric
23432,29325833,pediátrico
23433,29325833,survey
23439,29353393,autoimmunity
23440,29353393,graves’ disease
23441,29353393,hyperthyroidism
23442,29353393,iodine induced
23443,29353393,trab
23444,29353393,toxic goitre
23446,29909393,general practice / family medicine
23447,29909393,hyperthyroidism
23448,29909393,liver disease
23449,29909393,thyroid disease
23450,29909393,thyroiditis cois
23451,29525760,malignant and benign haematology
23452,29525760,thyroid disease cois
23453,29721730,goitre
23454,29721730,medical diagnosis
23455,29721730,painting
23456,29721730,raphael
23458,30949910,*biomarker
23459,30949910,*graves’ disease
23460,30949910,*microrna
23461,30949910,*plasma
23463,31268129,*goiter
23464,31268129,*iodine deficiency
23465,31268129,*iodine status
23466,31268129,*thyroid-stimulating hormone concentration
23467,31268129,*urinary iodine concentration
23468,30996065,respiratory medicine
23469,30996065,thyroid disease cois
23472,31292360,graves disease
23473,31292360,marine-lenhart syndrome
23474,31292360,plummer disease
23475,30504400,graves' disease
23476,30504400,ki-67
23477,30504400,metallothionein
23478,30504400,nodular goiter
23479,30504400,thyroid
23483,32180887,anicteric cholestasis
23484,32180887,graves’ disease
23485,32180887,hyperthyroidism cois
23486,29728450,pre-tibial myxoedema
23487,29728450,thyroid acropachy
23488,29728450,thyroid associated ophthalmopathy
23489,29728450,vitiligo cois
23490,29962351,graves` associated ophthalmopathy
23491,29962351,il-6
23492,29962351,thyroid-associated ophthalmopathy
23493,29962351,extrathyroidal manifestation
23494,29962351,infiltrating cytokines
23495,29962351,tocilizumab.
23496,30935806,internal carotid artery thrombosis
23497,30935806,thromboembolic stroke
23498,30935806,thyroid goitre
23499,30257972,anaesthesia
23500,30257972,cardiovascular medicine
23501,30257972,"ear, nose and throat/otolaryngology"
23502,30257972,resuscitation
23503,30257972,thyroid disease cois
23504,32476968,graves’ disease
23505,32476968,eosinophil
23506,32476968,sarcoidosis
23507,30307028,graves’ disease
23508,30307028,depressive symptoms
23509,30307028,hyperthyroidism
23510,30307028,sexual functioning
23511,30307028,thyroid nodules
23512,29574428,emergency medicine
23513,29574428,endocrinology
23514,29574428,paediatrics
23515,29574428,thyroid disease cois
23516,29791909,fetal goiter
23517,29791909,fetal hypothyroidism
23518,29791909,intra-amniotic treatment
23519,29791909,iodine
23520,29791909,wolff-chaikoff effect
23522,30351170,fam167a-blk
23523,30351170,graves' disease (gd)
23524,30351170,hashimoto's thyroiditis (ht)
23525,30351170,autoimmune thyroid disease (aitd)
23526,30351170,polymorphism
23528,30311856,*pakistan
23529,30311856,*goiter prevalence
23530,30311856,*iodine deficiency disorder
23531,30311856,*iodized salt
23532,30311856,*pregnancy
23533,31383679,asthma
23534,31383679,"ear, nose and throat"
23535,31383679,pregnancy
23536,31383679,thyroid disease cois
23537,30509783,anestesia general
23538,30509783,general anaesthesia
23539,30509783,glucogenosis
23540,30509783,glycogenosis
23541,30509783,hipertermia maligna
23542,30509783,hipoglucemia
23543,30509783,hypoglycaemia
23544,30509783,malignant hyperthermia
23545,30509783,mcardle's syndrome
23546,30509783,mioglobinuria
23547,30509783,miopatía
23548,30509783,myoglobinuria
23549,30509783,myopathy
23550,30509783,síndrome de mcardle
23551,30455812,graves
23552,30455812,child
23553,30455812,treatment
23554,30541519,graves’ disease
23555,30541519,graves’ disease treatment.
23556,30541519,i131.
23557,30541519,radioiodine. cois metro south human research ethics committee (reference number: lnr/qms/43580). all necessary permissions to access medical records from the princess alexandra hospital were obtained. consent to participate was not a requirement. competing interests: the authors declare they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
23558,30626069,*graves’ orbitopathy
23559,30626069,*corticosteroids
23560,30626069,*hyperthyroidism
23561,30626069,*ophthalmopathy
23562,30626069,*prednisone cois
23565,31408196,*dicer1 syndrome
23566,31408196,*childhood
23567,31408196,*genetic counselling
23568,31408196,*multinodular goitre
23569,31408196,*thyroid pathologies
23573,31155292,*crispr/cas9
23574,31155292,*hearing loss
23575,31155292,*mouse model
23576,31155292,*pendred syndrome
23577,31155292,*slc26a4
23578,31155292,*vestibular dysfunction
23579,30537006,*graves' disease
23580,30537006,*rln injury
23581,30537006,*complications
23582,30537006,*hypoparathyroidism
23583,30537006,*thyroidectomy
23586,31377715,"ear, nose and throat/otolaryngology"
23587,31377715,hyperthyroidism
23588,31377715,otolaryngology/ent
23589,31377715,thyroid disease
23590,31377715,thyrotoxicosis cois
23593,31252621,ebv
23594,31252621,graves’ disease
23595,31252621,autoimmune thyroid disease
23596,31252621,hyperthyroidism
23597,31252621,viruses cois as prejudicing the impartiality of the research.
23599,30654201,depression
23600,30654201,hyperthyroidism
23601,30654201,thyroid disease
23602,30654201,women’s health
23603,31633822,*dfnb4
23604,31633822,*eva
23605,31633822,*pendred syndrome
23606,31633822,*slc26a4
23607,31633822,*genotype vs. phenotype
23608,31633822,*inner ear morphology
23609,31633822,*nonsyndromic enlarged vestibular aqueduct
23614,30955175,*fine-needle aspiration
23615,30955175,*goiter
23616,30955175,*hyperthyroidism
23617,30955175,*hypothyroidism
23618,30955175,*thyroid cancer
23619,30955175,*thyroid nodule
23620,30955175,*thyroid ultrasound
23621,31290382,fluorescence microscopy
23622,31290382,thyroid nodule
23623,31372509,*cell biology
23624,31372509,*endocrinology
23625,31372509,*genetics
23626,31372509,*pathogenesis cois
23629,31187663,*hearing loss
23630,31187663,*iran
23631,31187663,*missense variant
23632,31187663,*next-generation sequencing
23635,30862149,*graves’ disease
23636,30862149,*hyperthyroidism
23637,30862149,*antithyroid drugs cois
23638,31222404,corvis st
23639,31222404,goldmann applanation tonometry
23640,31222404,intraocular pressure
23641,31222404,ora
23642,31222404,thyroid-associated orbitopathy
23643,31222404,icare
23644,31217394,adenovirus
23645,31217394,graves disease
23646,31217394,model
23648,30173328,*cognitive function
23649,30173328,*graves’ disease
23650,30173328,*graves’ ophthalmopathy
23651,30173328,*hyperthyroidism
23652,30173328,*quality of life
23653,30688164,*graves' disease
23654,30688164,*graves' ophthalmopathy
23655,30688164,*graves' orbitopathy
23656,30688164,*patient knowledge
23657,30688164,*thyroid eye disease
23658,30924917,*cancer
23659,30924917,*inflammation
23660,30924917,*neutrophil to lymphocyte ratio
23661,30924917,*thyroid nodule
23662,30263008,*dgge
23663,30263008,*gd
23664,30263008,*gut microbiota
23665,30263008,*high-throughput sequencing
23666,30263008,*hyperthyroidism
23667,30263008,*ophthalmopathy cois
23668,29281760,*complications
23669,29281760,*epidemiology biochemistry
23670,29281760,*hypoparathyroidism
23671,29281760,*mortality
23672,29923059,cholesterol
23673,29923059,graves
23674,29923059,ophthalmopathy
23675,29923059,orbitopathy
23676,29923059,statins
23678,30057393,graves orbitopathy
23679,30057393,deppression
23680,30057393,quality of life
23681,31184263,*external branch of the superior laryngeal nerve
23682,31184263,*goiter
23683,31184263,*quality of life
23684,31184263,*recurrent laryngeal nerve
23685,31184263,*thyroidectomy
23686,31184263,*voice
23687,30390961,benign/goiter
23688,30390961,preoperative workup
23689,30390961,thyroid
23690,30390961,thyroid surgery
23691,30390961,ultrasound/imaging
23692,30409157,gitelman syndrome
23693,30409157,graves’ disease
23694,30409157,"hypokalemia cois ethics approval and consent to participate: this study was performed according to the helsinki declaration. written informed consent to participate in the study was obtained from the patient and his mother. the patient’s son was 17 years old, and written informed consent was obtained from him and his parents as legal guardians. consent for publication: written informed consent was obtained from the patient and his mother for publication of the details of the case report. the patient’s son was 17 years old, and written informed consent was obtained from him and his parents as legal guardians. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
23695,31758881,*hashimoto’s thyroiditis
23696,31758881,*hypothyroidism
23697,31758881,*precocious puberty
23698,31758881,*stature cois
23699,30339291,*cornea
23700,30339291,*dysthyroid optic neuropathy
23701,30339291,*orbital decompression
23702,30339291,*sight-threatening graves’ orbitopathy
23704,31655515,*lymphocyte
23705,31655515,*monocyte
23706,31655515,*neutrophil
23707,31655515,*platelet
23708,31655515,*ratio
23709,31655515,*thyrotoxicosis cois
23710,30760283,*myotonic dystrophy
23711,30760283,*papillary thyroid carcinoma
23712,30760283,*thyroid goiter
23713,30760283,*thyroid nodule
23714,30760283,"*ultrasound scan cois person (cpp), iorg 0009553 – institutional review board for the university hospital of lille. ethical committee under number: hp 1821 (benhamou_ethics_ojrd.pdf). consent for publication: na competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
23715,31323889,goiter
23716,31323889,hypothyroidism
23717,31323889,iodine deficiency
23718,31323889,iodine deficiency disorders
23719,31323889,iodine prophylaxis
23720,31323889,pregnancy
23721,31323889,schoolchildren cois as prejudicing the impartiality of the research reported.
23723,30880636,*graves' disease
23724,30880636,*autoimmune disease
23725,30880636,*balance
23726,30880636,*muscle strength
23727,30880636,*thyroid
23728,31715677,clinical protocols
23729,31715677,glaucoma
23730,31715677,graves ophthalmopathy
23731,31715677,ocular hypertension
23732,29306930,adolescents
23733,29306930,antithyroid drugs
23734,29306930,children
23735,29306930,hyperthyroidism
23736,29306930,management
23737,29306930,radioiodine
23738,29306930,thyrotoxicosis
23741,30302663,nodular recurrence
23742,30302663,thyroid lobectomy
23743,30302663,thyroid nodules
23744,32397019,disease attribute
23745,32397019,"lymphoma, non-hodgkin"
23746,32397019,prognosis
23747,32397019,thyroid neoplasms
23748,29595868,*goitre
23749,29595868,*hypocalcaemia
23750,29595868,*hypoparathyroidism
23751,29595868,*retrosternal goitre
23752,29595868,*thyroid gland
23753,29595868,*thyroidectomy
23754,29450866,diplopia
23755,29450866,graves’ orbitopathy
23756,29450866,orbital decompression
23757,29450866,proptosis
23758,29450866,quality of life
23759,29771881,endocrine ophthalmopathy
23760,29771881,multidimensional linear regression modeling
23761,29771881,prognostication
23762,29771881,risk factors
23763,29771881,toxic diffuse goiter
23765,30485487,*graves’ disease treatment
23766,30485487,*thyrotrophin receptor antibodies
23769,30540214,pulsed ivmp
23770,30540214,active ted
23771,30540214,efficacy and safety
23772,30540214,medical management
23773,30540214,steroid sparing agents
23776,30334140,*+49a/g polymorphism of the ctla4 gene
23777,30334140,*graves’ hyperthyroidism
23778,30334140,*graves’ orbitopathy
23779,30334140,*methimazole
23780,30334140,*predictors of remission
23781,31849350,cervical oesophageal perforation
23782,31849350,oesophageal injury
23783,31849350,oesophagogastroscopy
23784,31849350,oesophagus dilation
23785,31849350,thyroidectomy
23790,30369298,*ecological momentary assessments
23791,30369298,*patient-reported outcomes
23792,30369298,*thyroid diseases
23793,30369298,*thyroid-related quality of life
23795,30194634,graves’ ophthalmopathy
23796,30194634,tbii
23797,30194634,trab
23798,30194634,tsab
23799,31536167,afirma
23800,31536167,cytology
23801,31536167,fine-needle aspiration (fna)
23802,31536167,gene expression classifier (gec)
23803,31536167,genomic sequencing classifier (gsc)
23804,31536167,molecular
23805,31536167,thyroid
23809,29759035,*nis
23810,29759035,*slc5a5
23811,29759035,*congenital hypothyroidism
23812,29759035,*goiter
23813,29759035,*novel mutation
23814,29759035,*sodium–iodide symporter cois
23815,29332250,dysfunctional tear syndrome
23816,29332250,hyperthyroidism
23817,29332250,ocular surface inflammation
23818,29332250,tear cytokines
23819,29332250,thyroid-associated orbitopathy
23820,30135996,graves’ disease
23821,30135996,lipidomic analysis
23822,30135996,ophthalmopathy
23823,30135996,plasma
23824,30135996,urine
23825,30135996,nuplc-esi-ms/ms
23829,30696398,*acute airway obstruction
23830,30696398,*goitre
23831,30696398,*pregnancy
23832,30696398,*respiratory arrest cois publication: written informed consent for publication of the clinical details and clinical images was obtained from the patient. written informed consent for publication of the clinical details and clinical images was obtained from patient. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
23835,30387079,benign thyroid disease
23836,30387079,meta-analysis
23837,30387079,prospective study
23838,30387079,thyroid cancer
23840,31201593,extraocular muscle
23841,31201593,graves’ ophthalmopathy
23842,31201593,magnetic resonance imaging
23843,31201593,radiation therapy
23844,31201593,steroids
23845,31237847,intraocular pressure
23846,31237847,thyroid-associated orbitopathy
23848,30217613,basedow
23849,30217613,graves
23850,30217613,quality of life
23851,30217613,qualité de vie
23852,30217613,questionnaire
23853,30217613,strabisme
23854,30217613,strabismus
23855,30217613,thyroid
23856,30217613,thyroïde
23857,30217607,chirurgie de strabisme
23858,30217607,diplopia
23859,30217607,diplopie
23860,30217607,dysthyroid orbitopathy
23861,30217607,graves’ disease
23862,30217607,maladie de basedow
23863,30217607,orbitopathie dysthyroïdienne
23864,30217607,strabismus surgery
23868,31023276,bioassay
23869,31023276,graves’ disease
23870,31023276,trab
23871,31023276,"thyroid cois involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. the study protocol was approved by the local ethics committee (ethikkommission nordwest und zentralschweiz (eknz) project no. 2015/227). need for informed consent was waived by the local ethics committee due retrospective nature of analysis with no impact on health outcome. consent for publication: not applicable. competing interests: bm and ps received research support by thermo fisher scientific, roche diagnostics, abbott and siemens unrelated to this study. all authors confirm that they do not have a conflict of interest associated with this manuscript. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
23872,30132285,autoimmune thyroiditis
23873,30132285,graves’ disease
23874,30132285,graves’ ophthalmopathy
23875,30132285,graves’ orbitopathy
23876,30132285,insulin-like growth factor-1 receptor
23877,30132285,thyroid
23878,30132285,thyroid autoimmunity
23879,30132285,thyroid eye disease
23880,31641884,computed tomography
23881,31641884,deep lateral orbital wall decompression
23882,31641884,fat removal
23883,31641884,graves’ orbitopathy
23884,31641884,prediction
23885,31641884,the greater wing of the sphenoid
23886,30862763,graves’ disease
23887,30862763,children
23888,30862763,long-term outcome
23889,30862763,methimazole treatment
23890,30862763,remission
23891,31340806,bleeding
23892,31340806,hematoma
23893,31340806,risk factor
23894,31340806,thyroid surgery
23895,31340806,thyroidectomy cois
23896,30049435,*graves' disease
23897,30049435,*thyroid cancer
23898,30049435,*thyroid nodules
23899,30696370,*children
23900,30696370,*goiter
23901,30696370,*sufficient iodine intake
23902,30696370,*thyroid volume
23903,31622299,"thyroidectomy, complications, hypocalcaemia, recurrent laryngeal nerve injury,  haemorrhage. (jpma 69: 1470; 2019).doi:10.5455/jpma.301233"
23906,30767621,*graves' disease
23907,30767621,*ciliogenesis
23908,30767621,*nodular hyperplasia
23909,30767621,*primary cilia
23910,30767621,*thyrocytes
23911,29649988,lipid layer thickness
23912,29649988,meibomian gland dysfunction
23913,29649988,"thyroid eye diseases cois (irb)/ethics committee approval was obtained from the committee of medical ethics and human experiments of chang gung memorial hospital (cgmh), taiwan. informed consent was obtained from each subject in the cgmh. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
23916,31309667,fukushima
23917,31309667,japanese black
23918,31309667,cattle
23919,31309667,goiter
23920,31309667,thyroid gland
23923,31094460,hormones
23924,31094460,immunological
23925,31094460,liquidators of the chernobyl accident
23926,31094460,non-hospital pneumonia
23927,30197184,*autoimmune disease
23928,30197184,*celiac disease
23929,30197184,*graves’ disease
23930,30197184,*myotonic dystrophy type 2
23931,29183262,*sds
23932,29183262,*globus symptoms
23933,29183262,*quality of life
23934,29183262,*thyroid surgery
23935,30719623,cyclosporine
23936,30719623,graves’ orbitopathy
23937,30719623,intravenous glucocorticoids
23938,30719623,methotrexate
23939,30737677,*hashimoto’s thyroiditis
23940,30737677,*iodothyronine deiodinase
23941,30737677,*thyroid gland
23942,30737677,*thyroid hormone metabolism
23943,31170960,destructive thyrotoxicosis
23944,31170960,diagnostic meta-analysis
23945,31170960,differential diagnosis
23946,31170960,graves’ disease
23947,31170960,peak systolic velocity of superior thyroid artery
23948,31170960,thyrotoxicosis cois
23949,31933295,focus harmonic scalpel
23950,31933295,hypocalcaemia
23951,31933295,hypoparathyroidism
23952,31933295,thyroidectomy
23953,31514388,diagnosis
23954,31514388,exosomes
23955,31514388,goiter
23956,31514388,heat shock proteins (hsp)
23957,31514388,molecular chaperones
23958,31514388,papillary carcinoma
23959,31514388,thyroid gland cois
23960,30110704,congenital hypothyroidism
23961,30110704,duoxa2
23962,30110704,fetal goiter
23963,30110704,mutation
23964,30110704,polyhydramnios
23965,29354016,*computed tomography
23966,29354016,*euthyroidism
23967,29354016,*graves' disease
23968,29354016,*methimazole
23969,29354016,*single-photon emission computed tomography
23970,29943563,graves disease
23971,29943563,hepatitis a virus
23972,29943563,triggering factor
23975,30092670,*go-qol
23976,30092670,*graves’ ophthalmopathy (go)
23977,30092670,*thyroid eye disease (ted)
23978,30092670,*adults
23979,30092670,*psychometrics
23980,30092670,*reliability
23981,30092670,*validity
23982,30783963,*diabetes
23983,30783963,*graves’ disease
23984,30783963,*islet autoantibodies
23985,30783963,*thyroid autoantibodies cois ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. informed consent: informed consent was obtained from all individual participants included in the study.
23986,30690623,*endemic
23987,30690623,*goitre
23988,30690623,*iodine
23989,30690623,*urinary iodine excretion
23991,31411490,arhi
23992,31411490,fine-needle aspiration cytology
23993,31411490,imprinted gene
23994,31411490,thyroid nodule cois
23995,31028051,"ear, nose and throat"
23996,31028051,respiratory system
23997,31028051,venous thromboembolism cois
23999,30621642,hashimoto’s thyroiditis
24000,30621642,magnetic resonance
24001,30621642,ophthalmopathy
24002,30621642,"orbitopathy cois accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. this is a case report, retrospectively describing the course of the diagnostics and therapy, thus does not require the local bioethical committee approval. consent for publication: written informed consent was obtained from the patient for the publication of this report and any accompanying images. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
24003,31347001,euthyroid
24004,31347001,in vitro fertilization
24005,31347001,intra-cytoplasmic sperm injection
24006,31347001,pregnancy outcomes
24008,31696306,*epoprostenol
24009,31696306,*hyperthyroidism
24010,31696306,*prostanoids
24011,31696306,*pulmonary hypertension
24012,31696306,*selexipag
24014,30369343,*pps method
24015,30369343,*thyroid volume
24016,30369343,*urinary iodine concentration
24017,30710486,goiter
24018,30710486,iodine deficiency disorders
24019,30710486,urinary iodine
24020,30710486,urinary thiocyanate
24024,30431723,graves’ disease
24025,30431723,graves’ ophthalmopathy
24026,30431723,optic nerve diseases
24027,30431723,optic nerve injuries
24028,30431723,"ultrasonography, doppler, color"
24029,31420436,materno-fetal medicine
24030,31420436,pregnancy
24031,31420436,thyroid disease cois
24032,30515705,bihar
24033,30515705,intelligence quotient (iq)
24034,30515705,iodized salt consumption
24035,30515705,total goitre rate
24037,30484383,*cochlear implantation
24038,30484383,*enlarged endolymphatic sacs
24039,30484383,*enlarged vestibular aqueduct
24040,30484383,*pendred syndrome
24041,30484383,*slc26a4
24042,30484383,*temporal bone
24044,31565879,*autoantibodies
24045,31565879,*graves disease
24046,31565879,*recurrence
24047,31565879,*thyroid peroxidase antibody cois
24049,30667296,*graves' disease
24050,30667296,*qol
24051,30667296,*sf-36
24052,30667296,*thypro
24053,30667296,*long-term
24054,30667296,*radioiodine
24055,30392997,hipocalcemia
24056,30392997,hipoparatiroidismo
24057,30392997,hypocalcemia
24058,30392997,hypoparathyroidism
24059,30392997,parathormone
24060,30392997,paratohormona
24061,30392997,thyroidectomy
24062,30392997,tiroidectomía
24064,31677639,*goiter
24065,31677639,*salt iodine concentration
24066,31677639,*shanghai
24067,31677639,*thyroid volume
24068,31677639,*urinary iodine concentration cois
24069,31860407,*graves'
24070,31860407,"*disease, graves'"
24071,31860407,"*orbitopathy, radioiodine, glucocorticoids, tsh receptor antibodies"
24072,30814438,graves’ disease
24073,30814438,hashimoto’s thyroiditis
24074,30814438,interleukin-17
24075,30814438,interleukin-1β
24076,30814438,interleukin-23
24079,30890403,fna
24080,30890403,ptc
24081,30890403,mir-137
24082,30890403,mir-181b
24083,30890403,mir-214
24084,30890403,mir-222
24087,31691654,mechanical high-speed bone removal
24088,31691654,orbital bone decompression
24089,31691654,osteodestruction
24090,31691654,scanning electron microscopy
24091,31691654,thyroid eye disease
24092,31691654,ultrasonic bone removal
24093,30593716,blinking
24094,30593716,dry eye
24095,30593716,meibomian gland dysfunction
24096,30593716,thyroid eye disease
24097,30577987,thyroid surgery
24098,30577987,transcutaneous laryngeal ultrasound
24099,30577987,vocal cord mobility
24102,30701793,graves’ disease
24103,30701793,endocrine ophthalmopathy
24104,30701793,polymorphic genetic markers
24105,29446011,iodine
24106,29446011,iodine deficiency
24107,29446011,iodized salt
24108,29446011,iran
24109,29446011,uic cois ethical approval: the local ethics committee approved the study protocol. informed consent: informed consent was obtained from all individual participants included in the study.
24112,29946800,antithyroid drugs
24113,29946800,goiter
24114,29946800,graves’ disease
24115,29946800,graves’ orbitopathy
24116,29946800,hyperthyroidism
24117,29946800,predictive models
24118,29946800,recurrence
24119,29946800,tsh-receptor antibody
24120,31841476,accident at chnpp
24121,31841476,breast cancer
24122,31841476,functional parameters
24123,31841476,malignant tumors
24124,31841476,mammary gland
24125,31841476,structural parameters
24126,31841476,thyroid gland
24127,29937466,dysthyroid eye disease
24128,29937466,glucocortoid-resistant
24129,29937466,graves’ orbitopathy
24130,29937466,rituximab
24131,29940879,goiter
24132,29940879,iodine deficiency
24133,29940879,iodized salt
24134,29940879,pregnant women
24135,29940879,urinary iodine cois the institutional review board of hawassa university (irb 065-06). the local authorities were informed about the study objectives. after the study purpose was explained to the pregnant women informed written consent was obtained. confidentiality of the data obtained from participants was strictly secured and maintained. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
24136,29334119,elastography
24137,29334119,nodular goitre
24138,29334119,thyroid
24139,29334119,thyroid imaging reporting and data system
24140,29334119,ultrasound
24142,31660895,hmga2
24143,31660895,thyroid carcinoma
24144,31660895,microrna
24145,31660895,molecular markers
24146,31660895,preoperative diagnosis cois
24147,31810448,goitre
24148,31810448,iodine
24149,31810448,thyroid
24150,31810448,uic
24151,31810448,wic
24152,31810448,water cois
24153,29556769,ablation techniques
24154,29556769,high-intensity focused ultrasound ablation
24155,29556769,interventional ultrasonography
24156,29556769,nodular goitre
24157,29556769,ultrasound imaging
24159,30219088,antithyroid drugs
24160,30219088,cascore
24161,30219088,graves’ disease
24162,30219088,graves’ ophthalmopathy
24163,30219088,hyperthyroidism
24164,30219088,muscle index
24165,30219088,nospecs
24166,30219088,superonasal index
24167,30219088,"thyroidectomy cois medical university vienna gave a positive vote on the protocol and consent to participate. (protocol record 1839/2015). the trial was registered at the european clinical trials database (eudra-ct: 2015–003515-38). consent for publication: in consenting to participate in the clinical trial, all patients also consent to publication, as is stated in their consent form. competing interests: the author(s) declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
24169,31171533,acute renal failure
24170,31171533,liver disease
24171,31171533,thyroid disease cois
24172,31312298,graves´ disease
24173,31312298,hashimoto´s thyroiditis
24174,31312298,south africa
24175,31312298,autoimmune thyroid disease
24176,31312298,hyperthyroidism
24177,31312298,hypothyroidism cois
24178,30885146,cyclin d1
24179,30885146,cytology
24180,30885146,diagnosis
24181,30885146,ngs
24182,30885146,"thyroid nodule cois the patients, and the ethical committee of the national cancer center hospital, tokyo, japan, approved the procedures (approval #2010–077). the informed consent will be written or verbal from participants. the research poses no more than minimal risk to patients and includes appropriate safeguards to protect the patients’ rights, safety and privacy. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
24183,29983514,goitre
24184,29983514,difficult intubation
24185,29983514,modified intubation difficulty score
24186,29983514,predictive factors
24187,29983514,thyroidectomy
24188,30572375,cohort study
24189,30572375,school-aged children
24190,30572375,thyroid
24191,30572375,volume
24192,29764405,excessive iodine intake
24193,29764405,goitre
24194,29764405,iodine deficiency
24195,29764405,pregnant women
24196,29764405,"thyroid volume cois approved by the committee on human research, publications and ethics, knust, school of medical sciences and komfo anokye teaching hospital. the ethical approval reference number is chrpe/rc/058/16. permission to undertake the study at the hospitals was also sought from the hospital management. written informed consent was obtained from all participants recruited into the study. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
24197,29319381,dwi
24198,29319381,grave’s orbitopathy
24199,29319381,mri
24200,29319381,head and neck
24201,29319381,orbit
24202,29319381,thyroid eye disease
24203,29787340,cd8+ t cells
24204,29787340,cd8+ t-regulatory cells
24205,29787340,graves’ ophthalmopathy
24206,29787340,thyroid autoimmunity
24211,29708883,graves’ disease
24212,29708883,allogenic hematopoietic stem cell transplantation
24213,29708883,hyperthyroidism; severe aplastic anemia
24215,30458118,*rthβ
24216,30458118,*thrb gene
24217,30458118,*novel mutation
24219,30224619,graves’ disease
24220,30224619,glucose intolerance
24221,30224619,glycosuria
24222,30224619,hyperthyroidism
24223,30224619,urine glucose screening program
24224,29409479,dysthyroid optic neuropathy
24225,29409479,orbital radiotherapy
24226,29409479,three-wall decompression
24227,29409479,thyroid eye disease cois this case report was approved by the ethics committee of shanghai ninth people’s hospital (no. [2016]-29). the report was in compliance with the tenets of the declaration of helsinki for clinical research. consent for publication: written informed consent was obtained from the patient for publication of this case report and any accompanying images. a copy of the consent is available for review by the editor of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
24228,29307098,hybrid procedure
24229,29307098,lung tumor
24230,29307098,mediastinal tumor
24231,29307098,robotic surgery
24232,29307098,single incision
24233,29307098,thyroid tumor
24235,29786585,pesticides
24236,29786585,morbidity
24237,29786585,thyroid gland
24238,29786585,application rate
24242,30413358,(99m)tc-pertechnetate uptake
24243,30413358,calculated-dose
24244,30413358,captación de (99m)tc-pertecnetato
24245,30413358,clinical outcomes
24246,30413358,cálculo de dosis
24247,30413358,enfermedad de graves
24248,30413358,graves’ disease
24249,30413358,radioiodine
24250,30413358,resultados clínicos
24251,30413358,yodo radiactivo
24252,31670633,postoperativehypocalcemia
24253,31670633,recurrentlaryngealnervepalsy
24254,31670633,totalthyroidectomy
24255,31670633,tubercleofzuckekandl
24259,30610492,antithyroid antibodies
24260,30610492,antithyroid drugs
24261,30610492,graves’ disease
24262,30610492,hyperthyroidism
24263,30610492,type 2 deiodinase
24264,30426886,*graves' disease
24265,30426886,*tsh receptor antibody
24266,30426886,*incidence
24267,30426886,*neonatal hyperthyroidism
24268,30426886,*radioiodine therapy
24269,29633307,*graves’ disease
24270,29633307,*thypro
24271,29633307,*thyrotoxicosis
24272,29633307,*treatment choice
24273,29633307,*treatment satisfaction
24274,31369161,*grave's
24275,31369161,*cancer
24276,31369161,*nodules
24277,31369161,*thyroid
24278,31124148,*immunology
24279,31124148,*immunosuppression
24280,31124148,*thyroid diseases
24281,31124148,*vasculitis
24282,30658624,99mtc-dtpa
24283,30658624,graves’ orbitopathy
24284,30658624,mri
24285,30658624,"spect/ct cois involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964. helsinki declaration and its later amendments or comparable ethical standards. the study was approved by the bioethical commission of medical university of bialystok, poland. all participants provided written informed consent to participate. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
24286,30628510,clinical activity score
24287,30628510,color doppler imaging
24288,30628510,thyroid eye disease
24289,30616573,*diagnosis
24290,30616573,*graves’ disease
24291,30616573,*hashimoto’s thyroiditis
24292,30616573,*model
24293,29959506,computed tomography
24294,29959506,eyelid retraction
24295,29959506,graves’ orbitopathy
24296,29959506,inferior rectus muscle
24297,29959506,levator palpebrae superioris muscle
24298,29959506,margin reflex distance
24299,29959506,superior rectus muscle
24303,29469200,*dicer1
24304,29469200,*cryptic exon
24305,29469200,*deep intronic mutation
24306,29469200,*lung cyst
24307,29469200,*multinodular goiter
24308,29469200,*ovarian sertoli-leydig cell tumor
24309,30761931,graves’ disease
24310,30761931,movement disorders
24311,30761931,autoimmune
24312,30761931,chorea
24313,30761931,hyperthyroidism
24314,30761931,myoclonus
24315,30761931,tremor
24316,30721670,*bone morphogenic protein 4
24317,30721670,*orbit
24318,30721670,*pathology
24319,30721670,*site-specific adipogenesis
24324,29521049,graves’ disease
24325,29521049,matrix metalloproteinases
24326,29521049,orbithopathy
24327,29521049,tissue inhibitors of metalloproteinases
24328,30918165,antithyroid drug
24329,30918165,graves’ disease
24330,30918165,hyperthyroidism
24331,30918165,tsh receptor antibody
24332,30918165,thyroid
24334,30151919,*3d
24335,30151919,*thyroid-associated orbitopathy
24336,30151919,*eye-tracking
24337,30151919,*facial deformity
24338,30151919,*scanpath
24339,29739340,*brazil
24340,29739340,*hereditary deafness
24341,29739340,*pendrin gene
24342,29739340,"*slc26a4 cois written informed consent was obtained from all individuals or their legal guardians (if patients were under 18). the project was approved by the ethics committee, instituto de biociências, universidade de são paulo (protocol n(o) 109/2010). consent for publication: all subjects have approved the submission of the manuscript by written informed consent. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
24347,30167837,graves’ orbitopathy
24348,30167837,nasal airflow
24349,30167837,olfactory performance
24350,30167837,orbital decompression
24351,30167837,surgical outcome
24355,32202741,*igg4-associated disease
24356,32202741,*autoimmune thyroiditis
24357,32202741,*case report
24358,32202741,*inflammatory orbital disease
24359,32202741,*orbital involvement
24360,32202741,*thyroid eye disease
24365,30442552,graves’ orbitopathy
24366,30442552,deep lateral decompression
24367,30442552,proptosis
24368,30442552,rim-sparing
24369,32476690,"cholesterol, hdl"
24370,32476690,"igf1 protein, human"
24371,32476690,"igf2 protein, human"
24372,32476690,insulin
24373,32476690,insulin-like growth factor i
24374,32476690,insulin-like growth factor ii
24375,32476690,iodine
24376,32476690,"obesity, abdominal"
24377,32476690,thyroid nodule
24378,32476690,case-control studies
24379,32476690,insulin resistance
24380,32476690,metabolic syndrome
24381,30223781,*cd40
24382,30223781,*ctla-4
24383,30223781,*genetic polymorphism
24384,30223781,*graves’ disease cois the medical ethics committee of the affiliated hospital of guangdong medical university. the approval number was: pj2012029. all the above enrolled patients signed an informed consent document. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
24385,31188037,*bézier curves
24386,31188037,*graves orbitopathy
24387,31188037,*contour analysis
24388,31188037,*lower eyelid
24389,31188037,*lower eyelid retraction
24392,29627743,chronic autoimmune thyroiditis
24393,29627743,diffuse thyroid disease
24394,29627743,swe
24395,29627743,ft3/ft4 ratio
24396,30543152,*mapk/erk pathway
24397,30543152,*pi3k/akt pathway
24398,30543152,*tbx1
24399,30543152,*epithelial–mesenchymal transition
24400,30543152,*thyroid cancer
24401,30954956,endocrine system
24402,30954956,thyroid disease cois
24403,30084099,*craniosynostosis
24404,30084099,*graves’ orbitopathy
24405,31831041,graves disease
24406,31831041,thrombotic thrombocytopenic purpura cois
24408,30142011,color doppler imaging
24409,30142011,orbital decompression
24410,30142011,thyroid eye disease
24411,29937157,extraocular muscles
24412,29937157,graves’ ophthalmopathy
24413,29937157,grosor muscular
24414,29937157,muscle thickness
24415,29937157,músculos extraoculares
24416,29937157,oftalmopatía de graves
24417,29937157,optical coherence tomography
24418,29937157,orbitopatía tiroidea
24419,29937157,thyroid orbitopathy
24420,29937157,tocilizumab
24421,29937157,tomografía de coherencia óptica
24422,30009641,*human extraocular muscle
24423,30009641,*human extraocular muscle myoblasts
24424,30009641,*myogenesis
24425,30009641,*thyroid-associated ophthalmopathy
24426,30009641,*thyroid-stimulating hormone receptor
24428,30941511,anterior blepharotomy
24429,30941511,esthetic outcome
24430,30941511,graves’ ophthalmopathy
24431,30941511,tarsal platform show
24432,30941511,upper eyelid retraction
24437,31365979,graves orbitopathy
24438,31365979,graves orbitopathy guality of life questionnaire
24439,31365979,quality of life
24440,31059842,cxcl10
24441,31059842,cxcl8
24442,31059842,fibroblasts
24443,31059842,graves' disease
24444,31059842,graves' ophthalmopathy
24445,31059842,thyrocytes
24448,29319400,graves’
24449,29319400,orbital decompression
24450,29319400,strabismus
24452,30535759,autoimmune thyroid diseases
24453,30535759,graves’ disease
24454,30535759,hashimoto’s thyroiditis
24455,30535759,magi2
24456,30535759,single-nucleotide polymorphisms
24457,30513237,graves’ orbitopathy
24458,30513237,orbital decompression
24459,30513237,diplopia
24460,30513237,piezosurgery
24461,30513237,proptosis reduction
24463,30937820,hypoparathyroidism
24464,30937820,recurrent nerve injury
24465,30937820,reoperative thyroid surgery
24466,30937820,total thyroidectomy
24467,31604721,calcium and bone
24468,31604721,thyroid disease cois
24469,30801749,*calcium
24470,30801749,*hypoparathyroidism
24471,30801749,*dyspepsia
24472,30801749,*hospitalization
24473,30801749,*patient survey
24474,30801749,*vitamin d
24475,30176063,*chinese cohort
24476,30176063,*graves' disease
24477,30176063,*genome-wide association study
24478,30176063,*susceptibility loci
24479,29336220,*graves'
24480,29336220,*cholesterol
24481,29336220,*ophthalmopathy
24482,29336220,*orbitopathy
24483,29336220,*statins
24484,31271716,*graves’ disease
24485,31271716,*pretibial myxedema
24486,31271716,*thyroid dermopathy
24490,30092570,childhood onset
24491,30092570,graves’ disease
24492,30092570,papillary thyroid carcinoma
24493,30092570,slc5a5
24494,30092570,tfg/ntrk1
24495,30092570,tshr
24497,31685507,*graves' disease
24498,31685507,*cognitive impairment
24499,31685507,*functional near-infrared spectroscopy
24500,31685507,*hippocampus
24501,31685507,*magnetic resonance volumetry
24502,31685507,*quality of life cois and bristol-myers squibb.
24503,31338585,dexamethasone
24504,31338585,interleukin 6
24505,31338585,interleukin 6 receptor
24506,31338585,thyroid eye disease
24507,31338585,tocilizumab
24510,31462328,aggressive carcinoma
24511,31462328,graves’ disease
24512,31462328,matched cohort
24513,31462328,outcomes
24514,31462328,papillary thyroid carcinoma cois
24515,31304517,graves’ disease
24516,31304517,mig
24517,30825882,champagne bottle neck sign
24518,30825882,graves’ disease
24519,30825882,moyamoya vasculopathy
24520,30825882,recurrence
24521,30825882,vasculitis cois publication: written informed consent was obtained from the patient for publication of this case report. a copy of the written consent is available for review by the editor of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
24523,29742012,eyelid
24524,29742012,recession
24525,29742012,retraction
24526,29742012,spacer graft
24527,29742012,thyroid
24530,31482765,*graves' disease
24531,31482765,*antithyroid drugs
24532,31482765,*hyperthyroidism
24533,31482765,*long-term follow-up
24534,31482765,*radioiodine
24535,31482765,*recurrence
24536,31482765,*remission
24537,31482765,*thyroidectomy
24541,30803176,orbital fibroblast
24542,30803176,pirfenidone
24543,30803176,thyroid
24544,30803176,transforming growth factor
24547,29439614,*131i
24548,29439614,*graves' disease
24549,29439614,*thyroglobulin autoantibodies
24550,29439614,*thyroglobulin measurement
24551,29439614,*thyroglobulin metabolic clearance
24552,29439614,*thyroid cancer
24553,28776731,*+49a/g
24554,28776731,*131i
24555,28776731,*graves' disease
24556,28776731,*cytotoxic t lymphocyte antigen 4
24557,28776731,*polymorphism
24558,28776731,*radionuclide
24559,28776731,*−318c/t
24561,31152536,graves’ orbitopathy
24562,31152536,orbit decompression
24563,31152536,thyroid-associated orbitopathy
24567,29784035,american thyroid association guidelines
24568,29784035,graves’ disease
24569,29784035,hyperthyroid
24570,29784035,thyroid hormones
24571,29784035,thyroid storm
24572,29784035,thyroidectomy cois obtained through our review ethics board committee prior to the study. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
24573,29648895,autoimmune thyroid disease
24574,29648895,d1
24575,29648895,d2
24576,29648895,severity
24577,29648895,single nucleotide polymorphism
24578,29421653,*fibroblast proliferation
24579,29421653,*hyaluronan
24580,29421653,*igf-1
24581,29421653,*membrane potential
24582,29421653,*molecular weight
24583,29421653,*ph20
24586,30354697,*graves’ disease
24587,30354697,*thyroid stimulating hormone receptor antagonist
24588,30354697,*antithyroid drugs
24589,30354697,*hyperthyroidism
24590,30354697,*immunosuppressive treatment
24591,30354697,*radioiodine
24592,30354697,*thyroid receptor antagonists
24593,30354697,*thyroid stimulating hormone
24594,30354697,*thyrotoxicosis
24595,30229982,*intravenous methylprednisolone
24596,30229982,*thyroid-associated ophthalmopathy
24597,30229982,*triglycerides
24599,29448964,exophthalmos
24600,29448964,myxedema
24601,29448964,primary hyperthyroidism
24602,29448964,rituximab cois case to the institutional ethics committee. consent for publication: written informed consent was obtained from the patient for publication of this case report and any accompanying images. copies of the written consent are available for review by the editor-in-chief of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
24605,30924084,*gene
24606,30924084,*graves’ disease
24607,30924084,*polymorphisms
24608,30924084,*vdr
24609,30924084,*vitamin d receptor
24610,30173330,*i-ionm
24611,30173330,*neuromonitoring
24612,30173330,*recurrent laryngeal nerve stimulation
24613,30173330,*staged thyroidectomy
24614,30173330,*thyroid
24616,31530446,*dunhill procedure
24617,31530446,*graves' disease
24618,31530446,*graves' ophthalmopathy
24619,31530446,*bilateral subtotal thyroidectomy
24620,31530446,*subtotal thyroidectomy
24621,31530446,*total thyroidectomy
24622,29343299,graves’ disease
24623,29343299,hashimoto’s thyroiditis
24624,29343299,metamorphic autoimmunity
24625,29343299,natural history
24626,29343299,thyroid status cois publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
24627,30912336,*antithyroid agents
24628,30912336,*cure
24629,30912336,*graves hyperthyroidism
24630,30912336,*long term outcome
24631,30912336,*radioactive iodine
24632,30912336,*remission
24633,30912336,*thyroidectomy cois
24634,31169822,arteriovenous fistula
24635,31169822,false aneurysm
24636,31169822,goiter
24637,31169822,thyroidectomy
24638,31391354,graves’ disease
24639,31391354,hyperthyroidism
24640,31391354,iodine-131 radioactive iodine uptake
24641,31391354,radioiodine therapy
24642,31379878,*graves' disease
24643,31379878,*tshr
24644,31379878,*next-generation sequencing
24645,31379878,*splicing isoforms
24646,31379878,*thymus
24647,31379878,*thyroid
24648,31379878,*tolerance
24652,30256028,autografts
24653,30256028,dermis-fat graft
24654,30256028,eyelids – surgery
24655,30256028,graves ophthalmopathy – surgery
24656,30256028,reconstructive surgical procedures – methods
24657,30256028,skin transplantation
24658,31146635,*jordan
24659,31146635,*hyperthyroidism
24660,31146635,*hypothyroidism
24661,31146635,*prevalence
24662,31146635,*thyroid dysfunction
24663,31665858,hypercholesterolemia
24664,31665858,thyroid associated ophthalmopathy
24666,29562915,extra-thyroidal autoimmunity
24667,29562915,graves’ disease
24668,29562915,hashimoto’s thyroiditis
24669,29562915,metamorphic autoimmunity
24670,29562915,thyroid status cois publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
24672,30506346,gender
24673,30506346,graves’ disease (gd)
24674,30506346,hyperthyroidism
24675,30506346,hyperuricemia
24676,30506346,serum uric acid (sua)
24677,30170970,diplopia
24678,30170970,dysthyroid optic neuropathy
24679,30170970,exophthalmos
24680,30170970,grave's disease
24681,30170970,orbital decompression
24682,30170970,vision loss
24686,29996609,"decompression, surgical"
24687,29996609,graves ophthalmopathy
24688,29996609,optic nerve diseases
24689,29996609,orbit
24692,29367360,"ear, nose and throat/otolaryngology"
24693,29367360,head and neck surgery
24694,29367360,otolaryngology / ent
24695,29367360,thyroid disease cois
24697,31418705,*haemoglobin a2
24698,31418705,*hyperthyroidism
24699,31418705,*β-thalassemia trait
24700,30220185,choroid
24701,30220185,graves ophthalmopathy
24702,30220185,"tomography, optical coherence"
24703,29996608,"decompression, surgical"
24704,29996608,endoscopy
24705,29996608,graves ophthalmopathy
24706,29996608,orbit
24708,29890310,forkhead box p3 (foxp3)
24709,29890310,graves' disease
24710,29890310,regulatory t cells
24711,29890310,restriction fragment length polymorphism
24712,29890310,single nucleotide polymorphism
24717,30099999,*autoimmune disorders
24718,30099999,*crohn disease
24719,30099999,*graves disease
24720,30099999,*hashimoto thyroiditis
24721,30099999,*inflammatory bowel disease
24722,30099999,*multiple sclerosis
24723,30099999,*systemic lupus erythematosus
24724,30099999,*ulcerative colitis
24725,30244229,cardiovascular medicine
24726,30244229,thyroid disease cois
24727,30670519,*clinical trials
24728,30670519,*immunology
24729,30670519,*paediatric endocrinology
24730,30670519,*thyroid disease cois
24732,31460819,endocrine ophthalmopathy
24733,31460819,endoscopic sinus surgery
24734,31460819,orbital complication
24735,31460819,rhinosinusitis
24736,31460819,vision loss
24738,29510406,autoimmune thyroid disease (aitd)
24739,29510406,graves’ disease (gd)
24740,29510406,hashimoto’s thyroiditis (ht)
24741,29510406,ikaros family of zinc finger3 (ikzf3)
24742,29510406,single nucleotide polymorphism (snp)
24744,30226207,graves’ disease
24745,30226207,membranoproliferative glomerulonephritis
24746,30226207,proteinuria
24747,29310665,*graves’ disease
24748,29310665,*hyperthyroidism
24749,29310665,*methimazole
24750,29310665,"*thyroid receptor antibodies cois analysis of de-identified data collected for another purpose. all data are retrospective and presented in an aggregated fashion. so, no irb approval was required. patient numbers used in the model validation section of the article are spreadsheet numbers from data, which can not be used to identify the patients name, family name or other specific details. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
24751,31280470,*arterial stiffness
24752,31280470,*blood pressure
24753,31280470,*graves’ disease
24754,31280470,*pulse wave analysis
24758,29976201,*circulating mirnas
24759,29976201,*graves’ disease
24760,29976201,*let-7b
24761,29976201,*thyrotropin receptor antibody
24764,29549672,autoantibodies
24765,29549672,autoimmune thyroid diseases
24766,29549672,blood platelets
24767,29549672,chronic inflammation
24768,29549672,lymphocytes
24773,30369529,graves’ disease
24774,30369529,cerebral venous thrombosis
24775,30369529,factor viii procoagulant protein
24776,30369529,hyperthyroidism
24777,29319130,anaplastic thyroid carcinoma
24778,29319130,thyrotoxicosis
24780,31932147,*autoimmune thyroid diseases
24781,31932147,*chemokines
24782,31932147,*cytokines
24783,31932147,*dermatological autoimmune diseases
24784,31932147,*systemic autoimmune diseases cois
24785,30843111,*anti-pla2r
24786,30843111,*children
24787,30843111,*graves’ disease
24788,30843111,*membranous nephropathy
24789,30843111,*rituximab
24796,31279175,*autoimmune thyroid disease
24797,31279175,*development
24798,31279175,*ifng
24799,31279175,*methylation
24800,31279175,*prognosis
24801,30880626,*graves'
24802,30880626,*bimatoprost
24803,30880626,*fat atrophy
24804,30880626,*orbitopathy
24805,30880626,*prostaglandin f
24806,30880626,*thyroid eye disease
24807,30565709,*graves ophthalmopathy
24808,30565709,*inactive phase
24809,30565709,*interleukin-15
24810,30565709,*interleukin-17
24811,30057255,anca
24812,30057255,antineutrophil cytoplasmic antibodies
24813,30057255,methimazole
24814,30057255,metimazol
24815,30057255,vasculite
24816,30057255,vasculitis
24817,29517388,blood vessel density
24818,29517388,graves’ orbitopathy
24819,29517388,oct angiography
24820,29517388,decompression
24821,29517388,dysthyroid optic neuropathy
24822,29325496,*graves' disease
24823,29325496,*trab
24824,29325496,*neonatal thyrotoxicosis
24825,29325496,*pregnancy
24826,29325496,*thyroid
24829,30044728,*graves’ disease
24830,30044728,*autoimmune
24831,30044728,*monoclonal antibody
24832,30044728,"*signaling cois antibody-mediated inflammatory auto-immune disorders (us 6936426), the diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders (us 7998681 and us 8153121), and diagnostic methods related to graves’ disease and other autoimmune disorders (us 8178304). he was previously a paid consultant for river vision."
24833,29601105,*graves' ophthalmopathy
24834,29601105,*graves' orbitopathy
24835,29601105,*glucocorticoids
24836,29601105,*rituximab
24837,29601105,*thyroid eye disease
24841,31223030,graves' disease
24842,31223030,inflammation
24843,31223030,neutrophils platelet count.
24845,30187962,corticosteroid
24846,30187962,endocrine disorders
24847,30187962,topical
24849,30358895,*graves' disease
24850,30358895,*hcp5
24851,30358895,*autoimmunity
24852,30358895,*children
24853,30358895,*genetics
24854,30358895,*single nucleotide polymorphism
24855,30358895,*thyroid
24860,30854863,iodine radioisotopes
24861,30854863,neck dissection
24862,30854863,thyroid neoplasms
24863,30854863,thyrotoxicosis
24864,30814442,anti-thyroid drugs
24865,30814442,autotaxin
24866,30814442,graves’ disease
24867,30814442,lysophosphatidic acids
24868,30814442,thyroid hormones
24869,30488266,asymmetric enlargement
24870,30488266,lacrimal gland
24871,30488266,malignancy
24872,30488266,thyroid eye disease
24873,30463536,8-ohdg
24874,30463536,graves’ orbitopathy
24875,30463536,mda
24876,30463536,oxidative stress
24877,30463536,"tear cois all patients, and the study was conducted with approval from the institutional review board at chonnam national university hospital. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
24878,30148416,graves disease
24879,30148416,lasik
24880,30148416,salzmann’s nodular degeneration
24881,30148416,thyroid eye disease
24883,29949121,coagulation
24884,29949121,graves’ orbitopathy
24885,29949121,methylprednisolone
24886,29949121,pulmonary embolism
24887,29949121,venous thromboembolic event cois ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. informed consent: informed consent was obtained from all individual participants included in the study.
24889,29507013,adrenal disorders
24890,29507013,endocrine system
24891,29507013,thyroid disease cois
24893,30568070,graves’ disease
24894,30568070,surgical complications
24895,30568070,total thyroidectomy
24896,29482520,case report
24897,29482520,graves’ ophthalmopathy
24898,29482520,graves’ disease
24899,29482520,loss of vision
24900,29482520,orbital decompression
24901,29482520,strabismus cois publication: written informed consent was obtained from the patient for publication of this case report and any accompanying images. a copy of the written consent is available for review by the editor of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
24902,30325581,99mtc-anti-tnf
24903,30325581,graves disease
24904,30325581,graves ophthalmopathy
24905,30325581,diagnosis
24906,30325581,nuclear medicine
24907,30188609,*aggregation
24908,30188609,*autoimmune thyroid diseases
24909,30188609,*blood platelets
24910,30188609,*platelet-derived microparticles
24912,31257166,*graves’ disease
24913,31257166,*hashimoto’s thyroiditis
24914,31257166,*autoimmune disease
24915,31257166,*dysbiosis
24916,31257166,*enterohepatic cycling of thyroid hormones
24917,31257166,*probiotics
24918,30302684,*hyperthyreodism
24919,30302684,*antithyroid drug
24920,30302684,*radioiodine therapy
24921,30302684,*thermoablation
24922,30302684,*thyroid surgery
24924,31240859,slco1b1
24925,31240859,grave's disease
24926,31240859,drug-induced liver injury
24927,31240859,methimazole
24928,31240859,polymorphisms
24929,31715678,acellular dermis
24930,31715678,eyelids
24931,31715678,graves ophthalmopathy
24932,31715678,reconstructive surgical procedures
24933,31715678,"transplantation, heterologous"
24935,29440561,*graves’ disease
24936,29440561,*polymorphism
24937,29440561,*tumor necrosis factor-α cois manuscript.
24940,31453725,graves’ disease
24941,31453725,thyrotropin
24942,31453725,hyperthyroidism
24943,31453725,immunoassay
24944,31453725,thyroid-stimulating antibody
24947,29571699,apparent diffusion coefficient
24948,29571699,diffusion-weighted imaging
24949,29571699,graves’ disease
24950,29571699,orbit
24951,29571699,thyroid associated ophthalmopathy
24952,31612195,cxcr3
24953,31612195,graves’ophthalmoapthy
24954,31612195,mig
24955,31612195,thyroid eye disease
24957,31316787,*aih
24958,31316787,*graves' ophthalmopathy
24959,31316787,*methylprednisolone-induced liver injury
24960,31316787,*multiple sclerosis
24961,31316787,*steroid pulses
24962,30261581,graves’ disease
24963,30261581,nt-probnp
24964,30261581,ambulatory blood pressure monitoring
24965,30261581,blood pressure
24966,30261581,glucocorticoids
24967,30261581,graves’ orbitopathy
24968,30261581,hypertension
24969,30261581,methylprednisolone
24970,30261581,pulse therapy cois
24971,30222206,graves’ disease
24972,30222206,hashimoto thyroiditis
24973,30222206,alopecia areata
24974,30222206,autoimmune disease
24975,30222206,autoimmune thyroid disease
24976,29457989,"*aav, anti-neutrophil cytoplasmic antibody-associated vasculitis"
24977,29457989,"*anca, anti-neutrophil cytoplasmic antibody"
24978,29457989,"*dress, drug reaction with eosinophilia and systemic symptoms"
24979,29457989,"*ivig, intravenous ɤ-globulin"
24980,29457989,"*kd, kawasaki disease"
24981,29457989,*kawasaki disease
24982,29457989,"*mmi, methimazole"
24983,29457989,"*mpo, myeloperoxidase"
24984,29457989,"*ptu, propylthiouracil"
24985,29457989,*propylthiouracil
24986,29457989,*anti-neutrophil cytoplasmic antibody
24987,29457989,*general paediatrics
24988,29457989,*immunology
24989,29457989,*intravenous ɤ-globulin
24990,31393984,*basedow disease
24991,31393984,*dysthyroid optic neuropathy
24992,31393984,*endoscopic endonasal surgery
24993,31393984,*graves disease
24994,31393984,*optic nerve decompression
24995,31393984,*orbital apex
24996,31393984,*thyroid eye disease
24997,31236779,*antithyroid drug
24998,31236779,*graves’ disease
24999,31236779,*relapse
25000,31236779,*remission
25002,30179522,graves' disease
25003,30179522,autopsy
25004,30179522,high-altitude cerebral edema
25005,30179522,high-altitude pulmonary edema
25006,30179522,hyperthyroidism
25007,30179522,sudden death
25009,31672295,cytology
25010,31672295,false-negative diagnoses
25011,31672295,false-positive diagnoses
25012,31672295,fine-needle aspiration
25013,31672295,thyroid cancer
25014,31672295,thyroid nodule cois this work did not receive any specific grant funding.
25015,31207925,graves’ disease
25016,31207925,oxidative stress
25017,31207925,thiol/disulphide homeostasis cois
25018,31091045,*graves’ disease
25019,31091045,*alpha-2-macroglobulin
25020,31091045,*cytokines
25021,31091045,*lactoferrin
25022,30618332,*graves' disease
25023,30618332,*autoimmunity
25024,30618332,*peptides
25025,30618332,*thyroid
25028,29383806,*hla
25029,29383806,*association study
25030,29383806,*autoimmunity
25031,29383806,*haplotype
25032,29383806,*type 1 diabetes
25033,31255731,*autoimmune thyroid disease (aitd)
25034,31255731,*fas
25035,31255731,*hla-dr
25036,31255731,*hypothyroidism
25037,31255731,*il-1β
25038,31255731,*uterus globulin associated protein 1 (ugrp1)
25039,31176495,estrabismo
25040,31176495,fistula
25041,31176495,fístula
25042,31176495,hipertiroidismo
25043,31176495,hyperthyroidism
25044,31176495,orbit
25045,31176495,orbitopatía tiroidea
25046,31176495,strabismus
25047,31176495,thyroid orbitopathy
25048,31176495,órbita
25050,29866676,stroke
25051,29866676,thyroid disease cois
25052,29371709,"grave's disease, pcr-rflp, snps, cd 28, cd 40."
25054,30474825,acute pancreatitis
25055,30474825,drug-induced pancreatitis
25056,30474825,methimazole
25059,29566435,*graves’ disease
25060,29566435,*anaemia
25061,29566435,*haemoglobin
25062,29566435,*hyperthyroidism
25063,29566435,*thyroid function tests
25064,29566435,*thyroid hormones
25065,29566435,*thyrotoxicosis
25066,29412482,*3d reconstruction
25067,29412482,*orbital soft tissue volume
25068,29412482,*thyroid associated ophthalmopathy
25069,31301652,mutation
25070,31301652,polymorphism
25071,31301652,thyroid digenesis
25072,31301652,thyroid gland
25073,31301652,thyroid hormones
25074,31612654,decompression
25075,31612654,extraocular muscles
25076,31612654,graves ophthalmopathy
25077,31612654,optic nerve
25078,31612654,optical coherence tomogrphy cois
25079,31202168,drug-induced liver injury
25080,31202168,human leukocyte antigens
25081,31202168,methimazole
25082,31202168,molecular docking
25086,30086864,*graves' disease
25087,30086864,*childhood
25088,30086864,*fetus
25089,30086864,*hyperthyroidism
25090,30086864,*neonates
25092,30414981,*biomarkers
25093,30414981,*fibrosis
25094,30414981,*graves' disease
25095,30414981,*inflammatory cytokines
25096,30414981,*orbitopathy
25097,30414981,*pai-1
25098,30414981,*plasmin cascade
25099,30414981,*serpins
25100,30414981,*tgf-β
25101,30414981,*tissue remodeling cois
25102,31023005,*graves’ disease
25103,31023005,*methimazole
25104,31023005,*selenium
25105,31023005,*trab
25106,31023005,*tpoab
25107,31023005,*tgab cois
25109,31446546,131i therapy
25110,31446546,hyperthyroidism
25111,31446546,hypothyroidism
25112,31446546,ku-70
25113,31446546,radiosensitivity
25115,29300515,b-cell lymphoma
25116,29300515,graves’ orbitopathy
25117,29300515,r-chop
25118,29300515,rituximab
25119,29300515,immunochemotherapy
25120,29300515,thyroid orbitopathy
25124,29308951,alexis retractor
25125,29308951,retractor
25126,29308951,lateral orbit
25127,29308951,thyroid eye disease
25129,30012381,anemarrhena bunge
25130,30012381,case report
25131,30012381,graves’ disease
25132,30012381,herbal decoction
25133,30012381,tsh binding inhibitory immunoglobulins
25134,30012381,thyroid stimulating hormone
25144,30913888,adjustable sutures
25145,30913888,congenital fibrosis of the extraocular muscles
25146,30913888,double elevator palsy
25147,30913888,thyroid eye disease
25148,30913888,transposition procedure sec. knapp
25149,30913888,vertical strabismus
25150,30103255,*graves’ orbitopathy
25151,30103255,*methotrexate
25152,30103255,*methylprednisolone
25153,30103255,*steroid-sparing agents
25154,30103255,*thyroid eye disease
25155,29652204,corticoresistant
25156,29652204,graves’ orbitopathy
25157,29652204,low-dose
25158,29652204,rituximab
25159,29652204,treatment
25160,29491282,graves' disease
25161,29491282,central diabetes insipidus
25162,29491282,hyperthyroidism
25163,29491282,lymphocytic infundibulo-neurohypophysitis and thyroid crisis
25166,29397435,aldehyde dehydrogenase 2
25167,29397435,autoantigen
25168,29397435,graves’ orbitopathy
25169,29397435,orbital fat
25170,29397435,proteomic analysis
25171,31194638,*graves' disease
25172,31194638,*autoimmune thyroid disease
25173,31194638,*desensitization
25174,31194638,*immunomodulation
25175,31194638,*peptide immunotherapy
25176,31194638,"*thyroid stimulating hormone receptor cois attending study meetings and for ad hoc advice. s.h.s.p. has received speaker fees from sanofi, quidel, and berlin-chemie. c.d. has consulted for apitope, has received speaker fees, and has consulted for sanofi-genzyme. d.c.w. serves as chief scientific officer for apitope technology (bristol) ltd. and apitope international nv on a consultative basis; is on the scientific advisory board for apitope international nv and has sat on scientific advisory boards for actelion pharma and zealand pharma; received travel funding from apitope international nv; is a senior editor for immunotherapy; holds patents for peptides, tolerization-inducing composition, fviii peptides, and their use in tolerizing hemophiliacs, composition, disease markers, tolerogenic peptides from mbp, peptide selection method, and improvements relating to influenza vaccine; has consulted for peptide therapeutics ltd., teva, gsk bio, hoffmann-la roche, novartis, dti, and the food standards agency; received research support within the past three years from apitope international nv, ucb celltech, mrc, the immune tolerance network, and the wellcome trust; holds stock and stock options with apitope international nv; and was an expert witness for geron. k.b. is employed by apitope technology (bristol) ltd. n.o. was a contractor to apitope technology (bristol) ltd., a subsidiary of apitope international nv. l.j. is an employee of apitope international nv. t.w.-s. was an employee of apitope technology (bristol) ltd., a subsidiary of apitope international nv. c.c. serves as chief medical officer for apitope technology (bristol) ltd. and apitope international nv on a consultative basis. k.f.m. was an executive director of apitope international nv and its subsidiary, apitope technology (bristol) ltd. he was an employee of apitope technology (bristol) ltd. he is currently a non-executive director of and shareholder in apitope international nv. p.p. consults for ibsa. b.v. has received speaker fees from berlin-chemie. s.r. has received speaker fees from merck plc and abbott india ltd. g.j.k. consults for apitope and quidel and has received speaker fees from merck and berlin-chemie. k.b., j.g., c.e.h., i.m., r.d.m., and f.w. report no disclosures."
25178,30562606,ampk/mtor signaling pathway
25179,30562606,orbital preadipocyte
25180,30562606,sf1
25181,30562606,thyroid-associated ophthalmopathy
25184,31271712,*graves’ disease
25185,31271712,*acromegaly
25186,31271712,*case report
25187,31271712,*panhypopituitarism
25188,31271712,*radiosurgical treatment
25189,31271712,*secondary hypothyroidism
25190,31271712,*thyrotoxicosis
25192,30674011,16s rrna gene
25193,30674011,graves’ orbitopathy (go)
25194,30674011,gut microbiota
25195,30674011,thyrotropin receptor antibody (trab)
25197,30269213,graves’ disease
25198,30269213,hyperthyroidism
25199,30269213,robotic-assisted surgery
25200,30269213,surgical outcomes
25201,29848886,th2
25202,29848886,autoimmune thyroid disease
25203,29848886,intractability
25204,29848886,polymorphism
25205,29848886,severity
25207,30938833,cd4+p35+ebi3+t cell
25208,30938833,graves’ disease
25209,30938833,immunology
25210,30938833,interleukin 35
25214,30777066,corneal dynamic scheimpflug analyser
25215,30777066,corvis st
25216,30777066,graves ophthalmopathy
25217,30777066,orbital soft tissue
25218,30777066,whole eye movement cois the tenets of the declaration of helsinki and received institutional review board (irb) approval from seoul st. mary’s hospital for the analysis of their medical records. the need for consent was waived by irb (name of irb: cmc irb). consent for publication: not applicable. competing interests: hhs is a member of the editorial board (associate editor) of bmc ophthalmology. the other authors declare that they have no competing interests. the authors declare that they have no financial competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
25219,30470210,intraoperative relaxed muscle positioning
25220,30470210,restrictive strabismus
25221,30470210,thyroid orbitopathy cois approval from the local ethical committee (cerrahpasa ethics committee) was received. informed consent was obtained from the patients for the participation in the study. consent for publication: additional consent was obtained from the patients whose preoperative and postoperative photos were used in the manuscript. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
25222,30297028,*dry eye disease
25223,30297028,*graves' ophthalmopathy
25224,30297028,*tear break up time
25225,30297028,*tear osmolarity
25226,30297028,*thyroid eye disease
25227,30232923,*graves' disease
25228,30232923,*x chromosome
25229,30232923,*association analysis
25230,30232923,*dosage compensation
25231,30232923,*genetic model
25232,29875930,graves´ disease
25233,29875930,hyperthyroidism
25234,29875930,nuclear medicine
25235,29875930,thyroid neoplasms
25236,29377729,*ct
25237,29377729,*thyroid eye disease
25238,29377729,*exophthalmometer
25239,29377729,*exophthalmos
25240,31310160,*graves' disease
25241,31310160,*long-term
25242,31310160,*methimazole
25243,31310160,*remission rates
25245,30384566,*shear wave elastography
25246,30384566,*virtual touch tissue imaging quantification
25247,30384566,*thyroid
25248,30384566,*hashimoto’s thyroiditis
25249,30384566,*graves’ disease
25250,30281845,*b-lymphocytes
25251,30281845,*b-cell activating factor
25252,30281845,*graves
25253,30281845,*autoimmune
25254,30281845,*disease
25255,30281845,*genotyping
25256,30281845,*polymorphism
25257,30281845,*thyroid
25258,29478847,breast cancer
25259,29478847,cancer du sein
25260,29478847,graves’ disease
25261,29478847,hyperthyroidism
25262,29478847,hyperthyroïdie
25263,29478847,maladie de basedow
25264,29478847,thyroxine
25265,29478847,triiodothyronine
25266,31209622,ablation techniques
25267,31209622,graves’ disease
25268,31209622,high-intensity focused ultrasound ablation
25269,31209622,interventional ultrasonography
25270,31209622,thyrotoxicosis
25273,31552761,*il-6
25274,31552761,*autoimmune thyroid disease
25275,31552761,*intractability
25276,31552761,*methylation
25277,31552761,*severity
25278,31308303,abo
25279,31308303,blood groups
25280,31308303,hashimoto
25281,31308303,thyroid
25282,31184281,*graves' disease
25283,31184281,*thyroglobulin antibody
25284,31184281,*thyroid peroxidase antibody
25285,31184281,*thyroiditis
25286,31184281,*thyrotropin receptor
25287,31184281,*transgenics cois
25288,31111437,pd-1 inhibitor
25289,31111437,pdl-1 inhibitor
25290,31111437,pembrolizumab
25291,31111437,small cell carcinoma of ovary
25292,31111437,thyroid
25293,31111437,thyroiditis
25294,31111437,thyrotoxicosis
25296,29319128,graves’ disease
25297,29319128,hif-1α
25298,29319128,pdgf-bb
25299,29319128,immunology
25300,29319128,macrophages
25301,31473202,biotin
25302,31473202,biotin interference
25303,31473202,biotin supplements
25304,31473202,immunoassay
25308,31554206,b lymphocytes
25309,31554206,graves’ disease
25310,31554206,t lymphocytes
25311,31554206,toll-like receptor 2
25312,31554206,toll-like receptor 4
25313,31554206,cytokines cois
25314,31134819,*graves’ disease
25315,31134819,*treg-th17-related immunosuppressive cytokines
25316,31134819,*dihydrotestosterone
25317,31134819,*mice
25318,31134819,*oxidative stress
25320,29372654,*functional tsh receptor antibodies
25321,29372654,*autoimmune thyroid diseases
25322,29372654,*bioassays
25323,29372654,*children
25324,29372654,*drug delivery
25325,29372654,*thyroid associated orbitopathy
25326,29372654,*thyroid blocking antibodies
25327,29372654,*thyroid stimulating antibodies
25328,29336230,*dnmt
25329,29336230,*graves' disease
25330,29336230,*autoimmune thyroid disease
25331,29336230,*global dna methylation
25332,29336230,*lymphocyte
25333,31387688,hipocalcemia
25334,31387688,hipoparatiroidismo
25335,31387688,hormona paratiroidea
25336,31387688,hypocalcemia
25337,31387688,hypoparathyroidism
25338,31387688,parathyroid hormone
25339,31387688,thyroidectomy
25340,31387688,tiroidectomía
25341,31407938,*graves’ orbitopathy
25342,31407938,*thyroid eye disease
25343,31407938,*ocular ductions
25344,31407938,*recession
25345,31407938,*resection
25346,31407938,*squint surgery
25347,30927115,autoimmune thyroid disease
25348,30927115,chronic widespread pain
25349,30927115,fibromyalgia
25350,30927115,hashimoto thyroiditis
25351,30927115,osteoarthritis
25352,30927115,spinal degenerative disc disease
25354,29960265,ct
25355,29960265,graves' orbitopathy
25356,29960265,iterative model reconstruction
25357,29420104,decompression
25358,29420104,graves’ orbitopathy
25359,29420104,dysthyroid optic neuropathy
25360,29420104,steroids
25361,29420104,tocilizumab
25365,31034694,choroid
25366,31034694,optical coherence tomography
25367,31034694,thickness
25368,31034694,thyroid-associated orbitopathy
25369,30270655,diplopia
25370,30270655,graves ophthalmopathy
25371,30270655,inferior oblique muscle
25372,30270655,orbital decompression
25374,29614339,*co-expression modules
25375,29614339,*functional pathways
25376,29614339,*graves' disease
25377,29614339,*pathogenesis
25378,29614339,*weighted gene co-expression network analysis
25379,29463244,duration of eye symptoms
25380,29463244,intravenous glucocorticoid therapy
25381,29463244,pretreatment clinical activity score
25382,29463244,restoration of euthyroidism
25383,29463244,thyroid-associated ophthalmopathy cois by the ethics committee of shanghai ninth people’s hospital. the written informed consents were obtained from all participants. this study was in compliance with the tenets of the declaration of helsinki for clinical research. consent for publication: not applicable competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
25384,29360077,graves' disease
25385,29360077,hyperthyroidism
25386,29360077,struma ovarii
25388,30646996,decompression
25389,30646996,graves ophthalmopathy
25390,30646996,strabismus
25391,30646996,surgical
25392,30850507,*graves’ disease
25393,30850507,*hemoglobin
25394,30850507,*multispectral optoacoustic tomography (msot)
25395,30850507,*thyroid nodule
25396,30257816,graves’ disease
25397,30257816,hashimoto thyroiditis
25398,30257816,mrc 65/93
25399,30257816,antithyroglobulin antibodies
25400,30257816,immunoassays
25401,30257816,thyroglobulin
25402,30204589,*graves’ disease
25403,30204589,*biotin
25404,30204589,*multiple sclerosis
25405,30204589,*thyroid
25407,31055979,graves’ disease
25408,31055979,il-21
25409,31055979,th17 cells
25410,31055979,treg cells
25411,31055979,immune
25412,31494956,*graves' disease
25413,31494956,*hashimoto's thyroiditis
25414,31494956,*autoimmune thyroid disease
25415,31494956,*interferon regulatory factor 3
25416,31494956,*interferon regulatory factor 7
25417,29361886,*antiretroviral therapy
25418,29361886,*graves’ disease
25419,29361886,*hiv
25420,29361886,*iris
25421,29361886,*immune thrombocytopenic purpura
25423,30560705,graves’ ophthalmopathy
25424,30560705,oxidative stress
25425,30560705,thiol-disulfide homeostasis
25426,30351237,*graves’
25427,30351237,*antagonist
25428,30351237,*disease
25429,30351237,*hyperthyroidism
25430,30351237,*orbitopathy
25431,30351237,*small molecule
25432,30351237,*thyrotropin receptor
25436,31366254,*cd4+cd8+
25437,31366254,*graves’ disease
25438,31366254,*rtes
25439,31366254,*trab
25440,31366254,*effector memory cd8
25441,31366254,*lymphocyte subpopulations
25443,30814476,*antithyroid drug-induced agranulocytosis
25444,30814476,*antithyroid drug-induced neutropenia
25445,30814476,*association
25446,30814476,*flavin-containing monooxygenase 3
25447,30814476,*graves’ disease
25449,31036428,cigarette
25450,31036428,cigarro
25451,31036428,dejar de fumar
25452,31036428,graves orbitopathy
25453,31036428,orbitopatía de graves
25454,31036428,orbitopatía tiroidea
25455,31036428,smoke cessation
25456,31036428,tabaco
25457,31036428,thyroid orbitopathy
25458,31036428,tobacco
25459,30182361,cd-20
25460,30182361,graves’ disease
25461,30182361,graves’ ophthalmopathy
25462,30182361,graves’ orbitopathy
25463,30182361,lymphocytes
25464,30182361,thyroid
25465,30182361,thyroid eye disease
25466,29987165,*graves’ disease
25467,29987165,*hla
25468,29987165,*mhc
25469,29987165,*amino acid position
25470,29987165,*genome-wide association studies cois
25474,30335539,ocular pulse amplitude
25475,30335539,choroidal perfusion in thyroid eye disease
25476,30335539,choroidal thickness in thyroid eye disease
25477,30335539,dynamic contour tonometry
25478,30335539,thyroid eye disease
25481,29973096,*children
25482,29973096,*graves’ disease
25483,29973096,*hashimoto’s disease
25484,29973096,*ifih1 gene
25485,29973096,*ptpn gene
25486,29973096,*tshr gene
25487,29973096,*single nucleotide polymorphisms
25489,31266487,*dfnb4
25490,31266487,*deafness
25491,31266487,*haplotype
25492,31266487,*hearing
25493,31266487,*noncoding
25494,31266487,*pendred syndrome
25495,31266487,*slc26a4 cois
25496,31267667,hyperthyroidism
25497,31267667,obesity
25498,31267667,treatment
25499,31267667,weight changes
25501,31108563,*agranulocytosis
25502,31108563,*antithyroid drug
25503,31108563,*human leucocyte antigen
25504,31108563,*meta-analysis cois
25505,30528501,national health insurance research database
25506,30528501,cohort study
25507,30528501,hyperthyroidism
25508,30528501,hypothyroidism
25509,30528501,psoriasis
25510,30528501,psoriatic arthritis
25511,30528501,thyroid diseases
25512,29485308,*diplopia
25513,29485308,*resection
25514,29485308,*thyroid eye disease
25515,29485308,*vertical strabismus
25516,31444554,macular vasculature
25517,31444554,peripapillary vasculature
25518,31444554,thyroid eye disease
25519,30372544,*graves’ disease
25520,30372544,*trab
25521,30372544,*tshr
25522,30372544,*hyperthyroidism
25523,30372544,*thyroid scintigraphy
25524,30197231,*adderall
25525,30197231,*attention deficit hyperactivity disorder
25526,30197231,*etomidate
25527,30197231,*fentanyl
25528,30197231,*graves disease
25529,30197231,*hyperthyroidism
25530,30197231,*midazalom
25531,30197231,*moderate sedation
25532,30197231,*procedural sedation
25533,30197231,*propofol
25534,30197231,*rapid sequence intubation
25535,30197231,*rocuronium
25536,30197231,*thyroid storm
25538,29329570,case report
25539,29329570,graves’ disease
25540,29329570,graves’ orbitopathy
25541,29329570,igg4-related disease
25542,29329570,igg4-related orbitopathy cois of the declaration of helsinki. approval by the institutional ethics comittee was not required as this was a single case report. consent for publication: written informed consent was obtained from the patient for publication of this case report and any accompanying images. a copy of written consent is available for review by the editor of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
25544,29288501,*graves’ disease
25545,29288501,*iodine
25546,29288501,*iodine restricted
25547,29288501,*iodine supplemented
25548,29288501,*recurrence rate
25549,30900216,angptl8
25550,30900216,graves’ disease cois
25551,30673921,*autoantigen
25552,30673921,*autoimmune
25553,30673921,*flow cytometry
25554,30673921,*immune
25555,30673921,*interleukin 2
25556,30673921,*lupus
25557,30673921,*metformin
25558,30673921,*multiple sclerosis
25559,30673921,*orbitopathy
25560,30673921,*pcsk9
25561,30673921,*rheumatoid arthritis
25562,30673921,*somatostatin
25563,30673921,*statin
25564,30673921,*testosterone
25565,30673921,*thyroid
25566,30291728,*graves’ disease
25567,30291728,*graves’ ophthalmopathy
25568,30291728,*hypothyroidism
25569,30291728,*iodine radioisotopes
25570,30291728,*thyroid function tests
25571,30291728,*thyrotoxicosis
25572,30291728,*treatment failure
25573,30291728,*weight gain
25575,31580214,*epstein-barr virus
25576,31580214,*graves' disease
25577,31580214,*asymptomatic infection
25578,31580214,*autoantibody
25579,31580214,*thyrotropin receptor autoantibody (trab)
25580,31580214,*viral reactivation cois
25581,30911279,biomarker
25582,30911279,diagnostics
25583,30911279,genetic signature
25584,30911279,molecular alteration
25585,30911279,papillary thyroid cancer cois
25586,31033004,cd32b
25587,31033004,fcγr
25588,31033004,fcγrii
25589,31033004,graves' disease
25590,31033004,autoimmunity
25592,29974826,*cd4+ helper t cells
25593,29974826,*graves’ disease
25594,29974826,*t cell immunoglobulin domain and mucin domain 3
25595,29974826,*thyroid-associated ophthalmopathy
25596,29974826,*autoimmune thyroid disease
25597,29974826,*immune tolerance.
25598,31557136,graves’ ophthalmopathy
25599,31557136,graves’ orbitopathy
25600,31557136,calcium
25601,31557136,methylprednisolone
25602,31557136,phosphate
25604,30549306,*graves' orbitopathy
25605,30549306,*immunosuppression
25606,30549306,*methotrexate
25607,30549306,*methylprednsolone
25608,30549306,*rituximab
25611,30979639,dysthyroid optic neuropathy
25612,30979639,medial orbital wall decompression
25613,30979639,transcaruncular approach
25614,30979639,transnasal endoscopic approach
25615,30979639,vision
25618,30771152,*autoimmune thyroid disease
25619,30771152,*ctla-4
25620,30771152,*foxp3
25621,30771152,*graves’ disease
25622,30771152,*hashimoto’s thyroiditis
25623,30771152,*polymorphism
25625,29589999,*graves'
25626,29589999,*adipogenesis
25627,29589999,*extracellular-regulated kinase (erk)
25628,29589999,*hyaluronan production
25629,29589999,"*orbitopathy, biguanides, amp-activated protein kinase"
25630,29526990,false-positive
25631,29526990,lithium-heparin plasma
25632,29526990,tsh receptor antibody (trab)
25633,29526990,third-generation
25635,30616690,*graves disease
25636,30616690,*hashimoto thyroiditis
25637,30616690,*macrophage-nk cells cross talk
25638,30616690,*thyroid cancer
25639,30616690,*tumor immunity cois competing interests: the authors declare that they have no conflict of interest. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
25640,30335556,graves’ disease
25641,30335556,orbital decompression
25642,30335556,infraorbital anaesthesia
25643,30335556,piezoelectric surgery
25644,30335556,thyroid eye disease
25645,29631510,*graves' ophthalmopathy immunoglobulins
25646,29631510,*igf-1 receptor
25647,29631510,*tsh receptor
25648,29631510,*pakt
25649,29631510,*perk1/2 cois
25650,30246383,*t follicular helper cells (tfh)
25651,30246383,*t helper 17 (th17)
25652,30246383,*t helper 22 (th22)
25653,30246383,*autoimmune thyroid diseases (aitds)
25654,30246383,*cytokines
25655,30246383,*immune tolerance
25656,30246383,*interleukin 17 (il-17)
25657,30246383,*interleukin 21 (il-21)
25658,29941778,autoimmune thyroid disease
25659,29941778,celiac disease
25660,29941778,glandular autoimmunity
25661,29941778,polyglandular autoimmune syndrome
25662,29941778,type 1 diabetes cois
25666,30973094,*graves' orbitopathy
25667,30973094,*toll-like receptor 2
25668,30973094,*high mobility group box 1
25669,30973094,*inflammation
25670,30973094,*receptor for advanced glycation end products
25671,30391932,*foxp3 acetylation
25672,30391932,*graves’ disease (gd)
25673,30391932,*treg function defect
25674,30391932,*mir-23a-3p
25677,30519958,bone mineral density
25678,30519958,bone turnover markers
25679,30519958,glucocorticoid
25680,30284412,donor sclera
25681,30284412,ocular deviations
25682,30284412,strabismus
25683,30284412,surgical technique
25684,30515677,*continuous glucose monitoring
25685,30515677,*glycemic variation
25686,30515677,*graves’ disease
25687,30515677,*mean amplitude of glycemic excursions cois
25688,29804271,*durvalumab
25689,29804271,*graves’ orbitopathy
25690,29804271,*tremelimumab
25694,30196781,*ophthalmoplegia
25695,30196781,*carotid-cavernous sinus fistula
25696,30196781,*cranial neuropathy
25697,30196781,*diplopia
25698,30196781,*hypoglobus
25699,30196781,*proptosis
25700,29482415,inter-ethnic
25701,29482415,orbit
25702,29482415,orbital decompression
25703,29482415,trigone
25704,31062662,*graves’ disease
25705,31062662,*autoantibody
25706,31062662,*decoy effect
25707,31062662,*exosome
25708,31062662,*thyrotropin receptor
25709,29656212,autoimmune thyroid disease
25710,29656212,calgranulins
25711,29656212,mrp14
25712,29656212,mrp6
25713,29656212,mrp8
25714,29656212,oxidative stress
25716,30222515,*epstein–barr virus
25717,30222515,*epstein–barr virus reactivation
25718,30222515,*epstein–barr virus-encoded small rna1
25719,30222515,*graves' disease
25720,30222515,*igg4-related disease cois
25722,30503299,*coronary artery vasospasm
25723,30503299,*graves’ disease
25724,30503299,*interleukin-6
25725,30503299,*silent myocardial infarction
25726,29557700,*decompression
25727,29557700,*graves’ orbitopathy
25728,29557700,*dose-effect
25729,29557700,*eye muscle surgery
25730,29557700,*tendon elongation of medial rectus muscle
25731,30938100,*graves' disease
25732,30938100,*ptpn22 gene
25733,30938100,*gene polymorphism cois
25735,30724135,*graves' orbitopathy
25736,30724135,*pdgf-bb
25737,30724135,*adipogenesis
25738,30724135,*basic-fgf
25739,30724135,*tyrosine kinase inhibitor
25741,29780146,anca-related vasculitis
25742,29780146,mpo-anca
25743,29780146,omaav
25744,29780146,propylthiouracil
25746,30679116,autologous fat
25747,30679116,esthetic
25748,30679116,hyaluronic acid
25749,30679116,lateral orbital wall decompression
25750,30679116,temporal hollowing
25751,30679116,thyroid eye disease
25753,29800560,*graves' opthalmopathy
25754,29800560,*lfa-1/icam-1/gsk-3β pathway
25755,29800560,*logistic regression
25756,29800560,*mdr model
25757,29800560,*single nucleotide polymorphism
25758,29800560,*smoking
25759,29454070,graves’ disease
25760,29454070,interleukin-1 receptor antagonist
25761,29454070,interleukin-1-β
25762,29454070,restriction fragment length polymorphism
25763,29454070,single nucleotide polymorphism
25765,31328557,*circadian rhythm
25766,31328557,*graves’ disease
25767,31328557,*hashimoto’s thyroiditis
25768,31328557,*polymorphism
25769,29970608,endocrine system
25770,29970608,thyroid disease cois
25771,31411123,*graves' disease
25772,31411123,*levothyroxine
25773,31411123,*radioiodine treatment
25774,31411123,*thyrotropin
25775,31411123,*triiodothyronine cois
25776,31088643,abhormone
25777,31088643,colloid antigen 2
25778,31088643,graves’ disease
25779,31088643,thyroid blocking antibody
25780,31088643,thyroid stimulating antibody
25781,29666119,*experimental – laboratory
25782,29666119,*inflammation
25783,29666119,*orbit
25784,29666119,*pathology
25785,29666119,*stem cells cois
25786,29729713,autoimmune diseases
25787,29729713,meta-analysis.
25788,29729713,ptpn22
25789,31399042,*adipogenesis
25790,31399042,*go animal model
25791,31399042,*graves’ disease
25792,31399042,*graves’ ophthalmopathy
25793,31399042,*thyroid disease
25794,31399042,*hpmscs cois
25795,31034586,b cell-activating factor
25796,31034586,graves' disease
25797,31034586,hashimoto's thyroiditis
25798,31034586,autoimmune thyroid disease
25799,31034586,osteopontin
25800,30208979,* aitd autoimmune thyroid disease
25801,30208979,* dio deiodinases
25802,30208979,* gd graves’ disease
25803,30208979,* gpx glutathione peroxidases
25804,30208979,* ht hashimoto's thyroiditis
25805,30208979,* id iron deficiency
25806,30208979,* l-t4 levothyroxine
25807,30208979,* rct randomised controlled trial
25808,30208979,* t3 tri-iodothyronine; t4
25809,30208979,* tpo thyroid peroxidase
25810,30208979,* tsh thyroid-stimulating hormone
25811,30208979,* tg thyroglobulin
25812,30208979,* thyroxine
25813,30208979,*autoimmune thyroid disease
25814,30208979,*autoimmune thyroiditis
25815,30208979,*iodine
25816,30208979,*iron
25817,30208979,*nutrition
25818,30208979,*selenium
25821,31091046,*graves’ ophthalmopathy
25822,31091046,*fibrosis
25823,31091046,*glycosaminoglycans
25824,31091046,*matrix metalloproteinases
25825,31091046,*pathogenesis
25826,31091046,*tissue inhibitor of metalloproteinases
25827,30684216,*autoantibodies
25828,30684216,*graves’ disease
25829,30684216,*hashimoto’s thyroiditis
25830,30684216,*tsh receptor
25831,30684216,*thyroid
25832,31439560,dermatology
25833,31439560,meningitis
25834,31439560,paediatrics cois
25835,31384956,fibroblast growth factor 23
25836,31384956,graves’ disease
25837,31384956,osteoporosis
25838,31384956,phosphorus
25839,30725486,*graves’ disease
25840,30725486,*hashimoto’ s thyroiditis
25841,30725486,*autoimmune thyroid disease
25842,30725486,*metabolomics
25843,30725486,*polyamine metabolites
25844,30725486,*serum
25845,30725486,*spermine
25846,29709954,carcinoembryonic antigen
25847,29709954,hypothyroidism
25848,30506426,*bone mineral density
25849,30506426,*graves’ ophthalmopathy
25850,30506426,*graves’ orbitopathy
25851,30506426,*gucocorticoid-induced osteoporosis
25852,30506426,*methylprednisolone
25853,30506426,*trabecular bone score cois
25854,29526119,*graves’ disease
25855,29526119,*hashimoto’s disease
25856,29526119,*tnf-α
25857,29526119,*methylation
25858,29526119,*polymorphism
25860,31750736,4q21.1
25861,31750736,cxcl9
25862,31750736,hashimoto's thyroiditis
25863,31750736,naaa
25864,31750736,single nucleotide polymorphisms
25866,29864750,*autoimmunity
25867,29864750,*rheumatic diseases
25868,29864750,*thyroiditis
25869,31359380,autoimmune thyroid diseases
25870,31359380,dna methylation
25871,31359380,graves’ disease
25872,31359380,hashimoto thyroiditis
25873,31359380,icam-1
25875,30589937,b lymphocyte kinase
25876,30589937,graves' disease
25877,30589937,hashimoto’s thyroiditis
25878,30589937,autoimmune thyroid disease
25879,30589937,secreted phosphoprotein 1
25880,30133352,*ebv reactivation
25881,30133352,*graves’ disease
25882,30133352,*ig production
25883,30133352,*estradiol cois
25884,29791034,cd10
25885,29791034,adenomatous goitre
25886,29791034,anaplastic thyroid carcinoma
25887,29791034,immunohistochemistry
25888,29791034,thyroid tumour
25890,30067105,antibody
25891,30067105,antithyroid drugs
25892,30067105,autoimmunity
25893,30067105,cutaneous reactions
25894,30067105,hepatotoxicity
25895,31573408,*antithyroid drugs
25896,31573408,*drug-induced hepatotoxicity
25897,31573408,*drug-induced liver injury
25898,31573408,*metimazole
25899,31573408,*propylthiouracil
25901,30417843,goitre
25902,30417843,incidence
25903,30417843,pyramidal lobe
25904,30417843,thyroidectomy cois
25906,31105122,gitelman syndrome
25907,31105122,slc12a3 gene
25908,31105122,eplerenone
25909,31105122,hypokalemia
25910,31105122,thyrotoxic hypokalemic periodic paralysis
25911,30201436,*autoimmunity
25912,30201436,*immune regulation
25913,30201436,*t cells
25914,30201436,*microrna-183
25915,30201436,*microrna-96
25916,31434818,graves’ disease
25917,31434818,hashimoto’s thyroiditis
25918,31434818,immune-checkpoint inhibitors
25919,31434818,immunoglobulin g4
25920,31434818,riedel’s thyroiditis
25921,30599051,*benign thyroid disease
25922,30599051,*radioiodine therapy
25923,30599051,*radioiodine uptake test
25924,30599051,*thyroid
25925,30599051,*thyroid stunning
25926,31301659,autopsy
25927,31301659,goiter
25928,31301659,malignancy
25929,31301659,metastatic disease
25930,31301659,thyroid
25931,31301659,thyroid nodule
25932,29956299,l-thyroxine in utero treatment
25933,29956299,dyshormonogenesis
25934,29956299,foetal goitre
25935,30936024,*biological therapy
25936,30936024,*disease progression
25937,30936024,*prognosis
25938,30936024,*treatment
25939,31387553,diagnostic criteria
25940,31387553,metastasis
25941,31387553,painful goiter
25942,31387553,subacute thyroiditis
25943,31387553,thyroid cancer cois
25944,29923170,ancient greece
25945,29923170,endocrinology
25946,29923170,galen
25947,29923170,goitre
25948,29923170,hippocrates
25949,29923170,history
25950,29923170,thyroid
25951,30589040,nodular goiters
25952,30589040,ultrasound grayscale ratio (usgr)
25953,30589040,papillary carcinoma
25954,30589040,thyroid nodules cois
25955,29396842,age-related changes
25956,29396842,chemical elements
25957,29396842,inductively coupled plasma mass spectrometry
25958,29396842,neutron activation analysis
25959,29396842,thyroid
25960,30175973,casc2
25961,30175973,long non-coding rna
25962,30175973,lymph node metastasis
25963,30175973,papillary thyroid cancer
25964,29724875,diabetes
25965,29724875,thyroid disease cois
25968,30860079,*endoscopic thyroidectomy using vestibular approach
25969,30860079,*scar.free thyroidectomy
25970,30860079,*transoral endoscopic thyroidectomy cois
25971,30939883,* thyroid nodules
25972,30939883,*fnab of thyroid gland
25973,30939883,*the bethesda 2017 revised classification of thyroid fnab
25974,30939883,*the bethesda system for reporting thyroid cytology 2010
25975,30939883,*goitre
25976,30939883,*thyroid cancer
25977,31691509,*echogenicity
25978,31691509,*nodular goiters
25979,31691509,*papillary thyroid carcinoma
25980,31691509,*ultrasonic diagnosis
25981,31691509,*ultrasound gray scale ratio cois
25984,31155540,deiodinase
25985,31155540,ft3/ft4 ratio
25986,31155540,hashimoto thyroiditis
25987,31155540,thyroid hormone
25988,31155540,thyroid volume
25989,29996756,*thyroid diseases
25990,31670631,calciumsupliments
25991,31670631,calciumvalue
25992,31670631,thyroidectomy
25993,29626393,fnac
25994,29626393,children
25995,29626393,thyroid
25996,29409458,*breast cancer
25997,29409458,*goitre
25998,29409458,*lobular breast cancer
25999,29409458,*metastases to thyroid cois publication: written informed consent was obtained from the patient for the publication of this case report and any accompanying images. a copy of the written consent is available for review by the editor-in-chief of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
26000,31178475,congenital hypothyroidism
26001,31178475,gene mutation
26002,31178475,goiter
26003,31178475,thyroglobulin cois
26004,31292912,c cell hyperplasia
26005,31292912,c cells
26006,31292912,papillary carcinoma
26007,31292912,thyroid
26008,31292912,thyroidectomy
26009,31127647,*dnmt1
26010,31127647,*mgmt
26011,31127647,*ms-hrm
26012,31127647,*ctdna
26013,31127647,*methylation
26014,31127647,*papillary thyroid cancer
26015,31255196,autoimmune thyroiditis
26016,31255196,graves’ disease
26017,31255196,hashimoto's thyroiditis
26018,31255196,surgical management
26019,29724805,spect/ct
26020,29724805,parallax error
26021,29724805,parathyroid scintigraphy
26022,29724805,pinhole collimator
26023,29724805,thyroid scintigraphy
26024,30927996,history of thymectomy
26025,30927996,myasthenia gravis
26026,30927996,myasthenic
26027,30927996,surgical management of myasthenia gravis
26028,30927996,thymoma
26029,30927996,thymus
26030,30927996,transcervical
26031,30884127,cep78
26032,30884127,wdr62
26033,30884127,lateral lymph node metastasis
26034,30884127,thyroid cancer
26035,30739612,*deficiency
26036,30739612,*excess
26037,30739612,*iodine
26038,30739612,*sub-saharan africa
26039,29459090,cancer thyroïdien
26040,29459090,goitre ovarien
26041,29459090,ovarian teratoma
26042,29459090,struma ovarii
26043,29459090,thyroid carcinoma
26044,29459090,tératome ovarien
26045,31430255,tpo gene
26046,31430255,congenital goiter
26047,31430255,congenital hypothyroidism
26048,31430255,thyroid carcinoma
26049,31430255,thyroid dyshormonogenesis
26050,29313120,ablation techniques
26051,29313120,high-intensity focused ultrasound ablation
26052,29313120,induced hyperthermia
26053,29313120,interventional ultrasonography
26054,29313120,nodular goitre
26057,29845469,*family health
26058,29845469,*health promotion
26059,29845469,*screening cois
26060,31267862,*nrf2
26061,31267862,*personalized nutrition
26062,31267862,*flavonoid
26063,31267862,*goiter
26064,31267862,*hyperthyroidism
26065,31267862,*hypothyroidism
26066,31267862,*phytochemical
26067,31267862,*thyroid.
26068,29676344,histopathology
26069,29676344,retrospective
26070,29676344,thyroid diseases cois
26071,31297898,*bipolar disorders
26072,31297898,*lithium
26073,31297898,*thyroid hormones
26074,31297898,*thyroid structure
26076,30665612,*hypocalcemia
26077,30665612,*indocyanine green
26078,30665612,*multinodular goiter
26079,30665612,*parathyroid
26080,30665612,*parathyroid hormone
26081,30665612,*thyroidectomy
26083,29354015,*benign thyroid nodule
26084,29354015,*laser
26085,29354015,*laser ablation
26086,29354015,*quality of life
26087,29354015,*thyroid
26088,29354015,*thyroid nodule
26089,29330630,ablation techniques
26090,29330630,high-intensity focused ultrasound ablation
26091,29330630,interventional ultrasonography
26092,29330630,nodular goitre
26093,29330630,pain management
26094,30009365,galen
26095,30009365,thomas wharton
26096,30009365,botium
26097,30009365,thyroid foramen
26098,30949714,autonomous thyroid function
26099,30949714,hyperthyroidism
26100,30949714,hypothyroidism
26101,30949714,iodine exposure
26102,30949714,nodular goiter
26105,30903785,children
26106,30903785,morbidity
26107,30903785,pesticides
26108,30903785,thyroid gland
26109,30717458,diet
26110,30717458,gestational diabetes mellitus
26111,30717458,microbiota
26112,30717458,"pregnancy cois design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."
26113,31670642,crp
26114,31670642,anaplastic
26115,31670642,cancer
26116,31670642,ferritin
26117,31670642,inflammatorymarkers
26118,31670642,thyroid
26119,30732901,congenital hypothyroidism
26120,30732901,goiter
26121,30732901,idd
26122,30732901,iran
26123,30732901,salt iodisation
26125,30358496,*goiter
26126,30358496,*iodine deficiency
26127,30358496,*iodine in salt
26128,30358496,*thyroid volume
26129,30358496,*urinary iodine
26130,30378716,*foxq1
26131,30378716,*papillary thyroid carcinoma
26132,30378716,*poor prognosis
26133,30568076,infertility
26134,30568076,negative thyroid antibody
26135,30568076,nongoitrous
26136,30568076,subclinical hypothyroidism
26137,30568076,thyroid autoimmunity
26138,29770856,benign thyroid disease
26139,29770856,mixed follicular-papillary variant
26140,29770856,multifocality
26141,29770856,papillary thyroid microcarcinoma
26142,29770856,risk factors
26143,29770856,thyroid weight
26144,29770856,tumour size
26145,31237859,vegf-a
26146,31237859,angiogenic factor
26147,31237859,histopathological factors
26148,31237859,immunohistochemistry
26149,31237859,papillary thyroid carcinoma
26150,31237859,thyroid carcinoma
26152,31445060,environmental chemicals
26153,31445060,pesticides
26154,31445060,thyroid diseases
26155,31445060,case–control study
26156,30521675,*goiter
26157,30521675,*health insurance
26158,30521675,*socioeconomic disparities
26159,30521675,*thyroid disease
26160,30521675,*thyroid volume
26161,30773379,*fusion imaging
26162,30773379,*hybrid imaging
26163,30773379,*single-photon emission computed tomography/ultrasound
26164,30773379,*thyroid
26165,30773379,*ultrasound
26167,31074384,follicular proliferation
26168,31074384,lobectomy
26169,31074384,malignancy
26170,31074384,surgery
26171,31074384,tir3b
26172,31074384,thyroid cancer
26173,31074384,total thyroidectomy cois
26174,30734891,dysgenesis
26175,30734891,dyshormonogenesis
26176,30734891,hashimoto thyroiditis
26177,30734891,hypothyroidism
26178,30734891,iodine deficiency
26179,30734891,levothyroxine
26180,30734891,mental retardation
26181,30734891,stunted growth
26182,32312925,benign thyroidectomy
26183,32312925,cervical thyroid remnant
26184,32312925,papillary thyroid carcinoma
26189,31142293,hashimoto’s thyroiditis
26190,31142293,papillary thyroid carcinoma cois
26191,29544745,adults
26192,29544745,influences
26193,29544745,prevalence
26194,29544745,thyroid nodules
26197,30371103,neuromonitoring
26198,30371103,nonrecurrent laryngeal nerve
26199,30371103,palsy
26200,30371103,recurrent laryngeal nerve
26201,30371103,thyroidectomy
26202,29573939,*shear wave
26203,29573939,*cancer
26204,29573939,*elastography
26205,29573939,*thyroid nodules
26206,29573939,"*ultrasound cois device or technology referenced in this paper. ag, mb, vk, bhk, jw, ddm, mr, jmk, mf, and aa have no competing financial interests in the technology described in this study. the content is solely the responsibility of the authors and does not necessarily represent the official views of the national institutes of health."
26207,30829140,*benign/goiter
26208,30829140,*endocrine
26209,30829140,*thyroid
26210,30829140,*thyroid cancer
26211,30829140,*thyroid/parathyroid
26212,30829140,*thyroidectomy
26213,30086865,*complication prevention
26214,30086865,*congenital hypothyroidism
26215,30086865,*goiter
26216,30086865,*next generation sequencing
26217,30086865,*systemic disease complications
26218,30086865,*thyroid
26219,30637454,hypocalcemia
26220,30637454,postoperative hypoparathyroidism
26221,30637454,thyroid surgery
26222,30637454,thyroidectomy
26223,30637454,vitamin d deficiency
26224,29695560,*bad
26225,29695560,*bax
26226,29695560,*bcl-2
26227,29695560,*benign thyroid nodules
26228,29695560,*apoptosis
26229,29695560,*gene expression
26230,29720101,*congenital hypothyroidism
26231,29720101,*goiter
26232,29720101,*novel mutations
26233,29720101,*tg
26234,29720101,"*thyroglobulin cois performed in miami has been approved by the human subject research office of the university of miami (irb number: 20140632). written informed consent for participating in the study has been obtained from all study participants and in the case of subjects under the age of 18 assent was obtained from the child and consent from their parents. consent for publication: written informed consent for publishing all data of the study, such as medical data, images and genetic results has been obtained from all study participants or in the case of subjects under the age of 18 assent was obtained from the child and consent from their parent. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
26235,31326901,genetics
26236,31326901,pituitary disorders
26237,31326901,thyroid disease cois
26239,30666977,iccidd
26240,30666977,iodine deficiency disorder
26241,30666977,iodized salt
26242,30666977,last mile
26243,30666977,public health nutrition
26244,30666977,success story
26245,30666977,way forward cois
26246,31169246,anaplastic thyroid carcinoma
26247,31169246,giant cells
26248,31169246,osteoclasts cois
26251,30610567,collision
26252,30610567,double tumor
26253,30610567,pit-1
26254,30610567,pituitary tumor
26255,30610567,plurihormonal
26256,30610567,sf-1
26257,30610567,stem cell
26258,29717097,*complication
26259,29717097,*elderly
26260,29717097,*morbidity
26261,29717097,*mortality
26262,29717097,*tracheostomy cois
26263,30707410,early diagnosis of rth β
26264,30707410,rth β management
26265,30707410,resistance to thyroid hormones
26266,30707410,spanish cohort
26267,30707410,thrb gene
26269,31250039,billing diagnosis
26270,31250039,coding quality
26271,31250039,prevalence of thyroid disorders
26272,31250039,primary data
26273,31250039,validation
26274,30700956,cardiovascular disease
26275,30700956,hyperthyroidism
26276,30700956,pattern
26277,30700956,presentation
26278,30700956,thyro-cardiac disease
26279,31489070,sarcoidosis
26280,31489070,endoscopy
26281,31489070,hypothalamus
26282,31489070,neurosarcoidosis
26283,31489070,pituitary gland
26284,31489070,sella turcica cois
26285,30450534,congenital hypothyroidism
26286,30450534,screening
26287,30450534,thyroid dysgenesis
26288,30450534,thyroid scintigraphy
26289,29409365,*percutaneous laser ablation
26290,29409365,*hyperthyroidism
26291,29409365,*toxic nodules
26292,31243250,igg4
26293,31243250,hypertrophic pachymeningitis
26294,31243250,non-caseating granuloma
26295,31243250,sarcoidosis
26297,30236136,conventional
26298,30236136,hypocalcemia
26299,30236136,ligasure® small jaw
26300,30236136,recurrent laryngeal nerve
26301,30236136,"thyroidectomy cois chancellor of research and development, tabriz university of medical sciences (committee reference number: 92170), and registered in iranian registry of clinical trials (www.irct.com), trial registration: irct2014010516077n1, registered: 23 may 2014). all patients provided written consent form in order to participate in the study and the procedures followed were in accordance with the ethical standards of the ethics committee of the tabriz university of medical sciences. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
26302,30919068,ablation techniques
26303,30919068,high-intensity focused ultrasound ablation
26304,30919068,interventional ultrasonography
26305,30919068,nodular goiter
26306,30919068,pain management
26307,30778718,ablation techniques
26308,30778718,high-intensity focused ultrasound ablation
26309,30778718,interventional ultrasonography
26310,30778718,nodular goiter
26311,30778718,ultrasound imaging
26312,32202723,*cancer
26313,32202723,*cytology
26314,32202723,*nodular goiter
26315,32202723,*stratification
26316,32202723,*thyroid gland
26317,32202723,*ultrasonography
26318,30105949,*tirads
26319,30105949,*imaging
26320,30105949,*multinodular goiter
26321,30105949,*scoring system
26322,30105949,*ultrasonography
26323,30039748,*graves' disease
26324,30039748,*hashimoto's thyroiditis
26325,30039748,*quality of life
26326,30039748,*sexual dysfunction
26327,30039748,*thyroid autoimmunity
26328,30833205,e-learning
26329,30833205,personalized learning environment
26330,30833205,practice-based learning and improvement
26331,30833205,professionalism
26332,30833205,systems-based practice
26333,30833205,vodcast vs. lecture
26335,30666981,anaemia
26336,30666981,diagnosis
26337,30666981,hypertension
26338,30666981,interventions
26339,30666981,recovery
26340,30666981,status fluorosis
26341,30666981,stillbirth cois
26342,29239041,familial adenomatous polyposis
26343,29239041,familial medullary thyroid carcinoma
26344,29239041,familial non-medullary thyroid carcinoma
26345,29239041,familial thyroid carcinoma
26346,29239041,multiple endocrine neoplasia
26347,29683529,*braf mutation
26348,29683529,*immunocytochemistry
26349,29683529,*molecular testing
26350,29683529,*plump cells
26351,29683529,*thyroid malignancies
26352,29683529,*thyroid nodules
26353,31752761,bilateral cataract
26354,31752761,hypocalcemia
26355,31752761,hypoparathyroidism
26356,31752761,serum calcium and ethiopia
26357,31752761,tetany
26358,31752761,total thyroidectomy cois authors have any proprietary interests or conflicts of interest related to this submission.
26359,30595314,autopsy
26360,30595314,hypothyroidism
26361,30595314,ischemic heart disease
26362,30595314,thyroid
26363,31074392,cancer
26364,31074392,fine needle aspiration citology
26365,31074392,follicular
26366,31074392,goiter
26367,31074392,kidney transplantation
26368,31074392,papillary
26369,31074392,thyroid
26370,31074392,thyroid nodule cois
26372,31396854,ezh2
26373,31396854,h3k27me3
26374,31396854,immunohistochemistry
26375,31396854,thyroid cancer
26376,30197365,carcinoma thyroid
26377,30197365,poorly differentiated
26378,30197365,thyroglobulin cois
26379,31254103,"chronic hypocalcaemia, permanent hypoparathyroidism, operative volume"
26380,31254103,endocrine surgery
26381,31254103,surgeon volume
26382,31254103,thyroidectomy
26383,31254103,volume-outcome
26384,29637242,notes
26385,29637242,parathyroid gland
26386,29637242,toetva
26387,29637242,thyroid gland
26388,30252648,adolescent
26389,30252648,anthropometry
26390,30252648,blood pressure
26391,30252648,child
26392,30252648,glucose metabolism
26393,30252648,lipid metabolism
26394,30252648,subclinical hypothyroidism
26395,29885011,*biobanking
26396,29885011,*fine needle aspiration cytology
26397,29885011,*preanalytical procedures
26398,29885011,*thyroid
26403,29319359,hyperthyroidism
26404,29319359,hypothyroidism
26405,29319359,pregnancy and thyroid
26406,29319359,prevention
26407,29319359,screening
26408,29319359,thyroid cancer
26409,29319359,thyroid disease
26410,31565844,*intraoperative neuromonitoring
26411,31565844,*nerves at risk
26412,31565844,*phonosurgical therapy
26413,31565844,*recurrent laryngeal nerve
26414,31565844,*vocal fold paralysis
26415,31565844,*vocal function
26416,31133065,children
26417,31133065,deficiency
26418,31133065,excess
26419,31133065,nepal
26420,31133065,salt iodine
26421,31133065,thyroid
26422,31133065,urinary iodine cois
26423,31671395,choriocarcinoma
26424,31671395,germ cell tumors
26425,31671395,human chorionic gonadotropin
26426,31671395,hyperthyroidism
26428,29886838,anaplastic thyroid carcinoma
26429,29886838,aetiology
26430,29886838,new approaches
26431,29886838,prognostic factors
26432,29886838,risk factors
26433,29886838,treatment.
26434,31409088,dicer1
26435,31409088,cystic nephroma
26436,31409088,genetic testing
26437,31409088,hereditary cancer syndromes
26438,31409088,pleuropulmonary blastoma
26439,31238185,carotid body tumor
26440,31238185,ectopic thyroid
26441,31238185,in-111 pentetreotide
26442,31238185,paraganglioma
26443,29444549,body weight
26444,29444549,endocrine surgery
26445,29444549,general surgery
26446,29444549,thyroidectomy
26447,30259504,calcifediol
26448,30259504,sunlight
26449,30259504,thyroid disease
26450,30259504,ultraviolet rays
26451,30259504,vitamin d deficiency
26452,31400012,*epidemiology
26453,31400012,*hyperthyroidism
26454,31400012,*hypothyroidism
26455,31400012,*incidence
26456,31400012,*iodine
26457,31400012,*myxoedema
26458,31400012,*thyrotoxicosis
26459,29851122,*epidemiology
26460,29851122,*hyperthyroidism
26461,29851122,*incidence
26462,29851122,*iodine
26463,29851122,*thyrotoxicosis
26465,30681972,hashimoto’s thyroiditis
26466,30681972,thrβ gene mutation
26467,30681972,resistance to thyroid hormone
26468,29798143,collagen triple helix repeat containing 1
26469,29798143,epithelial-mesenchymal transition
26470,29798143,immunohistochemistry
26471,29798143,thyroid neoplasms cois relevant financial relationships with commercial interests to disclose.
26472,29333819,autoimmune thyroiditis
26473,29333819,child
26474,29333819,hashimoto's disease
26475,29333819,hypothyroidism
26476,31468286,anaplastic thyroid carcinoma
26477,31468286,ham-1
26478,31468286,in situ hybridization
26479,31468286,long non-coding rna
26480,31468286,pca3
26481,31468286,pcr array
26482,31468286,papillary thyroid carcinoma
26483,31468286,rt-pcr
26484,31468286,thyroid carcinoma
26485,30413933,aggressiveness
26486,30413933,id genes
26487,30413933,thyroid cancer
26488,30413933,bhlh
26492,31610911,children
26493,31610911,conseil génétique
26494,31610911,dicer1
26495,31610911,dépistage
26496,31610911,enfant
26497,31610911,genetic counseling
26498,31610911,ovarian sertoli-leydig tumor
26499,31610911,pleuropneumoblastoma
26500,31610911,pleuropneumoblastomes
26501,31610911,rare tumors
26502,31610911,screening
26503,31610911,surveillance
26504,31610911,tumeur ovarienne de sertoli-leydig
26505,31610911,tumeurs rares
26506,31375535,cancer
26507,31375535,cytopathology
26508,31375535,endocrine pathology
26509,31375535,thyroid cancer cois
26510,30074074,benign thyroid surgery
26511,30074074,head and neck surgery
26512,30074074,postoperative complications
26513,30074074,thyroid surgery
26514,30074074,vocal fold palsy
26516,30387163,*rct
26517,30387163,*cholecalciferol
26518,30387163,*hypocalcaemia
26519,30387163,*thyroidectomy
26520,30387163,*vitamin d
26521,30306604,adolescents
26522,30306604,autoimmune thyroiditis
26523,30306604,children
26524,30306604,l-selenomethionine
26525,30306604,organic selenium
26527,30902382,*carcinoma de células renales
26528,30902382,*neoplasia metastásica
26529,30902382,*neoplasm metástasis
26530,30902382,*renal cell carcinoma
26531,30902382,*thyroid
26532,30902382,*tiroides
26533,29466241,graves’ disease
26534,29466241,amiodarone-induced thyrotoxicosis
26535,29466241,hyperthyroidism
26537,32372175,c cell
26538,32372175,cancer
26539,32372175,diagnosis
26540,32372175,foxa1
26541,32372175,thyroid
26543,30891786,*iodine
26544,30891786,*iodine excess
26545,30891786,*iodized salt
26546,30891786,*thyroglobulin
26547,30891786,*thyroid autoimmunity
26549,29459556,autoimmune polyglandular syndrome
26550,29459556,hashimoto’s thyroiditis
26551,29459556,pulmonary hypertension
26552,29459556,type 1 diabetes
26556,30953492,epidemiology
26557,30953492,hepatitis c infection
26558,30953492,interferon
26559,30953492,morbidity
26560,30953492,ribavirin
26561,30953492,"thyroid dysfunction cois database. according to the regulation of ministry of health and welfare, taiwan, all of the nhir datasets are only available from the information center, ministry of health and welfare, taiwan. the study was approved by the institute review board of the show chwan memorial hospital, taiwan (no. 1051201). informed consent from the subjects was not obtained because there was no personal contact between the patients and the data collectors. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
26562,30168266,inguinal hernia
26563,30168266,uroflowmetry
26564,30168266,visual analog scale
26565,30168266,voiding dysfunction
26567,31881874,acdf
26568,31881874,anterior cervical discectomy and fusion
26569,31881874,c7/t1 anterior discectomy
26570,31881874,cervicothoracic junction
26571,31881874,hemithyroidectomy cois
26572,30955264,"carcinoma, papillary"
26573,30955264,prognosis
26574,30955264,thyroid neoplasms
26575,29993215,color doppler
26576,29993215,neoplasms
26577,29993215,thyroid nodule
26578,29993215,ultrasonography
26581,30298217,cross-sectional studies
26582,30298217,epidemiology
26583,30298217,general practice
26584,30298217,health services research
26585,30298217,otolaryngologists
26586,30298217,thyroid gland
26587,30272298,*co-morbidities
26588,30272298,*endometriosis
26589,30272298,*whole exome sequencing
26590,30272298,*autoimmune diseases
26591,30272298,*family history
26592,29730784,*neuromonitoring
26593,29730784,*quality of life
26594,29730784,*surgery
26595,29730784,*thyroid
26596,29730784,*voice cois ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. informed consent: informed consent was obtained from all individual participants included in the study.
26597,31248397,3d printing
26598,31248397,airway pathology
26599,31248397,bronchial tree
26600,31248397,bronchoscopy
26601,31248397,multi-material
26602,31248397,simulation cois
26604,30264384,choline
26605,30264384,parathyroid adenoma
26606,30264384,positron emission tomography computed tomography
26607,30264384,primary hyperparathyroidism
26608,29380231,*diagnose
26609,29380231,*glucocorticoid treatment
26610,29380231,*igg4
26611,29380231,*inflammation
26612,29380231,*riedel cois ethical approval: for this type of retrospective study formal consent was not required.
26615,30260174,gh
26616,30260174,igf-1
26617,30260174,acromegaly
26618,30260174,cancer
26619,30260174,neoplasms
26620,30260174,registry
26621,29504626,rdw
26622,29504626,heart failure
26623,29504626,hypothyroidism
26624,29504626,radioiodine therapy
26625,29317181,extramedullary hematopoiesis
26626,29317181,fine needle aspiration
26627,29317181,thyroid
26628,31914295,lymphatic metastasis
26629,31914295,melatonin
26630,31914295,melatonin receptor
26631,31914295,papillary thyroid cancer cois relevant financial relationships with commercial interests to disclose.
26634,30691690,"abordaje biaxilo-biareolar, ba-ba"
26635,30691690,abordaje extracervical
26636,30691690,baba endoscopic thyroidectomy
26637,30691690,bilateral axillo-breast approach
26638,30691690,endoscopic thyroidectomy
26639,30691690,scarless thyroidectomy
26640,30691690,tiroidectomía endoscópica
26641,30691690,tiroidectomía sin cicatriz cervical
26642,30406929,autoimmune
26643,30406929,empty sella
26644,30406929,pituitary adenoma
26645,30406929,prolactin
26646,30406929,thyroid
26647,30218312,iodine
26648,30218312,iodine deficiency disorder
26649,30218312,pregnancy
26650,30218312,thyroid
26651,29582344,hypothyroidism
26652,29582344,levothyroxine formulation
26653,29582344,liquid levothyroxine
26654,29582344,tsh
26655,30740757,*18f-fdg pet/ct
26656,30740757,*eu-tirads
26657,30740757,*diagnosis
26658,30740757,*thyroid cancer
26659,30740757,*ultrasound
26660,30443896,difficulty scale
26661,30443896,operative time
26662,30443896,total thyroidectomy
26663,30267376,autoimmune thyroid disease
26664,30267376,greece
26665,30267376,iodine
26666,30267376,thyroid
26667,30267376,thyroiditis
26668,30182360,incidence
26669,30182360,recurrence
26670,30182360,risk factors
26671,30182360,thyroid lobectomy
26672,30182360,thyroid nodules
26673,29774590,*anatomy handbook
26674,29774590,*pathogenesis and classification of neoplasms
26675,29774590,*prostatic hyperplasia
26676,30058426,electrophoresis
26677,30058426,mass spectrometry
26678,30058426,proteomics
26679,30058426,serum
26680,30058426,thyroid cancer
26681,29698806,14q32 deletion
26682,29698806,cancer
26683,29698806,dicer1 syndrome
26684,29536247,indocyanine green
26685,29536247,mivat
26686,29536247,near-infrared fluorescence
26687,29536247,parathyroid
26688,29536247,video-assisted thyroidectomy
26690,29438906,*fgf19
26691,29438906,*fgfr4
26692,29438906,*serum concentration
26693,29438906,*thyroid cancer
26694,29438906,*βklotho
26695,31841457,131і
26696,31841457,chornobyl disaster
26697,31841457,late endocrine and neuropsychiatric effects
26698,31841457,pathogenesis
26699,31841457,prenatal irradiation
26700,29968224,*apheresis
26701,29968224,*therapeutic plasma exchange
26702,29968224,*thyroid hormones
26703,29968224,*thyrotoxicosis
26704,29340973,age
26705,29340973,iodine status
26706,29340973,reference intervals
26707,29340973,thyroid dysfunction
26708,29340973,thyrotropin
26709,31190472,cold nodule
26710,31190472,cytology
26711,31190472,histopathology
26712,31190472,hot nodule
26713,31190472,warm nodule
26715,30639646,autoimmune thyroid diseases
26716,30639646,autoimmune thyroiditis
26717,30639646,celiac disease
26718,30639646,chronic autoimmune gastritis
26719,30639646,graves' diseases
26720,30639646,graves' ophthalmopathy
26721,30639646,multiple sclerosis
26722,30639646,polymyalgia rheumatica
26723,30639646,rheumatoid arthritis
26724,30639646,sarcoidosis
26725,30639646,sjogren disease
26726,30639646,systemic lupus erythematosus
26727,30639646,type 1 diabetes (type 1)
26728,30639646,vitiligo
26729,29949024,cytology
26730,29949024,diagnosis
26731,29949024,fine-needle aspiration
26732,29949024,niftp
26733,29949024,negative
26734,29949024,thyroid
26736,31365889,etiology
26737,31365889,thyroid disease
26738,31365889,thyroid tissue
26739,31365889,toxic/essential trace metals
26741,29703200,classification and regression tree method (cart)
26742,29703200,low transmission
26743,29703200,malaria exposure
26744,29703200,plasmodium falciparum
26745,29703200,plasmodium vivax
26746,29703200,reservoir of infection
26747,29703200,sero-epidemiology
26748,29703200,vietnam
26749,30410095,*diagnostic evaluation
26750,30410095,*etiology
26751,30410095,*genetic
26752,30410095,*hydrops fetalis
26753,30410095,"*nonimmune cois through the ucsf center for maternal-fetal precision medicine. m.e.n. is a consultant to invitae and has received research funding from natera, but this funding was not applied to this study. the other authors declare no conflicts of interest."
26754,31699952,congenital
26755,31699952,hypothyroidism
26756,31699952,young adult
26758,30997493,*developing countries
26759,30997493,*effectiveness
26760,30997493,*folic acid
26761,30997493,*fortification
26762,30997493,*functional outcomes
26763,30997493,*iodine
26764,30997493,*iron
26765,30997493,*micronutrient status
26766,30997493,*systematic review
26767,30997493,*vitamin a
26769,31323353,hypocalcemia
26770,31323353,intact parathyroid hormone (pth)
26771,31323353,pediatric thyroidectomy
26772,30973063,*tbab
26773,30973063,*trab
26774,30973063,*tsab
26775,30973063,*fetal hyperthyroidism
26776,30973063,*fetal malformation
26777,30973063,*maternal hashimoto's disease
26778,30772970,tyumen region
26779,30772970,iodine deficiency
26780,30772970,iodized salt
26781,30772970,nutrition
26782,30772970,prevention cois publication of this article.
26783,30963819,*s1pr1
26784,30963819,*sphingosine 1 phosphate
26785,30963819,*sphingosine kinase 1
26786,30963819,*thyroiditis
26787,29650436,concentración urinaria de yodo
26788,29650436,epidemiological survey
26789,29650436,escolares
26790,29650436,estudio epidemiológico
26791,29650436,schoolchildren
26792,29650436,tsh en sangre capilar
26793,29650436,tsh in capillary blood
26794,29650436,urinary iodine concentration
26795,30891966,*classification
26796,30891966,*convolutional neural network
26797,30891966,*deep learning
26798,30891966,*head and neck cancer
26799,30891966,*hyperspectral imaging
26800,30891966,*optical biopsy
26801,30891966,*squamous cell carcinoma
26802,30472362,carbon nanoparticles
26803,30472362,parathyroid glands
26804,30472362,recurrent laryngeal nerve
26805,30472362,total thyroidectomy
26806,30443770,foxp3
26807,30443770,garp
26808,30443770,papillary thyroid carcinoma
26809,30443770,thyroid cancer
26810,29848235,*central neck
26811,29848235,*hypocalcemia
26812,29848235,*hypoparathyroidism
26813,29848235,*parathyroid hormone
26814,29848235,*paresthesia
26815,29848235,*thyroidectomy
26817,31619220,calcitonin
26818,31619220,carcinoembryogenic antigen
26819,31619220,medullary thyroid carcinoma
26820,31619220,thyroid cancer cois
26821,31135104,*braf mutation
26822,31135104,*hyalinizing trabecular tumor
26823,31135104,*immunocytochemistry
26824,31135104,*molecular testing
26825,31135104,*personalized medicine
26826,31135104,*thyroid malignancy
26827,31135104,*thyroid nodule
26829,30684524,diagnostic marker
26830,30684524,ptc
26831,30684524,plasma microrna
26832,30684524,qrt-pcr
26833,30509240,braf v600e
26834,30509240,matrix metalloproteinase-9
26835,30509240,"papillary thyroid cancer cois institutional review board and ethics committee of the research institute for endocrine sciences, shahid beheshti university of medical sciences, tehran, iran (25ecries93/10/23); and was conducted in accordance with the declaration of helsinki guidelines a written informed consent was obtained from all participants. consent for publication: not applicable. competing interests: the authors do not report any relevant conflict of interest. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
26837,30909759,*statement
26838,30909759,*minimally invasive treatments
26839,30909759,*percutaneous thermal ablation
26840,30909759,*thyroid gland
26841,30909759,*thyroid nodule
26842,30909759,*ultrasonography
26843,31182340,*autoimmunity
26844,31182340,*graves' disease
26845,31182340,*ifnγ
26846,31182340,*immune checkpoints
26847,31182340,*pd-1
26848,31182340,*pd-l1
26849,31182340,*pd-l2
26850,31182340,*t-lymphocytes
26851,31182340,*tolerances
